Clinical.Annotation.ID,Variant,Gene,Level.of.Evidence,Score,Phenotype.Category,PMID.Count,Evidence.Count,Drug,Phenotype,URL
981755803,rs75527207,CFTR,1A,234.875,Efficacy,28,30,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/981755803
1449311190,rs4149056,SLCO1B1,3,2,Dosage,1,1,mercaptopurine;methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1449311190
981204774,rs1799971,OPRM1,4,-2,Efficacy,2,3,Drugs used in nicotine dependence;nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/981204774
1449191690,rs141033578,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191690
1449191746,rs78769542,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191746
981419532,rs4693075,COQ2,3,3.25,Toxicity,3,3,atorvastatin;hmg coa reductase inhibitors;rosuvastatin,Muscular Diseases,https://www.pharmgkb.org/clinicalAnnotation/981419532
981419266,HLA-B*15:02,HLA-B,1A,315.75,Toxicity,18,23,phenytoin,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/981419266
1451259580,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",CYP2D6,1A,211.375,Toxicity,6,9,amitriptyline,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451259580
1451265560,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5",CYP2D6,1A,208.125,Dosage,3,6,imipramine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451265560
1451288200,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN",CYP2D6,1A,203.625,Toxicity,8,11,codeine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451288200
1451282240,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6",CYP2D6,1A,201.75,Toxicity,2,4,atomoxetine,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1451282240
1451285240,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41",CYP2D6,1A,226.5625,Efficacy,56,143,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451285240
1451226160,rs4680,COMT,3,2.25,Toxicity,2,3,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451226160
1451226166,rs4680,COMT,3,0,Toxicity,1,1,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451226166
1451226200,rs4732636,PNOC,3,0,Toxicity,1,1,buprenorphine,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451226200
1451226206,rs4732636,PNOC,3,0,Toxicity,1,1,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451226206
1451226212,rs740603,COMT,3,0,Toxicity,1,1,buprenorphine,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451226212
1451226220,rs740603,COMT,3,0,Toxicity,1,1,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451226220
1450930839,rs1948,CHRNB4,3,3,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450930839
1451356840,rs696,NFKBIA,3,1.75,Dosage,1,1,sufentanil,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451356840
1451225360,rs4680,COMT,3,2.5,Toxicity,1,2,buprenorphine,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451225360
1450930464,rs16917234,BDNF;BDNF-AS,3,2.25,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450930464
1451290960,rs5219,KCNJ11,3,3.75,Efficacy,2,2,gliclazide,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1451290960
1451350801,HLA-B*55:01,HLA-B,3,3,Toxicity,1,1,penicillin g;penicillin v,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1451350801
655386913,"CYP2C19*1, CYP2C19*17",CYP2C19,3,6,Toxicity,15,16,clopidogrel,Acute coronary syndrome;Coronary Artery Disease;Hemorrhage;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/655386913
1451356180,rs28379954,NFIB,3,0,Metabolism/PK,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451356180
1451151506,rs61974485,ARID4A,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451151506
1451356356,rs11265549,NECTIN4,3,1,Toxicity,1,1,methadone,Opioid-Related Disorders;Pruritus,https://www.pharmgkb.org/clinicalAnnotation/1451356356
1451356386,rs11265549,NECTIN4,3,2.25,Metabolism/PK,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451356386
1451225320,rs4680,COMT,3,0,Toxicity,1,1,buprenorphine,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451225320
1451356380,rs11265549,NECTIN4,3,2.75,Dosage,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451356380
1451240740,rs2228001,TMEM43;XPC,3,2.75,Toxicity,1,1,cisplatin,Neutropenia;Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451240740
1451240746,rs2228001,TMEM43;XPC,3,2.75,Toxicity,1,1,cisplatin,Drug Toxicity;Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451240746
1450815092,rs2636697,PPA2,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815092
1451351160,rs1799971,OPRM1,3,2,Toxicity,1,1,opioids,Sleep Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451351160
1451277440,rs1414334,HTR2C,3,6.875,Toxicity,5,5,risperidone,Metabolic Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451277440
1451121880,rs11615,ERCC1,3,3.25,Toxicity,6,6,cisplatin,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451121880
1451350944,rs1799971,OPRM1,3,1.75,Toxicity,1,1,morphine,Sleep Apnea Syndromes,https://www.pharmgkb.org/clinicalAnnotation/1451350944
1451357200,rs4149056,SLCO1B1,1A,105.5,Toxicity,8,9,rosuvastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451357200
1451244720,rs4149056,SLCO1B1,1A,101.25,Toxicity,2,3,fluvastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451244720
1450810357,rs3778156,OPRM1,3,3.25,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810357
1451241320,"NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*12, NAT2*13",NAT2,3,2,Toxicity,1,1,"Antivirals for treatment of HIV infections, combinations;Drugs For Treatment Of Tuberculosis",drug-induced liver injury;HIV Infections;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1451241320
1451240880,HLA-B*15:02,HLA-B,3,4,Toxicity,1,2,dapsone,severe cutaneous adverse reactions;Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451240880
1450375047,rs1050565,BLMH,3,4.5,Toxicity,1,2,bleomycin;cisplatin;etoposide,Alopecia;Pain;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450375047
1451357763,rs6990851,CSMD1,3,0,Efficacy,1,1,anastrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451357763
1451357783,rs2449598,DLG2,3,0,Efficacy,1,1,anastrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451357783
1451357790,rs6981827,CSMD1,3,0,Efficacy,1,1,anastrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451357790
1451238460,rs4680,COMT,3,0,Toxicity,1,2,buprenorphine;fentanyl;tramadol,Exanthema;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451238460
1448256712,rs7574296,UGT1A9,3,1.75,Toxicity,1,1,sorafenib,"Carcinoma, Hepatocellular;hand-foot syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448256712
1451328325,rs10455872,LPA,3,7,Toxicity,2,3,hmg coa reductase inhibitors,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1451328325
1451238365,rs495491,OPRM1,3,3.5,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451238365
1451237983,rs7905446,HTR7;RPP30,3,2.5,Efficacy,1,1,antidepressants,Depression,https://www.pharmgkb.org/clinicalAnnotation/1451237983
1451238020,rs7905446,HTR7;RPP30,3,2.5,Efficacy,1,1,paroxetine,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451238020
1451238040,rs7905446,HTR7;RPP30,3,2.75,Efficacy,1,1,escitalopram,Depression,https://www.pharmgkb.org/clinicalAnnotation/1451238040
1451336041,rs10248420,ABCB1,3,1.75,Toxicity,1,1,olanzapine,somnolence,https://www.pharmgkb.org/clinicalAnnotation/1451336041
1451336047,"CYP3A5*1, CYP3A5*3",CYP3A5,3,1.75,Toxicity,1,1,olanzapine,somnolence,https://www.pharmgkb.org/clinicalAnnotation/1451336047
1451336074,rs4728709,ABCB1,3,1.75,Toxicity,1,1,olanzapine,Asthenia,https://www.pharmgkb.org/clinicalAnnotation/1451336074
1451336100,rs3842,ABCB1,3,1.75,Toxicity,1,1,olanzapine,"Arrhythmias, Cardiac",https://www.pharmgkb.org/clinicalAnnotation/1451336100
1451246040,rs4680,COMT,3,1.5,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451246040
1450377208,rs1799930,NAT2,3,2.25,Toxicity,1,1,isoniazid;phenytoin,Drug interaction with drug;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1450377208
1451245600,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,3,8.5,Efficacy,1,3,clobazam,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451245600
1451245620,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,3,1,Dosage,1,1,clobazam,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451245620
1451352140,rs6517442,KCNJ6,3,2.5,Dosage,1,1,opioids,Low Back Pain,https://www.pharmgkb.org/clinicalAnnotation/1451352140
1451352146,rs1045642,ABCB1,3,2.5,Toxicity,1,1,opioids,Low Back Pain,https://www.pharmgkb.org/clinicalAnnotation/1451352146
1451253880,rs1051740,EPHX1,3,5.75,Dosage,4,5,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451253880
1451163868,"UGT1A1*1, UGT1A1*28",UGT1A1,3,3.75,Toxicity,2,3,indinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1451163868
1450934061,rs28656907,ABCB1;RUNDC3B,3,0,Dosage,1,1,imatinib,Drug Toxicity;Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450934061
1450934169,rs1567817380,SCN4A,3,0,Efficacy,1,1,mexiletine,Myotonic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450934169
1450934181,rs121908560,SCN4A,3,0,Efficacy,1,1,mexiletine,Myotonic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450934181
1451359886,rs4680,COMT,3,0,Efficacy,2,2,propranolol,Temporomandibular joint-pain-dysfunction syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451359886
1451351302,rs11322783,IFNL4,3,1.75,Efficacy,1,1,sofosbuvir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1451351302
1451244869,rs4680,COMT,3,0,Efficacy,1,1,fentanyl,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451244869
1451244900,rs4680,COMT,3,5,Efficacy,1,2,remifentanil,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451244900
1451359601,rs1611114,DBH,3,3,Toxicity,1,1,heroin,Heroin Dependence;Memory Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451359601
1451245004,rs4680,COMT,3,2.75,Dosage,6,6,opioids,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451245004
981204995,rs1799793,ERCC2,4,-0.75,Efficacy;Toxicity,11,15,Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204995
1451121940,rs11615,ERCC1,3,3.75,Efficacy,3,3,cisplatin,Esophageal Neoplasms;Ovarian Neoplasms;Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451121940
1451245081,rs4680,COMT,3,2.25,Efficacy,4,5,morphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451245081
1451245764,"NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6",NUDT15,3,5.5,Toxicity,2,2,mercaptopurine,Leukopenia,https://www.pharmgkb.org/clinicalAnnotation/1451245764
1451245800,"NUDT15*1, NUDT15*6",NUDT15,3,2.75,Toxicity,1,1,mercaptopurine,Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1451245800
1451254580,rs11045879,SLCO1B1,3,1.5,Metabolism/PK,6,6,methotrexate,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451254580
1451245925,rs1042713,ADRB2,3,3.75,Efficacy,5,5,salbutamol,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1451245925
981237878,rs1105879,UGT1A6,3,5,Dosage,2,3,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981237878
827848785,rs9316233,HTR2A,3,2.75,Efficacy,1,2,escitalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/827848785
981238234,rs1360780,FKBP5,3,2.5,Toxicity,1,2,clomipramine;nefazodone;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/981238234
1449718265,rs12248560,CYP2C19,3,2.25,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718265
1451245040,rs4680,COMT,3,1.25,Efficacy,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451245040
1451257000,rs1057868,POR,3,0.5,Metabolism/PK,15,15,tacrolimus,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451257000
1451330460,"CYP2D6*1, CYP2D6*10",CYP2D6,3,1.5,Efficacy,1,1,propafenone,"Arrhythmias, Cardiac",https://www.pharmgkb.org/clinicalAnnotation/1451330460
1451354640,rs1386493,TPH2,3,2.25,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451354640
1451354647,rs2229205,OPRL1,3,2.25,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451354647
1451354700,rs16974799,CYP2B6,3,2.75,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451354700
1450813849,rs3758987,HTR3B,3,3,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813849
1451338440,rs11322783,IFNL4,3,6,Efficacy,4,4,direct acting antivirals,sustained virological response (svr),https://www.pharmgkb.org/clinicalAnnotation/1451338440
1451150066,rs75967634,ADH1B,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451150066
1451354560,rs806368,CNR1,3,2.75,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451354560
1451346385,rs71647871,CES1,3,1.75,Dosage,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1451346385
981201387,rs2236225,MTHFD1,3,1,Efficacy,4,4,methotrexate,Mesothelioma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/981201387
1451337885,rs1041983,NAT2,3,3,Toxicity,1,1,isoniazid;pyrazinamide;rifampin,Toxic liver disease;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1451337885
1451223506,rs1801133,MTHFR,3,2.125,Efficacy,11,11,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451223506
1451337408,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,3,2.5,Efficacy,2,4,"sulfonamides, urea derivatives",Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1451337408
655384558,rs10932125,NRP2,3,2.5,Other,1,2,daunorubicin,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/655384558
827847725,rs9981861,DSCAM,3,0,Efficacy,1,1,carboplatin;paclitaxel,"Carcinoma, Non-Small-Cell Lung;Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/827847725
827847759,rs963468,DRD3,3,2,Efficacy,1,1,duloxetine,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/827847759
827848740,rs9340799,ESR1,3,2,Efficacy,1,1,leflunomide,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/827848740
827848365,rs1801133,MTHFR,2A,23.25,Toxicity,32,35,methotrexate,Drug Toxicity;hematotoxicity;Leukopenia;Lymphoma;mucositis;Neoplasms;Neutropenia;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma;primary central nervous system lymphoma;Thrombocytopenia;Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/827848365
981201642,rs11280056,ENOSF1;TYMS,3,0,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/981201642
827863928,rs1051375,CACNA1C,3,3,Efficacy,1,3,atenolol;verapamil,Coronary Artery Disease;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/827863928
981201408,rs2278294,IMPDH1,3,2.25,Efficacy,5,6,mycophenolate mofetil,Kidney Transplantation;Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/981201408
981201424,rs2278294,IMPDH1,3,0.75,Toxicity,2,2,mycophenolate mofetil,Leukopenia,https://www.pharmgkb.org/clinicalAnnotation/981201424
981201443,rs2070744,NOS3,3,3.25,Efficacy,1,1,Antihypertensives;Antihypertensives And Diuretics In Combination;diuretics,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/981201443
981201455,rs2284017,CACNG2,3,2,Efficacy,2,2,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/981201455
981201584,rs3215400,CDA,3,2,Toxicity,2,2,capecitabine,hand-foot syndrome;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981201584
981201770,rs4149117,SLCO1B3,3,4.75,Dosage;Toxicity,4,7,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/981201770
981201788,rs2740574,CYP3A;CYP3A4,3,0.75,Other,2,2,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981201788
981201881,rs3093726,LST1;LTA;LTB,3,0,Toxicity,1,1,abacavir,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/981201881
981201854,rs28399499,CYP2B6,3,5.25,Metabolism/PK,7,7,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981201854
981201637,rs11280056,TYMS,4,-2.5,Toxicity,5,5,methotrexate,"Arthritis, Rheumatoid;Drug Toxicity;hematopoietic stem cell transplantation;Psoriasis;Toxic liver disease",https://www.pharmgkb.org/clinicalAnnotation/981201637
827848732,rs9344,CCND1,3,1.25,Toxicity,2,2,methotrexate,Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/827848732
827864513,rs2230345,GRK5,4,-3.25,Efficacy,6,9,Beta Blocking Agents,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/827864513
981201888,rs2069514,CYP1A2,4,-0.875,Toxicity,2,2,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/981201888
981202103,rs7297610,YEATS4,3,4.5,Efficacy,2,2,hydrochlorothiazide,Essential hypertension;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/981202103
981202240,rs11280056,TYMS,3,3.5,Efficacy,1,1,fluorouracil,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981202240
981202334,rs3745274,CYP2B6,3,2.5,Toxicity,1,1,cyclophosphamide,Hepatic Veno-Occlusive Disease;Transplantation,https://www.pharmgkb.org/clinicalAnnotation/981202334
981202356,rs3745274,CYP2B6,3,2,Dosage,1,1,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981202356
981202366,rs3758149,GGH,3,3.75,Efficacy,2,2,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/981202366
981202440,rs396991,FCGR3A,3,1.25,Efficacy,6,6,cetuximab,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981202440
981202520,rs4149601,NEDD4L,3,2.5,Efficacy,2,2,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/981202520
981202551,rs4244285,CYP2C19,3,3,Efficacy,2,2,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981202551
981202562,rs4244285,CYP2C19,3,6.75,Toxicity,2,3,cyclophosphamide,"Lupus Erythematosus, Systemic",https://www.pharmgkb.org/clinicalAnnotation/981202562
981237704,rs1805087,MTR,4,-0.75,Toxicity,4,4,methotrexate,Brain Diseases;Drug Toxicity;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/981237704
981202646,rs4680,COMT,3,1.5,Toxicity,1,1,antipsychotics,tardive dyskinesia,https://www.pharmgkb.org/clinicalAnnotation/981202646
981202674,rs4680,COMT,3,1.75,Other,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/981202674
981204525,rs1801131,MTHFR,3,2.75,Efficacy,4,4,bevacizumab;carboplatin;cisplatin;cyanocobalamin;folic acid;pemetrexed,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204525
981204864,rs1801131,MTHFR,3,4.75,Efficacy,4,4,capecitabine;fluorouracil;leucovorin;oxaliplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204864
981204874,rs16969968,CHRNA5,3,2.5,Efficacy,7,11,bupropion;Drugs used in nicotine dependence;nicotine;varenicline,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/981204874
981238057,rs2032582,ABCB1,3,1.25,Other,1,1,doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981238057
981238092,rs2032582,ABCB1,3,2,Dosage;Efficacy,4,8,antiepileptics;carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981238092
981238562,rs1051266,SLC19A1,4,-2.375,Metabolism/PK,14,14,methotrexate,"Burkitt Lymphoma;Leukemia;Lymphoma, T-Cell;Neoplasms;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/981238562
981238910,rs5219,KCNJ11,3,2.5,Efficacy,1,1,"metformin;sulfonamides, urea derivatives","Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/981238910
981345277,rs25487,XRCC1,3,3,Efficacy,1,2,fluorouracil,Colonic Neoplasms;Colorectal Neoplasms;Neoplasms;Rectal Neoplasms;Uterine Cervical Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981345277
981345285,rs25487,XRCC1,4,-0.25,Efficacy;Toxicity,2,4,cyclophosphamide,Neoplasms;Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981345285
1448256098,rs2413739,PACSIN2,3,4.5,Toxicity,2,2,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448256098
1184654135,HLA-B*48:01,HLA-B,3,0.75,Toxicity,4,4,allopurinol,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1184654135
1447814482,rs2298805,FCER1A,3,2,Efficacy,1,1,desloratadine;mizolastine,Urticaria,https://www.pharmgkb.org/clinicalAnnotation/1447814482
1447943646,rs2177370,CHAT,3,2,Efficacy,1,1,galantamine,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1447943646
1448100389,rs1415744,EPM2A,3,2.5,Efficacy,1,1,chlorpromazine;clozapine;haloperidol;olanzapine;quetiapine;risperidone;trifluoperazine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448100389
1448100396,rs13393173,CERS6,3,2.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1448100396
1448100426,rs9373839,ATG5,3,2.25,Efficacy,1,1,adalimumab,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448100426
1448104131,rs14158,LDLR,3,2,Efficacy,1,2,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic;HIV Infections",https://www.pharmgkb.org/clinicalAnnotation/1448104131
1448264442,rs11322783,IFNL4,3,3.25,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;simeprevir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448264442
1448616845,rs2072671,CDA,3,0.5,Toxicity,3,3,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616845
1448616870,rs2279199,UMPS,3,2.75,Toxicity,1,1,capecitabine,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1448616870
1448616910,rs2853741,TYMS,3,3.25,Toxicity,1,1,capecitabine,Diarrhea;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616910
1448624459,rs12050587,PIGB,3,0.5,Toxicity,1,2,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Leukopenia;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1448624459
1449144376,rs1521470,ADCY1,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449144376
1449144382,rs79403677,FAM177A1,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449144382
1449144396,rs2298881,ERCC1,3,2.5,Efficacy,1,1,fluorouracil;Platinum compounds;radiotherapy,Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449144396
1449155607,rs8177374,TIRAP,3,3,Efficacy,1,1,ustekinumab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1449155607
981202230,rs11280056,TYMS,3,1.25,Toxicity,5,5,fluorouracil;FOLFOX,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981202230
1449155614,rs11465996,LY96,3,3.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1449155614
1449155625,rs5744174,TLR5,3,3,Efficacy,1,1,ustekinumab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1449155625
1449155631,rs1143627,IL1B,3,3.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors;ustekinumab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1449155631
1449155637,rs1143623,IL1B,3,3.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors;ustekinumab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1449155637
1449155643,rs352139,TLR9,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1449155643
1449155649,rs4696480,TLR2,3,3.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1449155649
1449156117,HLA-B*15:12,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156117
1449164603,rs1883112,NCF4,3,2.5,Efficacy,1,1,idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1449164603
1449192303,rs113993960,CFTR,3,1.5,Efficacy,3,3,lumacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449192303
1449566691,rs10817464,SLC31A1,3,1.75,Toxicity,1,2,Platinum compounds,Anemia;Leukopenia;Nausea;Neutropenia;Thrombocytopenia;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1449566691
1449576622,rs3857532,EYS,3,1,Toxicity,1,1,hmg coa reductase inhibitors,Rhabdomyolysis,https://www.pharmgkb.org/clinicalAnnotation/1449576622
1449713649,rs2070096,BARD1,3,2.5,Efficacy,1,1,carboplatin;docetaxel;trastuzumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449713649
1449713660,rs2284922,RNF8,3,2.5,Efficacy,1,1,carboplatin;docetaxel;trastuzumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449713660
1449713666,rs2229046,ERBB3,3,3,Efficacy,1,1,carboplatin;docetaxel;trastuzumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449713666
1449713676,rs773123,ERBB3,3,2.5,Efficacy,1,1,carboplatin;docetaxel;trastuzumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449713676
1449191740,rs202179988,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191740
1449713682,rs1136201,ERBB2,3,2.5,Efficacy,1,1,carboplatin;docetaxel;trastuzumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449713682
1450373589,rs628031,SLC22A1,3,1.5,Efficacy;Toxicity;Metabolism/PK,4,4,imatinib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450373589
1450373595,rs1202283,ABCB4,3,2.5,Efficacy,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373595
1450373604,rs2273697,ABCC2,3,2,Efficacy,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373604
1450814557,rs2236256,OPRM1,3,1.5,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450814557
1450814659,rs363225,SLC18A2,3,2.75,Efficacy,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814659
1450814665,rs363226,SLC18A2,3,2.25,Efficacy,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814665
1450814923,rs1801282,PPARG,3,1.25,Efficacy,2,2,pioglitazone,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1450814923
1450815142,rs17742120,MIR582;PDE4D,3,0,Efficacy,1,1,quetiapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815142
1451323336,"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",CYP2D6,4,-1.625,Efficacy,9,11,oxycodone,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451323336
1449004733,rs2273697,ABCC2,3,0,Efficacy,1,1,cisplatin;pemetrexed,Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1449004733
1449004739,rs13181,ERCC2;KLC3,3,0,Efficacy,1,1,cisplatin;gemcitabine,Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1449004739
1449004745,rs3212986,CD3EAP;ERCC1;PPP1R13L,3,0,Efficacy,1,1,cisplatin;gemcitabine,Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1449004745
1449005041,rs776746,CYP3A;CYP3A5;ZSCAN25,3,0,Metabolism/PK,1,2,lumefantrine,Malaria,https://www.pharmgkb.org/clinicalAnnotation/1449005041
1449005047,rs2740574,CYP3A4,3,1.75,Efficacy;Metabolism/PK,1,2,lumefantrine,Malaria,https://www.pharmgkb.org/clinicalAnnotation/1449005047
1449718242,rs1056836,CYP1B1,3,2.25,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718242
1449718248,rs2231142,ABCG2,3,2.75,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718248
1449718259,rs714368,SLC22A16,3,4.25,Efficacy;Toxicity,2,2,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718259
1451323205,"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",CYP2D6,4,-5.625,Toxicity,6,9,oxycodone,cns depression;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451323205
1451352420,rs1799971,OPRM1,4,-0.5,Toxicity,3,3,sufentanil,"adverse events;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451352420
1451244740,rs4149056,SLCO1B1,1A,102,Toxicity,3,5,pravastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451244740
1451350580,rs8187710,ABCC2,4,-2.25,Toxicity,3,3,tenofovir,Fanconi Syndrome;HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1451350580
1451254826,rs1051266,SLC19A1,4,-2.25,Efficacy,5,5,methotrexate,Neoplasms;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451254826
1451254820,rs1051266,SLC19A1,4,-0.5,Toxicity,12,12,methotrexate,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451254820
1449167568,rs1061115,PYROXD2,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167568
1449167086,rs6090041,OPRL1;RGS19,3,0.5,Toxicity,1,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449167086
1449167093,rs6090043,LKAAEAR1;OPRL1,3,0.5,Toxicity,1,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449167093
1449168621,rs61908410,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168621
1450376133,rs795484,TAOK3,3,0,Dosage;Efficacy,1,1,morphine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450376133
1450810451,rs671,ALDH2,2B,4.75,Toxicity,2,2,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450810451
1450044809,rs2273697,ABCC2,3,0.25,Metabolism/PK,1,1,ceftriaxone,Central Nervous System Infections,https://www.pharmgkb.org/clinicalAnnotation/1450044809
1450112772,rs4148324,UGT1A1;UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9,3,0,Metabolism/PK,1,1,methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1450112772
1450112778,rs12505410,ABCG2,3,2,Metabolism/PK,1,1,methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1450112778
1450112789,rs13120400,ABCG2,3,2,Metabolism/PK,1,1,methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1450112789
1450820971,rs3787138,CHRNA4,3,0,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450820971
1450928829,rs2036527,CHRNA5,3,2.25,Efficacy,1,1,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450928829
1451397762,rs4240803,SLC7A5,3,2.75,Toxicity,1,1,gabapentin,adverse events;neuropathic pain,https://www.pharmgkb.org/clinicalAnnotation/1451397762
1449753234,rs887829,UGT1A1,3,1.75,Toxicity,1,1,risperidone,Hyperprolactinemia,https://www.pharmgkb.org/clinicalAnnotation/1449753234
1451397780,rs4240803,SLC7A5,3,2.75,Toxicity,1,1,pregabalin,adverse events;neuropathic pain,https://www.pharmgkb.org/clinicalAnnotation/1451397780
1450806874,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17",CYP2C19,1A,214.9375,Metabolism/PK,9,16,lansoprazole,Gastroesophageal Reflux,https://www.pharmgkb.org/clinicalAnnotation/1450806874
1451400040,"CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4",CYP2C8,4,-0.75,Efficacy,2,2,ibuprofen,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451400040
981237959,rs13181,ERCC2,3,5.75,Efficacy;Toxicity,3,3,fluorouracil;leucovorin;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981237959
981478131,rs10919035,NOS1AP,3,3,Toxicity,1,2,amiodarone,Long QT Syndrome,https://www.pharmgkb.org/clinicalAnnotation/981478131
1449715584,rs4587017,UGT2B7,3,0,Efficacy,1,1,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449715584
1450376188,rs5219,KCNJ11,3,2.75,Toxicity,1,1,tacrolimus,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1450376188
1450932697,rs2234918,OPRD1,3,2.75,Toxicity,1,1,buprenorphine;fentanyl;tramadol,"Opioid-Related Disorders;Sexual Dysfunctions, Psychological",https://www.pharmgkb.org/clinicalAnnotation/1450932697
1450934506,rs28935195,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934506
1450934515,rs1569304898,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934515
1450934525,rs104894827,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934525
1450934678,rs727505292,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934678
1450934761,rs746071566,NUDT15,3,2.5,Toxicity,1,1,azathioprine;mercaptopurine,Pancytopenia;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1450934761
1451397860,rs4240803,SLC7A5,3,3.25,Efficacy,1,1,gabapentin,neuropathic pain,https://www.pharmgkb.org/clinicalAnnotation/1451397860
981204941,rs1801019,UMPS,3,5,Toxicity,2,2,tegafur,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/981204941
1450935917,rs4430924,XPO1,3,2.25,Toxicity,1,1,Drugs For Treatment Of Tuberculosis,Drug Toxicity;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1450935917
1450936563,rs1049305,AQP1,3,2,Toxicity,1,1,cisplatin,Leukopenia;Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1450936563
1451397880,rs4240803,SLC7A5,3,3.25,Efficacy,1,1,pregabalin,neuropathic pain,https://www.pharmgkb.org/clinicalAnnotation/1451397880
982031741,rs7439366,UGT2B7,4,-0.5,Metabolism/PK,3,4,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/982031741
982030998,rs9376230,MAP3K5,3,2,Efficacy,1,1,hydroxyurea,Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/982030998
982040494,rs6265,BDNF,3,1,Efficacy,2,2,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982040494
1043880476,rs5186,AGTR1,3,2.5,Efficacy;Toxicity,1,1,"Ace Inhibitors, Plain",Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1043880476
982032756,rs1801260,CLOCK,4,-1.5,Toxicity,2,2,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982032756
982037571,rs2242480,CYP3A4,4,-6.75,Efficacy,8,8,clopidogrel,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/982037571
1451397872,rs4240803,SLC7A5,3,2.25,Dosage,1,1,gabapentin,neuropathic pain,https://www.pharmgkb.org/clinicalAnnotation/1451397872
1183617979,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7",CYP2D6,2A,12.4375,Metabolism/PK,10,11,oxycodone,Pain,https://www.pharmgkb.org/clinicalAnnotation/1183617979
1043880659,rs2207396,ESR1,3,2.5,Toxicity,1,1,Alkylating Agents;cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1043880659
1127092670,rs2500535,UST,3,0,Efficacy,1,1,nortriptyline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1127092670
1153928101,rs1143684,NQO2,3,1,Efficacy,2,2,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1153928101
1183491157,rs776746,CYP3A5,3,1.5,Efficacy,1,1,lovastatin,Arteriosclerosis,https://www.pharmgkb.org/clinicalAnnotation/1183491157
1183491278,"CYP3A5*1, CYP3A5*3",CYP3A5,3,1,Efficacy;Toxicity,3,4,atorvastatin,Myalgia unspecified,https://www.pharmgkb.org/clinicalAnnotation/1183491278
1183491380,rs1922242,ABCB1,3,1.75,Efficacy,1,1,fluvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183491380
1183681866,rs12041331,PEAR1,3,2.25,Toxicity,1,1,aspirin,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1183681866
1451397900,HLA-B*38:02,HLA-B,3,3,Toxicity,2,2,propylthiouracil,Agranulocytosis;Graves Disease,https://www.pharmgkb.org/clinicalAnnotation/1451397900
1183682421,CYP2C19*2,CYP2C19,3,0.125,Metabolism/PK,1,1,venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183682421
1183614605,rs1799998,CYP11B2,3,1.5,Efficacy,1,2,benazepril;imidapril,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183614605
1183630286,rs12659,SLC19A1,3,1.5,Efficacy,1,1,carboplatin;cisplatin;fluorouracil,Uterine Cervical Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183630286
1183693390,HLA-B*13:01,HLA-B,3,3,Toxicity,3,4,phenytoin,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1183693390
1183693395,HLA-B*58:01,HLA-B,3,2.5,Toxicity,1,1,antiepileptics,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1183693395
1183698846,rs2631372,SLC22A5,3,2.25,Efficacy,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1183698846
1183700503,rs11600347,KCNJ1,3,3.75,Toxicity,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183700503
1183700536,rs10757274,CDKN2B-AS1,3,3.25,Toxicity,1,1,"Antiinflammatory agents, non-steroids",Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183700536
1183689114,"CYP2D6*2, CYP2D6*10",CYP2D6,3,0.25,Toxicity,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1183689114
1451397920,"CYP2D6*1, CYP2D6*4",CYP2D6,3,2.5,Dosage,1,1,sertraline,Depression,https://www.pharmgkb.org/clinicalAnnotation/1451397920
1183700383,rs1042713,ADRB2,3,1.75,Efficacy,2,2,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183700383
1183700522,rs1105525,DHFR,3,2.75,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1183700522
1183700891,rs6265,BDNF,4,-0.5,Other,3,5,heroin;methamphetamine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183700891
1183701234,HLA-B*51:01,HLA-B,3,3.5,Toxicity,1,1,phenobarbital,Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183701234
982029857,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",CYP2D6,1A,109.4375,Metabolism/PK,13,20,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982029857
1183700410,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14",CYP2D6,1A,103.4375,Metabolism/PK,10,13,fluvoxamine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1183700410
1451401800,rs4149081,SLCO1B1,3,1.25,Metabolism/PK,5,5,methotrexate,Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451401800
982030873,rs10036156,GABRP,3,0,Efficacy,1,1,antidepressants;Selective serotonin reuptake inhibitors;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030873
982031855,rs588765,CHRNA5,3,2.5,Efficacy,2,4,Drugs used in nicotine dependence;nicotine;varenicline,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031855
982032763,rs1800532,TPH1,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982032763
982036328,rs1799752,ACE,3,2.25,Efficacy,1,1,spironolactone,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/982036328
982046386,rs61767072,ADRA2C,3,2,Efficacy,1,1,bucindolol,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/982046386
1451398000,rs1801253,ADRB1,3,2.25,Dosage,1,1,carvedilol,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1451398000
1043880098,rs7311358,SLCO1B3,3,1,Other,2,3,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1043880098
1043880276,rs1799752,ACE,3,4.5,Efficacy,1,3,atorvastatin;quinapril,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1043880276
1043880293,rs3211371,CYP2B6,3,0,Toxicity,1,1,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1043880293
1043880323,rs1051685,XRCC5,3,1.5,Efficacy,1,1,thalidomide,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/1043880323
1043880454,rs4986790,TLR4,3,0.5,Efficacy,1,2,pravastatin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1043880454
1140655380,rs1045642,ABCB1,3,1,Toxicity,2,2,atorvastatin,Coronary Artery Disease;Myalgia unspecified,https://www.pharmgkb.org/clinicalAnnotation/1140655380
1152661500,rs2032582,ABCB1,3,1,Toxicity,2,2,simvastatin,Hypercholesterolemia;Myalgia unspecified,https://www.pharmgkb.org/clinicalAnnotation/1152661500
1183490952,rs2244613,CES1,3,4.25,Toxicity,2,3,dabigatran,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1183490952
1183491359,rs4783961,CETP,3,1.75,Efficacy,1,1,fluvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183491359
1183491403,rs428785,ADAMTS1,3,4,Efficacy,1,1,pravastatin,Coronary Disease;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1183491403
1183630246,rs1042858,RRM1,4,-0.5,Efficacy,3,4,gemcitabine,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183630246
1183632170,rs10426377,SULT2B1,4,-1.5,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183632170
1451398106,rs4713916,FKBP5,3,1.75,Efficacy,1,1,fluoxetine,Mood Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451398106
1183617832,rs6295,HTR1A,3,5.25,Efficacy,4,4,paroxetine,Panic Disorder,https://www.pharmgkb.org/clinicalAnnotation/1183617832
1183689931,"CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22",CYP3A4,2A,20.5,Metabolism/PK,30,35,tacrolimus,Kidney Transplantation;laparoscopic sleeve gastrectomy;liver transplantation;lung transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183689931
1183681792,HLA-B*13:01,HLA-B,2A,22.25,Toxicity,6,8,dapsone,Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Leprosy;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183681792
1183684162,rs2515641,CYP2E1,3,2.75,Toxicity,1,1,cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183684162
1183689987,rs2740574,CYP3A4,3,2.25,Other,1,1,sirolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183689987
1183693433,rs1594160,XDH,3,1.75,Toxicity,1,1,didanosine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183693433
1183689409,rs1799724,TNF,4,-1.125,Efficacy,6,7,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid;Crohn Disease;Psoriasis;Spondylitis, Ankylosing",https://www.pharmgkb.org/clinicalAnnotation/1183689409
1451398120,rs4713916,FKBP5,3,1.75,Efficacy,1,1,mirtazapine,Mood Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451398120
982047840,rs761142,GCLC,3,6.25,Toxicity,1,2,sulfamethoxazole,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/982047840
982047910,rs1799752,ACE,3,6.75,Efficacy,8,8,enalapril,"Arteriosclerosis;Coronary Disease;Essential hypertension;glomerular disease;Glomerulonephritis, IGA;Kidney Diseases",https://www.pharmgkb.org/clinicalAnnotation/982047910
1183491026,rs8187710,ABCC2,3,0.75,Efficacy,2,2,lopinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183491026
1183533945,rs3740066,ABCC2,3,1,Toxicity,1,2,irinotecan,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183533945
1183533950,rs3025000,VEGFA,3,6.5,Efficacy,1,2,bevacizumab;ranibizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1183533950
1183533966,rs2305089,TBXT,3,3,Efficacy,1,1,flunisolide,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183533966
1183556309,rs7787082,ABCB1,3,2.25,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183556309
1183604793,rs2245705,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183604793
1183612432,rs2227310,CASP7,3,5.5,Efficacy,1,2,docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183612432
1183612731,rs2106809,ACE2,3,0.5,Efficacy,1,2,captopril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183612731
1183614499,rs1801133,MTHFR,3,2,Efficacy,1,1,disulfiram,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183614499
1183615135,rs1414334,HTR2C,3,2.25,Toxicity,1,1,olanzapine,Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183615135
1183615621,rs2229437,PRCP,3,3.5,Efficacy,1,1,benazepril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183615621
1183619864,rs1050828,G6PD,3,0,Toxicity,1,1,amodiaquine;pyrimethamine;sulfadoxine,"Malaria;Malaria, Falciparum",https://www.pharmgkb.org/clinicalAnnotation/1183619864
1183631404,rs11960832,SV2C,3,2,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183631404
1183697592,rs2306283,SLCO1B1,3,2.25,Metabolism/PK,4,4,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1183697592
1183679828,rs17574269,DCBLD1,3,0,Efficacy,1,1,cisplatin;irinotecan,"Carcinoma, Small Cell",https://www.pharmgkb.org/clinicalAnnotation/1183679828
1183679848,rs17060812,SLC39A14,3,2.75,Efficacy,1,1,nortriptyline,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183679848
1183680570,rs12819210,OASL,3,2.25,Efficacy,1,1,peginterferon alfa-2b;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1183680570
1183697557,rs602950,CDA,3,3,Toxicity,1,3,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183697557
1451398140,rs1695,GSTP1,3,2,Efficacy,1,1,cyclophosphamide;epirubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451398140
1183689585,rs28401781,ABCB1,3,0,Efficacy,1,1,citalopram;fluoxetine;paroxetine;sertraline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183689585
1183693443,rs11191561,NT5C2,3,2.25,Toxicity,1,1,didanosine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183693443
1183699226,rs2494752,AKT1,3,2,Efficacy,1,1,carboplatin;cisplatin,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183699226
1183700243,rs1265138,RRM2B,3,1.75,Efficacy,1,1,cladribine;cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183700243
1183700279,rs7194667,ABCC11,3,3,Toxicity,1,1,fluorouracil,Leukopenia;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183700279
1183700396,rs1042713,ADRB2,3,3.75,Efficacy,3,3,corticosteroids;selective beta-2-adrenoreceptor agonists,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183700396
1183700527,rs10919563,PTPRC,3,2,Efficacy,2,2,adalimumab;etanercept;infliximab;Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1183700527
1183698531,rs2304016,SCN2A,3,3.25,Efficacy,1,1,antiepileptics,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1183698531
1451398160,rs1695,GSTP1,3,2.5,Toxicity,1,1,cyclophosphamide;epirubicin,Breast Neoplasms;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451398160
1183698868,rs4124874,UGT1A1,4,-1.75,Toxicity,6,7,irinotecan,Lymphoma;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183698868
982031026,rs7787082,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031026
982032567,rs7118900,ANKK1,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032567
982032727,rs2071427,NR1D1;THRA,3,0.25,Efficacy,2,3,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982032727
982037796,rs1137101,LEPR,3,2.25,Efficacy,1,1,simvastatin,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/982037796
1043859380,rs2228478,MC1R,3,2.25,Efficacy,1,1,desipramine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043859380
1043880318,rs735482,ERCC1,3,2,Efficacy,1,1,thalidomide,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/1043880318
1043880328,rs4630,GSTT1,3,1.5,Toxicity,1,1,thalidomide,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/1043880328
1043880841,rs1979277,SHMT1,3,4,Efficacy,1,2,bevacizumab;fluorouracil;irinotecan;leucovorin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1043880841
1183491162,rs776746,CYP3A5,4,-6.375,Other,7,10,simvastatin,Hypercholesterolemia;Myalgia unspecified,https://www.pharmgkb.org/clinicalAnnotation/1183491162
1451398180,rs1695,GSTP1,3,2.5,Toxicity,1,1,cyclophosphamide;epirubicin,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1451398180
982030222,"NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6A, NAT2*6B, NAT2*6J, NAT2*6O, NAT2*7A, NAT2*7B, NAT2*7G, NAT2*12A, NAT2*13A, NAT2*14A",NAT2,2A,16.6875,Metabolism/PK,13,15,isoniazid,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/982030222
1183492035,rs662799,APOA5,3,4.5,Efficacy,2,2,atorvastatin;lovastatin;simvastatin,Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/1183492035
1043858965,rs5186,AGTR1,3,1.75,Efficacy,1,1,captopril,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1043858965
1183603764,rs2497538,HTR2C,3,2.25,Toxicity,1,1,olanzapine,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1183603764
1183607901,rs2230806,ABCA1,3,4.5,Efficacy,1,2,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1183607901
1183614761,rs1128503,ABCB1,3,2.25,Toxicity,1,1,sirolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183614761
1183615261,rs2276302,HTR3A,3,2.5,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183615261
1183615359,rs1800471,TGFB1,3,3.25,Efficacy,1,1,rituximab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1183615359
1183615367,rs3740556,EIF3A,3,4.25,Efficacy,1,3,carboplatin;cisplatin,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615367
1183615424,rs767455,TNFRSF1A,3,0.5,Efficacy,1,2,adalimumab;etanercept;infliximab,"Arthritis, Psoriatic",https://www.pharmgkb.org/clinicalAnnotation/1183615424
1183618924,rs6314,HTR2A,3,6.5,Efficacy,3,4,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183618924
1183629315,rs2235067,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183629315
1183632145,rs880054,WNK1,3,2.5,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183632145
1183632165,rs10423928,GIPR,3,4,Toxicity,2,2,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183632165
1451398187,rs1695,GSTP1,3,2.75,Efficacy,1,1,capecitabine;epirubicin;platinum,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451398187
1183533955,rs3024530,IL4R,3,2.5,Efficacy,1,1,pitrakinra,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183533955
1183601914,rs3091244,CRP,3,4.5,Efficacy,1,2,fenofibrate,Metabolic Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183601914
1183602560,rs2742435,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183602560
1183614466,rs1805087,MTR,3,1,Efficacy,1,2,benazepril,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183614466
1183614600,rs1799998,CYP11B2,3,2.5,Efficacy,1,1,candesartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183614600
1183615587,rs669,A2M,3,4,Efficacy,1,1,Enzymes,Stroke,https://www.pharmgkb.org/clinicalAnnotation/1183615587
1183617644,rs2472304,CYP1A2,3,2,Efficacy,1,1,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183617644
1183622622,rs4646425,CYP1A2,3,4.5,Toxicity,1,3,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183622622
1183629310,rs4148740,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183629310
1183684153,rs2302948,SULT2B1,3,2.75,Toxicity,1,1,cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183684153
1183697540,rs2306283,SLCO1B1,3,2.5,Efficacy,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183697540
1183698831,rs1800795,IL6,3,1.5,Efficacy,1,1,fenofibrate,Cardiovascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/1183698831
1451398240,rs1800566,NQO1,3,3,Efficacy,1,1,epirubicin;fluorouracil;oxaliplatin,Neoplasm Metastasis;Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451398240
1183617724,rs4713916,FKBP5,3,4.5,Efficacy,2,2,antidepressants;Selective serotonin reuptake inhibitors,Depressive Disorder;Mood Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183617724
1183617478,"CYP2D6*1, CYP2D6*3, CYP2D6*4",CYP2D6,1A,101.6875,Metabolism/PK,2,3,zuclopenthixol,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183617478
1183701210,HLA-A*33:03,HLA-A,2B,12.75,Toxicity,6,7,allopurinol,Drug Hypersensitivity;Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183701210
1183698786,rs28371759,CYP3A4,3,1.25,Other,1,1,cyclosporine,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183698786
1183698818,rs4148323,UGT1A1,3,2.25,Toxicity,1,1,indinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183698818
1183700230,rs1130609,RRM2,3,1.5,Efficacy,1,1,cladribine;cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183700230
1183700238,rs5030743,RRM2,3,1.75,Efficacy,1,1,cladribine;cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183700238
1183700248,rs2898950,RRM1,3,1.75,Efficacy,1,1,cladribine;cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183700248
1183700253,rs1561876,RRM1,3,2.75,Efficacy,1,1,cladribine;cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183700253
1183700258,rs1042919,RRM1,3,2.25,Efficacy,1,1,cladribine;cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183700258
1183700512,rs11189381,SFRP5,3,0,Toxicity,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1183700512
1451398300,rs1800566,NQO1,3,3,Efficacy,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451398300
1451398340,rs17782313,MC4R,3,1.5,Toxicity,1,1,quetiapine,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398340
1183700488,rs1532624,CETP,3,3.5,Efficacy,1,1,hmg coa reductase inhibitors,Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/1183700488
982047500,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55",CYP2C9,1A,337.125,Metabolism/PK,19,52,phenytoin,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/982047500
982030907,rs502434,GRIA3,3,2.5,Efficacy,1,1,antidepressants;Selective serotonin reuptake inhibitors;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030907
982030990,rs9483947,MAP3K5,3,1.5,Efficacy,1,1,hydroxyurea,Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/982030990
982031767,rs762551,CYP1A2,3,4.5,Dosage;Toxicity,2,3,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982031767
982031864,rs1051730,CHRNA3,3,1.75,Efficacy,2,2,Drugs used in nicotine dependence;nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031864
982032257,rs7934165,BDNF,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032257
982032396,rs2289658,NTRK2,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032396
982036556,rs4148416,ABCC3,3,1.5,Efficacy,1,1,cisplatin;cyclophosphamide;doxorubicin;methotrexate;vincristine,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/982036556
982037368,rs5918,ITGB3,3,3.75,Efficacy,6,6,clopidogrel,Coronary Artery Disease;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/982037368
1148480056,rs2070676,CYP2E1,3,1.25,Efficacy;Toxicity,1,2,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1148480056
982037603,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,4,-3,Efficacy,9,13,clopidogrel,Acute coronary syndrome;Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/982037603
1451398281,rs1801253,ADRB1,3,4.5,Efficacy,2,2,bucindolol,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1451398281
1451398293,rs17782313,MC4R,3,1.5,Toxicity,1,1,paliperidone,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398293
1183607419,rs2231137,ABCG2,3,1,Toxicity,1,2,irinotecan,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183607419
1183607656,rs2230808,ABCA1,3,3.25,Efficacy,1,1,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1183607656
1183614504,rs1801020,F12,3,3.5,Efficacy,1,1,Enzymes,Stroke,https://www.pharmgkb.org/clinicalAnnotation/1183614504
1183614802,rs1110470,IL4R,3,2,Efficacy,1,1,pitrakinra,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183614802
1183614989,"CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7",CYP2B6,3,1.5,Other,1,1,mirtazapine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183614989
1043858656,rs2243250,IL4,3,1.75,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858656
1043859297,rs10306114,PTGS1,3,3.5,Efficacy,1,1,aspirin;clopidogrel,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1043859297
1043859386,rs72551330,UGT1A9,3,3.5,Toxicity,1,3,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1043859386
1143176298,rs1045642,ABCB1,3,1,Toxicity,2,2,simvastatin,Hypercholesterolemia;Myalgia unspecified,https://www.pharmgkb.org/clinicalAnnotation/1143176298
1146391450,rs4713916,FKBP5,3,2.75,Efficacy,1,1,corticosteroids,Crohn Disease,https://www.pharmgkb.org/clinicalAnnotation/1146391450
1148995043,rs2032582,ABCB1,3,5,Efficacy,4,5,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1148995043
1183532599,rs5888,SCARB1,3,2.75,Efficacy,1,1,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183532599
1183619312,rs11983225,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183619312
1183564259,rs5370,EDN1,3,0.75,Efficacy,1,3,atenolol;irbesartan,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183564259
1183623069,rs1051640,ABCC3,3,2,Toxicity,5,5,cisplatin,Drug Toxicity;Neoplasms;Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1183623069
1183629480,rs1806201,GRIN2B,3,1.75,Toxicity,1,1,risperidone,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1183629480
1183631536,rs544093,OPRM1,3,2.5,Toxicity,1,1,carboplatin;docetaxel;paclitaxel,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183631536
1183631564,rs4483927,HRH4,3,1.25,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183631564
1183679813,rs17626122,PARD3B,3,0,Toxicity,1,1,fluorouracil;oxaliplatin,Colorectal Neoplasms;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1183679813
1451398307,rs489693,MC4R,3,2,Toxicity,1,1,haloperidol,Hypertriglyceridemia;schizoaffective disorder;Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398307
1451398314,rs489693,MC4R,3,3.25,Toxicity,2,2,quetiapine,Hypertriglyceridemia;schizoaffective disorder;Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398314
1183492249,rs7412,APOE,2B,12.5,Efficacy,5,5,atorvastatin,Coronary Disease;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/1183492249
1183679833,rs17376848,DPYD,1A,94.5,Toxicity,11,13,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183679833
1183617651,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",CYP2D6,1A,213,Metabolism/PK,10,19,amitriptyline,Depressive Disorder;Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183617651
1183617701,rs4646427,CYP1A2,3,4.5,Efficacy,1,2,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183617701
1183620959,"G6PD A- 202A_376G, G6PD B (reference)",G6PD,3,1.125,Efficacy;Toxicity,18,18,methylene blue,"Anemia, Hemolytic;Hemolysis;Protein Deficiency",https://www.pharmgkb.org/clinicalAnnotation/1183620959
1183680531,rs13266634,SLC30A8,3,1.5,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1183680531
1451398287,rs489693,MC4R,3,1.25,Efficacy,1,1,paliperidone,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398287
1183632108,rs16960228,PRKCA,3,0,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183632108
1183693532,rs11872992,MC4R,3,0,Toxicity,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183693532
1183679853,rs17024608,RBMS3,3,0,Efficacy,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1183679853
1183679858,rs16950650,ABCC4,3,0,Efficacy,1,1,cisplatin;irinotecan,"Carcinoma, Small Cell",https://www.pharmgkb.org/clinicalAnnotation/1183679858
1183684144,rs2070673,CYP2E1,3,2.75,Toxicity,1,1,cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183684144
1183684167,rs4149056,SLCO1B1,3,2.75,Toxicity,1,1,cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183684167
1183693438,rs1429376,XDH,3,1.75,Toxicity,1,1,didanosine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183693438
1183693448,rs11598702,NT5C2,3,2.25,Toxicity,1,1,didanosine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183693448
1183679823,rs17583889,HNMT,4,-1.5,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183679823
1451398347,rs489693,MC4R,3,2.25,Toxicity,3,3,risperidone,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398347
1451403400,rs11030096,BDNF-AS,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403400
1451403420,rs4906902,GABRB3,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403420
1183690892,rs1045642,ABCB1,3,2.25,Efficacy,1,1,highly active antiretroviral therapy (haart),HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183690892
1183680546,rs12979860,IFNL3;IFNL4,1A,213.25,Efficacy,5,7,boceprevir;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1183680546
1183689079,"CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96",CYP2D6,1A,210.8125,Metabolism/PK,9,15,atomoxetine,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1183689079
982036604,rs1128503,ABCB1,3,0,Efficacy,2,2,cisplatin;cyclophosphamide;doxorubicin;methotrexate;vincristine,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/982036604
982037753,rs1137101,LEPR,3,1.75,Efficacy,1,1,simvastatin,Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/982037753
982045124,rs9934438,VKORC1,3,6,Efficacy,1,2,fluindione,Thromboembolism,https://www.pharmgkb.org/clinicalAnnotation/982045124
1183697531,rs1051266,SLC19A1,3,2.5,Efficacy,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183697531
1183697570,rs1045642,ABCB1,3,2,Efficacy,1,2,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183697570
1183698841,rs1050152,SLC22A4,3,3.75,Efficacy,2,5,imatinib,"Gastrointestinal Stromal Tumors;Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1183698841
982038273,rs7997012,HTR2A,3,2,Efficacy,1,3,venlafaxine,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/982038273
1043858632,rs1800532,TPH1,4,-1,Efficacy,4,6,antidepressants;citalopram;escitalopram;fluoxetine;paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043858632
1183697623,rs833069,VEGFA,4,-2,Efficacy,2,4,ranibizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1183697623
1451398299,rs17782313,MC4R,3,1.5,Toxicity,1,1,risperidone,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398299
1451403428,rs1079596,DRD2,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403428
1183697575,rs1801131,MTHFR,4,-1.75,Efficacy,11,11,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1183697575
1183620032,"G6PD A- 202A_376G, G6PD B (reference)",G6PD,3,0.5,Toxicity,2,2,glyburide,"Anemia, Hemolytic",https://www.pharmgkb.org/clinicalAnnotation/1183620032
1043859365,rs2228479,MC1R,3,2.25,Efficacy,1,1,desipramine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043859365
1043880165,rs4680,COMT,3,1.5,Efficacy,3,4,venlafaxine,Anxiety Disorders;Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1043880165
1131245975,rs11568695,ABCC4,3,0.125,Other,1,1,zidovudine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1131245975
1183491298,rs1801368,MAD1L1,3,0.75,Efficacy,1,1,carboplatin;paclitaxel,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183491298
1183491385,rs5882,CETP,3,0,Efficacy,1,1,fluvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183491385
1183533972,rs2301339,GNB3,3,9.25,Efficacy,1,3,atenolol,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183533972
1183614701,rs153549,REEP5,3,3,Efficacy,1,1,citalopram;fluoxetine;paroxetine;sertraline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183614701
1183615383,rs9561765,ABCC4,3,2.25,Efficacy,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1183615383
1183615450,"CYP2C19*1, CYP2C19*2",CYP2C19,3,1.25,Dosage,1,2,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183615450
1183630271,rs10981694,SLC31A1,3,1,Toxicity,2,2,cisplatin,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183630271
1183632160,rs2061051,GABRG3,3,3,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183632160
1183634192,rs28399433,CYP2A6,3,5.375,Other,6,6,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183634192
1183679775,rs762551,CYP1A2,3,3.5,Toxicity,1,2,antipsychotics;chlorpromazine;fluphenazine;thioridazine;trifluoperazine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183679775
1183679799,rs17868320,UGT1A9,3,1.75,Toxicity,1,1,sorafenib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183679799
1451398380,rs489693,MC4R,3,3.25,Toxicity,2,2,amisulpride,Hypertriglyceridemia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398380
1451403440,rs1125394,DRD2,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403440
1183631507,rs4149601,NEDD4L,3,3,Efficacy,3,4,diuretics;hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183631507
1183679808,rs17751934,MEX3C,3,0,Toxicity,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1183679808
1183684132,rs11231825,SLC22A12,3,2.75,Toxicity,1,1,cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183684132
1451398387,rs17782313,MC4R,3,1.5,Toxicity,1,1,amisulpride,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398387
1451398394,rs489693,MC4R,3,2,Toxicity,1,1,aripiprazole,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451398394
1183689492,"CYP2D6*1, CYP2D6*3, CYP2D6*4",CYP2D6,3,2,Toxicity,1,1,olanzapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1183689492
1183693378,HLA-B*40:01,HLA-B,2A,8.25,Toxicity,6,6,carbamazepine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1183693378
1183682148,rs7668258,UGT2B7,3,2.75,Metabolism/PK,5,5,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1183682148
1043859063,rs4238001,SCARB1,3,3.5,Efficacy,1,1,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1043859063
1183491044,rs3745274,CYP2B6,3,3.5,Other,1,2,mitotane,Adrenocortical Carcinoma,https://www.pharmgkb.org/clinicalAnnotation/1183491044
1183594148,rs4291,ACE,3,2,Efficacy,1,1,amlodipine;chlorthalidone;lisinopril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183594148
1183603970,rs2440390,DRD2,3,2,Toxicity,1,1,olanzapine,Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183603970
1183614807,rs11064426,GNB3,3,9.25,Efficacy,1,3,atenolol,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183614807
1183615242,rs1799752,ACE,4,-0.25,Efficacy,2,2,lisinopril,"Diabetes Mellitus, Type 1;Heart Failure",https://www.pharmgkb.org/clinicalAnnotation/1183615242
1183615268,rs11615,ERCC1,3,0.75,Toxicity,2,2,fluorouracil;leucovorin;oxaliplatin,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615268
1183615317,rs2273697,ABCC2,3,1.25,Other,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615317
1183697628,rs776746,CYP3A5,3,2,Other,1,1,nifedipine,Pregnancy,https://www.pharmgkb.org/clinicalAnnotation/1183697628
1183697633,rs1042713,ADRB2,3,2.75,Efficacy,1,1,methacholine,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183697633
1183698813,rs4148323,UGT1A1,3,1,Other,1,1,carvedilol,Angina Pectoris;Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1183698813
1451403437,rs2654754,DRD3,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403437
1183689558,rs6025,F5,1A,107,Toxicity,6,7,hormonal contraceptives for systemic use,Thrombosis,https://www.pharmgkb.org/clinicalAnnotation/1183689558
1183624570,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,3,3,Efficacy,38,60,rabeprazole,Gastroesophageal Reflux;Helicobacter Infections;Peptic Ulcer,https://www.pharmgkb.org/clinicalAnnotation/1183624570
1183700493,rs13273672,GATA4,3,2.25,Efficacy,1,1,Drugs used in alcohol dependence,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1183700493
1183701206,HLA-A*02:07,HLA-A,3,3,Toxicity,1,1,zonisamide,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1183701206
1183700857,rs25648,VEGFA,3,2.75,Efficacy,1,1,cisplatin;fluorouracil;oxaliplatin,Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183700857
1183701224,HLA-A*31:01,HLA-A,1A,242.875,Toxicity,16,29,carbamazepine,"Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1183701224
1451403454,rs9288993,DRD3,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403454
1451403500,rs510769,OPRM1,3,1.25,Toxicity,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403500
982009415,rs1137617,KCNH2,3,2.75,Efficacy,1,1,calcium channel blockers;nitrendipine,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/982009415
1451403476,rs7597593,ZNF804A,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403476
981239773,rs8099917,IFNL3,1B,93.75,Efficacy,45,59,interferons;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/981239773
1451403467,rs735668,TACR1,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403467
1450375074,rs3212986,ERCC1,3,2.5,Toxicity,1,1,bleomycin;cisplatin;etoposide,Testicular Neoplasms;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1450375074
1450811417,rs1051660,OPRK1,3,0,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450811417
982031013,rs8192440,CRY1,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031013
982031125,rs35599367,CYP3A4,3,1,Other,1,1,erythromycin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982031125
982032512,rs4877900,NTRK2,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032512
982032657,rs558025,OPRM1,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032657
982034831,rs1045642,ABCB1,3,2.5,Efficacy,1,1,oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982034831
1043880077,rs1800629,TNF,3,2.5,Efficacy,1,1,cyclosporine;mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1043880077
1043880467,rs4986790,TLR4,3,2.5,Toxicity,1,1,folic acid;methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1043880467
1043880792,rs5443,GNB3,3,4.5,Efficacy,2,3,atenolol,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1043880792
1043880828,rs55754655,AOX1,3,2.5,Efficacy,1,1,azathioprine,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1043880828
1050579065,rs1800591,MTTP,3,0,Efficacy,1,1,pravastatin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1050579065
1183490994,rs702553,PDE4D,3,2.5,Efficacy,1,1,diuretics,Nephrosclerosis,https://www.pharmgkb.org/clinicalAnnotation/1183490994
982030283,"GSTT1 non-null, GSTT1 null",GSTT1,4,-8,Toxicity,11,13,Drugs For Treatment Of Tuberculosis;ethambutol;isoniazid;pyrazinamide;rifampin;streptomycin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/982030283
982030308,"GSTM1 non-null, GSTM1 null",GSTM1,4,-5,Toxicity,12,14,Drugs For Treatment Of Tuberculosis;ethambutol;isoniazid;pyrazinamide;rifampin;streptomycin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/982030308
982037307,rs5918,ITGB3,4,-6.25,Efficacy,14,14,aspirin,Acute coronary syndrome;Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/982037307
1154959505,rs11706052,IMPDH2,4,-3,Efficacy,6,10,cyclosporine;mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1154959505
1150414901,rs2032582,ABCB1,3,5.25,Efficacy,2,3,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1150414901
982032442,rs4358872,NTRK2,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032442
982034869,rs1128503,ABCB1,3,6,Efficacy,1,2,oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982034869
1451403484,rs2023239,CNR1,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403484
1183616940,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5",CYP2D6,1A,205.8125,Metabolism/PK,9,12,imipramine,"Depressive Disorder, Major;Mental Disorders",https://www.pharmgkb.org/clinicalAnnotation/1183616940
1183621866,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",CYP2D6,1A,107.5625,Metabolism/PK,4,7,trimipramine,Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183621866
1183621726,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36",CYP2D6,1A,104.125,Metabolism/PK,4,5,flecainide,"Arrhythmias, Cardiac",https://www.pharmgkb.org/clinicalAnnotation/1183621726
1183617103,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,1A,212,Metabolism/PK,6,11,imipramine,"Depressive Disorder;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183617103
982037811,rs708272,CETP,3,4.75,Efficacy,3,6,pravastatin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/982037811
982040619,rs2032582,ABCB1,3,2.5,Efficacy,1,1,cyclosporine;mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/982040619
1043859494,rs6318,HTR2C,3,1.5,Efficacy,1,1,escitalopram,neuropathic pain,https://www.pharmgkb.org/clinicalAnnotation/1043859494
1043873013,rs12903202,ALDH1A2,3,0,Efficacy,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1043873013
1043880039,rs4680,COMT,3,1,Efficacy,1,1,fluvoxamine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043880039
1043880426,rs12487736,SCAP,3,1.75,Efficacy,1,1,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1043880426
1157204541,rs1150226,HTR3A,3,0,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1157204541
982040676,rs17868320,UGT1A9,4,-1.25,Efficacy,2,4,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/982040676
1451403580,rs6928499,CNR1,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403580
1183491004,rs1800566,NQO1,3,2.75,Efficacy,3,3,Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183491004
1183618725,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",CYP2D6,1A,228.375,Metabolism/PK,16,34,nortriptyline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183618725
1043859020,rs5051,AGT,3,1.75,Efficacy,1,2,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1043859020
1043859046,rs4253778,PPARA,3,2.5,Efficacy,1,1,fenofibrate,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1043859046
1183491098,rs11887534,ABCG8,3,0.25,Efficacy,3,4,atorvastatin,Coronary Artery Disease;Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183491098
1183491262,rs1042173,SLC6A4,3,2.25,Efficacy,1,1,ondansetron,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1183491262
1183491310,"CYP3A4*1, CYP3A4*4",CYP3A4,3,2,Efficacy,1,1,simvastatin,Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/1183491310
1183630057,"GSTM1 non-null, GSTM1 null",GSTM1,3,0,Toxicity,1,1,sulfamethoxazole / trimethoprim,Acquired Immunodeficiency Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183630057
1183491390,rs5882,CETP,3,2,Efficacy,1,1,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183491390
1183617783,rs57098334,SLC6A4,3,2.5,Toxicity,1,1,antidepressants,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183617783
1183602693,rs2742423,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183602693
1183604439,rs2251954,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183604439
1183614711,rs1344706,ZNF804A,3,2,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183614711
1183614726,rs6313,HTR2A,3,2.5,Toxicity,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183614726
1183614860,rs1042640,UGT1A,3,1.75,Toxicity,1,1,acetaminophen,"Liver Failure, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183614860
1183615140,rs717620,ABCC2,3,2.25,Toxicity,1,1,fluorouracil;leucovorin;oxaliplatin,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615140
1183615273,rs11615,ERCC1,3,1.5,Efficacy,2,2,fluorouracil;leucovorin;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615273
1183619037,"CYP2D6*1, CYP2D6*4",CYP2D6,3,2.5,Dosage,1,1,Selective serotonin reuptake inhibitors,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183619037
1183622651,rs4646427,CYP1A2,3,4.5,Toxicity,1,3,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183622651
1183629305,rs4148739,ABCB1,3,2.75,Efficacy,2,2,amitriptyline;citalopram;fluoxetine;paroxetine;sertraline;venlafaxine,"Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183629305
1183629475,rs1806201,GRIN2B,3,1.75,Toxicity,1,2,quetiapine,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1183629475
1183533961,rs2740574,CYP3A4,4,-1.75,Efficacy,1,4,amlodipine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183533961
1183615208,rs3832043,UGT1A9,4,-2.75,Toxicity,2,5,irinotecan,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183615208
1183619225,rs6265,BDNF,4,-0.75,Toxicity,1,2,fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183619225
1183620242,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41",CYP2D6,4,-2.125,Toxicity,3,4,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183620242
1451403608,rs6280,DRD3,3,2.5,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403608
1451403621,rs1065852,CYP2D6,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403621
1451403720,rs1384401,TACR3,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403720
1183533940,rs4149015,SLCO1B1,3,0.5,Toxicity,1,2,irinotecan,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183533940
1183592332,rs4353229,CASP7,3,3.5,Efficacy,1,3,docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183592332
1183614766,rs1127687,CASP7,3,2,Efficacy,1,1,paclitaxel;Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183614766
1183631460,rs1523130,NR1I2,3,2,Other,1,1,memantine,Dementia,https://www.pharmgkb.org/clinicalAnnotation/1183631460
1183631787,rs915120,GRK5,3,0,Efficacy,1,1,citalopram;escitalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1183631787
1183632190,rs1045642,ABCB1,3,1.75,Efficacy,1,1,anthracyclines and related substances;taxanes,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183632190
1183679780,rs7588295,CSRNP3,3,0,Toxicity,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1183679780
1183679818,rs1760217,DPYD,3,2.5,Efficacy,1,1,antineoplastic agents,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183679818
1183679843,rs17091162,SERPINA3,3,2.5,Efficacy,1,1,antineoplastic agents,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183679843
1183679863,rs1678387,ABCC4,3,0,Toxicity,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1183679863
1183680415,rs16944,IL1B,3,2.5,Efficacy,3,4,lansoprazole;omeprazole;rabeprazole,Helicobacter Infections,https://www.pharmgkb.org/clinicalAnnotation/1183680415
1183680555,rs12946454,PLCD3,3,3,Efficacy,1,1,diltiazem,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183680555
1183680560,rs12943590,SLC47A2,3,4.375,Efficacy,4,5,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1183680560
1183680575,rs12210538,SLC22A16,3,1.75,Toxicity,2,2,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183680575
1183680665,rs4253728,PPARA,3,1,Toxicity,2,2,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183680665
1451403600,rs3745274,CYP2A7P1;CYP2B6,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403600
1183680511,rs1517114,C8orf34,3,0,Toxicity,1,1,irinotecan,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183680511
1183680526,rs13306278,COMT,3,2.5,Efficacy,1,1,Selective serotonin reuptake inhibitors,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183680526
1450377339,rs290487,TCF7L2,3,2,Toxicity,1,1,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1450377339
1450814641,rs8075924,ACE,3,2.75,Efficacy,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814641
1450814647,rs2770296,HTR2A,3,2.25,Efficacy,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814647
1450822023,rs1799971,OPRM1,3,0.5,Toxicity,2,2,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450822023
1451403680,rs324029,DRD3,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403680
1451403687,rs718656,EXOC4,3,2,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451403687
982031106,rs35599367,CYP3A4,3,3.75,Other,2,2,midazolam,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982031106
982032329,rs2120266,NTRK2,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032329
982032477,rs1948308,NTRK2,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032477
982032672,rs2239622,NGF,3,0.75,Dosage,2,2,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032672
982034400,rs2301149,KCNIP1;KCNMB1,3,2.5,Efficacy,1,1,verapamil,Coronary Artery Disease;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/982034400
1043858661,rs2228079,ADORA1,3,2.25,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858661
1043858680,rs11587213,FCER1G,3,4.5,Toxicity,2,2,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858680
1043873008,rs1364043,HTR1A,3,2,Efficacy,1,1,fluvoxamine;milnacipran;paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043873008
1043873023,rs12795437,KCNJ1,3,3.75,Toxicity,1,1,hydrochlorothiazide,Diabetes Mellitus;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1043873023
1043873028,rs12782374,CYP2C9,3,2,Dosage,1,3,phenytoin,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1043873028
1043880298,rs12721655,CYP2B6,3,1,Efficacy,2,2,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1043880298
1043880723,rs4606,RGS2,3,2,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1043880723
1043880750,rs324420,FAAH,3,2.25,Toxicity,2,2,aripiprazole;clozapine;haloperidol;olanzapine;quetiapine;risperidone,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1043880750
1043880900,rs2306283,SLCO1B1,3,0.5,Toxicity,4,4,hmg coa reductase inhibitors,Coronary Artery Disease;Diabetes Mellitus;Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1043880900
1135389481,rs6714486,UGT1A9,4,-3.5,Efficacy,4,6,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1135389481
1183491792,rs352046,CXCL5,3,4.5,Efficacy,1,2,hmg coa reductase inhibitors,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183491792
1183491822,rs3917643,F3,3,1.75,Efficacy,1,1,simvastatin,Myocardial Ischemia,https://www.pharmgkb.org/clinicalAnnotation/1183491822
1183492023,rs61764370,KRAS,3,2.75,Efficacy,6,6,cetuximab;panitumumab,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183492023
1183549413,rs8330,UGT1A;UGT1A9,3,1.75,Toxicity,2,2,acetaminophen,"Liver Failure, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183549413
1183605282,rs2239347,IL4R,3,2,Efficacy,1,1,pitrakinra,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183605282
1183607013,rs2237895,KCNQ1,3,2,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1183607013
1183607142,rs2237892,KCNQ1,3,1.5,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1183607142
1183614716,rs2231142,ABCG2,3,3,Toxicity,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183614716
1183614825,rs10929303,UGT1A,3,1.75,Toxicity,1,1,acetaminophen,"Liver Failure, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183614825
1183614830,rs1065852,CYP2D6,3,1,Toxicity,1,1,iloperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183614830
1183614835,rs1048943,CYP1A1,3,2.25,Efficacy,1,1,capecitabine;docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183614835
1183629489,rs6313,HTR2A,3,2.25,Toxicity,1,1,risperidone,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1183629489
1183618159,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",CYP2D6,2A,22.875,Dosage,8,14,tramadol,Pain,https://www.pharmgkb.org/clinicalAnnotation/1183618159
1183631061,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17",CYP2D6,1A,107.4375,Metabolism/PK,14,20,haloperidol,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183631061
982014094,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN",CYP2D6,1A,102.25,Efficacy,3,5,ondansetron,Vomiting,https://www.pharmgkb.org/clinicalAnnotation/982014094
1183614682,rs17135437,COL26A1,3,0,Toxicity,1,1,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183614682
1183614886,rs10248420,ABCB1,3,2.25,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183614886
1183615041,"CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7",CYP2B6,3,1.5,Efficacy,1,1,mirtazapine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183615041
1183680521,rs13306673,SLC12A3,3,2.25,Efficacy,1,1,"Thiazides, plain",Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183680521
1448640327,"TPMT*1, TPMT*3B, TPMT*3C",TPMT,3,4.5,Efficacy,1,2,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448640327
1183533986,rs2246709,CYP3A4,4,-3,Efficacy,1,4,amlodipine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183533986
1183679117,rs9806699,GATM,4,-1.75,Toxicity,2,4,hmg coa reductase inhibitors;simvastatin,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1183679117
1183614676,rs17782313,MC4R,3,3.5,Toxicity,3,3,antipsychotics,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1183614676
1183680463,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,3,4.125,Efficacy,13,22,esomeprazole,Gastroesophageal Reflux;Helicobacter Infections,https://www.pharmgkb.org/clinicalAnnotation/1183680463
1183621997,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14",CYP2D6,1A,125.875,Metabolism/PK,23,32,risperidone,Psychotic Disorders;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183621997
982034197,rs1799971,OPRM1,3,4.25,Dosage,16,16,morphine,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/982034197
982030757,rs2297480,FDPS,3,1.75,Toxicity,1,1,zoledronate,Neoplasms;Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/982030757
982030887,rs3761555,GRIA3,3,2.5,Efficacy,1,1,antidepressants;Selective serotonin reuptake inhibitors;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030887
982030900,rs3761554,GRIA3,3,2.5,Efficacy,1,1,antidepressants;Selective serotonin reuptake inhibitors;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030900
982031241,rs3794271,SLCO1C1,3,1.75,Efficacy,3,3,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Psoriatic;Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/982031241
982032306,rs1491850,BDNF,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032306
982030381,rs1954787,GRIK4,3,2.75,Efficacy,3,4,antidepressants,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/982030381
982044867,rs9344,CCND1,3,3.25,Efficacy,1,1,fluorouracil,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982044867
982045137,rs1801262,NEUROD1,3,4,Efficacy,1,2,repaglinide,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/982045137
1043858698,rs1131882,TBXA2R,3,2.25,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858698
1043880066,rs1800872,IL10,3,3,Efficacy,1,1,cyclosporine;mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1043880066
1043880082,rs1042597,UGT1A8,3,3.5,Toxicity,1,3,cyclosporine;mycophenolate mofetil;sirolimus;tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1043880082
1051394394,rs1800591,MTTP,3,0,Efficacy,1,2,atorvastatin,Hyperlipoproteinemia Type II,https://www.pharmgkb.org/clinicalAnnotation/1051394394
1139265477,rs1045642,ABCB1,3,0.25,Efficacy,4,4,atorvastatin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1139265477
1158793019,rs4149081,SLCO1B1,3,4.5,Efficacy,1,2,rosuvastatin,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1158793019
1183491333,rs4673,CYBA,3,2.25,Other,1,1,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183491333
1183491809,rs1800629,TNF,3,2.25,Other,1,1,atorvastatin,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183491809
1183532521,rs12003906,ABCA1,3,3.5,Efficacy,1,1,atorvastatin;pravastatin;simvastatin,Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/1183532521
1183617623,rs2470890,CYP1A2,3,3,Efficacy,1,1,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183617623
1183617685,rs4646425,CYP1A2,3,7,Efficacy,1,3,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183617685
1043880170,rs708272,CETP,4,-3.25,Efficacy,2,3,simvastatin,Hypercholesterolemia;Hyperlipoproteinemia Type II,https://www.pharmgkb.org/clinicalAnnotation/1043880170
1183619004,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,1A,212.125,Metabolism/PK,6,12,sertraline,Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183619004
982037423,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",CYP2D6,1A,217.375,Metabolism/PK,11,18,venlafaxine,Depressive Disorder;Obsessive-Compulsive Disorder,https://www.pharmgkb.org/clinicalAnnotation/982037423
1183619068,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",CYP2D6,1A,105.875,Metabolism/PK,7,11,aripiprazole,Psychotic Disorders;schizoaffective disorder;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183619068
1183620386,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,1A,224.75,Metabolism/PK,14,25,citalopram,"Depressive Disorder;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183620386
1183603016,rs2742417,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183603016
1183614476,rs1805010,IL4R,3,2,Efficacy,1,1,pitrakinra,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183614476
1183615328,rs45445694,TYMS,3,1.75,Toxicity,1,1,irinotecan;raltitrexed,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615328
1183619292,rs10248420,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183619292
1183619303,rs10280101,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183619303
1183619317,rs12720067,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183619317
1183614850,rs1042713,ADRB2,4,-1,Efficacy,1,3,benazepril,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183614850
1183632195,rs1045642,ABCB1,3,4.5,Efficacy,2,2,ondansetron,Postoperative Nausea and Vomiting;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1183632195
1183620575,"CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36",CYP2D6,1A,103.5,Metabolism/PK,3,4,propafenone,"Arrhythmias, Cardiac;Tachycardia",https://www.pharmgkb.org/clinicalAnnotation/1183620575
981204549,rs1799752,ACE,3,3,Efficacy,2,3,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/981204549
981204851,rs1800497,ANKK1,3,4.5,Efficacy,4,4,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/981204851
981237871,rs11045585,SLCO1B3,3,4.25,Toxicity,2,3,docetaxel,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981237871
981237930,rs11615,ERCC1,3,1.25,Toxicity,2,2,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981237930
981238415,rs1127354,ITPA,3,2.5,Efficacy;Toxicity,8,9,methotrexate,"Arthritis, Rheumatoid;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/981238415
1451288220,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40",CYP2D6,1A,210.25,Efficacy,7,12,codeine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451288220
1183629972,"GSTM1 non-null, GSTM1 null",GSTM1,3,1.25,Toxicity,2,2,cisplatin,Deafness;Ototoxicity;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183629972
1183680506,rs1522113,CLOCK,3,0,Efficacy,1,1,salbutamol,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183680506
1449713231,rs2205986,IRF6,3,3.5,Toxicity,1,1,interferon beta-1a;interferon beta-1b,drug-induced liver injury;Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1449713231
1449752810,rs701829,HLA-DRB1,3,3,Toxicity,1,1,dapsone,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1449752810
981204210,rs17602729,AMPD1,4,-0.75,Efficacy;Toxicity,7,7,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/981204210
1183630118,"GSTT1 non-null, GSTT1 null",GSTT1,4,-3.5,Toxicity,4,4,cisplatin,Deafness;Neoplasms;Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1183630118
1183679838,rs1736557,FMO3,4,-1.5,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183679838
1183615480,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",CYP2D6,3,7.5,Metabolism/PK,4,11,carvedilol,Heart Diseases,https://www.pharmgkb.org/clinicalAnnotation/1183615480
981238550,rs1051740,EPHX1,3,4.75,Metabolism/PK,3,3,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981238550
1450373520,rs1143634,IL1B,3,3,Dosage;Efficacy,1,1,morphine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450373520
1450373622,rs305968,CYP2F1,3,1.5,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373622
981204902,rs16969968,CHRNA5,2B,11.5,Toxicity,17,19,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/981204902
981238501,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,1A,243.25,Toxicity,21,33,phenytoin,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981238501
981419487,rs118192172,RYR1,3,0,Toxicity,1,1,hmg coa reductase inhibitors,Muscular Diseases,https://www.pharmgkb.org/clinicalAnnotation/981419487
981419550,rs2819742,RYR2,3,0,Toxicity,1,1,cerivastatin,Rhabdomyolysis,https://www.pharmgkb.org/clinicalAnnotation/981419550
981478113,rs10800397,NOS1AP,3,5,Toxicity,1,2,amiodarone,Long QT Syndrome,https://www.pharmgkb.org/clinicalAnnotation/981478113
981419263,"HLA-B*15:02, HLA-B*15:11",HLA-B,1A,413.5,Toxicity,49,59,carbamazepine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/981419263
981419257,HLA-B*57:01,HLA-B,1A,325.75,Toxicity,11,14,abacavir,Drug Hypersensitivity;HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981419257
981419260,HLA-B*58:01,HLA-B,1A,181.375,Toxicity,38,41,allopurinol,"Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/981419260
1449167328,rs4902333,CHURC1,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167328
1449168079,rs9873889,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168079
1449167453,rs9032,STRBP,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167453
982029652,rs324420,FAAH,3,5.25,Other,2,3,methamphetamine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982029652
982030862,rs1992647,GABRA6,3,0,Efficacy,1,1,antidepressants;Selective serotonin reuptake inhibitors;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030862
982031308,rs4532,DRD1,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031308
982031346,rs2499984,OR52J2P;OR52J3,3,2.5,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031346
982031374,rs2314339,NR1D1;THRA,3,2.5,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031374
982031407,rs2284018,CACNG2,3,2,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031407
982031795,rs568408,IL12A,3,3,Toxicity,1,1,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/982031795
982032228,rs10835210,BDNF,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032228
982032638,rs2283265,DRD2,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032638
982029578,rs699947,VEGFA,4,-3.5,Efficacy,3,4,ranibizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/982029578
982030916,rs948854,GAL,3,3,Efficacy,1,2,antidepressants;benzodiazepine derivatives;mirtazapine;Selective serotonin reuptake inhibitors,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030916
982031034,rs6809699,P2RY12,3,2.75,Efficacy,4,6,clopidogrel,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/982031034
982037378,rs1126643,ITGA2,3,1,Efficacy,5,5,aspirin;clopidogrel,Coronary Artery Disease;Coronary Disease;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/982037378
982045674,rs2069502,CDK4,3,2,Other,1,1,somatropin recombinant,Turner Syndrome,https://www.pharmgkb.org/clinicalAnnotation/982045674
1451406523,rs1799971,OPRM1,3,2.5,Efficacy,1,1,tramadol,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451406523
982045082,rs6988229,COL22A1,3,0,Efficacy,1,1,salbutamol,Asthma,https://www.pharmgkb.org/clinicalAnnotation/982045082
982032743,rs2032582,ABCB1,3,1.25,Toxicity,1,1,clomipramine;lithium;nefazodone;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/982032743
1043858606,rs6265,BDNF,3,1,Efficacy,7,7,antidepressants;citalopram;paroxetine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1043858606
1043858642,rs7179742,FSIP1,3,2.5,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858642
1043858651,rs3856806,PPARG,3,5.5,Toxicity,1,2,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858651
1043858666,rs16851030,ADORA1,3,3.25,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858666
1043858872,rs8060157,ZNF423,3,0,Efficacy,1,1,raloxifene;tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1043858872
1043859119,rs9380524,FKBP5,3,0,Efficacy,1,1,citalopram;escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043859119
1043858990,rs10306114,PTGS1,3,6,Efficacy,2,2,aspirin,Coronary Artery Disease;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1043858990
982030399,rs3810651,GABRQ,3,3,Efficacy,1,1,venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030399
982045146,rs114202595,PAX4,3,1.5,Efficacy,1,1,repaglinide,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/982045146
1043880214,rs35068180,MMP3,3,4.5,Efficacy,1,2,pravastatin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1043880214
1043880229,rs35068180,MMP3,3,6,Efficacy,1,2,chlorthalidone;lisinopril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1043880229
1043880234,rs1799752,ACE,3,3.25,Efficacy,1,2,fluvastatin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1043880234
1043880447,rs8016905,BDKRB2,3,3.25,Toxicity,1,1,"Ace Inhibitors, Plain",Cough,https://www.pharmgkb.org/clinicalAnnotation/1043880447
1043880818,rs4149056,SLCO1B1,1A,207.25,Toxicity,17,19,atorvastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1043880818
1145963221,rs7160796,DCAF4,3,2,Efficacy,1,1,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1145963221
1147261601,rs6413432,CYP2E1,3,1.75,Efficacy,1,1,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1147261601
1157877076,rs776746,CYP3A5,3,1,Dosage;Toxicity,2,2,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1157877076
1183490967,rs2283265,DRD2,3,2.25,Efficacy,1,1,disulfiram,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183490967
1183490978,rs1800497,ANKK1,3,2.25,Efficacy,1,1,disulfiram,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183490978
1183491035,rs1801394,MTRR,3,2.5,Efficacy,1,1,"folic acid;vitamin b-complex, plain",Migraine with Aura,https://www.pharmgkb.org/clinicalAnnotation/1183491035
1183491189,rs17161788,CYP3A5,3,1.75,Efficacy,1,1,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1183491189
1183491354,rs2298826,SLC6A5,3,2.5,Toxicity,1,1,haloperidol,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183491354
1183491775,rs1801133,MTHFR,3,2.5,Efficacy,1,1,pravastatin,Coronary Artery Disease;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1183491775
1183492030,rs2279020,GABRA1,3,4.5,Efficacy,1,2,carbamazepine;phenytoin;valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1183492030
1183492235,rs2230806,ABCA1,3,2.25,Efficacy,1,1,pravastatin,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1183492235
1183614547,rs12948783,RHBDF2,3,0,Efficacy,1,1,fentanyl;morphine;opioids;oxycodone,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183614547
1183614624,rs3812718,SCN1A,3,4.75,Efficacy,5,5,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1183614624
1183614578,rs17183814,SCN2A,4,-2.5,Efficacy,4,5,antiepileptics;carbamazepine;phenobarbital;phenytoin;valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1183614578
1183614591,rs2298771,SCN1A,4,-2.5,Efficacy,3,5,carbamazepine;oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1183614591
1183614776,rs8192726,CYP2A6,4,-0.5,Other,6,6,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183614776
1154221922,rs2231142,ABCG2,2A,10.75,Efficacy,4,4,rosuvastatin,Hypercholesterolemia;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1154221922
1183615573,rs699,AGT,3,1.875,Efficacy,4,4,irbesartan,"Hypertension;Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1183615573
982031323,rs334558,GSK3B,3,0.5,Efficacy,2,3,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982031323
982032495,rs2378676,NTRK2,3,0,Dosage,1,1,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/982032495
982032734,rs6438552,GSK3B,3,1.25,Efficacy,2,3,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/982032734
982047849,rs6280,DRD3,3,2.75,Efficacy,1,1,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982047849
1043858637,rs7572857,CEP68,3,6.5,Toxicity,1,2,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1043858637
1043858675,rs1613662,GP6,3,2.5,Efficacy,1,1,aspirin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1043858675
1043858703,rs1062535,ITGA2,3,2.25,Efficacy,1,1,aspirin,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1043858703
1183590959,rs495794,SRP19,3,2.5,Efficacy,1,1,citalopram;fluoxetine;paroxetine;sertraline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183590959
1183614696,rs153560,REEP5,3,3,Efficacy,1,1,citalopram;fluoxetine;paroxetine;sertraline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183614696
1183617565,rs130058,HTR1B,3,0.75,Other,1,1,paroxetine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183617565
1043858615,rs5443,GNB3,4,-0.625,Efficacy,1,3,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043858615
1183618859,rs6313,HTR2A,3,2.75,Toxicity,4,5,paroxetine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183618859
1183617765,rs57098334,SLC6A4,3,2.5,Efficacy,4,5,fluoxetine,"Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183617765
1183616699,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,1A,206,Metabolism/PK,4,8,clomipramine,Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183616699
1183621000,"G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",G6PD,1A,103,Toxicity,21,23,rasburicase,Hemolysis;Methemoglobinemia,https://www.pharmgkb.org/clinicalAnnotation/1183621000
1043859029,rs430397,HSPA5,3,10.5,Efficacy,1,4,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1043859029
1183545767,rs964184,APOA1,3,3.5,Efficacy,1,1,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1183545767
1183620349,rs5030868,G6PD,3,0.25,Toxicity,1,1,glyburide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1183620349
1183622557,rs2069526,CYP1A2,3,1.5,Toxicity,1,1,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183622557
1183624306,rs324026,DRD3,3,2,Efficacy,1,1,duloxetine,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183624306
1183624313,rs324023,DRD3,3,2,Efficacy,1,1,duloxetine,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183624313
1183624328,rs167770,DRD3,3,2,Efficacy,1,1,duloxetine,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183624328
1183624421,rs130058,HTR1B,3,2.25,Toxicity,1,1,clomipramine;liothyronine;lithium;nefazodone;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183624421
1183630276,rs1130214,AKT1,3,2,Efficacy,1,1,carboplatin;cisplatin,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183630276
1451406840,rs16952570,FTO,3,4,Toxicity,2,3,azathioprine,"Colitis, Ulcerative;Crohn Disease;Irritable Bowel Syndrome;Leukopenia;Neutropenia",https://www.pharmgkb.org/clinicalAnnotation/1451406840
1183624646,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",CYP2D6,3,5,Metabolism/PK,10,18,fluoxetine,"Depressive Disorder, Major;Mental Disorders",https://www.pharmgkb.org/clinicalAnnotation/1183624646
1183622099,"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10",CYP2D6,1A,116.625,Metabolism/PK,12,18,desipramine,"Depressive Disorder, Major;Mental Disorders",https://www.pharmgkb.org/clinicalAnnotation/1183622099
1043872993,rs861539,XRCC3,3,0.5,Efficacy,2,3,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1043872993
1043876904,rs242941,CRHR1,3,1.75,Efficacy,1,1,fluoxetine,"Anxiety Disorders;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1043876904
1043880438,rs6755571,UGT1A4,3,1.5,Other,1,1,ABT-751,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1043880438
1043880608,rs2306283,SLCO1B1,3,4.25,Efficacy,4,4,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1043880608
1043880783,rs11039149,NR1H3,3,2.75,Toxicity,1,1,atenolol;verapamil,Coronary Artery Disease;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1043880783
1183492244,rs17655652,NPC1L1,3,5.5,Efficacy,1,2,pravastatin,Diabetes Mellitus;Hypertension;Vascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/1183492244
1183533592,rs12654264,HMGCR,3,5.5,Other,1,3,hmg coa reductase inhibitors,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183533592
1183617714,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,1A,119.5,Metabolism/PK,9,23,amitriptyline,"Depressive Disorder, Major;Mental Disorders",https://www.pharmgkb.org/clinicalAnnotation/1183617714
1183533981,rs2290732,GABRA1,3,2.75,Efficacy,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1183533981
1183603158,rs2742390,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183603158
1183614509,rs1800545,ADRA2A,3,2,Efficacy,1,1,atenolol,"Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1183614509
1183614752,rs12082710,TGFBR3,3,2.5,Efficacy,1,1,antidepressants,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183614752
1183614845,rs1042714,ADRB2,3,2,Efficacy,1,1,enalapril,"Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1183614845
1183614891,rs10042486,HTR1A,3,3,Efficacy,1,1,amisulpride;antipsychotics;olanzapine;quetiapine;risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183614891
1183615150,rs7079,AGT,3,3.5,Efficacy,1,1,benazepril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183615150
1183615213,rs1801133,MTHFR,3,4.25,Efficacy,2,3,benazepril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183615213
1183615415,rs767455,TNFRSF1A,3,2.75,Efficacy,2,3,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1183615415
982037557,rs11706052,IMPDH2,4,-3,Efficacy;Toxicity,6,10,mycophenolate mofetil;mycophenolic acid,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/982037557
1451406860,rs16952570,FTO,3,4,Toxicity,2,3,mercaptopurine,"Colitis, Ulcerative;Crohn Disease;Irritable Bowel Syndrome;Leukopenia;Neutropenia",https://www.pharmgkb.org/clinicalAnnotation/1451406860
1183615582,rs699,AGT,3,0.25,Efficacy,3,4,atenolol,"Hypertension;Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1183615582
982031045,rs1799983,NOS3,3,2,Toxicity,1,1,aspirin;Beta Blocking Agents;clopidogrel;hmg coa reductase inhibitors,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/982031045
982031956,rs8832,IL4R,3,3,Efficacy,1,1,pitrakinra,Asthma,https://www.pharmgkb.org/clinicalAnnotation/982031956
982036595,rs4148737,ABCB1,3,0,Efficacy,2,2,cisplatin;cyclophosphamide;doxorubicin;methotrexate;vincristine,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/982036595
1183564845,rs5186,AGTR1,3,3.75,Efficacy,1,3,candesartan,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1183564845
1183614481,rs1801701,APOB,3,2,Efficacy,1,1,irbesartan,"Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1183614481
1183614619,rs1799752,ACE,3,2.75,Efficacy,2,3,benazepril;perindopril,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1183614619
1183614706,rs1417938,CRP,3,2.75,Efficacy,1,1,fenofibrate,Metabolic Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1183614706
1183614771,rs1127687,CASP7,3,2,Efficacy,1,1,gemcitabine;Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183614771
1183614840,rs1045642,ABCB1,3,4.5,Toxicity,1,2,sirolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183614840
1183614881,rs1029489,IL4R,3,3,Efficacy,1,1,pitrakinra,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1183614881
1183614970,rs7412,APOE,3,2.5,Efficacy,1,1,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1183614970
1183615145,rs717620,ABCC2,3,0,Toxicity,1,1,fluorouracil;leucovorin;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615145
1183615186,rs4149056,SLCO1B1,3,0,Toxicity,2,3,irinotecan,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183615186
1183543916,rs2241883,FABP1,4,-1.5,Efficacy,1,3,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1183543916
1183615288,rs1062613,HTR3A,3,2.5,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183615288
1183615373,rs2066844,NOD2,3,0.75,Efficacy,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183615373
1183619322,rs2235040,ABCB1,3,2.75,Efficacy,1,1,amitriptyline;citalopram;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1183619322
1183630065,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26",CYP2C19,1A,228.8125,Metabolism/PK,28,38,omeprazole,Gastroesophageal Reflux,https://www.pharmgkb.org/clinicalAnnotation/1183630065
1043859108,rs4149056,SLCO1B1,3,2,Dosage,1,1,SN-38,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1043859108
1043880059,rs3832043,UGT1A9,3,2.5,Other,1,2,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1043880059
1183554425,rs7921977,CASP7,3,0.5,Efficacy,1,2,docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183554425
1183602849,rs2742421,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183602849
1183613866,rs1969624,SACM1L,3,0,Toxicity,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1183613866
1183615435,"CYP2C19*1, CYP2C19*2",CYP2C19,3,1.25,Efficacy,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183615435
1183615199,rs3832043,UGT1A9,3,4.25,Metabolism/PK,3,3,SN-38,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183615199
1183630036,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,1A,264.5,Efficacy,27,57,omeprazole,Esophagitis;Gastroesophageal Reflux;Helicobacter Infections;Peptic Ulcer,https://www.pharmgkb.org/clinicalAnnotation/1183630036
1183624499,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,1A,218.75,Efficacy,6,13,pantoprazole,Helicobacter Infections;Ulcer,https://www.pharmgkb.org/clinicalAnnotation/1183624499
1183629796,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,1A,256.75,Efficacy,22,57,lansoprazole,Gastroesophageal Reflux;Helicobacter Infections,https://www.pharmgkb.org/clinicalAnnotation/1183629796
982030948,rs962369,BDNF,3,2.5,Toxicity,1,1,escitalopram;nortriptyline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/982030948
982040598,rs4244285,CYP2C19,3,2.5,Efficacy,2,4,prasugrel,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/982040598
982040717,rs1065776,P2RY1,3,1.875,Efficacy,3,4,aspirin,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/982040717
1183631554,rs2849380,BCL2,3,3,Toxicity,1,1,carboplatin;docetaxel;paclitaxel,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183631554
1183631559,rs139887,SOX10,3,3,Toxicity,1,1,carboplatin;docetaxel;paclitaxel,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183631559
1183632091,rs4791040,PRKCA,3,0,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183632091
982047862,rs1799752,ACE,2A,13.5,Efficacy,7,8,captopril,"Diabetes Mellitus, Type 2;Heart Failure;Pulmonary Disease, Chronic Obstructive",https://www.pharmgkb.org/clinicalAnnotation/982047862
1183632150,rs878949,HSPG2,3,2,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183632150
1183632155,rs2445142,HSPG2,3,2.5,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183632155
1183632175,rs1042713,ADRB2,3,3,Toxicity,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183632175
1451407200,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,4,-3,Toxicity,4,6,sertraline,"Anxiety Disorders;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1451407200
1183632140,rs885004,SLC28A3,3,2,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183632140
1183614735,rs12415607,CASP7,3,4,Efficacy,1,3,docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183614735
1183614793,rs11269124,ADRA2C,3,2.25,Efficacy,1,1,clonidine,Liver Cirrhosis,https://www.pharmgkb.org/clinicalAnnotation/1183614793
1448636930,rs10515074,PIK3R1,3,5,Toxicity,1,2,everolimus,Breast Neoplasms;Hyperglycemia;Leukopenia,https://www.pharmgkb.org/clinicalAnnotation/1448636930
1451407348,rs6311,HTR2A,4,-1.25,Toxicity,6,6,sertraline,"Depressive Disorder, Major;Sexual Dysfunctions, Psychological",https://www.pharmgkb.org/clinicalAnnotation/1451407348
1451407329,rs6313,HTR2A,3,1,Toxicity,3,5,citalopram,"Depressive Disorder, Major;Sexual Dysfunctions, Psychological",https://www.pharmgkb.org/clinicalAnnotation/1451407329
1451407321,rs6313,HTR2A,4,-3,Toxicity,4,5,sertraline,"Depressive Disorder, Major;Sexual Dysfunctions, Psychological",https://www.pharmgkb.org/clinicalAnnotation/1451407321
1449003934,rs652888,EHMT2,3,0,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis,https://www.pharmgkb.org/clinicalAnnotation/1449003934
1449003956,rs11125883,XPO1,3,0.75,Toxicity,2,2,isoniazid,drug-induced liver injury;Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1449003956
1449165479,rs1801274,FCGR2A,3,6.75,Efficacy,4,4,cetuximab,Colorectal Neoplasms;Head and Neck Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449165479
1449157773,rs118192168,RYR1,1A,101.25,Toxicity,12,13,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449157773
1449752825,rs17211071,HLA-DRB1,3,3,Toxicity,1,1,dapsone,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1449752825
1450810236,rs511435,OPRM1,3,6.75,Toxicity,2,2,heroin;opioids,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810236
1450931416,rs4807493,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931416
1451408000,rs6269,COMT,4,-1.5,Dosage,2,2,morphine,"Neoplasms;Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451408000
1449716056,rs2275913,IL17A,3,2.75,Dosage,1,1,opioids,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449716056
1449716178,rs9397685,OPRM1,3,2.25,Toxicity,1,1,fentanyl,"Nausea;Pain, Postoperative;Vomiting",https://www.pharmgkb.org/clinicalAnnotation/1449716178
1450810351,rs3778156,OPRM1,3,3.25,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450810351
1450810381,rs495491,OPRM1,3,3.25,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810381
1449191379,rs368505753,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191379
1449191385,rs115545701,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191385
1449191367,rs397508328,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191367
1449191401,rs397508537,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191401
1449191395,rs121908751,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191395
1449270967,rs4968187,TP53,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270967
1449750773,rs2236947,RASSF1,3,2.75,Efficacy,1,1,cetuximab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449750773
1449750832,rs4261893,ZNF385D,3,3,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449750832
1449750838,rs117986340,KMT2E,3,2.5,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449750838
1449750843,rs2303377,NCAM1,3,3,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449750843
1449191407,rs113993958,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191407
1449191413,rs77834169,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191413
1449191424,rs397508759,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191424
1449191430,rs121908752,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191430
1449169484,rs7668258,UGT2B7,3,2.25,Metabolism/PK,3,4,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1449169484
1449169546,rs11568732,CYP2C19,3,0,Toxicity,1,1,clopidogrel,Hemorrhage;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1449169546
1449169675,rs1105879,UGT1A6,3,0,Efficacy,1,1,aspirin,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449169675
1449564720,rs7270101,ITPA,3,3.25,Dosage;Toxicity,1,1,mercaptopurine;methotrexate,Leukopenia;Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1449564720
1449566673,rs4979223,SLC31A1,3,5.75,Efficacy;Toxicity,1,2,Platinum compounds,overall survival;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1449566673
1449566679,rs4978536,SLC31A1,3,2.5,Toxicity,1,1,Platinum compounds,Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1449566679
1449566685,rs2233914,SLC31A1,3,5.5,Efficacy;Toxicity,1,2,Platinum compounds,Drug Toxicity;overall survival,https://www.pharmgkb.org/clinicalAnnotation/1449566685
1450044803,rs13120400,ABCG2,3,1,Metabolism/PK,1,1,ceftriaxone,Central Nervous System Infections,https://www.pharmgkb.org/clinicalAnnotation/1450044803
1450813484,rs1800497,ANKK1;DRD2,3,2.5,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813484
1450928835,rs2036527,CHRNA5,3,2.25,Efficacy,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450928835
1450929015,rs1277441,TAOK3,3,0,Efficacy,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450929015
1450929025,rs1277441,TAOK3,3,2,Dosage,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450929025
1450929816,rs1045642,ABCB1,3,1,Efficacy,2,2,tramadol,"Fractures, Bone;Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450929816
1450929851,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN",CYP2D6,1A,103.25,Efficacy,1,2,tropisetron,Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1450929851
1450930536,rs7606603,XIRP2,3,2.25,Efficacy,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1450930536
1449005372,rs3888190,SH2B1,3,2.25,Toxicity,1,1,amisulpride;aripiprazole;clozapine;lithium;mirtazapine;olanzapine;paliperidone;quetiapine;risperidone;valproic acid,Bipolar Disorder;Depressive Disorder;Psychotic Disorders;schizoaffective disorder,https://www.pharmgkb.org/clinicalAnnotation/1449005372
1448821500,rs2231142,ABCG2,3,1.75,Metabolism/PK,1,1,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1448821500
1449164681,rs1801278,IRS1,3,1.25,Efficacy,1,1,Drugs Used In Diabetes,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1449164681
1449192313,rs121909047,CFTR,3,1.5,Efficacy,1,1,lumacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449192313
1449718300,rs2228100,ALDH3A1,3,2.75,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718300
1450821128,rs3890011,CYP4A11,3,2,Efficacy,1,1,spironolactone,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1450821128
1450928486,rs362267,HTT;MSANTD1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928486
1448995134,rs2231142,ABCG2,3,1.5,Metabolism/PK,1,1,dolutegravir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1448995134
1449157530,rs3131003,PSORS1C1,3,3,Toxicity,1,1,allopurinol,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1449157530
1450820856,rs1800497,ANKK1;DRD2,3,1.75,Efficacy,1,1,prochlorperazine,Nausea,https://www.pharmgkb.org/clinicalAnnotation/1450820856
1450820863,rs1079597,DRD2,3,1.75,Efficacy,1,1,prochlorperazine,Nausea,https://www.pharmgkb.org/clinicalAnnotation/1450820863
1450820963,rs6090378,CHRNA4,3,0,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450820963
1450821349,rs9479757,OPRM1,3,2.75,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450821349
1449167289,rs17712523,CDH23,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167289
1449167300,rs2799018,ARHGAP12,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167300
1449167317,rs12409352,PIGM,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167317
1449167339,rs2295490,TRIB3,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167339
1449167350,rs4627790,CMTM8,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167350
1449167361,rs1048786,PDIA2,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167361
1449167409,rs751655,OPCML,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167409
1449167420,rs11559290,ETFDH,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167420
1449167431,rs7858,NFIB,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167431
1449167442,rs929740,ARHGEF28,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167442
1449168364,rs12630569,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168364
1449168371,rs9824595,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168371
1449168378,rs4334661,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168378
1449168447,rs12657120,TTC37,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168447
1449156066,HLA-B*13:02,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156066
1449156127,HLA-B*15:25,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156127
1449004504,rs10132552,MEG3,3,1.5,Toxicity,1,2,Platinum compounds;radiotherapy,Anemia;Dermatitis;Leukopenia;mucositis;Myelosuppression;Neutropenia;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1449004504
1449155838,HLA-B*51:02,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155838
1449156144,HLA-B*15:27,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156144
1449156162,HLA-B*52:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156162
1449156071,HLA-B*38:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156071
1449155848,HLA-B*55:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155848
1449156149,HLA-B*15:32,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156149
1449155853,HLA-B*55:02,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155853
1449155858,HLA-B*56:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155858
1449156107,HLA-B*57:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156107
1449155863,HLA-B*56:06,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155863
1449156029,rs503464,CHRNA5,3,5,Efficacy;Toxicity,1,2,bupropion;nicotine;varenicline,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449156029
1449156045,rs55781567,CHRNA5,3,2.75,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449156045
1449156204,HLA-C*05:01,HLA-C,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156204
1449156089,HLA-B*39:05,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156089
1449156094,HLA-B*39:06,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156094
1449155833,HLA-B*51:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155833
1449155843,HLA-B*54:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155843
1449156099,HLA-B*39:09,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156099
1449156061,HLA-B*78:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156061
1449156157,HLA-B*15:35,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156157
1449156209,HLA-C*05:09,HLA-C,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156209
1449156189,HLA-C*04:03,HLA-C,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156189
1449156194,HLA-C*04:06,HLA-C,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156194
1449156199,HLA-C*04:07,HLA-C,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156199
1449156236,HLA-DRB1*04:04,HLA-DRB1,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156236
1449156241,HLA-DRB1*08:01,HLA-DRB1,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156241
1449156214,HLA-C*18:01,HLA-C,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156214
1449156231,HLA-DRB1*01:03,HLA-DRB1,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156231
1449156249,HLA-DRB1*10:01,HLA-DRB1,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156249
1449156112,HLA-B*15:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156112
1450377187,rs1801280,NAT2,3,2.25,Toxicity,1,1,isoniazid;phenytoin,Drug interaction with drug;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1450377187
1450810255,rs524731,OPRM1,3,2.75,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810255
1450930470,rs4654327,OPRD1,3,1,Toxicity,2,2,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450930470
1450934632,rs397515870,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934632
1450934693,rs104894828,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934693
1450934717,rs190347120,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934717
1449155310,rs4149117,SLCO1B3,3,2.5,Efficacy,1,1,sunitinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1449155310
1450807912,rs4680,COMT,3,1,Toxicity,2,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450807912
1449270961,rs77769901,CCNK,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270961
1450934684,rs869312399,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934684
1449154729,rs113993960,CFTR,1A,108.75,Efficacy,3,4,ivacaftor / tezacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449154729
1450373854,rs6517442,KCNJ6,3,5,Efficacy,1,2,morphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450373854
1449171162,rs5746136,SOD2,3,0.5,Toxicity,1,2,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1449171162
1449271051,rs145623321,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271051
1450928430,rs362306,HTT;MSANTD1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928430
1450928499,rs2515641,CYP2E1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928499
1449171168,rs2758339,SOD2,3,3,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1449171168
1450932674,rs1799971,OPRM1,3,3.5,Toxicity,1,4,buprenorphine;fentanyl;tramadol,adverse events;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450932674
1450928528,rs4633,COMT,4,-1.5,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928528
1450933017,rs731236,VDR,3,2,Efficacy,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1450933017
1449713738,rs1061622,TNFRSF1B,3,2,Efficacy,1,1,etanercept,"Spondylitis, Ankylosing",https://www.pharmgkb.org/clinicalAnnotation/1449713738
1449732040,rs1045642,ABCB1,4,-1.125,Metabolism/PK,4,4,risperidone,Bipolar Disorder;Depression;Psychotic Disorders;Schizophrenia;Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449732040
1451410200,"CYP3A4*1, CYP3A4*22",CYP3A4,4,-0.125,Metabolism/PK,3,3,everolimus,Breast Neoplasms;Kidney Neoplasms;Kidney Transplantation;Neuroendocrine Tumors,https://www.pharmgkb.org/clinicalAnnotation/1451410200
1450813881,rs7164594,HYKK,3,2.75,Efficacy,1,1,varenicline,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813881
1450813994,rs4680,COMT,3,2,Efficacy,1,1,modafinil,methamphetamine dependence,https://www.pharmgkb.org/clinicalAnnotation/1450813994
1449565066,rs780668,SLC29A3,4,-0.25,Efficacy,1,3,gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1449565066
1451410221,"CYP3A5*1, CYP3A5*3",CYP3A5,3,0.375,Metabolism/PK,6,6,everolimus,Breast Neoplasms;heart transplantation;Kidney Neoplasms;Kidney Transplantation;lung transplantation;Neuroendocrine Tumors,https://www.pharmgkb.org/clinicalAnnotation/1451410221
1448820584,rs9200,C6,3,1,Metabolism/PK,1,2,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448820584
1448820590,rs10052999,C6,3,1.5,Metabolism/PK,1,2,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448820590
1449157883,rs2266780,FMO3,3,4.25,Metabolism/PK,1,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449157883
1449296290,rs762551,CYP1A2,3,0.25,Toxicity,1,1,caffeine,insomnia,https://www.pharmgkb.org/clinicalAnnotation/1449296290
1449296320,rs2162145,CPA6,3,0,Efficacy,1,1,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1449296320
1449296326,rs57081354,NBEA,3,0,Efficacy,1,1,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1449296326
1449296332,rs254271,PRPF31,3,0,Efficacy,1,1,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1449296332
1449565060,rs2231142,ABCG2,3,3.5,Efficacy;Toxicity,1,4,gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1449565060
1449563861,rs772226819,CACNA1S,1A,100.25,Toxicity,2,3,desflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449563861
1449004841,rs4149056,SLCO1B1,3,1.75,Efficacy,2,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1449004841
1449165169,rs2273697,ABCC2,4,-1.25,Toxicity,3,3,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1449165169
1449165158,rs1128503,ABCB1,4,-0.25,Toxicity,2,2,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1449165158
1450810228,rs511435,OPRM1,3,3.25,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450810228
1450810283,rs3823010,OPRM1,3,3.25,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450810283
1450810289,rs3823010,OPRM1,3,3.25,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810289
1450810369,rs609148,OPRM1,3,2.75,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810369
1450810393,rs548646,OPRM1,3,2.25,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810393
1450934647,rs28935490,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934647
1449715596,rs10028494,UGT2B7,3,2.25,Efficacy,1,1,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449715596
1451410280,rs2024627,MTOR,3,1.5,Efficacy,1,1,everolimus,Breast Neoplasms;Kidney Neoplasms;Neuroendocrine Tumors,https://www.pharmgkb.org/clinicalAnnotation/1451410280
1450373489,rs3192723,OPRM1,3,0,Efficacy,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450373489
1449003976,rs2070401,BACH1,3,0.75,Toxicity,2,2,isoniazid,drug-induced liver injury;Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1449003976
1450374101,rs1902023,UGT2B15,3,1.75,Efficacy,1,1,acetaminophen,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450374101
1450375059,rs1799793,ERCC2,3,2.5,Toxicity,1,1,bleomycin;cisplatin;etoposide,Anemia;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450375059
1450931447,rs1476592,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931447
1451410920,HLA-DQB1*02:01,HLA-DQB1,3,2.75,Toxicity,1,1,infliximab,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1451410920
1450931822,rs1799971,OPRM1,3,2,Toxicity,1,1,fentanyl,somnolence,https://www.pharmgkb.org/clinicalAnnotation/1450931822
1451410860,"HLA-B*08:01, HLA-B*39:01",HLA-B,3,4.5,Toxicity,1,2,infliximab,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1451410860
1450932703,rs1045280,ARRB2,3,2.25,Toxicity,1,1,buprenorphine;fentanyl;tramadol,adverse events;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450932703
1450932995,rs887829,UGT1A1,3,2.5,Efficacy,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1450932995
1451411000,"HLA-DRB1*03:01, HLA-DRB1*04:04",HLA-DRB1,3,4,Toxicity,1,2,infliximab,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1451411000
1451410900,HLA-C*12:03,HLA-C,3,1.75,Toxicity,1,1,infliximab,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1451410900
1451410960,HLA-DPB1*10:01,HLA-DPB1,3,1.75,Toxicity,1,1,infliximab,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1451410960
1450813988,rs6265,BDNF,3,1.5,Toxicity,1,1,methamphetamine,methamphetamine dependence,https://www.pharmgkb.org/clinicalAnnotation/1450813988
1450929031,rs795484,TAOK3,3,2,Efficacy,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450929031
1450934049,rs762551,CYP1A2,3,3.75,Dosage,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450934049
1451412140,rs3219489,MUTYH,3,3.75,Efficacy,1,1,cisplatin;fluorouracil;radiotherapy,"Carcinoma, Squamous Cell;progression-free survival",https://www.pharmgkb.org/clinicalAnnotation/1451412140
1449566697,rs10759637,SLC31A1,3,2.75,Efficacy,1,1,Platinum compounds,overall survival;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1449566697
1449753229,rs1976391,UGT1A1,3,1.75,Toxicity,1,1,risperidone,Hyperprolactinemia,https://www.pharmgkb.org/clinicalAnnotation/1449753229
1450042856,rs73208473,SORCS2,3,2.625,Metabolism/PK,2,2,atazanavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1450042856
1450934175,rs1567817380,SCN4A,3,0,Efficacy,1,1,flecainide,Myotonic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450934175
1450934494,rs398123212,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934494
1450934533,rs372966991,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934533
1449718271,rs4244285,CYP2C19,3,2.75,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718271
1449718277,rs2273697,ABCC2,3,2.75,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718277
1449718283,rs3740066,ABCC2,3,5.5,Toxicity,1,2,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718283
1449718289,rs1801516,ATM,3,5.5,Toxicity,1,2,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718289
1449718311,rs3212986,ERCC1,3,3.25,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718311
1449718317,rs11615,ERCC1,3,3.25,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718317
1449718323,rs20572,CBR1,3,3.25,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718323
1449718331,rs25487,XRCC1,3,2.75,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718331
1449718337,rs1695,GSTP1,3,2.25,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718337
1449718343,rs1045642,ABCB1,3,2.75,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449718343
1450374095,rs224534,TRPV1,3,1.75,Efficacy,1,1,acetaminophen,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450374095
1450374917,rs2283265,DRD2,3,2.5,Toxicity,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1450374917
1450375041,rs1695,GSTP1,3,5,Toxicity,1,2,bleomycin;cisplatin;etoposide,Infection;Nausea;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450375041
1450375080,rs11615,ERCC1,3,2.5,Toxicity,1,1,bleomycin;cisplatin;etoposide,febrile neutropenia;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450375080
1450376139,rs1277441,TAOK3,3,0,Dosage;Efficacy,1,1,morphine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450376139
1451411080,rs1051792,MICA,3,6,Efficacy,1,2,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451411080
1451412069,rs1799782,XRCC1,3,2.75,Efficacy,1,1,cisplatin;fluorouracil;radiotherapy,"Carcinoma, Squamous Cell;overall survival",https://www.pharmgkb.org/clinicalAnnotation/1451412069
1450934209,rs121908547,SCN4A,3,0,Efficacy,1,1,flecainide,Myotonic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450934209
1450934539,rs869312146,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934539
1450934641,rs398123223,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934641
1451412100,rs1760944,APEX1;OSGEP,3,2.25,Efficacy,1,1,cisplatin;fluorouracil;radiotherapy,"Carcinoma, Squamous Cell;overall survival",https://www.pharmgkb.org/clinicalAnnotation/1451412100
1451411220,rs2253201,KCNMA1,3,3,Toxicity,1,1,"Ace Inhibitors, Plain",Angioedema,https://www.pharmgkb.org/clinicalAnnotation/1451411220
1449576610,rs9342288,EYS,3,1,Toxicity,1,1,"HMG CoA reductase inhibitors, other combinations",Cardiovascular Diseases;Rhabdomyolysis,https://www.pharmgkb.org/clinicalAnnotation/1449576610
1449576616,rs1337512,EYS,3,1,Toxicity,1,1,hmg coa reductase inhibitors,Rhabdomyolysis,https://www.pharmgkb.org/clinicalAnnotation/1449576616
1451413082,rs10494366,NOS1AP,3,2.75,Toxicity,1,1,glyburide,"Diabetes Mellitus, Type 2;Hypoglycemia",https://www.pharmgkb.org/clinicalAnnotation/1451413082
1449747595,rs193922768,RYR1,1A,100,Toxicity,2,3,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449747595
1449747617,rs193922762,RYR1,1A,100,Toxicity,1,2,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449747617
1449747643,rs193922748,RYR1,1A,100,Toxicity,2,3,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449747643
1450373514,rs1143634,IL1B,3,2.5,Dosage;Efficacy,1,1,morphine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450373514
1450373583,rs11249454,UGT2A1,3,1.5,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373583
1450373745,rs471760,CDA,3,2.25,Toxicity,1,1,gemcitabine,Neutropenia;Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450373745
1449170621,rs2229109,ABCB1,3,1,Efficacy,1,3,dexamethasone;lenalidomide,Multiple Myeloma;progression-free survival,https://www.pharmgkb.org/clinicalAnnotation/1449170621
1449171464,"CYP3A7*1A, CYP3A7*1C",CYP3A7,3,1,Metabolism/PK,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449171464
1449171921,rs890293,CYP2J2,3,2.5,Toxicity,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449171921
1449171933,rs3740066,ABCC2,3,1.5,Metabolism/PK,2,3,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449171933
1451413140,rs10494366,NOS1AP,3,2.75,Toxicity,1,1,glipizide,"Diabetes Mellitus, Type 2;Hypoglycemia",https://www.pharmgkb.org/clinicalAnnotation/1451413140
1449171944,"CYP2C8*1, CYP2C8*3",CYP2C8,3,1.5,Metabolism/PK,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449171944
1449172004,"CYP2C8*1, CYP2C8*3",CYP2C8,3,6,Toxicity,3,4,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449172004
1449269612,rs2231142,ABCG2,3,1.5,Metabolism/PK,2,2,apixaban,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1449269612
1449269830,rs776746,CYP3A5,3,1,Metabolism/PK,2,2,apixaban,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1449269830
1449269938,rs429358,APOE,3,2.75,Toxicity,1,1,acenocoumarol;warfarin,Hemorrhage;venous thromboembolism,https://www.pharmgkb.org/clinicalAnnotation/1449269938
1451413120,rs10494366,NOS1AP,3,2.75,Toxicity,1,1,glimepiride,"Diabetes Mellitus, Type 2;Hypoglycemia",https://www.pharmgkb.org/clinicalAnnotation/1451413120
1451411555,rs17004921,ADORA2A-AS1,3,2,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451411555
1449155302,rs1057868,POR,3,3,Efficacy,1,1,sunitinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1449155302
1449271045,rs148013902,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271045
1449271349,rs1799972,OPRM1,3,3,Toxicity,1,1,cocaine;ethanol;nicotine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449271349
1449748187,rs20455,KIF6,3,1,Efficacy,2,4,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1449748187
1450808938,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12",CYP2A6,3,1.5,Toxicity,2,5,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450808938
1450811273,rs1044394,CHRNA4,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450811273
1450812235,rs3758987,HTR3B,3,0,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812235
1450808951,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*46",CYP2A6,3,7.625,Dosage,4,4,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450808951
1450812998,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2.75,Efficacy,1,1,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450812998
655385462,rs1045642,ABCB1,3,4.25,Efficacy;Toxicity,8,8,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655385462
655385379,rs2276307,HTR3B,3,2.5,Toxicity,1,1,atorvastatin;pravastatin;simvastatin,Myalgia unspecified,https://www.pharmgkb.org/clinicalAnnotation/655385379
655385388,rs762551,CYP1A2,3,0,Toxicity,1,2,caffeine,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/655385388
655385404,rs688,LDLR,3,0.5,Efficacy,1,2,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/655385404
655385418,rs165599,COMT,3,2.75,Efficacy,1,1,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/655385418
655385426,rs1935349,HTR7,3,2,Toxicity,1,1,atorvastatin;hmg coa reductase inhibitors;pravastatin;simvastatin,Myalgia unspecified,https://www.pharmgkb.org/clinicalAnnotation/655385426
655385466,rs7992226,NALCN,3,0,Other,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/655385466
655385471,rs10821936,ARID5B,3,1.5,Other,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/655385471
655385475,rs4846051,MTHFR,3,1.5,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid;Drug Toxicity",https://www.pharmgkb.org/clinicalAnnotation/655385475
655385479,rs1800909,GGH,3,2.5,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655385479
655385483,rs1079598,DRD2,3,2.25,Toxicity,1,1,antipsychotics;clozapine;olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385483
655385491,rs6277,DRD2,3,1.75,Toxicity,1,1,antipsychotics;clozapine;olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385491
655385701,rs1045642,ABCB1,3,5.75,Efficacy;Toxicity,6,8,efavirenz;nelfinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/655385701
655385705,rs61888800,BDNF,3,2.5,Efficacy,1,1,antidepressants;desipramine;fluoxetine,"Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/655385705
655385763,rs290487,TCF7L2,3,1.5,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/655385763
655385818,rs1800629,LTA;TNF,3,2.25,Toxicity,1,1,carbamazepine,Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/655385818
655385856,rs2032582,ABCB1,3,3.75,Efficacy,2,2,paclitaxel,Breast Neoplasms;Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655385856
655385969,rs13058338,RAC2,3,2.25,Toxicity,5,5,doxorubicin;idarubicin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655385969
655385973,rs17222723,ABCC2,3,2.25,Toxicity,1,1,doxorubicin,"Arrhythmias, Cardiac;Drug Toxicity;Lymphoma, Non-Hodgkin",https://www.pharmgkb.org/clinicalAnnotation/655385973
655385977,rs1883112,NCF4,3,3.75,Toxicity,5,5,doxorubicin;idarubicin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655385977
655385981,rs45511401,ABCC1,3,3.25,Toxicity,1,1,doxorubicin,"Arrhythmias, Cardiac;Drug Toxicity;Lymphoma, Non-Hodgkin",https://www.pharmgkb.org/clinicalAnnotation/655385981
655385985,rs4673,CYBA,3,5.25,Toxicity,3,3,doxorubicin;idarubicin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655385985
655385989,rs1051740,EPHX1,3,2,Toxicity,1,1,phenytoin,Congenital Abnormalities;Craniofacial Abnormalities,https://www.pharmgkb.org/clinicalAnnotation/655385989
655385993,rs2234922,EPHX1,3,2,Toxicity,1,1,phenytoin,Congenital Abnormalities;Craniofacial Abnormalities,https://www.pharmgkb.org/clinicalAnnotation/655385993
655385814,rs2273697,ABCC2,4,-6.25,Toxicity,8,10,antiepileptics;carbamazepine;oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/655385814
655385422,rs1800497,ANKK1,3,2,Efficacy,6,6,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/655385422
655385495,rs1800497,ANKK1;DRD2,3,2.25,Toxicity,3,3,risperidone,Hyperprolactinemia;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385495
655385674,rs1414334,HTR2C,3,6.875,Toxicity,5,5,clozapine,Metabolic Syndrome;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385674
655385384,rs5443,GNB3,3,2,Efficacy,1,1,hmg coa reductase inhibitors,Hypercholesterolemia;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/655385384
655386421,rs1051266,SLC19A1,3,7.5,Toxicity,6,6,methotrexate,"Arthritis, Rheumatoid;Drug Toxicity",https://www.pharmgkb.org/clinicalAnnotation/655386421
655386436,rs1801131,MTHFR,3,4.75,Toxicity,9,9,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655386436
655386070,rs9024,CBR1,3,5.75,Dosage;Metabolism/PK,2,5,doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386070
655386079,rs8187710,ABCC2,3,2.25,Toxicity,1,1,doxorubicin,"Lymphoma, Non-Hodgkin",https://www.pharmgkb.org/clinicalAnnotation/655386079
655386083,rs714368,SLC22A16,3,3.75,Other,2,3,doxorubicin;doxorubicinol,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386083
655386088,rs20572,CBR1,3,3.5,Metabolism/PK,1,3,doxorubicin;doxorubicinol,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386088
655386093,rs7769719,PPARD,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386093
655386099,rs730720,CHST3,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386099
655386104,rs6922548,PPARD,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386104
655386109,rs4646487,CYP4B1,3,2,Toxicity,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386109
655386114,rs4148950,CHST3,3,3.5,Efficacy;Toxicity,1,2,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386114
655386120,rs4148947,CHST3,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386120
655386126,rs4148945,CHST3,3,3.5,Efficacy;Toxicity,1,2,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386126
655386131,rs4148943,CHST3,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386131
655386136,rs3734254,PPARD,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386136
655386141,rs2301159,SLC10A2,3,2,Toxicity,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386141
655386146,rs2292954,SPG7,3,2,Toxicity,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386146
655386151,rs2238472,ABCC6,3,2,Toxicity,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386151
655386156,rs2227291,ATP7A,3,2,Toxicity,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386156
655386161,rs2016520,PPARD,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386161
655386166,rs1883322,PPARD,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386166
655386171,rs1871450,CHST3,3,3.5,Efficacy;Toxicity,1,2,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386171
655386176,rs1799931,NAT2,3,2,Toxicity,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386176
655386181,rs1402467,SULT1C4,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386181
655386186,rs12960,RPL13;SNORD68;SPG7,3,2,Toxicity,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386186
655386191,rs12418,CHST3,3,2,Efficacy,1,1,docetaxel;thalidomide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386191
655386212,rs2070995,KCNJ6,3,3.75,Efficacy,2,3,Analgesics,Pain,https://www.pharmgkb.org/clinicalAnnotation/655386212
655386585,rs1142345,TPMT,3,3.75,Toxicity,8,8,cisplatin,Drug Toxicity;Neoplasms;Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/655386585
655386310,rs870995,PIK3CA,3,0.25,Dosage,1,1,docetaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/655386310
655386315,rs518329,PRDX4,3,0.25,Dosage,1,1,docetaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/655386315
655386320,rs2234922,EPHX1,3,0.25,Dosage,1,1,docetaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/655386320
655386324,rs1382368,XRCC4,3,0.25,Dosage,1,1,docetaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/655386324
655386447,rs11042725,ADM,3,3.25,Efficacy,1,1,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/655386447
655386550,rs1801133,CLCN6;MTHFR,3,2.25,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655386550
655386589,rs4646316,COMT,3,2.25,Toxicity,7,7,cisplatin,Drug Toxicity;Neoplasms;Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/655386589
655386593,rs12201199,TPMT,3,1.75,Toxicity,9,9,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386593
655386597,rs1800460,TPMT,3,2.25,Toxicity,6,6,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386597
655386601,rs9332377,COMT,3,2.75,Toxicity,8,8,cisplatin,Drug Toxicity;Neoplasms;Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/655386601
655386616,rs13181,ERCC2;KLC3,3,3.5,Efficacy,9,10,cisplatin;oxaliplatin;platinum;Platinum compounds,Colorectal Neoplasms;Esophageal Neoplasms;Osteosarcoma;Ovarian Neoplasms;Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386616
655386649,rs1799735,GSTM3,3,2.75,Toxicity,2,5,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386649
655386665,rs3212986,CD3EAP;ERCC1;PPP1R13L,3,2,Efficacy,1,1,Platinum compounds,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386665
655386801,rs3957357,GSTA1,3,1.75,Toxicity,1,1,cisplatin;cyclophosphamide,Anemia;Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386801
655386830,rs60369023,CDA,3,1.5,Toxicity,3,3,gemcitabine,Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/655386830
655386852,rs1799889,SERPINE1,3,2,Efficacy,1,1,antidepressants;citalopram;fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/655386852
655386856,rs2227631,SERPINE1,3,2,Efficacy,1,1,antidepressants;citalopram;fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/655386856
655386869,rs1544410,VDR,3,3.75,Efficacy,2,2,alendronate,Osteoporosis,https://www.pharmgkb.org/clinicalAnnotation/655386869
655386873,rs731236,VDR,3,2.75,Efficacy,1,1,clodronate,Osteitis Deformans,https://www.pharmgkb.org/clinicalAnnotation/655386873
655386888,rs16944,IL1B,3,3,Efficacy,1,1,Bisphosphonates;clodronate;etidronic acid;risedronate;tiludronate,Osteitis Deformans,https://www.pharmgkb.org/clinicalAnnotation/655386888
655386244,rs1045642,ABCB1,3,6.25,Toxicity,3,3,nevirapine,HIV Infections;Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/655386244
655386612,rs2228001,XPC,3,0.75,Toxicity,2,2,cisplatin,Neoplasms;Osteosarcoma;Ototoxicity;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386612
655386639,rs11615,ERCC1,3,3.25,Toxicity,6,6,carboplatin;cisplatin;oxaliplatin;platinum;Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386639
655386661,rs3212986,ERCC1,3,4,Toxicity,3,3,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386661
655386657,rs25487,XRCC1,2B,11.25,Efficacy,16,19,Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386657
655387949,rs4149056,SLCO1B1,3,6.875,Metabolism/PK,9,9,methotrexate,Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/655387949
655386969,rs3761422,ADORA2A,3,2.75,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655386969
655386981,rs2267076,ADORA2A,3,2.75,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655386981
655387942,rs11045879,SLCO1B1,4,-0.25,Toxicity,3,3,methotrexate,Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/655387942
655386990,rs2279343,CYP2B6,3,3,Toxicity,1,1,cyclophosphamide,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/655386990
655386995,rs2740574,CYP3A4,3,2.25,Toxicity,1,1,cyclophosphamide,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655386995
655386999,rs8192709,CYP2B6,3,2.5,Toxicity,1,1,cyclophosphamide,Cystitis;Transplantation,https://www.pharmgkb.org/clinicalAnnotation/655386999
655387004,rs9561778,ABCC4,3,7.75,Toxicity,1,3,cyclophosphamide,Breast Neoplasms;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/655387004
655387009,rs1799983,NOS3,3,3.25,Efficacy,2,3,cyclophosphamide;doxorubicin;fluorouracil;methotrexate,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655387009
655387014,rs2070744,NOS3,3,3,Efficacy,1,1,cyclophosphamide;doxorubicin;fluorouracil;methotrexate,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655387014
655387023,rs2072671,CDA,3,7,Toxicity,7,9,cytarabine,Leukemia;Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/655387023
655387027,rs532545,CDA,3,6.5,Efficacy,4,6,cytarabine,"Leukemia, Myeloid, Acute;Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/655387027
699639332,rs1801131,MTHFR,4,-1.125,Toxicity,22,23,methotrexate,"Burkitt Lymphoma;Lymphoma, Non-Hodgkin;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/699639332
655387221,rs6280,DRD3,3,1.5,Efficacy,1,1,risperidone,Autistic Disorder,https://www.pharmgkb.org/clinicalAnnotation/655387221
655387229,rs1128503,ABCB1,3,1.5,Efficacy,1,1,risperidone,Autistic Disorder,https://www.pharmgkb.org/clinicalAnnotation/655387229
655387237,rs6311,HTR2A,3,1.5,Efficacy,1,1,risperidone,Autistic Disorder,https://www.pharmgkb.org/clinicalAnnotation/655387237
655387257,rs7799039,LEP,3,6,Toxicity,4,4,antipsychotics;risperidone,Autism Spectrum Disorder;Mood Disorders,https://www.pharmgkb.org/clinicalAnnotation/655387257
655387688,rs1800497,ANKK1,3,1.5,Toxicity,1,1,nemonapride,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655387688
699639249,"CYP3A5*1, CYP3A5*3",CYP3A5,3,2,Toxicity,1,1,paclitaxel,Neoplasms;Neurotoxicity Syndromes,https://www.pharmgkb.org/clinicalAnnotation/699639249
655387821,rs2853539,TYMS,3,3.25,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655387821
655387825,rs1544105,FPGS,3,3.25,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655387825
655387876,rs167771,DRD3,3,2.75,Toxicity,1,1,risperidone,Bipolar Disorder;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655387876
655388022,rs1045642,ABCB1,3,1.75,Other,1,1,prednisone;tacrolimus,Organ Transplantation;Transplantation,https://www.pharmgkb.org/clinicalAnnotation/655388022
655388510,rs1799732,DRD2,3,1.25,Efficacy,10,11,antipsychotics;aripiprazole;bromperidol;chlorpromazine;clozapine;nemonapride;olanzapine;risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655388510
699639336,rs1801131,MTHFR,3,1.25,Efficacy,9,11,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/699639336
699639343,rs2016848,MME,3,2.5,Toxicity,1,1,"Ace Inhibitors, Plain",Cough;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/699639343
699639347,rs11209716,PTGER3,3,2.5,Toxicity,1,1,"Ace Inhibitors, Plain",Cough;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/699639347
699639351,rs8012552,BDKRB2,3,2,Toxicity,1,1,"Ace Inhibitors, Plain",Cough;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/699639351
699642190,rs10879346,TPH2,3,3,Efficacy,1,1,antidepressants;mirtazapine;venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/699642190
769171387,rs1695,GSTP1,3,2.5,Toxicity,1,1,fluorouracil,Rectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/769171387
769171582,rs334558,GSK3B,3,2.5,Efficacy,1,1,citalopram;fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/769171582
655387245,rs3813928,HTR2C,3,1.5,Efficacy,1,1,risperidone,Autistic Disorder,https://www.pharmgkb.org/clinicalAnnotation/655387245
655387938,rs4149081,SLCO1B1,3,4,Toxicity,1,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/655387938
655386985,rs2236624,ADORA2A,3,1.75,Toxicity,2,2,methotrexate,"adverse events;Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655386985
655386961,rs2298383,ADORA2A,3,1.25,Toxicity,2,2,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655386961
655386945,rs7793837,CRHR2,3,2.75,Efficacy,1,3,salbutamol,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655386945
655387053,"CYP3A5*1, CYP3A5*3",CYP3A5,3,3.25,Dosage,3,3,cyclosporine,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/655387053
655387895,rs70991108,DHFR,3,0.5,Toxicity,3,3,methotrexate,drug-induced liver injury;Leukopenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/655387895
637879869,rs11545078,GGH,3,2,Toxicity,2,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/637879869
637879631,rs25531,SLC6A4,4,-1.25,Efficacy,2,3,fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/637879631
613977037,rs2227956,HSPA1L,3,2.25,Toxicity,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/613977037
613977064,rs2236196,CHRNA4,3,2,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/613977064
613979021,rs1042714,ADRB2,3,5.25,Efficacy,4,4,carvedilol,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/613979021
613979403,rs5443,GNB3,3,3,Efficacy,1,1,sumatriptan,Cluster Headache,https://www.pharmgkb.org/clinicalAnnotation/613979403
618376538,rs2236196,CHRNA4,3,0.25,Other,2,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/618376538
619523389,rs12720441,KCNH2,3,0,Toxicity,1,1,amiodarone,Torsades de Pointes,https://www.pharmgkb.org/clinicalAnnotation/619523389
619523400,rs9937,RRM1,3,5.75,Efficacy;Toxicity,5,8,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/619523400
619523414,rs2032583,ABCB1,3,5.25,Efficacy,3,3,amitriptyline;antidepressants;citalopram;fluvoxamine;paroxetine;sertraline;venlafaxine,"Depression;Depressive Disorder;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/619523414
619523422,rs2235015,ABCB1,3,1,Efficacy,2,2,amitriptyline;antidepressants;citalopram;paroxetine;venlafaxine,"Depression;Depressive Disorder;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/619523422
637879637,rs1127354,ITPA,3,2.25,Efficacy,1,1,azathioprine;purine analogues,"Lupus Erythematosus, Systemic",https://www.pharmgkb.org/clinicalAnnotation/637879637
637879864,rs5760410,ADORA2A;SPECC1L,3,3.25,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879864
637879932,rs2814707,MOB3B,3,2.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879932
637879937,rs3849942,C9orf72,3,0,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879937
637879942,rs437943,ARAP2,3,0,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879942
637879947,rs6138150,CST5,3,2.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879947
637879952,rs7046653,MOB3B,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879952
637879957,rs854555,PON1,3,2.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879957
637879962,rs854548,PON1,3,0,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879962
637879967,rs854547,PON1,3,0,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879967
637879972,rs6028945,MAFB,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879972
637879977,rs6071980,MAFB,3,2.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879977
637879982,rs983332,CSRP3,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879982
637879987,rs774359,C9orf72,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879987
637879992,rs868856,MOB3B,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879992
637879997,rs928655,GBP6,3,0,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/637879997
613976757,rs2234922,EPHX1,3,4.25,Dosage,6,7,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/613976757
613978937,rs3812718,SCN1A,3,2.25,Dosage,2,2,phenytoin,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/613978937
613979643,rs730012,LTC4S,3,4.5,Toxicity,3,3,aspirin,Urticaria,https://www.pharmgkb.org/clinicalAnnotation/613979643
619523395,rs2297480,FDPS,3,2.5,Efficacy,2,2,Bisphosphonates,"Osteoporosis;Osteoporosis, Postmenopausal",https://www.pharmgkb.org/clinicalAnnotation/619523395
637880014,rs2032582,ABCB1,3,2.5,Toxicity,1,1,Platinum compounds;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880014
655384011,rs4149056,SLCO1B1,1A,211.75,Toxicity,9,12,simvastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/655384011
637880217,rs1695,GSTP1,3,6,Toxicity,6,6,cisplatin;oxaliplatin;Platinum compounds,"Carcinoma, Non-Small-Cell Lung;Colorectal Neoplasms;Gastrointestinal Neoplasms;Ovarian Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/637880217
637880425,rs7997012,HTR2A,3,6.75,Efficacy,5,6,citalopram,Depression;Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/637880425
637880226,rs1695,GSTP1,3,1.5,Efficacy,3,4,Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880226
637880243,rs712829,EGFR,3,0,Efficacy,1,1,erlotinib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880243
637880250,rs712829,EGFR,3,0,Efficacy,1,1,topoisomerase I inhibitors,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880250
637880258,rs712829,EGFR,3,0,Efficacy,1,1,geldanamycin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880258
637880263,rs712829,EGFR,3,0,Efficacy,1,1,Alkylating Agents,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880263
637880267,rs712829,EGFR,3,4.5,Efficacy,1,2,gefitinib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880267
637880078,rs2075252,LRP2,4,-1,Toxicity,3,3,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880078
652472012,rs12050217,BDKRB1,3,5.5,Efficacy,2,2,perindopril,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/652472012
652509715,rs275651,AGTR1,3,5.5,Efficacy,2,2,perindopril,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/652509715
652519736,rs5182,AGTR1,3,3,Efficacy,2,2,perindopril,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/652519736
652595205,rs10836235,CAT,3,1.75,Toxicity,1,1,anthracyclines and related substances,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/652595205
652882846,rs8133052,CBR3,3,5.75,Efficacy;Toxicity,1,4,doxorubicin,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/652882846
655384474,rs2032582,ABCB1,3,2.5,Toxicity,1,1,Platinum compounds;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655384474
655384485,rs9344,CCND1,3,2,Efficacy,3,3,cetuximab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655384485
655384510,rs7569963,CREB1;METTL21A,3,5,Efficacy;Toxicity,2,2,antidepressants;citalopram,Depression,https://www.pharmgkb.org/clinicalAnnotation/655384510
655384529,rs742105,DTNBP1,3,2.5,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384529
655384539,rs2032582,ABCB1,3,3,Efficacy,1,1,cyclosporine,"Colitis, Ulcerative",https://www.pharmgkb.org/clinicalAnnotation/655384539
655384546,rs1128503,ABCB1,3,2.75,Dosage,4,4,cyclosporine,Kidney Transplantation;Myasthenia Gravis,https://www.pharmgkb.org/clinicalAnnotation/655384546
637880221,rs1695,GSTP1,3,7.75,Toxicity,3,3,Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880221
652779372,rs1056892,CBR3,3,2.75,Toxicity,2,2,anthracyclines and related substances,Heart Failure;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/652779372
655384534,rs4880,SOD2,3,2.5,Efficacy,1,1,cyclophosphamide,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655384534
655384563,rs3800373,FKBP5,3,2.5,Efficacy,5,6,antidepressants,Depression,https://www.pharmgkb.org/clinicalAnnotation/655384563
655384568,rs1360780,FKBP5,3,5.75,Efficacy,7,9,antidepressants;citalopram;clomipramine;lithium;nefazodone;paroxetine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/655384568
655384578,rs2740574,CYP3A4,3,3.5,Toxicity;Metabolism/PK,4,5,docetaxel,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655384578
655384582,rs11045819,SLCO1B1,3,3,Efficacy,1,1,fluvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/655384582
655384592,rs12721627,CYP3A;CYP3A4,3,0,Dosage,1,1,paclitaxel,"Carcinoma, Non-Small-Cell Lung;Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/655384592
655384602,rs951439,RGS4,3,1.75,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384602
655384607,rs951439,RGS4,3,5,Efficacy,1,3,antipsychotics;olanzapine;perphenazine;quetiapine;ziprasidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384607
655384794,rs1799722,BDKRB2,4,-1.25,Toxicity,7,7,"Ace Inhibitors, Plain",Cough,https://www.pharmgkb.org/clinicalAnnotation/655384794
655384670,rs7412,APOE,3,1.75,Toxicity,2,2,"Antivirals for treatment of HIV infections, combinations;ritonavir",HIV Infections;Hyperlipidemias;Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/655384670
655384694,rs4343,ACE,3,2.5,Efficacy,1,1,sildenafil,Erectile Dysfunction,https://www.pharmgkb.org/clinicalAnnotation/655384694
655384767,rs5065,NPPA,3,2,Efficacy,1,3,amlodipine;chlorthalidone,Cardiovascular Diseases;Coronary Disease;Stroke,https://www.pharmgkb.org/clinicalAnnotation/655384767
655384772,rs6295,HTR1A,3,5.75,Efficacy,7,8,antidepressants;fluvoxamine;paroxetine;Selective serotonin reuptake inhibitors;sertraline,"Depressive Disorder;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/655384772
655384781,rs4253778,PPARA,3,2.5,Efficacy,1,1,Beta Blocking Agents,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/655384781
655384804,rs2781659,ARG1,3,3,Efficacy,1,1,selective beta-2-adrenoreceptor agonists,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655384804
655384809,rs622342,SLC22A1,3,3,Efficacy,2,4,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/655384809
655384813,rs1801253,ADRB1,3,0,Toxicity,1,1,muraglitazar,Diabetes Mellitus;Edema;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/655384813
655384817,rs5370,EDN1,3,2.75,Toxicity,1,1,muraglitazar,Diabetes Mellitus;Edema;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/655384817
1184747247,HLA-A*02:01,HLA-A,3,1.75,Toxicity,3,3,allopurinol,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1184747247
655384597,rs1934951,CYP2C8,4,-1.25,Toxicity,2,2,Bisphosphonates;pamidronate;zoledronate,Multiple Myeloma;Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/655384597
655384799,rs1800629,TNF,2B,14.625,Efficacy,7,7,etanercept,"Arthritis, Psoriatic;Arthritis, Rheumatoid;Crohn Disease;Inflammation;Psoriasis;Spondylitis, Ankylosing",https://www.pharmgkb.org/clinicalAnnotation/655384799
655384621,rs20455,KIF6,2B,8.5,Efficacy,4,5,pravastatin,Coronary Disease;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/655384621
655384966,rs518147,HTR2C,3,3.25,Toxicity,5,5,olanzapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/655384966
655384975,rs2842030,RGS4,3,2,Efficacy,1,1,olanzapine;perphenazine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384975
655384842,rs11572080,CYP2C8,3,2,Toxicity,1,1,paclitaxel,Drug Toxicity;Neurotoxicity Syndromes,https://www.pharmgkb.org/clinicalAnnotation/655384842
655384846,rs1045642,ABCB1,3,1.75,Toxicity,1,1,nortriptyline,"Depression;Depressive Disorder;Depressive Disorder, Major;Hypotension",https://www.pharmgkb.org/clinicalAnnotation/655384846
655384850,rs1045642,ABCB1,3,1,Metabolism/PK,1,1,lansoprazole;tacrolimus,Gastroesophageal Reflux;Transplantation,https://www.pharmgkb.org/clinicalAnnotation/655384850
655384854,rs2740574,CYP3A4,3,1,Other,1,1,indinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/655384854
655384862,rs10042486,HTR1A,3,2.5,Efficacy,1,1,fluvoxamine;milnacipran;paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/655384862
655384866,rs909706,DTNBP1,3,0,Efficacy,1,1,haloperidol,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384866
655384878,rs4933824,NRG3,3,0,Toxicity,1,1,iloperidone,Acquired Long QT Syndrome (aLQTS),https://www.pharmgkb.org/clinicalAnnotation/655384878
655384882,rs7142881,NUBPL,3,0,Toxicity,1,1,iloperidone,Acquired Long QT Syndrome (aLQTS),https://www.pharmgkb.org/clinicalAnnotation/655384882
655384886,rs4799915,CELF4,3,0,Toxicity,1,1,iloperidone,Acquired Long QT Syndrome (aLQTS),https://www.pharmgkb.org/clinicalAnnotation/655384886
655384890,rs993648,CERKL,3,0,Toxicity,1,1,iloperidone,Acquired Long QT Syndrome (aLQTS),https://www.pharmgkb.org/clinicalAnnotation/655384890
655384894,rs10918594,NOS1AP,3,0,Toxicity,1,1,verapamil,Acquired Long QT Syndrome (aLQTS),https://www.pharmgkb.org/clinicalAnnotation/655384894
655384898,rs10494366,NOS1AP,3,3,Toxicity,1,1,verapamil,Acquired Long QT Syndrome (aLQTS),https://www.pharmgkb.org/clinicalAnnotation/655384898
655384902,rs762551,CYP1A2,4,-0.75,Toxicity,2,2,leflunomide,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655384902
655384906,rs3213422,DHODH,3,0,Efficacy,1,1,leflunomide,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655384906
655384918,rs2076369,PICK1,3,2.25,Toxicity,1,1,methamphetamine,Psychotic Disorders;Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/655384918
655384922,rs3213207,DTNBP1,3,2.75,Toxicity,1,1,methamphetamine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/655384922
655384926,rs2619538,DTNBP1,3,0,Toxicity,1,1,methamphetamine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/655384926
655384930,rs2115819,ALOX5,3,1.75,Efficacy,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655384930
655384934,rs2660845,LTA4H,3,2.25,Efficacy,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655384934
655384938,rs730012,LTC4S,3,2.25,Efficacy,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655384938
655384942,rs5443,GNB3,3,2,Toxicity,1,1,olanzapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/655384942
655384946,rs6313,HTR2A,3,2.5,Toxicity,1,1,olanzapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/655384946
655384950,rs6313,HTR2A,3,0,Efficacy,1,1,olanzapine;risperidone,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/655384950
655384954,rs6318,HTR2C,3,1.25,Toxicity,5,5,risperidone,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/655384954
655384958,rs4994,ADRB3,3,2,Toxicity,1,1,olanzapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/655384958
655384962,rs6280,DRD3,3,1.75,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384962
655384979,rs2842030,RGS4,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384979
655384983,rs4731426,LEP,3,2.5,Toxicity,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655384983
655384987,rs1123617,SLC14A2,3,4.5,Efficacy,1,2,nifedipine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/655384987
655384991,rs3745009,SLC14A2,3,4.5,Efficacy,1,2,nifedipine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/655384991
655385054,rs1800497,ANKK1;DRD2,4,-0.75,Efficacy,3,3,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385054
655385033,rs1136201,ERBB2,3,2.25,Toxicity,1,1,trastuzumab,Breast Neoplasms;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/655385033
655385037,rs6280,DRD3,3,1.5,Efficacy,1,1,pramipexole,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/655385037
655385050,rs2661319,RGS4,3,2.5,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385050
655385062,rs2494732,AKT1,3,0.25,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385062
655385067,rs3803300,AKT1,3,0.25,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385067
655385072,rs165599,COMT,3,2,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385072
655385077,rs724226,GRM3,3,2,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655385077
655385082,rs2854117,APOC3,3,4.25,Toxicity,2,2,ritonavir,HIV Infections;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/655385082
655385087,rs2854116,APOC3,3,2.5,Toxicity,1,1,ritonavir,HIV Infections;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/655385087
655385092,rs5128,APOC3,3,2.5,Toxicity,1,1,ritonavir,HIV Infections;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/655385092
655385097,rs10192566,LPIN1,3,2.75,Efficacy,1,1,rosiglitazone,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/655385097
655385110,rs2267715,CRHR2,3,0.75,Efficacy,1,2,salbutamol;selective beta-2-adrenoreceptor agonists,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655385110
655384971,rs3813929,HTR2C,3,1.5,Toxicity,3,3,antipsychotics,Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/655384971
655385102,rs1042713,ADRB2,2A,11.75,Efficacy,7,7,salmeterol,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655385102
655385164,rs1138272,GSTP1,3,1.5,Metabolism/PK,1,1,thiotepa,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/655385164
655385134,rs12255372,TCF7L2,3,3,Efficacy,1,1,"sulfonamides, urea derivatives","Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/655385134
655385139,rs5219,KCNJ11,3,1.5,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/655385139
655385159,rs1751034,ABCC4,3,0.5,Metabolism/PK,5,5,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/655385159
655385307,rs1801133,MTHFR,2A,12.75,Toxicity,12,12,methotrexate,"Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Arthritis, Rheumatoid;Drug Toxicity",https://www.pharmgkb.org/clinicalAnnotation/655385307
655385168,rs1487278,TPH2,3,2.5,Efficacy,1,1,mirtazapine;venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/655385168
655385178,rs119774,ABCC1,3,2.25,Efficacy,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655385178
655385195,rs12422149,SLCO2B1,3,1.625,Efficacy,2,2,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655385195
655385210,rs2368564,REN,3,2.75,Toxicity,1,1,muraglitazar,Diabetes Mellitus;Edema;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/655385210
655385257,rs28364006,ABCC1,3,2.25,Efficacy,1,1,methotrexate,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/655385257
655385262,rs2238476,ABCC1,3,5,Efficacy;Toxicity,1,2,methotrexate,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/655385262
655385267,rs35592,ABCC1,3,1.75,Efficacy,2,2,methotrexate,"Arthritis, Rheumatoid;Psoriasis",https://www.pharmgkb.org/clinicalAnnotation/655385267
655385272,rs17731538,ABCG2,3,2.75,Efficacy,1,1,methotrexate,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/655385272
655385277,rs246240,ABCC1,3,2.75,Toxicity,1,1,methotrexate,Drug Toxicity;Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/655385277
655385286,rs13120400,ABCG2,3,2.25,Efficacy,1,1,methotrexate,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/655385286
655385299,rs2372536,ATIC,3,5.75,Efficacy,11,14,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655385299
655385323,rs45445694,C18orf56;TYMS,3,2,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/655385323
655385115,rs2284220,CRHR2,4,-1.25,Efficacy,1,3,salbutamol;selective beta-2-adrenoreceptor agonists,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655385115
655385361,rs1044396,CHRNA4,3,5.5,Other,2,3,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/655385361
655385369,rs1367117,APOB,3,4,Efficacy,1,2,irbesartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/655385369
655385120,rs255100,CRHR2,4,-0.75,Efficacy,1,3,salbutamol;selective beta-2-adrenoreceptor agonists,Asthma,https://www.pharmgkb.org/clinicalAnnotation/655385120
655385125,rs5443,GNB3,3,3,Efficacy,1,1,sildenafil,Erectile Dysfunction,https://www.pharmgkb.org/clinicalAnnotation/655385125
655385205,rs4680,COMT,3,0.5,Dosage,9,9,morphine,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/655385205
1449713004,HLA-A*11:01,HLA-A,3,3.25,Toxicity,1,1,levetiracetam,adverse events;Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1449713004
1449716951,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35, CYP2A6*46",CYP2A6,3,4.875,Metabolism/PK,3,3,letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449716951
1449748511,rs1128503,ABCB1,3,2.25,Efficacy,1,1,tacrolimus,Nephrotic Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1449748511
1450371713,rs1801274,FCGR2A,3,2.25,Efficacy,1,1,rituximab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1450371713
1450373100,rs7905446,HTR7,3,4.75,Efficacy,1,2,Selective serotonin reuptake inhibitors,Depression,https://www.pharmgkb.org/clinicalAnnotation/1450373100
1450373628,rs12659,SLC19A1,3,1.5,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373628
1450373634,rs1051266,SLC19A1,3,1.5,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373634
981237695,rs17222723,ABCC2,3,0.5,Toxicity,2,2,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981237695
981237950,rs1695,GSTP1,3,0.5,Efficacy,2,2,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981237950
981204890,rs1800497,ANKK1;DRD2,3,0.5,Toxicity,9,9,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/981204890
981344897,rs4149056,SLCO1B1,3,3.5,Toxicity,1,1,cerivastatin,Rhabdomyolysis,https://www.pharmgkb.org/clinicalAnnotation/981344897
981352141,rs1050828,G6PD,4,-2,Toxicity,2,3,artesunate;chlorproguanil;dapsone,Malaria,https://www.pharmgkb.org/clinicalAnnotation/981352141
827830327,rs1127354,DDRGK1;ITPA,3,3,Efficacy,1,1,azathioprine,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/827830327
827831021,rs532545,CDA,3,4.5,Toxicity,4,5,cytarabine,"Leukemia, Myeloid",https://www.pharmgkb.org/clinicalAnnotation/827831021
827831123,rs712829,EGFR,3,2.25,Toxicity,1,1,erlotinib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/827831123
827831417,rs3212986,ERCC1,4,-3.875,Efficacy,5,7,Platinum compounds,"Carcinoma, Non-Small-Cell Lung;Ovarian Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/827831417
1451415425,rs7668258,UGT2B7,3,2.75,Dosage,1,1,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451415425
981188336,rs45445694,TYMS,3,1.75,Efficacy,8,8,methotrexate,Neoplasms;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/981188336
827847738,rs9895420,ABCC3,3,3.25,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/827847738
827847744,rs9679162,GALNT14,3,7.25,Efficacy,2,3,cisplatin;fluorouracil;mitoxantrone,"Carcinoma, Hepatocellular;Liver Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/827847744
827847751,rs9657182,IDO1,3,1.5,Toxicity,1,2,"interferon alfa-2a, recombinant;peginterferon alfa-2b","Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/827847751
827847768,rs9597,UBE2I,3,3,Efficacy,1,1,cisplatin;irinotecan,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/827847768
827848563,rs943580,AGT,3,2.75,Toxicity,1,1,"Antiinflammatory agents, non-steroids",Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/827848563
827849079,rs1042028,SULT1A1,3,0,Toxicity,1,1,conjugated estrogens,Endometrial Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/827849079
827849095,rs9274407,HLA-DQB1,3,0,Toxicity,1,1,amoxicillin;clavulanate,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/827849095
827848555,rs9514091,SLC10A2,4,-1.5,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/827848555
981201399,rs2273697,ABCC2,4,-4.5,Toxicity,5,5,tenofovir,HIV Infections;Kidney Diseases,https://www.pharmgkb.org/clinicalAnnotation/981201399
981188353,rs2070959,UGT1A10;UGT1A6;UGT1A7;UGT1A8;UGT1A9,3,5,Dosage,2,3,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981188353
981188379,rs2072671,CDA,3,1,Toxicity,6,6,gemcitabine,"Carcinoma, Non-Small-Cell Lung;Mesothelioma;Pancreatic Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/981188379
981201333,rs2227983,EGFR,3,1,Toxicity,4,4,egfr inhibitors,"Carcinoma, Non-Small-Cell Lung;Colorectal Neoplasms;Neoplasms;Pancreatic Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/981201333
981201817,rs28399454,CYP2A6,4,-6,Other,8,8,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981201817
981201864,rs2046934,P2RY12,4,-4.5,Efficacy,19,19,clopidogrel,Acute coronary syndrome;Angina Pectoris,https://www.pharmgkb.org/clinicalAnnotation/981201864
981201895,rs1045642,ABCB1,4,-5.75,Efficacy,15,16,antiepileptics,"Epilepsies, Partial;Epilepsy;Epilepsy, Generalized",https://www.pharmgkb.org/clinicalAnnotation/981201895
981202068,rs662,PON1,4,-37.25,Efficacy;Toxicity,29,40,clopidogrel,Angina Pectoris;Coronary Artery Disease;Myocardial Infarction;Myocardial Ischemia;Thrombosis,https://www.pharmgkb.org/clinicalAnnotation/981202068
981202261,rs3740066,ABCC2,4,-5,Efficacy,4,5,antiepileptics,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981202261
827848548,rs9561778,ABCC4,3,2.75,Toxicity,1,1,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/827848548
978608464,rs1801133,MTHFR,3,4.25,Efficacy,2,2,methotrexate,"Graft vs Host Disease;Leukemia;Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/978608464
827923032,rs3745274,CYP2B6,1A,229.0625,Metabolism/PK,77,89,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/827923032
827923042,rs3745274,CYP2B6,1A,109.25,Toxicity,29,31,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/827923042
981201535,rs2297595,DPYD,1A,75.5,Toxicity,17,19,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981201535
981201981,rs1801265,DPYD,1A,93.25,Toxicity,17,19,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981201981
981202294,rs3745274,CYP2B6,2A,24.625,Metabolism/PK,16,17,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981202294
981202609,rs4673993,ATIC,2B,11.875,Efficacy,5,5,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/981202609
981202714,rs4961,ADD1,2B,12,Efficacy,8,8,hydrochlorothiazide,Essential hypertension;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/981202714
981755820,rs113993960,CFTR,4,-3.25,Efficacy,9,9,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/981755820
1451415660,HLA-DRB1*08:03,HLA-DRB1,3,4.25,Toxicity,2,2,Antithyroid Preparations,Agranulocytosis;Graves Disease,https://www.pharmgkb.org/clinicalAnnotation/1451415660
981204695,rs1799971,OPRM1,4,-2.125,Efficacy,16,17,naltrexone,Alcoholism;hypersexuality state;Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/981204695
981237907,rs1127354,ITPA,3,6.75,Dosage,2,3,"interferon alfa-2b, recombinant;ribavirin","Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/981237907
1451415686,HLA-DQB1*06:01,HLA-DQB1,3,2.75,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis;Graves Disease,https://www.pharmgkb.org/clinicalAnnotation/1451415686
1451415680,HLA-B*39:01,HLA-B,3,3,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis;Graves Disease,https://www.pharmgkb.org/clinicalAnnotation/1451415680
1451416140,rs745364489,BCHE,3,0.5,Toxicity,2,2,succinylcholine,Apnea,https://www.pharmgkb.org/clinicalAnnotation/1451416140
981238370,rs1979277,SHMT1,3,0.5,Toxicity,3,3,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/981238370
1451416408,rs6311,HTR2A,3,1.125,Toxicity,1,1,antidepressants,"adverse events;Bipolar Disorder;Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1451416408
981237900,rs11212617,ATM;C11orf65,4,-2,Efficacy,6,6,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/981237900
1451416400,rs6311,HTR2A,4,-3,Efficacy,3,5,antidepressants,"Bipolar Disorder;Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1451416400
1451416422,rs6313,HTR2A,3,1.5,Toxicity,1,1,antidepressants,"adverse events;Bipolar Disorder;Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1451416422
1451416434,rs7997012,HTR2A,3,1.5,Efficacy,5,6,antidepressants,"Bipolar Disorder;Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1451416434
981238025,rs2032582,ABCB1,3,1.5,Efficacy,2,2,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981238025
981240029,rs5219,KCNJ11,3,1.25,Efficacy,4,7,"sulfonamides, urea derivatives","Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/981240029
1451416940,"UGT1A1*1, UGT1A1*28",UGT1A1,3,3,Toxicity,1,1,FOLFIRINOX,Pancreatic Neoplasms;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1451416940
1451416946,rs2072671,CDA,3,2.25,Toxicity,1,1,gemcitabine;paclitaxel,Nausea;Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451416946
1451417123,rs1128503,ABCB1,3,1.25,Metabolism/PK,1,1,temozolomide,Glioma,https://www.pharmgkb.org/clinicalAnnotation/1451417123
981202598,rs4444903,EGF,3,3.75,Efficacy,5,5,cetuximab,Colorectal Neoplasms;Rectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981202598
981202618,rs4680,COMT,3,5,Efficacy,4,5,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/981202618
981220481,rs1801133,MTHFR,3,4,Toxicity,4,5,cisplatin;oxaliplatin;Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981220481
981475986,rs11568315,EGFR,3,7.5,Efficacy,4,4,gefitinib,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/981475986
981202393,rs1801394,MTRR,3,1.75,Toxicity,2,2,methotrexate,Drug Toxicity;Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/981202393
1451264120,rs772226819,CACNA1S,1A,100.25,Toxicity,2,3,methoxyflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451264120
1451282340,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,1A,384.625,Efficacy,100,159,clopidogrel,Cardiovascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/1451282340
1451282440,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17",CYP2C19,1A,380.25,Efficacy;Toxicity,62,117,clopidogrel,"Acute coronary syndrome;Cardiovascular Diseases;Ischemic Attack, Transient;Stroke",https://www.pharmgkb.org/clinicalAnnotation/1451282440
1451282840,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4",CYP2C19,1A,200.375,Toxicity,7,10,citalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451282840
1451286040,rs1801160,DPYD,1A,101.75,Toxicity,13,14,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451286040
1451286320,rs1801159,DPYD,1A,81.25,Toxicity,12,13,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451286320
1451286326,rs1801158,DPYD,1A,82.5,Toxicity,13,14,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451286326
1451287240,rs1801265,DPYD,1A,93.25,Toxicity,11,13,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451287240
1451287360,rs2297595,DPYD,1A,84,Toxicity,17,19,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451287360
1451287440,rs17376848,DPYD,1A,96.25,Toxicity,9,10,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451287440
1451329460,"UGT1A1*1, UGT1A1*6",UGT1A1,1B,34.5,Toxicity,15,21,FOLFIRI;irinotecan,Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1451329460
1451332611,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",CYP2D6,1A,102,Toxicity,3,4,desipramine,"Depressive Disorder;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1451332611
1451288269,rs56038477,DPYD,1A,199.75,Toxicity,11,13,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451288269
1451265780,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",CYP2D6,1A,209.375,Toxicity,5,8,clomipramine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1451265780
1451285360,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",CYP2D6,1A,204.875,Toxicity,6,8,nortriptyline,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451285360
1451282740,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,1A,241.875,Metabolism/PK,11,28,escitalopram,"Depressive Disorder, Major;Mental Disorders",https://www.pharmgkb.org/clinicalAnnotation/1451282740
981202790,rs4961,ADD1,3,1.75,Efficacy,2,2,diuretics,Hypertension;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/981202790
981204258,rs1045642,ABCB1,4,-1.25,Toxicity,3,4,paclitaxel,Drug Toxicity;Neoplasms;Neutropenia;Peripheral Nervous System Diseases,https://www.pharmgkb.org/clinicalAnnotation/981204258
981203854,rs776746,CYP3A5,3,2.25,Toxicity,1,1,tacrolimus,Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/981203854
981204026,rs9977268,SLC19A1,3,0,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/981204026
981204116,rs2032582,ABCB1,3,0.5,Efficacy,2,2,tacrolimus,"Colitis, Ulcerative;Kidney Transplantation",https://www.pharmgkb.org/clinicalAnnotation/981204116
981204433,rs1045642,ABCB1,3,2,Efficacy,1,1,dexamethasone;doxorubicin;vincristine,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/981204433
981204466,rs1045642,ABCB1,3,0.25,Toxicity,2,2,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204466
981237713,rs1805087,MTR,3,3.25,Efficacy;Toxicity,3,3,carboplatin;cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981237713
981238041,rs2032582,ABCB1,3,2.5,Efficacy,1,1,dexamethasone;doxorubicin;vincristine,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/981238041
981203697,rs717620,ABCC2,4,-2.5,Efficacy,5,6,antiepileptics,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981203697
981203790,"CYP3A5*1, CYP3A5*3",CYP3A5,4,-0.375,Toxicity,14,15,tacrolimus,nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/981203790
981203886,rs776746,CYP3A5,4,-1.375,Other,4,4,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981203886
981203954,rs7439366,UGT2B7,4,-3.5,Other,5,5,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981203954
981204345,rs1045642,ABCB1,4,-6.75,Efficacy,5,5,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981204345
981204912,rs1801133,MTHFR,4,-0.25,Toxicity,15,16,capecitabine;fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204912
981238288,rs2032582,ABCB1,4,-0.25,Efficacy,4,5,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981238288
981202806,rs4961,ADD1,3,3.5,Efficacy,1,1,furosemide;spironolactone,Liver Cirrhosis,https://www.pharmgkb.org/clinicalAnnotation/981202806
981475450,rs121434569,EGFR,2B,9,Efficacy,11,11,erlotinib,"Adenocarcinoma;Carcinoma, Non-Small-Cell Lung;Drug Resistance;Lung Neoplasms",https://www.pharmgkb.org/clinicalAnnotation/981475450
1451286020,rs1801160,DPYD,1A,108.5,Toxicity,14,15,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451286020
1451214480,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",CYP3A5,1A,421.75,Metabolism/PK,143,166,tacrolimus,heart transplantation;hematopoietic stem cell transplantation;Kidney Transplantation;lung transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451214480
981203618,rs67376798,DPYD,1A,233.75,Toxicity,23,25,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981203618
981345382,rs4149056,SLCO1B1,2A,11.75,Toxicity,9,10,hmg coa reductase inhibitors,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/981345382
981420042,rs121434568,EGFR,1A,190.5,Efficacy,24,45,gefitinib,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/981420042
981203518,rs5751876,ADORA2A,3,5,Toxicity,4,4,caffeine,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/981203518
1451141900,"CYP2D6*5, CYP2D6*17",CYP2D6,1A,101.75,Efficacy,2,3,hydrocodone,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451141900
981203578,rs6280,DRD3,3,1.25,Efficacy,2,2,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/981203578
981203641,rs6759892,UGT1A10;UGT1A6;UGT1A7;UGT1A8;UGT1A9,3,5,Dosage,2,3,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981203641
981203709,rs7412,APOE,3,1.75,Toxicity,2,2,"Antivirals for treatment of HIV infections, combinations;ritonavir",HIV Infections;Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/981203709
981204080,rs9461684,HLA-C,3,3.25,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981204080
981204090,rs9024,CBR1,3,2.25,Toxicity,1,1,anthracyclines and related substances,Cardiomyopathies;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204090
981204107,rs20417,PTGS2,3,1.75,Efficacy,1,2,aspirin,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/981204107
1451241420,"NAT2*4, NAT2*5A, NAT2*5B, NAT2*5D, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*12A, NAT2*13A, NAT2*14A",NAT2,1B,45.75,Toxicity,33,37,Drugs For Treatment Of Tuberculosis;isoniazid,"drug-induced liver injury;Hepatitis, Toxic;Toxic liver disease;Tuberculosis",https://www.pharmgkb.org/clinicalAnnotation/1451241420
981204286,rs1045642,ABCB1,3,0.25,Metabolism/PK,4,4,cyclosporine,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/981204286
981204306,rs1045642,ABCB1,3,0,Efficacy,3,3,phenytoin,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981204306
981204361,rs1045642,ABCB1,3,0.75,Efficacy;Toxicity;Metabolism/PK,28,40,clopidogrel,Acute coronary syndrome;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/981204361
981203918,rs776746,CYP3A5,4,-2,Other,6,6,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981203918
981204137,rs2032582,ABCB1,4,-3.75,Efficacy,4,4,antiepileptics,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/981204137
981204403,rs1045642,ABCB1,4,-0.5,Efficacy,3,5,cisplatin;fluorouracil,Esophageal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204403
981204414,rs1045642,ABCB1,4,-1.25,Toxicity,3,3,fluorouracil,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204414
981204975,rs1801133,MTHFR,4,-0.5,Toxicity,3,3,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/981204975
981203808,"CYP3A5*1, CYP3A5*3",CYP3A5,4,-3,Efficacy,33,34,tacrolimus,hematopoietic stem cell transplantation;Kidney Transplantation;transplant rejection,https://www.pharmgkb.org/clinicalAnnotation/981203808
981203936,"CYP3A5*1, CYP3A5*3",CYP3A5,3,3.75,Metabolism/PK,6,6,sirolimus,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/981203936
1451241700,"CYP3A5*1, CYP3A5*3",CYP3A5,2A,16.75,Dosage,9,10,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451241700
981204272,rs1045642,ABCB1,4,-1,Efficacy,4,4,paclitaxel,Breast Neoplasms;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981204272
981203545,rs6275,DRD2,3,0.75,Dosage,2,2,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/981203545
981203719,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",CYP3A5,1A,390.75,Dosage,97,107,tacrolimus,heart transplantation;hemopoietic stem cell transplant;Kidney Transplantation;liver transplantation;lung transplantation,https://www.pharmgkb.org/clinicalAnnotation/981203719
981345350,rs4149056,SLCO1B1,1A,114.125,Metabolism/PK,13,16,rosuvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/981345350
1451241780,"CYP3A5*1, CYP3A5*3",CYP3A5,1B,37,Metabolism/PK,24,25,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451241780
1451243216,"CYP3A5*1, CYP3A5*3",CYP3A5,2A,8,Dosage,9,9,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451243216
1451261620,rs3788853,XPNPEP2,2B,8.25,Toxicity,3,3,"Ace Inhibitors, Plain",Angioedema,https://www.pharmgkb.org/clinicalAnnotation/1451261620
1451263877,rs1800559,CACNA1S,1A,100.5,Toxicity,3,5,enflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451263877
1451263973,rs1800559,CACNA1S,1A,100.5,Toxicity,4,6,sevoflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451263973
1451263980,rs1800559,CACNA1S,1A,100.5,Toxicity,4,5,halothane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451263980
1451263986,rs1800559,CACNA1S,1A,100.5,Toxicity,5,7,isoflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451263986
1451264020,rs1800559,CACNA1S,1A,100.5,Toxicity,5,7,succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451264020
1451264060,rs772226819,CACNA1S,1A,100.25,Toxicity,2,3,enflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451264060
1451264081,rs772226819,CACNA1S,1A,100.25,Toxicity,2,3,halothane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451264081
1451264087,rs772226819,CACNA1S,1A,100.25,Toxicity,2,3,isoflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451264087
1451264128,rs772226819,CACNA1S,1A,100.25,Toxicity,2,3,succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451264128
1451264140,rs772226819,CACNA1S,1A,100.25,Toxicity,2,3,sevoflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1451264140
1451274090,rs67376798,DPYD,1A,231.25,Toxicity,28,30,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451274090
1451274984,rs3918290,DPYD,1A,222.25,Toxicity,28,31,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451274984
1451276160,rs55886062,DPYD,1A,201.5,Toxicity,10,12,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451276160
1451274165,rs75017182,DPYD,1A,200,Toxicity,6,8,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451274165
1451428340,"CYP2D6*1, CYP2D6*45, CYP2D6*46",CYP2D6,3,2,Metabolism/PK,1,1,metoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451428340
981419540,rs6535454,COQ2,3,2.25,Toxicity,1,1,atorvastatin;hmg coa reductase inhibitors;rosuvastatin,Muscular Diseases,https://www.pharmgkb.org/clinicalAnnotation/981419540
981238323,rs1695,GSTP1,3,2.5,Efficacy,5,5,cyclophosphamide,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981238323
1451592476,rs7858836,ASTN2,3,3.25,Dosage,1,1,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451592476
1451431120,HLA-B*15:21,HLA-B,3,3.75,Toxicity,5,5,carbamazepine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1451431120
1451435940,rs267606619,MT-RNR1,1A,101,Toxicity,5,6,streptomycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451435940
1451592484,rs958804,ASTN2,3,3.25,Dosage,1,1,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451592484
1451435945,rs267606619,MT-RNR1,1A,101.25,Toxicity,8,9,gentamicin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451435945
1451436100,rs267606619,MT-ND1;MT-RNR1,3,0.25,Toxicity,1,1,micronomicin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436100
1451436121,rs267606619,MT-RNR1,1A,100.25,Toxicity,1,2,tobramycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436121
981238397,rs1695,GSTP1,3,3,Toxicity,1,1,mercaptopurine;methotrexate,Drug Toxicity;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/981238397
1451436133,rs267606618,MT-RNR1,1A,101,Toxicity,4,5,gentamicin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436133
1451436138,rs267606618,MT-RNR1,1A,100.5,Toxicity,2,3,kanamycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436138
1451436180,rs1556422499,MT-RNR1,3,0.25,Toxicity,1,1,aminoglycoside antibacterials,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436180
1451434860,rs267606617,MT-ND1;MT-RNR1,1A,108,Toxicity,28,29,gentamicin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451434860
1451436226,rs1603218569,MT-ND1;MT-RNR1,3,0.25,Toxicity,1,1,aminoglycoside antibacterials,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436226
1451599320,rs2304016,SCN2A,3,0.5,Efficacy,2,2,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451599320
1449004210,rs2307240,CES1,3,3.5,Efficacy,1,1,clopidogrel,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1449004210
1449004220,rs28898617,UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9,3,2,Metabolism/PK,1,1,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1449004220
1449004567,rs1045642,ABCB1,3,4,Efficacy;Metabolism/PK,1,2,oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1449004567
1449140063,rs3814055,NR1I2,3,3.5,Toxicity;Metabolism/PK,1,2,sirolimus;temsirolimus,adverse events;gastrointestinal toxicity;Myelosuppression;Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449140063
1449140273,rs2075685,TMEM167A;XRCC4,3,3.5,Efficacy,1,1,fluorouracil;Platinum compounds;radiotherapy,Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449140273
1449004229,rs2298771,SCN1A,4,-4,Efficacy,4,5,carbamazepine;clobazam;ethosuximide;lamotrigine;levetiracetam;oxcarbazepine;valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1449004229
1449144310,rs59724122,EPHX2,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449144310
1449144316,rs61123830,GRAMD1B,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449144316
1449005066,rs2740574,CYP3A;CYP3A4,3,3.25,Toxicity,1,1,cyclosporine;tacrolimus,Kidney Transplantation;transplant rejection,https://www.pharmgkb.org/clinicalAnnotation/1449005066
1451599327,rs2304016,SCN2A,3,2.25,Efficacy,1,1,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451599327
1449144322,rs7959663,MYO1H,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449144322
1449144340,rs6728642,FAM178B,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449144340
1449144346,rs62200793,ZNF804A,3,0,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1449144346
1449564190,rs3734704,HSP90AB1,3,0,Toxicity,1,1,bevacizumab,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449564190
1449564196,rs6929249,HSP90AB1,3,0,Toxicity,1,1,bevacizumab,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449564196
1449564202,rs834576,HSP90AB1,3,0,Toxicity,1,1,bevacizumab,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449564202
1451599340,rs2304016,SCN2A,3,0.5,Efficacy,2,2,oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451599340
1451434900,rs267606617,MT-RNR1,1A,107,Toxicity,34,35,streptomycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451434900
1449564208,rs9381299,PRKCA,3,0,Toxicity,1,1,bevacizumab,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449564208
1450112801,rs13137622,ABCG2,3,2,Metabolism/PK,1,1,methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1450112801
1451599347,rs2304016,SCN2A,3,2.25,Efficacy,1,1,phenytoin,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451599347
1451599354,rs2304016,SCN2A,3,2.25,Efficacy,1,1,topiramate,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1451599354
1449190656,HLA-B*15:02,HLA-B,4,-3.75,Toxicity,6,6,oxcarbazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1449190656
1451436481,rs1556422499,MT-RNR1,3,0.25,Toxicity,3,3,streptomycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436481
1450932687,rs4680,COMT,3,0.5,Toxicity,1,2,buprenorphine;fentanyl;tramadol,adverse events;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450932687
1451436473,rs1556422499,MT-RNR1,3,0.25,Toxicity,1,1,dihydrostreptomycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436473
1451434880,rs267606617,MT-RNR1,1A,101.75,Toxicity,11,12,kanamycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451434880
1451434905,rs267606617,MT-ND1;MT-RNR1,3,0.25,Toxicity,5,5,neomycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451434905
1451434920,rs267606617,MT-RNR1,1A,101.25,Toxicity,5,6,amikacin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451434920
1451434930,rs267606617,MT-RNR1,1A,100.25,Toxicity,5,7,tobramycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451434930
1448635968,HLA-DRB3*01:01,HLA-DRB3,3,3.75,Toxicity,1,1,heparin,heparin-induced thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1448635968
1449163252,rs724710,BCL2L11,3,3,Toxicity,1,2,corticosteroids,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1449163252
1449163306,rs2241843,BCL2L11,3,3.75,Toxicity,1,2,corticosteroids,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1449163306
1449164609,rs13058338,RAC2,3,2.5,Efficacy,1,1,idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1449164609
1449164746,rs274558,SLC22A5,3,3,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1449164746
1449164752,rs683369,SLC22A1,3,2.5,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1449164752
1449165034,rs2231142,ABCG2,3,0.75,Toxicity,2,2,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1449165034
1449271360,rs7668282,UGT2B7,3,1,Metabolism/PK,1,1,morphine,"Anemia, Sickle Cell",https://www.pharmgkb.org/clinicalAnnotation/1449271360
1449188570,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,1B,34,Toxicity,15,20,acenocoumarol,over-anticoagulation,https://www.pharmgkb.org/clinicalAnnotation/1449188570
1449169668,rs2070959,UGT1A6,3,0,Efficacy,1,1,aspirin,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449169668
1449170060,HLA-A*33:03,HLA-A,3,4.5,Toxicity,2,2,lamotrigine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1449170060
1449752771,rs2233678,PIN1,3,3.5,Efficacy,1,1,oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449752771
1450813825,rs11606194,HTR3B,3,3,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813825
1450415170,"CYP2D6*1, CYP2D6*4",CYP2D6,1A,103,Dosage,2,3,metoprolol,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1450415170
1450814653,rs2873804,DBH,3,2.75,Efficacy,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814653
1450928460,rs6706232,UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928460
1450928473,rs10012,CYP1B1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928473
1450928522,rs6280,DRD3,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928522
1450822470,rs2298897,OPRD1,3,3,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450822470
1450822778,rs1799971,OPRM1,3,2,Toxicity,1,1,antidepressants;antipsychotics;benzodiazepine derivatives;opioids;Sympathomimetics,Heart Arrest;Overdose;Respiratory Insufficiency,https://www.pharmgkb.org/clinicalAnnotation/1450822778
1450822829,rs3852209,HINT1,3,1.25,Other,1,1,nicotine,cessation;Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450822829
1450823316,rs1051730,CHRNA3,3,2.75,Dosage,1,1,Drugs used in nicotine dependence;nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450823316
1450823707,rs2514218,DRD2,3,1.75,Efficacy,1,1,aripiprazole;risperidone,Psychotic Disorders;schizoaffective disorder;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450823707
1448636924,rs351855,FGFR4,3,1.75,Efficacy,1,1,everolimus,discontinuation,https://www.pharmgkb.org/clinicalAnnotation/1448636924
1450812912,rs10055255,CRHBP,3,1.75,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450812912
1450820979,rs3787140,CHRNA4,3,0,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450820979
1449565072,rs2228130,POLR2A,3,0.25,Toxicity,1,3,gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1449565072
1449748502,rs2032582,ABCB1,3,2.25,Efficacy,1,1,tacrolimus,Nephrotic Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1449748502
1450810266,rs524731,OPRM1,3,6.25,Toxicity,2,2,heroin;opioids,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810266
1450822281,rs1799971,OPRM1,3,0.75,Toxicity,2,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450822281
1450823109,rs3778150,OPRM1,3,3.5,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450823109
1450823322,rs10485057,OPRM1,3,0,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450823322
1451437666,rs28358569,MT-RNR1,3,0.25,Toxicity,1,1,streptomycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451437666
1451437721,rs28358569,MT-RNR1,3,0.25,Toxicity,1,1,gentamicin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451437721
1450814671,rs17614642,FKBP5,3,2.25,Efficacy,1,1,bupropion,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814671
1450814929,rs17584499,PTPRD,3,2.25,Efficacy,1,1,pioglitazone,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1450814929
1450931522,rs738409,PNPLA3,3,3.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931522
1449269473,rs7439366,UGT2B7,3,0.5,Efficacy,1,2,oxycodone,Pain,https://www.pharmgkb.org/clinicalAnnotation/1449269473
1449269910,rs9923231,VKORC1,2A,12.25,Toxicity,26,26,warfarin,Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1449269910
1145231686,rs2032582,ABCB1,3,2.375,Efficacy,2,2,pravastatin,Acute coronary syndrome;Hyperlipoproteinemia Type II,https://www.pharmgkb.org/clinicalAnnotation/1145231686
1451605911,rs11872992,MC4R,3,0,Toxicity,1,1,olanzapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451605911
1451605946,rs2268639,GLP1R,3,0,Toxicity,1,1,olanzapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451605946
1450377214,rs1208,NAT2,3,2.25,Toxicity,1,1,isoniazid;phenytoin,Drug interaction with drug;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1450377214
1451606000,rs1800566,NQO1,3,0.25,Efficacy,1,1,warfarin,Thrombosis,https://www.pharmgkb.org/clinicalAnnotation/1451606000
1449271027,rs150688309,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271027
1449271033,rs79430272,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271033
1449271057,rs58695150,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271057
1449271063,rs8110364,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271063
1449271069,rs74743371,CBR3,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271069
1451439812,rs267606619,MT-RNR1,1A,100.25,Toxicity,1,2,kanamycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451439812
1451436140,rs267606618,MT-RNR1,1A,100.75,Toxicity,3,4,streptomycin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451436140
1449165794,rs237025,SUMO4,3,1,Metabolism/PK,1,1,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449165794
1448636814,rs9906827,RPTOR,3,5,Efficacy;Toxicity,1,2,everolimus,pneumonitis;progression-free survival,https://www.pharmgkb.org/clinicalAnnotation/1448636814
1448636842,rs2032582,ABCB1,3,2.25,Toxicity,1,1,everolimus,Breast Neoplasms;Lymphopenia,https://www.pharmgkb.org/clinicalAnnotation/1448636842
1448636848,rs1045642,ABCB1,3,2.25,Toxicity,1,1,everolimus,Breast Neoplasms;mucositis,https://www.pharmgkb.org/clinicalAnnotation/1448636848
1450822790,rs1800497,ANKK1;DRD2,3,0.75,Toxicity,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450822790
1450932989,rs10877012,CYP27B1,3,2.5,Efficacy,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1450932989
1451608148,rs1937840,AKR1C3,3,1.5,Other,1,1,doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451608148
1449164352,"CYP3A4*1, CYP3A4*22",CYP3A4,3,1.75,Metabolism/PK,1,1,sildenafil,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1449164352
1449189236,rs9943291,HMGCS2,3,1.625,Toxicity,1,1,chlorothiazide;hydrochlorothiazide,Hyperglycemia;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449189236
1450374881,rs2032582,ABCB1,3,2,Toxicity,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1450374881
1450375024,rs1045642,ABCB1,3,2.5,Toxicity,1,1,bleomycin;cisplatin;etoposide,Testicular Neoplasms;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1450375024
1450375035,rs2740574,CYP3A;CYP3A4,3,2.5,Toxicity,1,1,bleomycin;cisplatin;etoposide,Alopecia;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450375035
1449157113,"TPMT*1, TPMT*3A, TPMT*3C",TPMT,3,2,Metabolism/PK,1,1,thioguanine,Crohn Disease,https://www.pharmgkb.org/clinicalAnnotation/1449157113
1449557359,rs11574077,VDR,3,1.75,Metabolism/PK,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449557359
1449166824,rs186983396,RYR1,3,0,Other,1,1,caffeine;chlorocresol,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449166824
1449270865,rs115457081,IRS1,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270865
1449564951,rs5219,KCNJ11,3,3.25,Efficacy,3,3,"sulfonamides, urea derivatives",Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1449564951
1449270871,rs112242273,GNL3,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270871
1449270877,rs299293,HMMR,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270877
1449270889,rs299314,HMMR,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270889
1449270895,rs3805945,PPP2R5D,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270895
1449270901,rs78428806,PERP,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270901
1449270907,rs117101815,PERP,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270907
1449270925,rs9402944,PERP,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270925
1449270931,rs9389568,PERP,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270931
1449270937,rs117458836,CYP2C8,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270937
1449270943,rs118088833,TP53AIP1,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270943
1449270949,rs149212925,NOS1,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270949
1449270955,rs144991623,FOXO1,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270955
1449270973,rs181501757,TOP2A,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270973
1449270979,rs142244113,INSR,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270979
1449564957,rs757110,ABCC8;KCNJ11,3,0.75,Efficacy,2,2,"sulfonamides, urea derivatives",Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1449564957
1449564963,rs1803274,BCHE,3,0.5,Efficacy,4,4,donepezil,Alzheimer Disease;cognitive dysfunction,https://www.pharmgkb.org/clinicalAnnotation/1449564963
1450928454,rs1056827,CYP1B1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928454
1451553602,rs2231142,ABCG2,4,-0.875,Metabolism/PK,7,7,methotrexate,"Burkitt Lymphoma;Lymphoma, T-Cell;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1451553602
1450928505,rs4818,COMT,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928505
1451615421,rs3740065,ABCC2,4,-1.5,Metabolism/PK,4,4,methotrexate,"Leukemia, B-Cell, Acute;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1451615421
1450928534,rs4680,COMT,4,-1.5,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450928534
1450373610,rs9787901,CHST1,3,1.5,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373610
1450373616,rs10517,NQO1,3,2,Efficacy,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450373616
1450377181,rs1041983,NAT2,3,2.25,Toxicity,1,1,isoniazid;phenytoin,Drug interaction with drug;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1450377181
1450377193,rs1799929,NAT2,3,2.25,Toxicity,1,1,isoniazid;phenytoin,Drug interaction with drug;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1450377193
1450931422,rs10432303,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931422
1450931428,rs8109485,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931428
1450931440,rs10405681,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931440
1450931828,rs4680,COMT,3,2,Toxicity,1,1,fentanyl,somnolence,https://www.pharmgkb.org/clinicalAnnotation/1450931828
1450823773,rs1799971,OPRM1,4,-4,Toxicity,4,4,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450823773
1450823785,rs1799971,OPRM1,4,-5,Toxicity,4,4,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450823785
1449157600,rs367398,NOTCH4,3,2.5,Toxicity,1,1,allopurinol,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1449157600
1450377220,rs1799931,NAT2,3,2.25,Toxicity,1,1,isoniazid;phenytoin,Drug interaction with drug;Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1450377220
1450826907,rs1799971,OPRM1,3,2,Efficacy,2,2,alfentanil,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450826907
1450826913,rs1799971,OPRM1,3,1.125,Metabolism/PK,2,2,alfentanil,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450826913
1450826993,rs1799971,OPRM1,3,2.5,Efficacy,1,1,opioids,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450826993
1450933062,rs6920220,SH3BP2;TNFAIP3,3,2.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Psoriatic;Psoriasis",https://www.pharmgkb.org/clinicalAnnotation/1450933062
1450933116,rs1456862,ADGRL3,3,1.75,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450933116
1449140229,rs1128503,ABCB1,3,1.5,Metabolism/PK,1,1,sirolimus;temsirolimus,Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449140229
1450813534,rs1709083,CYP2A13,3,0,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813534
1450813554,rs28399433,CYP2A6,3,2.5,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813554
1449168065,rs4971678,NRXN1,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168065
1449168628,rs78482393,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168628
1449168635,rs78615940,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168635
1449168642,rs17724494,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168642
1449169490,rs12233719,UGT2B7,3,1.5,Metabolism/PK,1,2,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1449169490
1449271393,rs141084494,RBX1,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271393
1451447440,rs2413739,PACSIN2,3,2.25,Efficacy,1,1,azathioprine,Irritable Bowel Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451447440
1449004548,rs7439366,UGT2B7,3,1,Efficacy,2,3,oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1449004548
1449752787,rs2233678,PIN1,3,2.5,Efficacy,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449752787
1449156122,HLA-B*15:24,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156122
1449156084,HLA-B*39:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156084
1449155828,HLA-B*39:10,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449155828
1449747881,rs15524,CYP3A5,3,4,Metabolism/PK,2,2,tacrolimus,Kidney Transplantation;liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449747881
1450810387,rs495491,OPRM1,3,6,Toxicity,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810387
1449156076,HLA-B*38:02,HLA-B,4,-1.75,Toxicity,2,2,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156076
1449168086,rs9879065,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168086
1449269868,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,2A,10.5,Toxicity,11,15,acenocoumarol,Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1449269868
1450810247,rs524731,OPRM1,3,2.75,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450810247
1450810295,rs3823010,OPRM1,3,6.75,Toxicity,2,2,heroin;opioids,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810295
1450810345,rs1381376,OPRM1,3,2.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450810345
1449169795,rs717620,ABCC2,3,2.5,Efficacy,1,1,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1449169795
1449170133,rs9263726,PSORS1C1,3,3.75,Toxicity,1,1,allopurinol,drug reaction with eosinophilia and systemic symptoms;Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1449170133
1449170068,HLA-B*44:03,HLA-B,3,2.75,Toxicity,3,3,lamotrigine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1449170068
1449170055,HLA-A*02:07,HLA-A,3,2.25,Toxicity,1,1,lamotrigine,Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1449170055
1449577050,rs6151031,ALDH1A1,3,3,Efficacy,1,1,cyclophosphamide;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449577050
1449752561,rs1690924,MDM2,3,2,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1449752561
1449752602,rs1051266,SLC19A1,3,2,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1449752602
1450376443,rs28386840,SLC6A2,3,4.875,Efficacy,7,8,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1450376443
1451621726,rs1128503,ABCB1,3,2.5,Toxicity,3,3,methotrexate,Lymphoma;mucositis;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451621726
1450376745,rs4680,COMT,4,-6.25,Efficacy,14,14,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1450376745
1449157951,rs927650,CYP24A1,3,1.25,Metabolism/PK,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1449157951
1449157957,rs2585428,CYP24A1,3,2.25,Metabolism/PK,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1449157957
1449157963,rs2248359,CYP24A1,3,2.375,Metabolism/PK,2,2,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1449157963
1449170460,rs3212986,ERCC1,3,3,Efficacy,1,1,granisetron;palonosetron,Nausea;Neoplasms;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1449170460
1449270486,rs11940694,KLB,3,0,Dosage,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1449270486
1449270883,rs299313,HMMR,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270883
1452044040,rs6311,HTR2A,4,-5.75,Efficacy,4,5,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452044040
1449140263,rs34550074,SLCO2A1,3,2.5,Toxicity,1,1,"Thiazides, plain",Hypernatremia;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449140263
1449140279,rs10040363,XRCC4,3,3.5,Efficacy,1,1,fluorouracil;Platinum compounds;radiotherapy,Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449140279
1449752818,rs201929247,HLA-DRB1,3,3,Toxicity,1,1,dapsone,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1449752818
1450813566,"CYP2B6*1, CYP2B6*4",CYP2B6,3,2.5,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813566
1451448820,"NUDT15*1, NUDT15*2, NUDT15*3",NUDT15,1A,208.25,Toxicity,3,5,mercaptopurine,Leukopenia;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1451448820
1451621742,rs1045642,ABCB1,4,-0.375,Efficacy,7,7,methotrexate,"Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451621742
1452050105,rs7997012,HTR2A,4,-6,Efficacy,4,5,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452050105
1449310234,rs193922764,RYR1,1A,100.25,Toxicity,4,5,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449310234
1449310249,rs193922832,RYR1,1A,100,Toxicity,1,2,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449310249
1449310265,rs193922843,RYR1,1A,100,Toxicity,1,2,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449310265
1452044020,rs6313,HTR2A,4,-4.25,Efficacy,3,4,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452044020
1452044060,rs6311,HTR2A,4,-11.25,Efficacy,6,8,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452044060
1452044066,rs6313,HTR2A,4,-7.5,Efficacy,4,5,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452044066
1452050405,rs6311,HTR2A,4,-6.5,Efficacy,4,5,sertraline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452050405
1452043985,rs6311,HTR2A,4,-7,Efficacy,6,7,paroxetine,"Depressive Disorder, Major;Obsessive-Compulsive Disorder",https://www.pharmgkb.org/clinicalAnnotation/1452043985
1452043960,rs6313,HTR2A,4,-8.25,Efficacy,5,8,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452043960
1452050600,rs7997012,HTR2A,4,-5,Efficacy,3,4,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452050600
827863843,rs37973,GLCCI1,3,0,Efficacy,1,1,budesonide;flunisolide;fluticasone propionate;glucocorticoids;nedocromil;triamcinolone,Asthma,https://www.pharmgkb.org/clinicalAnnotation/827863843
827864159,rs1024323,GRK4,3,1.75,Efficacy,1,2,metoprolol,Hypertension;Kidney Diseases;Nephrosclerosis,https://www.pharmgkb.org/clinicalAnnotation/827864159
827864301,rs11739136,KCNIP1;KCNMB1,3,6.5,Efficacy,3,3,verapamil,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/827864301
1450930548,rs3784921,TXNDC11,3,2.75,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1450930548
1450930827,rs3743075,CHRNA3,3,3,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450930827
1450929786,rs1045642,ABCB1,4,-1.25,Efficacy,2,2,fentanyl,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450929786
827864250,rs1876828,CRHR1,3,3.5,Efficacy,6,6,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/827864250
827862764,rs12979860,IFNL3;IFNL4,1A,350.5,Efficacy,69,86,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/827862764
1452043460,rs6313,HTR2A,4,-8.25,Efficacy,5,6,sertraline,Anxiety Disorders;Depression,https://www.pharmgkb.org/clinicalAnnotation/1452043460
1452050620,rs7997012,HTR2A,4,-4.75,Efficacy,3,4,sertraline,Anxiety Disorders;Depression,https://www.pharmgkb.org/clinicalAnnotation/1452050620
1452050380,rs6311,HTR2A,3,1.5,Toxicity,3,4,paroxetine,"Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452050380
1452050260,rs6311,HTR2A,4,-2,Efficacy,3,5,fluvoxamine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452050260
1451634907,rs1805087,MTR,3,0,Efficacy,1,1,folic acid;hydroxychloroquine;methotrexate;sulfasalazine,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451634907
1451634914,rs1805087,MTR,3,2.5,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451634914
1451634940,rs1805087,MTR,3,1.75,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451634940
1452050120,rs7997012,HTR2A,4,-1.25,Efficacy,3,4,fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452050120
1452050340,rs6311,HTR2A,4,-2.75,Toxicity,4,5,fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452050340
1449310001,rs2273359,NELFCD,3,0,Efficacy,1,1,"diuretics;hydrochlorothiazide;Thiazides, plain",Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449310001
1449716392,rs2032582,ABCB1,3,0,Toxicity,1,2,fentanyl,Neoplasms;Pain,https://www.pharmgkb.org/clinicalAnnotation/1449716392
1449716764,rs1128503,ABCB1,3,3,Dosage;Efficacy,3,3,fentanyl,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449716764
1449748823,rs2229109,ABCB1,3,3.25,Efficacy,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449748823
1449309975,rs7270101,ITPA,4,-1.25,Toxicity,4,4,azathioprine,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1449309975
1449309937,rs121918596,RYR1,1A,100.5,Toxicity,2,3,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449309937
1452043786,rs6311,HTR2A,4,-6.25,Efficacy,4,5,venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452043786
1452043780,rs6313,HTR2A,4,-3.25,Efficacy,2,3,venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1452043780
1451635027,rs9344,CCND1,3,2.5,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451635027
1451635034,rs9344,CCND1,3,0,Efficacy,1,1,cisplatin;doxorubicin;methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451635034
1452046660,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,4,-6.625,Efficacy,9,11,venlafaxine,Anxiety Disorders;Depression,https://www.pharmgkb.org/clinicalAnnotation/1452046660
1450822476,rs2236855,OPRD1,3,3,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450822476
1450823350,rs10485057,OPRM1,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450823350
1450823626,rs9829896,KAT2B,3,2.5,Toxicity,1,1,amphetamine;cannabinoids;cocaine;opioids,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450823626
1450823791,rs1799971,OPRM1,3,0,Toxicity,1,1,cannabinoids,Marijuana Abuse,https://www.pharmgkb.org/clinicalAnnotation/1450823791
1449004876,rs2838958,SLC19A1,3,2.75,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1449004876
1449005017,rs41303343,CYP3A5,4,-1.25,Metabolism/PK,1,2,lumefantrine,Malaria,https://www.pharmgkb.org/clinicalAnnotation/1449005017
1449005031,rs10264272,CYP3A5,3,0,Metabolism/PK,1,2,lumefantrine,Malaria,https://www.pharmgkb.org/clinicalAnnotation/1449005031
1449005382,rs1000940,RABEP1,3,2.25,Other,1,1,amisulpride;aripiprazole;clozapine;lithium;mirtazapine;olanzapine;paliperidone;quetiapine;risperidone;valproic acid,Bipolar Disorder;Depressive Disorder;Psychotic Disorders;schizoaffective disorder,https://www.pharmgkb.org/clinicalAnnotation/1449005382
1449005393,rs1128503,ABCB1,3,4,Efficacy;Toxicity,1,2,remifentanil;sevoflurane,tonsillectomy,https://www.pharmgkb.org/clinicalAnnotation/1449005393
1449004807,rs10841753,SLCO1B1,4,-1.75,Metabolism/PK,1,3,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1449004807
1183702975,rs3745274,CYP2B6,3,2.75,Dosage,6,6,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1183702975
1183702959,rs10501087,BDNF-AS,3,3.25,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183702959
1183702964,rs6265,BDNF,3,3.25,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183702964
1184000346,"G6PD A- 202A_376G, G6PD B (reference)",G6PD,3,0.375,Toxicity,3,3,nitrofurantoin,"Anemia, Hemolytic;Hemolysis",https://www.pharmgkb.org/clinicalAnnotation/1184000346
1184000380,"G6PD B (reference), G6PD Mediterranean Haplotype",G6PD,3,0.25,Toxicity,2,2,phenazopyridine,"Anemia, Hemolytic;Hemolysis",https://www.pharmgkb.org/clinicalAnnotation/1184000380
1183945178,"CYP1A2*1A, CYP1A2*1F",CYP1A2,3,5.125,Toxicity,3,4,caffeine,"Abortion, Spontaneous",https://www.pharmgkb.org/clinicalAnnotation/1183945178
1183704233,rs9394992,SLC29A1,3,1,Toxicity,1,2,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183704233
1183704404,rs6427528,CD84,3,2,Efficacy,2,2,etanercept,"Arthritis, Rheumatoid;Psoriasis",https://www.pharmgkb.org/clinicalAnnotation/1183704404
1184136899,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2.5,Toxicity,2,3,risperidone,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1184136899
1184169936,rs1801274,FCGR2A,3,4.25,Efficacy,2,3,adalimumab;infliximab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1184169936
1183960795,rs267606723,CFTR,1A,202,Efficacy,2,4,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960795
1183944118,"G6PD A- 202A_376G, G6PD B (reference)",G6PD,4,-0.875,Toxicity,8,8,mefloquine,Malaria,https://www.pharmgkb.org/clinicalAnnotation/1183944118
1184136848,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,4,-2.5,Efficacy,9,14,escitalopram,Depression;Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1184136848
1183682436,rs80338792,SCN4A,3,0.25,Efficacy,2,3,flecainide;mexiletine,Myotonia,https://www.pharmgkb.org/clinicalAnnotation/1183682436
1183704316,rs699947,VEGFA,3,2.25,Efficacy,1,1,sildenafil,Erectile Dysfunction,https://www.pharmgkb.org/clinicalAnnotation/1183704316
1184136856,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2.25,Efficacy,1,1,ondansetron,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1184136856
1451635167,rs1801394,FASTKD3;MTRR,4,-1.25,Toxicity,2,2,methotrexate,"Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451635167
1184348731,rs1801280,NAT2,3,1.75,Toxicity,1,2,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348731
1184472737,rs2234693,ESR1,3,2.75,Toxicity,1,1,anastrozole;letrozole,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184472737
1184472746,rs9340799,ESR1,3,2.75,Toxicity,1,1,anastrozole;letrozole,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184472746
1183702981,rs2279343,CYP2B6,3,1,Dosage,4,4,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1183702981
1184516188,"G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",G6PD,3,0,Toxicity,1,1,sulfadoxine,Hemolysis,https://www.pharmgkb.org/clinicalAnnotation/1184516188
1183705788,rs118192170,RYR1,1A,100.25,Toxicity,3,4,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705788
1183960800,rs74503330,CFTR,1A,202,Efficacy,3,5,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960800
1183960766,rs121908757,CFTR,1A,204.75,Efficacy,4,6,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960766
1183960775,rs121909005,CFTR,1A,202.25,Efficacy,3,5,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960775
1183960785,rs121909041,CFTR,1A,202,Efficacy,2,4,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960785
1184136380,rs11322783,IFNL4,1B,65.25,Efficacy,23,29,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1184136380
1184233161,rs5522,NR3C2,3,2.75,Efficacy,1,1,enalapril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184233161
1184233180,rs1799752,ACE,3,1.25,Other,1,3,antidepressants;antiepileptics;Beta Blocking Agents;calcium channel blockers,Headache Disorders;Migraine with Aura;Migraine without Aura,https://www.pharmgkb.org/clinicalAnnotation/1184233180
1184348713,rs698,ADH1C,3,2.25,Efficacy,1,1,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348713
1184348718,rs1142345,TPMT,3,2.25,Efficacy,1,1,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348718
1184514202,rs10497203,TANC1,3,1.75,Toxicity,1,1,radiotherapy,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184514202
1183888959,rs8099917,IFNL3,2A,15.5,Efficacy,6,6,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;telaprevir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1183888959
1183960805,rs80282562,CFTR,1A,202,Efficacy,2,4,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960805
1184348872,rs2268639,GLP1R,3,0,Toxicity,1,1,clozapine,Schizophrenia;Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1184348872
1184642788,"G6PD A- 202A_376G, G6PD B (reference)",G6PD,3,0.125,Toxicity,1,1,sulfasalazine,Hemolysis,https://www.pharmgkb.org/clinicalAnnotation/1184642788
1184348774,rs1052536,LIG3,3,1.875,Toxicity,1,2,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348774
1184348859,rs13429709,GCG,3,2,Other,1,2,clozapine;olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1184348859
1184473019,"UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8",UGT1A6,3,4.5,Dosage,1,2,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1184473019
1184511154,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",CYP2D6,3,3.5,Other,2,4,donepezil,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1184511154
1183960318,rs121908755,CFTR,1A,202.5,Efficacy,5,7,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960318
1183704399,rs658903,KCNJ1,3,3.25,Toxicity,1,1,hydrochlorothiazide,Diabetes Mellitus;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183704399
1184348703,rs3219484,MUTYH,3,3,Toxicity,1,1,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348703
1184348708,rs1051740,EPHX1,3,1.5,Toxicity,1,2,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348708
1183704267,rs7319981,SLC10A2,4,-1.25,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183704267
1183888969,rs12979860,IFNL3;IFNL4,1A,219,Efficacy,9,11,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;telaprevir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1183888969
1184134160,rs11211524,CMPK1,3,0.75,Efficacy,2,2,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184134160
1184134170,rs4694362,DCK,3,2.5,Toxicity,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184134170
1184514449,rs274618,GRM3,3,2.5,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1184514449
1184514458,rs1990040,GRM3,3,2.5,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1184514458
1184514464,rs13242038,GRM3,3,2.5,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1184514464
1184514469,rs724226,GRM3,3,2.5,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1184514469
1184514474,rs2189814,GRM3,3,2.5,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1184514474
1184514253,rs264588,TANC1,3,1.75,Toxicity,1,1,radiotherapy,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184514253
1184514260,rs264631,TANC1,3,1.75,Toxicity,1,1,radiotherapy,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184514260
1184473080,rs717620,ABCC2,4,-1.75,Metabolism/PK,6,6,methotrexate,"Leukemia, Lymphoid;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1184473080
1184473109,rs717620,ABCC2,3,2.75,Toxicity,4,5,methotrexate,Leukemia;Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1184473109
1184563800,"G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like",G6PD,4,-0.375,Toxicity,10,10,sulfamethoxazole / trimethoprim,"Anemia, Hemolytic;Hemolysis",https://www.pharmgkb.org/clinicalAnnotation/1184563800
1183960780,rs121909013,CFTR,1A,202,Efficacy,2,4,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960780
1451635460,rs678849,OPRD1,3,2.25,Efficacy,1,1,disulfiram,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451635460
1183702969,rs11030104,BDNF,3,3.25,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183702969
1183703760,rs2232228,HAS3,3,3.5,Toxicity,1,1,anthracyclines and related substances,Cardiomyopathies,https://www.pharmgkb.org/clinicalAnnotation/1183703760
1183704248,rs7779029,SEMA3C,3,0,Toxicity,1,1,irinotecan,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183704248
1184472751,rs1048977,CDA,3,2.5,Other,5,5,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184472751
1184472890,rs2306744,DCK,3,2.5,Efficacy,1,2,cytarabine;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1184472890
1183704243,rs7851395,SLC31A1,3,2.25,Efficacy,1,1,carboplatin;cisplatin,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1183704243
1183848125,rs3785161,CES1P1,3,2,Efficacy,1,1,clopidogrel,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1183848125
1183960790,rs193922525,CFTR,1A,202,Efficacy,2,4,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1183960790
1184233166,"NAT2*4, NAT2*5D, NAT2*6B, NAT2*7A, NAT2*12A, NAT2*13A, NAT2*14A",NAT2,3,4.5,Efficacy,5,7,hydralazine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184233166
1184654253,HLA-DRB1*14:01,HLA-DRB1,3,2.75,Toxicity,1,1,allopurinol,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1184654253
1183680699,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C",TPMT,3,5,Toxicity,1,2,azathioprine,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183680699
1184513736,rs41271330,BMP5,3,5.75,Efficacy,1,2,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1184513736
1184653758,"TPMT*1, TPMT*21, TPMT*24, TPMT*25, TPMT*32, TPMT*33, TPMT*34, TPMT*37",TPMT,3,0,Metabolism/PK,6,7,mercaptopurine,"Lupus Erythematosus, Systemic;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1184653758
1184516153,"G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",G6PD,3,0.25,Toxicity,2,2,aspirin,Hemolysis,https://www.pharmgkb.org/clinicalAnnotation/1184516153
1184472708,rs747199,SLC29A1,3,0,Efficacy,1,1,gemcitabine;paclitaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184472708
1184513880,rs1803274,BCHE,3,2.5,Toxicity,8,8,succinylcholine,postanesthesia apnea,https://www.pharmgkb.org/clinicalAnnotation/1184513880
1184513863,rs1799807,BCHE,3,2.5,Toxicity,10,10,succinylcholine,postanesthesia apnea,https://www.pharmgkb.org/clinicalAnnotation/1184513863
1183863785,rs7176005,CYP19A1,3,3,Toxicity,2,2,exemestane,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183863785
1184472900,rs80143932,DCK,3,2.5,Efficacy,1,2,cytarabine;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1184472900
1184514240,rs264663,TANC1,3,0,Toxicity,1,1,radiotherapy,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184514240
1184514209,rs7582141,TANC1,3,1.75,Toxicity,1,1,radiotherapy,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184514209
1184514217,rs6432512,TANC1,3,1.75,Toxicity,1,1,radiotherapy,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184514217
1184514248,rs264651,TANC1,3,0,Toxicity,1,1,radiotherapy,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184514248
1184514050,rs116855232,NUDT15,1A,140.25,Toxicity,17,20,azathioprine,Inflammatory Bowel Diseases;Myelosuppression,https://www.pharmgkb.org/clinicalAnnotation/1184514050
1451636580,rs11045879,SLCO1B1,3,2.5,Toxicity,1,1,mercaptopurine,gastrointestinal toxicity;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451636580
1184472764,rs11598702,NT5C2,3,2,Metabolism/PK,2,2,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184472764
1184568404,"G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",G6PD,4,-0.625,Toxicity,2,2,sulfametopyrazine,Hemolysis,https://www.pharmgkb.org/clinicalAnnotation/1184568404
1184233711,rs1045642,ABCB1,3,0.5,Other,10,11,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1184233711
1184133889,rs3842,ABCB1,3,4.125,Other,6,6,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1184133889
1184349177,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2,Efficacy,23,32,paroxetine,"Depressive Disorder, Major;Mood Disorders;Panic Disorder",https://www.pharmgkb.org/clinicalAnnotation/1184349177
1184134274,rs1045642,ABCB1,3,2.5,Efficacy,1,1,morphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1184134274
1184348745,rs17655,ERCC5,3,3.75,Efficacy,1,2,platinum,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348745
1184472721,rs760370,SLC29A1,3,0,Efficacy,2,2,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184472721
1184472796,rs7867504,SLC28A3,3,0,Other,1,1,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184472796
1184348736,rs11226,RAD52,4,-0.25,Toxicity,1,2,cisplatin;cyclophosphamide,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184348736
1184661194,rs2108622,CYP4F2,2A,11.75,Dosage,14,15,acenocoumarol,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1184661194
1450826857,rs1799971,OPRM1,3,0.25,Toxicity,6,8,morphine,"adverse events;Constipation;Delirium;Dizziness;Nausea;Pain, Postoperative;Postoperative Nausea and Vomiting;Pruritus;Respiratory Insufficiency;somnolence;Urinary Retention;Vomiting",https://www.pharmgkb.org/clinicalAnnotation/1450826857
1183705354,"G6PD A- 202A_376G, G6PD B (reference)",G6PD,3,0.25,Toxicity,1,1,dimercaprol,"Hemolysis;Lead Poisoning, Nervous System, Childhood",https://www.pharmgkb.org/clinicalAnnotation/1183705354
1183705764,rs121918592,RYR1,1A,104.75,Toxicity,27,30,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705764
1183705773,rs118192162,RYR1,1A,102.5,Toxicity,4,5,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705773
1183705817,rs28933397,RYR1,1A,102.75,Toxicity,10,11,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705817
1183705822,rs121918595,RYR1,1A,100.75,Toxicity,6,7,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705822
1183705827,rs121918594,RYR1,1A,101.25,Toxicity,7,9,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705827
1183704257,rs7740004,TBC1D32,3,0,Toxicity,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1183704257
1183704390,rs6702335,EPB41,3,3.25,Efficacy,1,1,bupropion;nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1183704390
1183705010,rs2279345,CYP2B6,3,7.75,Metabolism/PK,5,6,efavirenz,HIV Infections;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1183705010
1450826788,rs6088638,ACSS2,3,2.25,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450826788
1450931434,rs4432372,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931434
1450931453,rs10419980,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931453
1450931583,rs6311,HTR2A,3,1.75,Toxicity,3,4,citalopram,"Depressive Disorder, Major;Nausea;Vomiting",https://www.pharmgkb.org/clinicalAnnotation/1450931583
1450929804,rs1045642,ABCB1,4,-1.25,Dosage,5,5,morphine,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450929804
1183863836,rs887829,UGT1A1,3,6.25,Other,3,4,atazanavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183863836
1450822836,rs3852209,HINT1,3,2.75,Efficacy,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450822836
1450934702,rs398123226,GLA,3,0,Efficacy,1,2,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934702
1450934767,rs116855232,NUDT15,3,3,Toxicity,3,3,azathioprine;mercaptopurine,Pancytopenia;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1450934767
1183705307,"G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",G6PD,3,0.25,Toxicity,1,1,ciprofloxacin,"Anemia, Hemolytic",https://www.pharmgkb.org/clinicalAnnotation/1183705307
1183704238,rs7853758,SLC28A3,3,2,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183704238
1449157419,rs1800497,DRD2,3,2.75,Toxicity,1,1,ethanol,Alcoholism;Death,https://www.pharmgkb.org/clinicalAnnotation/1449157419
1449157547,rs3099844,CYCSP5,3,6.75,Toxicity,2,2,allopurinol,drug reaction with eosinophilia and systemic symptoms;severe cutaneous adverse reactions;Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1449157547
1451434925,rs267606617,MT-ND1;MT-RNR1,3,0.25,Toxicity,1,1,isepamicin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451434925
1451475700,rs2236225,MTHFD1,3,2,Efficacy,1,1,cisplatin;doxorubicin;methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451475700
1183703019,rs1800544,ADRA2A,4,-2.625,Efficacy,11,14,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1183703019
1183705698,rs118192172,RYR1,1A,106.75,Toxicity,51,55,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705698
1183705759,rs118192161,RYR1,1A,107,Toxicity,26,27,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705759
1183705807,rs118192177,RYR1,1A,103.25,Toxicity,22,25,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705807
1183705812,rs121918593,RYR1,1A,105.5,Toxicity,35,36,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705812
1451475720,rs717620,ABCC2,3,2,Efficacy,1,1,cisplatin;doxorubicin;methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451475720
1451637100,rs9620007,WBP2NL,3,0,Toxicity,1,1,codeine,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637100
1451637140,rs62436463,OPRM1,3,0,Toxicity,1,1,hydrocodone,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637140
1183705783,rs118192167,RYR1,1A,100,Toxicity,1,2,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705783
1183705226,"G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",G6PD,4,-1.25,Toxicity,6,6,chloroquine,"Anemia, Hemolytic",https://www.pharmgkb.org/clinicalAnnotation/1183705226
1183705086,"G6PD A- 202A_376G, G6PD B (reference)",G6PD,3,0.875,Toxicity,5,5,chloramphenicol,"Anemia, Hemolytic;Hemolysis",https://www.pharmgkb.org/clinicalAnnotation/1183705086
1183704358,rs6907567,SLC22A16,3,4.25,Efficacy;Toxicity,2,2,cyclophosphamide;doxorubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183704358
1184233486,rs6269,COMT,3,2,Other,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1184233486
1184233504,rs4633,COMT,3,2,Other,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1184233504
1184233517,rs4818,COMT,3,2,Other,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1184233517
1451637147,rs62436463,OPRM1,3,0,Toxicity,1,1,oxycodone,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637147
1184233524,rs4680,COMT,3,1.5,Other,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1184233524
1451475800,rs1695,GSTP1,3,2,Efficacy,1,2,cisplatin;doxorubicin;methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451475800
1451475820,"GSTT1 non-null, GSTT1 null",GSTT1,3,0,Efficacy,1,1,cisplatin;doxorubicin;methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451475820
1449164763,rs10258429,EGFR,3,3,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1449164763
1449164769,rs2235040,ABCB1,3,2.5,Toxicity,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1449164769
1449192406,rs121909011,CFTR,3,0.25,Efficacy,1,1,ivacaftor / lumacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449192406
1449182358,rs1051660,OPRK1,3,2.5,Dosage,1,1,morphine,Neoplasms;Pain,https://www.pharmgkb.org/clinicalAnnotation/1449182358
1449191373,rs397508256,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191373
1451463900,rs4948496,ARID5B,3,1.5,Toxicity,1,1,methotrexate,Leukopenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451463900
1451637160,rs62436463,OPRM1,3,0,Toxicity,1,1,tramadol,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637160
1451637200,rs739296,SEPTIN3;WBP2NL,3,0,Toxicity,1,1,hydrocodone,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637200
1451476060,rs9344,CCND1,3,0,Efficacy,1,1,cisplatin;doxorubicin;methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476060
1183705778,rs118192163,RYR1,1A,101.5,Toxicity,12,13,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705778
1183702417,rs8103142,IFNL3,3,3.5,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1183702417
1183704409,rs6311,HTR2A,3,0,Efficacy,1,1,antipsychotics,tardive dyskinesia,https://www.pharmgkb.org/clinicalAnnotation/1183704409
1183705797,rs118192175,RYR1,1A,100,Toxicity,3,5,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705797
1183705802,rs118192176,RYR1,1A,103.75,Toxicity,21,23,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1183705802
1451464245,rs1801131,MTHFR,4,-0.25,Dosage,2,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451464245
1183703000,rs2010963,VEGFA,3,2,Efficacy,1,1,cyclophosphamide,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183703000
1184654214,HLA-C*08:01,HLA-C,3,3.25,Toxicity,3,3,allopurinol,Drug Hypersensitivity;Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184654214
1183703784,rs115232898,DPYD,1A,100.5,Toxicity,2,3,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183703784
1184654139,HLA-C*03:02,HLA-C,2B,19.5,Toxicity,5,6,allopurinol,"Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184654139
1184654247,HLA-DRB1*09:01,HLA-DRB1,3,2.75,Toxicity,1,1,allopurinol,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1184654247
1451637155,rs113100019,FIP1L1,3,0,Toxicity,1,1,meperidine,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637155
1444673084,rs2631367,SLC22A5,3,2.75,Efficacy,1,1,imatinib,Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1444673084
1444673142,rs2274567,CR1,3,2.75,Efficacy,1,1,eculizumab,paroxysmal nocturnal hemoglobinuria,https://www.pharmgkb.org/clinicalAnnotation/1444673142
1444673156,rs396991,FCGR3A,3,3.25,Efficacy,2,3,adalimumab;etanercept;infliximab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1444673156
1444700796,rs12768009,CYP2C19,3,0,Metabolism/PK,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444700796
1444703131,rs1799978,DRD2,3,2.25,Efficacy,1,1,olanzapine;risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444703131
1444703154,rs1800477,BCL2,3,2,Efficacy,1,1,interferons;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1444703154
1445401118,rs11942466,AREG,3,2.25,Efficacy,1,1,capecitabine;radiotherapy,Rectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401118
1445401125,rs11615,ERCC1,3,1.75,Efficacy,1,1,capecitabine;radiotherapy,Rectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401125
1445401897,rs2242480,CYP3A4,3,1.5,Metabolism/PK,2,2,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1445401897
1444673149,rs1801274,FCGR2A,4,-0.75,Efficacy,2,3,adalimumab;etanercept;infliximab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1444673149
1451476200,rs2236225,MTHFD1,3,3,Toxicity,4,4,methotrexate,"Anemia;Leukopenia;Lymphoma, Non-Hodgkin;mucositis;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia;Toxic liver disease",https://www.pharmgkb.org/clinicalAnnotation/1451476200
1451493592,rs4762,AGT,3,1,Efficacy,2,2,irbesartan,"Hypertension;Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1451493592
1445737062,rs1799983,NOS3,3,3.25,Efficacy,2,3,anthracyclines and related substances;cyclophosphamide;doxorubicin;epirubicin;fluorouracil;methotrexate;oxaliplatin;Platinum compounds,Neoplasms;Ovarian Neoplasms;Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445737062
1446898857,rs806378,CNR1,3,2,Toxicity,2,2,clozapine;olanzapine;risperidone,Autism Spectrum Disorder;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1446898857
1185000205,rs776746,CYP3A5,4,-1.125,Toxicity,3,3,tacrolimus,Neurotoxicity Syndromes,https://www.pharmgkb.org/clinicalAnnotation/1185000205
1444673025,rs2230345,GRK5,3,1.5,Efficacy,2,2,Antihypertensives;Beta Blocking Agents,Heart Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444673025
1444673072,rs20575,TNFRSF10A,3,4.75,Efficacy,1,4,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Arthritis,https://www.pharmgkb.org/clinicalAnnotation/1444673072
1444700830,rs1353411,PTGER2,3,1.5,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444700830
1444703178,rs1800795,IL6,3,2.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1444703178
1444703840,rs307826,FLT4,3,2.75,Efficacy,1,1,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1444703840
1444703848,rs307821,FLT4,3,2.25,Efficacy,1,1,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1444703848
1444704067,rs2472297,CYP1A1,3,2.25,Metabolism/PK,1,1,olanzapine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444704067
1444704074,rs4410790,AHR,3,2.25,Metabolism/PK,1,1,olanzapine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444704074
1444704134,rs4132670,TCF7L2,3,2.5,Toxicity,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444704134
1444704141,rs4133101,PTGER4,3,2.5,Toxicity,1,1,celecoxib,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444704141
1444930850,rs12979860,IFNL3;IFNL4,3,2,Efficacy,3,3,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;simeprevir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1444930850
1445401179,rs1570360,VEGFA,3,2,Efficacy,1,1,cyclophosphamide;docetaxel,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401179
1445401310,rs2291767,OTOS,3,0,Toxicity,2,2,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401310
1445117525,rs193922876,RYR1,1A,100.25,Toxicity,1,2,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445117525
1445401008,rs1800559,CACNA1S,1A,100.5,Toxicity,3,5,desflurane,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445401008
1451637183,rs739296,SEPTIN3;WBP2NL,3,0,Toxicity,1,1,codeine,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637183
1444666938,HLA-A*02:01,HLA-A,4,-2.75,Toxicity,5,5,carbamazepine,"Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1444666938
1444666950,HLA-B*51:01,HLA-B,3,1.25,Toxicity,4,5,carbamazepine,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1444666950
1184986744,rs2236861,OPRD1,3,1.75,Other,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1184986744
1184986770,rs948854,GAL,3,2.25,Other,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1184986770
1445722592,rs662,PON1,3,2,Efficacy,1,1,epirubicin;fluorouracil;oxaliplatin,Neoplasms;Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445722592
1450371701,rs396991,FCGR3A,3,2.25,Efficacy,1,1,tocilizumab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1450371701
1451637220,rs739296,SEPTIN3;WBP2NL,3,0,Toxicity,1,1,oxycodone,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637220
1444667234,rs2291078,UMPS,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667234
1444667256,rs3772809,UMPS,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667256
1444667263,rs3772810,UMPS,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667263
1444700362,rs10465180,NTRK2,3,3.5,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444700362
1444700371,rs1778929,NTRK2,3,0,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444700371
1444700382,rs1360780,FKBP5,3,0,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444700382
1444700597,rs11030918,RRM1,3,3,Toxicity,1,1,gemcitabine;Platinum compounds,Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1444700597
1444700605,rs11078659,ALOX12,3,2.5,Efficacy;Toxicity,1,1,celecoxib,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444700605
1444701017,rs1886629,KCNT2,3,0,Toxicity,1,1,Bisphosphonates,Osteonecrosis,https://www.pharmgkb.org/clinicalAnnotation/1444701017
1444701024,rs2070744,NOS3,3,2.25,Efficacy,1,1,sildenafil,Erectile Dysfunction,https://www.pharmgkb.org/clinicalAnnotation/1444701024
1444705158,rs5182,AGTR1,3,0,Toxicity,1,1,"Ace Inhibitors, Plain",Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444705158
1444705166,rs809736,RORA,3,0,Efficacy,1,1,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444705166
1445400945,rs1799983,NOS3,3,2.5,Efficacy,1,1,salvianolic acid b,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1445400945
1445401205,rs1128503,ABCB1,3,2.5,Efficacy,3,3,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1445401205
1445401218,rs11280056,TYMS,3,2.25,Efficacy,1,1,pemetrexed,Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1445401218
1445402144,rs2229109,ABCB1,3,3,Efficacy,1,1,doxorubicin;methotrexate;prednisolone;vincristine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1445402144
1445402163,rs846908,HSD11B1,3,1.75,Metabolism/PK,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1445402163
1445402175,rs4844880,HSD11B1,3,2.25,Metabolism/PK,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1445402175
1445402182,rs846910,HSD11B1,3,1.75,Metabolism/PK,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1445402182
1451476309,rs17222723,ABCC2,3,2,Toxicity,1,1,methotrexate,Leukopenia;Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476309
1451637280,rs739296,SEPTIN3;WBP2NL,3,0,Toxicity,1,1,tramadol,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637280
1184987460,rs1799971,OPRM1,3,2,Other,1,1,"Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan",Substance Withdrawal Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184987460
1444608441,rs6280,DRD3,3,1.75,Efficacy,1,1,methylphenidate,Autism Spectrum Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444608441
1444700740,rs11628713,PAPLN,3,0,Toxicity,1,1,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444700740
1444703339,rs2075797,PTGER2,3,1,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444703339
1444703346,rs2108622,CYP4F2,3,3.5,Other,2,2,aspirin;clopidogrel,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1444703346
1444703393,rs2216711,GDNF,3,2,Efficacy,1,1,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444703393
1444703869,rs4149081,SLCO1B1,3,4,Efficacy,1,2,simvastatin,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1444703869
1444703906,rs3836790,SLC6A3,3,4.25,Efficacy,1,2,levodopa,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1444703906
1444703250,rs2071197,HNF4A,4,-0.5,Metabolism/PK,2,4,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1444703250
1451476360,rs11615,ERCC1,3,2,Toxicity,1,1,cisplatin;doxorubicin,mucositis;Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476360
1444703619,rs3740065,ABCC2,3,2.5,Toxicity,1,1,methotrexate,"Carcinoma, Non-Small-Cell Lung;Drug Toxicity;Leukemia, B-Cell, Acute",https://www.pharmgkb.org/clinicalAnnotation/1444703619
1445400792,rs11264359,FDPS,3,4.25,Efficacy,2,2,atorvastatin;Bisphosphonates,Coronary Disease;Osteoporosis,https://www.pharmgkb.org/clinicalAnnotation/1445400792
1445400917,rs1611115,DBH,3,1.75,Efficacy,1,1,naltrexone,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1445400917
1445594343,rs113095083,ILKAP,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445594343
1445594352,rs12505746,TET2,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445594352
1445594359,rs7706429,FBXL17,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445594359
1446902927,rs4742610,PTPRD,3,1.75,Efficacy,1,1,trandolapril;verapamil,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1446902927
1446905759,rs2297480,FDPS,3,1.75,Other,1,1,atorvastatin,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1446905759
1446906439,rs2032582,ABCB1,3,1.75,Toxicity,1,1,capecitabine,Colorectal Neoplasms;hand-foot syndrome,https://www.pharmgkb.org/clinicalAnnotation/1446906439
1446906446,rs1800896,IL10,3,2.25,Toxicity,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1446906446
1451493693,rs5186,AGTR1,3,2.75,Efficacy,3,3,irbesartan,"Hypertension;Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1451493693
1445400910,rs193922747,RYR1,1A,100.75,Toxicity,6,7,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400910
1446905691,rs1127354,ITPA,2B,24,Toxicity,14,14,peginterferon alfa-2b;ribavirin,"Anemia;Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1446905691
1446905703,rs7270101,ITPA,2B,8,Toxicity,6,6,peginterferon alfa-2b;ribavirin,"Anemia;Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1446905703
1445400880,rs4240803,SLC7A5,3,3,Toxicity,1,1,melphalan,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/1445400880
1445401156,rs1056515,RGS5,3,2,Efficacy,1,1,bevacizumab;fluorouracil;irinotecan;leucovorin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401156
1445401168,rs6313,HTR2A,4,-2,Efficacy,3,6,antidepressants,"Bipolar Disorder;Depression;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1445401168
1445402111,rs4680,COMT,3,2.5,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1445402111
1445400887,rs112563513,RYR1,1A,102.25,Toxicity,7,9,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400887
1444694385,rs5030952,CAPN10,3,2.5,Toxicity,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694385
1444694562,rs1800872,IL10,3,0,Dosage,1,1,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694562
1444694574,rs1800871,IL10,3,0,Dosage,1,1,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694574
1445400873,rs1799983,NOS3,3,2,Efficacy,1,1,daunorubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1445400873
1449753224,rs10929302,UGT1A1,3,1.75,Toxicity,1,1,risperidone,Hyperprolactinemia,https://www.pharmgkb.org/clinicalAnnotation/1449753224
1450375053,rs13181,ERCC2,3,3,Toxicity,1,1,bleomycin;cisplatin;etoposide,Alopecia;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450375053
1445400894,rs28933396,RYR1,1A,102.25,Toxicity,16,17,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400894
1449747575,rs144336148,RYR1,3,0,Toxicity,1,1,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1449747575
1451476500,rs2231142,ABCG2,4,-2.25,Toxicity,4,4,methotrexate,"Burkitt Lymphoma;Drug Toxicity;Lymphoma, T-Cell;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1451476500
1451637320,rs185462714,SERINC5,3,0,Toxicity,1,1,meperidine,adverse events,https://www.pharmgkb.org/clinicalAnnotation/1451637320
1445400156,rs193922803,RYR1,1A,100.25,Toxicity,6,7,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400156
1444673177,rs144854329,VEGFA,3,2.25,Efficacy,1,1,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444673177
1444679942,rs529520,OPRD1,3,1.5,Efficacy,2,3,buprenorphine,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444679942
1444680131,rs4704559,HOMER1,3,4.5,Toxicity,1,2,levodopa,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1444680131
1444680138,rs2592551,GGCX,3,3.25,Dosage,1,1,warfarin,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1444680138
1444703768,rs5443,GNB3,3,2.75,Efficacy,1,2,nortriptyline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444703768
1444703777,rs6051702,ITPA,3,3,Toxicity,1,1,peginterferon alfa-2a;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1444703777
1444704025,rs2279343,CYP2B6,3,2.5,Metabolism/PK,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444704025
1444704032,rs2302821,PTGES,3,2.5,Toxicity,1,1,celecoxib,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444704032
1444704048,rs2973049,GDNF,3,2.75,Efficacy,1,1,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444704048
1444673170,rs699947,VEGFA,4,-0.75,Efficacy,2,2,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444673170
1444680101,rs581111,OPRD1,4,-0.75,Efficacy,2,3,buprenorphine,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444680101
1445400172,rs118192124,RYR1,1A,100.5,Toxicity,6,7,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400172
1451716760,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",CYP2C19,4,-0.625,Efficacy,6,8,citalopram,"Depressive Disorder, Major;Obsessive-Compulsive Disorder",https://www.pharmgkb.org/clinicalAnnotation/1451716760
1451476520,rs4673,CYBA,3,2.5,Toxicity,1,1,cisplatin;doxorubicin,Anemia;mucositis;Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476520
1447676595,HLA-B*15:02,HLA-B,1A,107.5,Toxicity,9,11,lamotrigine,"Epidermal Necrolysis, Toxic;Epilepsy;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1447676595
1451678080,rs1799971,OPRM1,4,-2,Toxicity,3,4,oxycodone,adverse events;Constipation;Delirium;Nausea;Pruritus;somnolence;Urinary Retention,https://www.pharmgkb.org/clinicalAnnotation/1451678080
1447521350,HLA-B*38:02,HLA-B,3,6.25,Toxicity,2,2,carbimazole;methimazole,Graves Disease,https://www.pharmgkb.org/clinicalAnnotation/1447521350
1446896644,rs6265,BDNF,3,2.5,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1446896644
1446897509,rs7794356,GALNT17,3,0,Efficacy,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1446897509
1446897520,rs6475448,MLLT3,3,0,Efficacy,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1446897520
1446897533,rs2073618,TNFRSF11B,3,4.25,Toxicity,1,2,anastrozole;letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446897533
1446897540,rs7984870,TNFSF11,3,4.25,Efficacy,1,2,anastrozole;letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446897540
1446897675,rs1128503,ABCB1,3,3.75,Toxicity,2,3,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1446897675
1446897710,rs2032582,ABCB1,3,5,Efficacy,2,2,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1446897710
1183632200,rs2032582,ABCB1,3,4.5,Efficacy,2,2,ondansetron,Postoperative Nausea and Vomiting;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1183632200
1451476540,rs1695,GSTP1,3,3,Toxicity,1,1,cisplatin;doxorubicin;methotrexate,cardiotoxicity;Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476540
1451648440,rs756770,ADAMTSL2,3,0,Efficacy,1,1,buprenorphine,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451648440
1446899209,"CYP2D6*1, CYP2D6*4",CYP2D6,3,6,Dosage;Toxicity,1,2,maprotiline;opipramol,Depression,https://www.pharmgkb.org/clinicalAnnotation/1446899209
1446899303,"CYP2B6*1, CYP2B6*6",CYP2B6,3,2,Metabolism/PK,1,1,ketamine,Neoplasms;Pain,https://www.pharmgkb.org/clinicalAnnotation/1446899303
1446899616,rs776746,CYP3A5,3,4.75,Dosage;Metabolism/PK,2,3,cyclosporine,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1446899616
1446899680,rs17885382,HLA-DRB1,3,3,Toxicity,1,1,asparaginase,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1446899680
1446899688,rs6021191,NFATC2,3,3,Toxicity,1,2,asparaginase,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1446899688
1446899949,rs1061472,ATP7B,3,3,Toxicity,1,1,carboplatin;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899949
1451476581,rs13181,ERCC2,3,1.5,Toxicity,1,1,cisplatin;doxorubicin;methotrexate,nephrotoxicity;Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476581
1451504280,rs774072493,BCHE,3,0.25,Toxicity,1,1,succinylcholine,Apnea,https://www.pharmgkb.org/clinicalAnnotation/1451504280
1444704928,rs3758785,GPR83,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444704928
1444608250,"CYP1A2*1A, CYP1A2*1C, CYP1A2*1F",CYP1A2,3,2.75,Toxicity,2,2,clozapine,Confusion;Drug Toxicity;Headache;Muscle Rigidity;Schizophrenia;sedation;Seizures;Tachycardia,https://www.pharmgkb.org/clinicalAnnotation/1444608250
1444607408,rs1045642,ABCB1,3,2.5,Efficacy,5,7,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444607408
1444607420,rs889895,CREB1,3,0.5,Efficacy,1,2,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444607420
1444607466,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6",CYP2C9,3,2.25,Toxicity,1,1,olanzapine,Hypotension,https://www.pharmgkb.org/clinicalAnnotation/1444607466
1444607666,rs12721646,CYP2B6,3,0,Other,2,2,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444607666
1444608238,rs4532,DRD1,3,4.5,Toxicity,1,3,dextroamphetamine;methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1444608238
1444666615,rs3213239,APLF,3,3,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666615
1444666622,rs13181,ERCC2,3,2.5,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666622
1444666629,rs1799793,ERCC2,3,4.5,Toxicity,2,2,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666629
1444686836,rs1800871,IL10,3,0.5,Metabolism/PK,3,4,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444686836
1444673108,rs11692021,UGT1A9,3,2.5,Toxicity,2,2,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444673108
1444673115,rs2070959,UGT1A6,3,2.5,Toxicity,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444673115
1444686824,rs2231142,ABCG2,3,2.5,Efficacy,1,1,sulfasalazine,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444686824
1444700688,rs1160351,MDGA2,3,0,Toxicity,1,1,fluvoxamine;milnacipran;paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444700688
1444704921,rs3740066,ABCC2,3,1.5,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1444704921
1444704936,rs3758785,GPR83,3,0,Efficacy,1,1,candesartan,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444704936
1444704943,rs3764043,SLCO1A2,3,2,Metabolism/PK,1,1,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444704943
1444843382,rs11231809,SLC22A11,3,2.5,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444843382
1444843389,rs246240,ABCC1,3,3,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444843389
1444843402,rs3784864,ABCC1,3,2.5,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444843402
1447681808,rs10046,CYP19A1,3,2.75,Other,1,2,hdl cholesterol;letrozole;triglycerides,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447681808
1444686803,rs2231142,ABCG2,4,-0.25,Efficacy,2,2,capecitabine;fluorouracil;leucovorin;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444686803
1444668444,rs10455872,LPA,3,6.75,Efficacy,3,4,hmg coa reductase inhibitors,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1444668444
1447673659,rs111888148,RYR1,3,0.25,Toxicity,3,3,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447673659
1444930642,rs12979860,IFNL3;IFNL4,3,5.75,Efficacy,2,2,ledipasvir;sofosbuvir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1444930642
1451678101,rs4680,COMT,4,-0.25,Toxicity,2,3,oxycodone,adverse events;Constipation;Delirium;Nausea;Pruritus;somnolence;Urinary Retention,https://www.pharmgkb.org/clinicalAnnotation/1451678101
1447672998,rs9923231,VKORC1,2A,17.75,Efficacy,11,12,warfarin,time to therapeutic inr,https://www.pharmgkb.org/clinicalAnnotation/1447672998
1447673015,rs9923231,VKORC1,2A,9,Efficacy,9,9,warfarin,time in therapeutic range,https://www.pharmgkb.org/clinicalAnnotation/1447673015
1447673669,rs193922809,RYR1,1A,100.25,Toxicity,2,3,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447673669
1451476547,rs1695,GSTP1,3,2,Toxicity,1,1,doxorubicin,Leukopenia;Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476547
1451465324,rs4149056,SLCO1B1,1A,103.5,Toxicity,1,2,lovastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451465324
1444607730,rs9852,TBC1D1,3,2,Toxicity,1,1,clozapine;olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444607730
1444667334,rs17431184,PTEN,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667334
1444667346,rs2236722,CYP19A1,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667346
1444703936,rs3750117,NT5C3A,3,3,Efficacy,1,1,cytarabine;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1444703936
1444704810,rs1045280,ARRB2,3,1.5,Other,1,1,methamphetamine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444704810
1444706854,rs11677416,IL1A,3,0,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444706854
1444706861,rs1880676,CHAT,3,0,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444706861
1444706883,rs3810950,CHAT,3,0,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444706883
1444706890,rs4436578,DRD2,3,3.25,Toxicity,1,1,clozapine;olanzapine;risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444706890
1445400939,rs1801131,MTHFR,3,1.5,Toxicity,1,1,clozapine;olanzapine,schizoaffective disorder;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1445400939
1445401413,rs11563250,UGT1A,3,2,Metabolism/PK,1,1,bilirubin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401413
1445401420,rs11563250,UGT1A,3,3.75,Toxicity,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401420
1445401439,rs1934969,CYP2C9,3,1.25,Metabolism/PK,1,1,phenytoin,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1445401439
1447678472,"CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*14",CYP2D6,3,0.75,Toxicity,12,15,antipsychotics,Dystonia,https://www.pharmgkb.org/clinicalAnnotation/1447678472
1447679509,"GSTM1 non-null, GSTM1 null",GSTM1,3,2.25,Efficacy,6,7,cisplatin;oxaliplatin;Platinum compounds,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447679509
1445400924,rs63749869,RYR1,1A,100.25,Toxicity,5,6,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400924
1451476564,rs1801133,CLCN6;MTHFR,3,0,Toxicity,1,1,cisplatin;doxorubicin;methotrexate,nephrotoxicity;Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1451476564
1451504300,rs568724445,BCHE,3,0.25,Toxicity,1,1,succinylcholine,Apnea,https://www.pharmgkb.org/clinicalAnnotation/1451504300
1444704784,rs1024323,GRK4,3,0,Toxicity,1,1,atenolol;verapamil,Coronary Artery Disease;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444704784
1444703739,rs6313,HTR2A,4,-1.75,Efficacy,1,4,fluvoxamine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444703739
1446904283,rs56061981,CXCL10,3,2.75,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1446904283
1446904972,rs717620,ABCC2,3,0.25,Toxicity,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1446904972
1446905018,rs8187710,ABCC2,3,0.25,Toxicity,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1446905018
1446906399,rs889299,SCNN1B,3,2.25,Toxicity,1,1,Farglitazar;glyburide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1446906399
1446906412,rs2429427,TANC2,3,2.25,Efficacy,1,1,calcium channel blockers,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1446906412
1446906421,rs2242480,CYP3A4,3,4.5,Toxicity,1,2,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1446906421
1446907957,rs7254579,CYP2B6,3,2,Metabolism/PK,1,1,cyclophosphamide,Lupus erythematosus,https://www.pharmgkb.org/clinicalAnnotation/1446907957
1446908002,rs4802101,CYP2B6,3,5.5,Toxicity;Metabolism/PK,1,2,cyclophosphamide,Lupus erythematosus,https://www.pharmgkb.org/clinicalAnnotation/1446908002
1447680028,rs371194629,HLA-G,3,3.25,Efficacy,1,1,capecitabine;fluorouracil,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447680028
1447680035,rs9380142,HLA-G,3,3.25,Efficacy,1,1,capecitabine;fluorouracil,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447680035
1447680045,rs17179108,HLA-G,3,2.25,Efficacy,1,1,capecitabine;fluorouracil,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447680045
1447680068,rs4646,CYP19A1,3,1.5,Other,1,1,letrozole,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447680068
1447681831,rs2289105,CYP19A1,3,2.75,Other,1,2,hdl cholesterol;letrozole;triglycerides,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447681831
1447682293,rs700518,CYP19A1,3,1.5,Other,1,1,letrozole,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447682293
1446905231,rs4803419,CYP2B6,3,1.375,Metabolism/PK,5,5,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1446905231
1451743169,rs17064642,MYOM2,3,4,Efficacy,1,1,aspirin;clopidogrel,Acute coronary syndrome;major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1451743169
1451496100,"G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like",G6PD,3,0.5,Toxicity,3,3,sulfamethoxazole,Hemolysis,https://www.pharmgkb.org/clinicalAnnotation/1451496100
1451504307,rs764841347,BCHE,3,0.25,Toxicity,1,1,succinylcholine,Apnea,https://www.pharmgkb.org/clinicalAnnotation/1451504307
1444666110,rs2231142,ABCG2,3,5.25,Toxicity,3,4,sunitinib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444666110
1444666589,rs3738948,ERCC3,3,2.25,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666589
1444666601,rs1800975,XPA,3,2.25,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666601
1444666608,rs1799801,ERCC4,3,2.25,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666608
1444666667,rs4413407,CXXC4,3,3,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666667
1444673184,rs35864111,VEGFA,3,2.25,Efficacy,1,1,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444673184
1444700639,rs1126510,PTGIR,3,1.5,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444700639
1444700647,rs113165732,OCRL,3,0.25,Other,1,1,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444700647
1444704081,rs4570625,TPH2,3,0,Efficacy,1,1,citalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444704081
1445402209,rs12044852,CD58,3,2,Efficacy,1,1,interferon beta-1a;interferon beta-1b,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1445402209
1446897159,rs1143634,IL1B,3,3,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1446897159
1451504376,rs201820739,BCHE,3,0.25,Toxicity,1,1,succinylcholine,Apnea,https://www.pharmgkb.org/clinicalAnnotation/1451504376
1446906350,rs6166,FSHR,3,1.375,Efficacy,1,1,follitropin beta;thyrotropin alfa;urofollitropin,"Infertility, Female;Ovarian hyperstimulation syndrome",https://www.pharmgkb.org/clinicalAnnotation/1446906350
1444607641,rs2269577,XBP1,3,2,Efficacy;Toxicity,1,4,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444607641
1444607648,rs58425034,CYP2B6,3,0,Other,2,2,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444607648
1444608053,rs3957357,GSTA1,3,1.5,Efficacy,1,1,doxorubicin,Sarcoma,https://www.pharmgkb.org/clinicalAnnotation/1444608053
1444666550,rs2273697,ABCC2,3,1.25,Metabolism/PK,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1444666550
1444667461,rs1047626,SLC30A9,3,3,Toxicity,1,1,aspirin,aspirin-induced asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667461
1444607611,rs1065852,CYP2D6,3,1.75,Efficacy,1,2,escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444607611
1444706830,rs3087879,SLC1A1,3,3.5,Efficacy,1,1,Selective serotonin reuptake inhibitors,Obsessive-Compulsive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444706830
1444930908,rs12979860,IFNL3;IFNL4,3,0,Efficacy,1,1,daclatasvir;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1444930908
1446906328,rs4688040,NR1I2,3,1.25,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1446906328
1446906335,rs4825476,GRIA3,3,3,Toxicity,1,1,citalopram,Depression;suicide,https://www.pharmgkb.org/clinicalAnnotation/1446906335
1446906363,rs6277,DRD2,3,2,Efficacy,1,1,aripiprazole,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1446906363
1446906391,rs944050,ESR2,3,2.25,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446906391
1447813539,rs1059751,ABCC4,3,2.25,Toxicity,1,1,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447813539
1447813554,"CYP2C19*1, CYP2C19*2, CYP2C19*17",CYP2C19,3,2.5,Efficacy;Metabolism/PK,8,10,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447813554
1447813855,rs10140457,ESR2,3,2.5,Toxicity,1,1,letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447813855
1447813873,rs4870061,ESR1,3,5,Toxicity,1,2,letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447813873
1447813969,rs1801133,MTHFR,3,7.25,Efficacy,3,3,fluorouracil;leucovorin;oxaliplatin,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447813969
1447814178,rs2010963,VEGFA,3,2.75,Toxicity,1,1,sorafenib,"Carcinoma, Renal Cell;hand-foot syndrome",https://www.pharmgkb.org/clinicalAnnotation/1447814178
1447814397,rs9322335,ESR1,3,5,Toxicity,1,2,exemestane;letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447814397
1447814403,rs717620,ABCC2,3,0,Metabolism/PK,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447814403
1447814424,rs3793790,CHAT,3,2,Efficacy,1,1,donepezil;galantamine;rivastigmine,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1447814424
1447814450,rs3917412,SELE,3,2.25,Efficacy,1,1,capecitabine;fluorouracil;leucovorin;oxaliplatin,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447814450
1451504360,rs1560022535,BCHE,3,0.25,Toxicity,1,1,succinylcholine,Apnea,https://www.pharmgkb.org/clinicalAnnotation/1451504360
1451504368,rs531738678,BCHE,3,0.25,Toxicity,1,1,succinylcholine,Apnea,https://www.pharmgkb.org/clinicalAnnotation/1451504368
1444666533,"CYP3A4*1, CYP3A4*8, CYP3A4*20, CYP3A4*22",CYP3A4,3,3,Toxicity,2,2,paclitaxel,Breast Neoplasms;Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444666533
1447943620,rs11313667,LRRC15,3,0,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447943620
1447943626,rs11313667,LRRC15,3,0,Efficacy,1,1,metoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447943626
1444686850,rs683369,SLC22A1,3,5.75,Efficacy;Metabolism/PK,1,3,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444686850
1444686868,rs34231037,KDR,3,2.5,Efficacy;Metabolism/PK,1,2,pazopanib,Kidney Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444686868
1444687039,rs4149570,TNFRSF1A,3,3.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Crohn Disease;Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444687039
1447814153,rs2239702,KDR,3,4,Efficacy,1,2,sorafenib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1447814153
1447814165,rs1570360,VEGFA,3,1.75,Efficacy,1,1,sorafenib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1447814165
1447814185,rs1045642,ABCB1,3,2.25,Toxicity,1,1,sorafenib,"Carcinoma, Renal Cell;Hypertension",https://www.pharmgkb.org/clinicalAnnotation/1447814185
1447814385,rs1967309,ADCY9,3,3,Efficacy;Toxicity,2,2,dalcetrapib,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1447814385
1447943597,rs1045642,ABCB1,3,0.5,Efficacy,2,2,venlafaxine,Depressive Disorder;Narcolepsy,https://www.pharmgkb.org/clinicalAnnotation/1447943597
1447943608,rs1045642,ABCB1,3,1.75,Efficacy,1,1,Selective serotonin reuptake inhibitors,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447943608
1447943614,rs11313667,LRRC15,3,0,Efficacy,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447943614
1447943700,rs1045642,ABCB1,3,2,Efficacy,1,1,modafinil,Narcolepsy,https://www.pharmgkb.org/clinicalAnnotation/1447943700
1447943721,rs1076560,DRD2,3,1.75,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447943721
1447943760,rs13250975,NRG1,3,1.625,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447943760
1447943772,rs1367094,ZMAT4,3,0,Efficacy,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447943772
1447944813,rs138337,ST13,3,1.5,Efficacy,1,1,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447944813
1444686843,rs4646437,CYP3A4,2A,10.5,Metabolism/PK,6,6,tacrolimus,Kidney Transplantation;liver transplantation;Proteinuria,https://www.pharmgkb.org/clinicalAnnotation/1444686843
1449157278,rs678849,OPRD1,3,5.75,Efficacy,3,5,buprenorphine,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449157278
1444700788,"CYP2C19*1, CYP2C19*17",CYP2C19,3,2.5,Toxicity,1,2,prasugrel,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1444700788
1445594491,rs4431329,FBXL17,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445594491
1445594505,rs11993031,CSMD1,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445594505
1446897166,rs16944,IL1B,3,3,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1446897166
1446897184,rs4849127,IL1B,3,3,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1446897184
1447672600,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14",CYP2C9,2A,10.5,Efficacy,10,15,warfarin,Atrial Fibrillation;heart valve replacement,https://www.pharmgkb.org/clinicalAnnotation/1447672600
1447673759,rs118192178,RYR1,1A,101.75,Toxicity,5,8,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447673759
1447673778,rs193922818,RYR1,1A,101,Toxicity,7,9,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447673778
1447673787,rs193922878,RYR1,1A,101,Toxicity,5,6,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447673787
1447675871,rs193922753,RYR1,1A,100.75,Toxicity,3,4,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447675871
1447676001,rs118192116,RYR1,1A,100,Toxicity,1,2,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447676001
1447676077,rs193922807,RYR1,1A,100,Toxicity,2,3,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447676077
1451725560,"CYP3A4*1, CYP3A4*22",CYP3A4,3,1.25,Toxicity,1,2,alprazolam,adverse events;Alcoholism;Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451725560
1444666290,rs1042713,ADRB2,3,2.25,Efficacy,1,1,tiotropium,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444666290
1444667758,rs1946518,IL18,3,3.25,Metabolism/PK,2,3,tacrolimus,Kidney Transplantation;lung transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444667758
1444686760,rs1799853,CYP2C9,3,3,Metabolism/PK,1,2,busulfan,hemopoietic stem cell transplant,https://www.pharmgkb.org/clinicalAnnotation/1444686760
1444686789,rs3745274,CYP2B6,3,6.5,Efficacy;Toxicity,1,3,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444686789
1444703803,rs36056065,SLC22A1,3,3,Toxicity,1,1,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1444703803
1447676781,rs8099917,IFNL3,3,2.5,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;simeprevir,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1447676781
1447681869,rs3759811,CYP19A1,3,1.5,Other,1,1,letrozole,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447681869
1447681876,rs4775936,CYP19A1,3,1.5,Other,1,1,letrozole,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447681876
1447681883,rs1008805,CYP19A1,3,1.25,Other,1,1,hmg coa reductase inhibitors;letrozole,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447681883
1451649020,rs671,ALDH2,3,2.5,Efficacy,1,1,naltrexone,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451649020
1447945787,"CYP2B6*1, CYP2B6*6",CYP2B6,3,2,Metabolism/PK,1,1,cyclophosphamide,"Lymphoma, B-Cell",https://www.pharmgkb.org/clinicalAnnotation/1447945787
1447945800,rs1056836,CYP1B1,3,2.5,Toxicity,1,1,cyclophosphamide;epirubicin;paclitaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447945800
1447945850,rs2229109,ABCB1,3,3.5,Toxicity,1,1,bleomycin;cyclophosphamide;doxorubicin;prednisone;rituximab;vincristine;vindesine,"Lymphoma, Non-Hodgkin",https://www.pharmgkb.org/clinicalAnnotation/1447945850
1447945887,rs396991,FCGR3A,3,0.5,Efficacy,2,2,infliximab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1447945887
1447945958,rs12817819,ATP2B1,3,1.75,Efficacy,1,2,Antihypertensives,Coronary Artery Disease;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447945958
1447945967,rs6465084,GRM3,3,5.25,Efficacy,2,2,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447945967
1447945978,rs1468412,GRM3,3,2.25,Toxicity,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447945978
1447945985,rs12467557,NRXN1,3,1.75,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447945985
1447945992,rs10490162,NRXN1,3,1.75,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447945992
1447945999,rs17671591,HMGCR,3,5.5,Efficacy,2,2,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1447945999
1447946011,rs10490924,ARMS2,3,4.25,Efficacy,2,2,bevacizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1447946011
1447946061,"CYP2E1*1A, CYP2E1*5B",CYP2E1,3,3.75,Toxicity,5,5,Drugs For Treatment Of Tuberculosis,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447946061
1447946088,rs1001179,CAT,3,2.75,Other,1,2,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1447946088
1449192991,rs1800497,DRD2,3,3,Toxicity,1,1,ethanol,Alcoholism;Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449192991
1444667668,rs3753380,PTGFR,3,1.75,Efficacy,2,2,latanoprost,"Glaucoma, Open-Angle",https://www.pharmgkb.org/clinicalAnnotation/1444667668
1451648980,rs698,ADH1C,3,2.5,Efficacy,1,1,naltrexone,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451648980
1451726525,rs1045642,ABCB1,4,-1.25,Efficacy,2,2,docetaxel,Breast Neoplasms;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451726525
1449156223,HLA-DRB1*01:02,HLA-DRB1,3,2,Toxicity,2,2,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156223
1444667680,rs3766355,PTGFR,3,1.75,Efficacy,2,2,latanoprost,"Glaucoma, Open-Angle",https://www.pharmgkb.org/clinicalAnnotation/1444667680
1444667704,rs10306114,PTGS1,3,0,Efficacy,1,1,latanoprost,"Glaucoma, Open-Angle",https://www.pharmgkb.org/clinicalAnnotation/1444667704
1444667733,rs11568658,ABCC4,3,2.75,Efficacy,1,1,latanoprost,"Glaucoma, Open-Angle",https://www.pharmgkb.org/clinicalAnnotation/1444667733
1444686893,rs6494223,CHRNA7,3,2,Efficacy,1,1,donepezil;galantamine;rivastigmine,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1444686893
1445400992,rs1563828,MDM4,3,2.5,Efficacy,1,1,docetaxel;epirubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445400992
1445401001,rs1056836,CYP1B1,3,2,Efficacy,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401001
1447681902,rs749292,CYP19A1,3,1.5,Other,1,1,letrozole,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447681902
1447682300,rs1062033,CYP19A1,3,1.25,Other,1,1,hmg coa reductase inhibitors;letrozole,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1447682300
1447943640,rs2177370,CHAT,3,2,Efficacy,1,1,donepezil,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1447943640
1447943653,rs2177370,CHAT,3,2,Efficacy,1,1,rivastigmine,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1447943653
1447943673,rs5443,GNB3,3,2.25,Efficacy,1,1,hydralazine / isosorbide dinitrate,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1447943673
1447943685,rs5443,GNB3,3,2,Efficacy,1,1,telmisartan,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447943685
1447943753,rs1128503,ABCB1,3,2,Efficacy,1,1,modafinil,Narcolepsy,https://www.pharmgkb.org/clinicalAnnotation/1447943753
1447944755,rs1079597,DRD2,3,2,Efficacy,1,1,amisulpride,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447944755
1447944806,rs138335,ST13,3,1.5,Efficacy,1,1,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447944806
1447944819,rs1449683,FGF2,3,1.5,Efficacy,1,1,fluvoxamine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447944819
1447944855,rs1544938,ADCY2,3,1.625,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447944855
1447943739,rs1128503,ABCB1,4,-0.625,Metabolism/PK,3,3,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447943739
1444686796,rs1741981,HDAC1,3,3.25,Efficacy,1,2,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444686796
1444704267,rs4702484,ADCY2,4,-1.75,Efficacy,1,2,capecitabine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444704267
1444704385,rs4506565,TCF7L2,3,2.5,Toxicity,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444704385
1444704392,rs4654327,OPRD1,3,1.5,Efficacy,1,1,naltrexone,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1444704392
1444704400,rs4680,COMT,3,1.5,Efficacy,1,1,entacapone,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1444704400
1447944882,rs17716295,NRG1,3,1.375,Efficacy,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447944882
1444704366,rs4329505,IL6R,4,-0.5,Efficacy,2,2,tocilizumab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444704366
1451648958,rs2066702,ADH1B,3,2.5,Efficacy,1,1,naltrexone,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451648958
1185000052,rs776746,CYP3A5,3,1,Toxicity,2,2,tacrolimus,Kidney Failure,https://www.pharmgkb.org/clinicalAnnotation/1185000052
1444667661,rs3792269,CAPN10,3,3,Efficacy,1,1,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1444667661
1444686907,rs4646437,CYP3A4,3,2.5,Efficacy;Metabolism/PK,1,2,cyclosporine,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444686907
1444686914,rs2276707,NR1I2,3,1.25,Metabolism/PK,2,2,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444686914
1444686921,rs4848306,IL1B,3,3,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Colitis, Ulcerative;Inflammatory Bowel Diseases",https://www.pharmgkb.org/clinicalAnnotation/1444686921
1444686927,rs4251961,IL1RN,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Colitis, Ulcerative",https://www.pharmgkb.org/clinicalAnnotation/1444686927
1184999911,"CYP3A5*1, CYP3A5*3",CYP3A5,1B,30.375,Metabolism/PK,26,30,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1184999911
1444700589,rs11023197,RRAS2,3,1.75,Efficacy,1,1,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444700589
1445401281,rs7317112,ABCC4,3,2.5,Toxicity,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1445401281
1448602689,rs2669429,DPYS,3,3,Toxicity,1,1,atenolol,Hyperglycemia;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448602689
1448602859,rs3217164,CES1,3,3,Toxicity,1,1,capecitabine,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1448602859
1448602865,rs2244614,CES1,3,3,Toxicity,1,1,capecitabine,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1448602865
1448602877,rs11861118,CES1P1,3,2.5,Toxicity,1,1,capecitabine,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1448602877
1448602883,rs7187684,CES1P1,3,2.5,Toxicity,1,1,capecitabine,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1448602883
1448602871,rs2244613,CES1,3,4.75,Toxicity,2,2,capecitabine,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1448602871
1444687046,rs2430561,IFNG,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Crohn Disease;Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444687046
1451678087,rs4680,COMT,4,-0.25,Toxicity,2,3,morphine,adverse events;Constipation;Delirium;Nausea;Pruritus;somnolence;Urinary Retention,https://www.pharmgkb.org/clinicalAnnotation/1451678087
1451638880,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,3,3,Efficacy,1,1,ketorolac,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451638880
1451679740,rs55944529,DAO,3,2.25,Metabolism/PK,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451679740
1451504901,rs1801133,MTHFR,3,7.75,Metabolism/PK,13,13,methotrexate,"Burkitt Lymphoma;Leukemia;Lymphoma;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1451504901
1444668597,rs9939609,FTO,3,2,Efficacy,1,1,"interferon alfa-2a, recombinant;interferon alfa-2b, recombinant;ribavirin","Hepatitis C, Chronic;HIV Infections",https://www.pharmgkb.org/clinicalAnnotation/1444668597
1444694373,rs7903146,TCF7L2,3,0,Toxicity,3,3,cyclosporine;sirolimus;tacrolimus,Kidney Transplantation;liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694373
1444695339,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,3,6.75,Metabolism/PK,8,8,clobazam,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1444695339
1446897191,rs6265,BDNF,3,5,Toxicity,2,2,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1446897191
1451720996,rs7317112,ABCC4,3,1.75,Toxicity,1,1,Glucarpidase,nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451720996
1448601910,rs2242446,SLC6A2,3,2.75,Efficacy,1,1,venlafaxine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448601910
1448602210,rs9361233,HTR1B,3,2.25,Efficacy,1,1,fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448602210
1451649500,rs997917,OPRK1,3,0,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451649500
1451649540,rs997917,OPRK1,3,0,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451649540
1448603309,rs324420,FAAH,3,2.5,Toxicity,3,4,morphine,Constipation;Delirium;Lung Neoplasms;Nausea;Pain;Postoperative Nausea and Vomiting;Pruritus;Respiratory Insufficiency;somnolence;Urinary Retention,https://www.pharmgkb.org/clinicalAnnotation/1448603309
1451679780,rs55944529,DAO,3,2.75,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451679780
1451721021,rs3824662,GATA3,3,0,Toxicity,1,1,Glucarpidase,nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451721021
1451737460,rs11640115,JMJD8;WDR24,3,3.5,Efficacy,1,1,aspirin;clopidogrel,Acute coronary syndrome;major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1451737460
1451721013,rs4149056,SLCO1B1,3,0,Toxicity,1,1,Glucarpidase,nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451721013
1446897696,rs2032582,ABCB1,3,5,Toxicity,2,2,sunitinib,"Carcinoma, Renal Cell;Neutropenia",https://www.pharmgkb.org/clinicalAnnotation/1446897696
1451638961,rs1128503,ABCB1,3,2.25,Toxicity,2,2,paclitaxel,Breast Neoplasms;Peripheral Nervous System Diseases,https://www.pharmgkb.org/clinicalAnnotation/1451638961
1451720980,rs10908521,INSRR;NTRK1,3,0,Toxicity,1,1,Glucarpidase,nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451720980
1184987404,rs10485828,TUBB1,3,0,Other,1,1,anastrozole;exemestane,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184987404
1184988860,rs2058878,GRIN2B,3,2,Efficacy,1,1,acamprosate,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1184988860
1184997092,HLA-B*44:02,HLA-B,3,2.5,Efficacy,1,1,"interferon alfa-2a, recombinant;ribavirin",Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1184997092
1451748840,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",TPMT,3,3.5,Toxicity,1,1,mercaptopurine,Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1451748840
1184998947,rs1045642,ABCB1,3,0,Other,1,1,morphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1184998947
1184998975,rs4793665,ABCC3,3,3.75,Other,2,2,morphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1184998975
1184997066,HLA-B*38:01,HLA-B,3,3,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1184997066
1451726789,"CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4",CYP2C8,4,-1,Toxicity,7,8,paclitaxel,Drug Toxicity;Neutropenia;Peripheral Nervous System Diseases;Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1451726789
1451737500,rs4736529,EFR3A,3,3.5,Efficacy,1,1,aspirin;clopidogrel,Acute coronary syndrome;major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1451737500
1184997072,HLA-B*38:02,HLA-B,3,3,Toxicity,1,1,oxcarbazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184997072
1451721028,rs10821936,ARID5B,3,0,Toxicity,1,1,Glucarpidase,nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451721028
1444666308,rs2832407,GRIK1,3,2.5,Efficacy;Metabolism/PK,1,2,topiramate,Alcohol-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444666308
1444673163,rs1057868,POR,3,2.75,Metabolism/PK,3,3,cyclosporine,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444673163
1444686935,rs352139,TLR9,3,3.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Crohn Disease;Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444686935
1444686942,rs4696480,TLR2,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Colitis, Ulcerative",https://www.pharmgkb.org/clinicalAnnotation/1444686942
1444686958,rs1816702,TLR2,3,2.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Crohn Disease,https://www.pharmgkb.org/clinicalAnnotation/1444686958
1444694504,rs2237895,KCNQ1,3,2,Toxicity,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694504
1444694544,rs1800896,IL10,3,2.25,Dosage,1,1,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694544
1444703639,rs3763980,SLC16A7,3,1.5,Efficacy,1,1,methotrexate,"Arthritis, Juvenile Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444703639
1444828083,G6PD A- 202A_376G,G6PD,3,0.375,Toxicity,2,2,pegloticase,Hemolysis;Methemoglobinemia,https://www.pharmgkb.org/clinicalAnnotation/1444828083
1445616165,rs77876672,DIAPH3,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445616165
1445619121,rs9590353,UGGT2,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445619121
1445619585,rs9915451,ANKFN1,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445619585
1444694511,rs2032582,ABCB1,4,-7.375,Dosage;Metabolism/PK,21,25,tacrolimus,Kidney Transplantation;liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694511
1444666386,rs28399499,CYP2B6,2A,9.5,Toxicity,4,4,nevirapine,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1444666386
1296599132,rs1045642,ABCB1,3,4.75,Toxicity,9,12,methotrexate,"Burkitt Lymphoma;Drug Toxicity;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1296599132
1451748940,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",TPMT,3,7,Toxicity,1,2,thioguanine,Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1451748940
1444713220,HLA-DRB3*02:02,HLA-DRB3,3,2,Toxicity,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444713220
1448573615,rs1128503,ABCB1,3,1,Efficacy,2,2,tacrolimus,"Colitis, Ulcerative",https://www.pharmgkb.org/clinicalAnnotation/1448573615
1448601692,rs3732759,P2RY12,3,2,Efficacy,1,1,clopidogrel,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1448601692
1448604082,rs113993960,CFTR,3,0.75,Efficacy,1,2,cavosonstat,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1448604082
1448604316,rs2277984,C3,3,0,Toxicity,1,1,clozapine,Metabolic Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1448604316
1451737520,rs74569896,NECAB1,3,3.5,Efficacy,1,1,aspirin;clopidogrel,Acute coronary syndrome;major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1451737520
1451748948,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",TPMT,3,3.5,Dosage,1,1,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451748948
1444607379,rs57098334,SLC6A4,4,-0.25,Efficacy,3,4,sertraline,"Depressive Disorder, Major;Panic Disorder",https://www.pharmgkb.org/clinicalAnnotation/1444607379
1184989970,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,4,-1.125,Efficacy,9,11,sertraline,"Depressive Disorder, Major;Panic Disorder",https://www.pharmgkb.org/clinicalAnnotation/1184989970
1184989960,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2.25,Toxicity,1,3,fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1184989960
1184989950,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,4,-5.75,Efficacy,13,17,fluoxetine,"Depressive Disorder, Major;Obsessive-Compulsive Disorder",https://www.pharmgkb.org/clinicalAnnotation/1184989950
1184986481,rs35599367,CYP3A4,3,5.875,Other,7,9,cyclosporine,Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1184986481
1184986491,rs4823613,PPARA,3,1.5,Other,1,1,tacrolimus,Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1184986491
1184990000,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2,Toxicity,1,1,mirtazapine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1184990000
1444607373,rs310786,E2F7,3,2,Toxicity,1,1,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444607373
1444607507,"TPMT*1, TPMT*3A, TPMT*3C",TPMT,3,2.25,Toxicity,1,1,olanzapine,Fatigue,https://www.pharmgkb.org/clinicalAnnotation/1444607507
1444607526,"UGT1A1*1, UGT1A1*28",UGT1A1,3,2.75,Toxicity,1,1,olanzapine,Fatigue,https://www.pharmgkb.org/clinicalAnnotation/1444607526
1444607634,rs628031,SLC22A1,3,4.5,Efficacy,2,2,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1444607634
1444607674,rs6295,HTR1A,3,1.25,Efficacy,2,2,fluoxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444607674
1444607851,rs4073,CXCL8,3,1.75,Efficacy,1,1,bevacizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1444607851
1444607863,rs11572076,CYP2C8,3,3,Toxicity,1,1,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444607863
1444672766,rs1799963,F2,3,3.5,Toxicity,4,4,hormonal contraceptives for systemic use,Stroke;Venous Thrombosis,https://www.pharmgkb.org/clinicalAnnotation/1444672766
1444672774,rs5443,GNB3,3,5,Efficacy,2,3,clonidine,Liver Cirrhosis,https://www.pharmgkb.org/clinicalAnnotation/1444672774
1451649631,rs12678747,EYA1,3,3,Toxicity,1,1,aspirin,Peptic Ulcer,https://www.pharmgkb.org/clinicalAnnotation/1451649631
1451737560,rs75750968,AGAP3,3,3.5,Efficacy,1,1,aspirin;clopidogrel,Acute coronary syndrome;major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1451737560
1451749040,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",TPMT,3,3.5,Dosage,1,1,thioguanine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451749040
1296598640,HLA-B*13:01,HLA-B,3,3,Toxicity,1,1,sulfasalazine,drug reaction with eosinophilia and systemic symptoms,https://www.pharmgkb.org/clinicalAnnotation/1296598640
1296598646,HLA-B*15:05,HLA-B,3,0,Toxicity,1,1,sulfasalazine,drug reaction with eosinophilia and systemic symptoms,https://www.pharmgkb.org/clinicalAnnotation/1296598646
1296598634,HLA-B*39:01,HLA-B,3,2.5,Toxicity,1,1,sulfasalazine,drug reaction with eosinophilia and systemic symptoms,https://www.pharmgkb.org/clinicalAnnotation/1296598634
1184986321,rs724710,BCL2L11,3,1.75,Efficacy,1,2,imatinib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184986321
1184986585,rs9535828,ATP7B,3,2.5,Efficacy,1,1,Platinum compounds,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184986585
1184986763,rs1045642,ABCB1,3,4.75,Other,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1184986763
1184987048,rs10267099,ABCB1,3,1.5,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184987048
1444700423,rs316019,SLC22A2,3,1,Toxicity,4,4,cisplatin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1444700423
1444700445,rs76228616,TRAF3IP2,3,2.5,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444700445
1444700767,rs12083537,IL6R,3,4.5,Efficacy,2,2,tocilizumab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444700767
1444700888,rs9516519,ABCC4,3,4,Toxicity,1,2,methotrexate,"Leukemia, B-Cell, Acute",https://www.pharmgkb.org/clinicalAnnotation/1444700888
1444706112,rs5744247,IL18,3,2.25,Metabolism/PK,2,3,tacrolimus,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444706112
1444706787,rs4680,COMT,3,2.25,Efficacy,1,1,paroxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444706787
1444706810,rs301434,SLC1A1,3,0,Efficacy,1,1,Selective serotonin reuptake inhibitors,Obsessive-Compulsive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444706810
1444706818,rs301435,SLC1A1,3,0,Efficacy,1,1,Selective serotonin reuptake inhibitors,Obsessive-Compulsive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444706818
1444709147,rs1387923,NTRK2,4,-1.75,Efficacy,2,2,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444709147
1451737600,rs140410716,ECHS1,3,3.5,Efficacy,1,1,aspirin;clopidogrel,Acute coronary syndrome;major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1451737600
1184986174,rs75017182,DPYD,1A,199.5,Toxicity,9,11,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184986174
1184989940,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,4,-0.75,Efficacy,10,15,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1184989940
1185000238,rs776746,CYP3A5,3,0.5,Efficacy,3,3,tacrolimus,"Colitis, Ulcerative",https://www.pharmgkb.org/clinicalAnnotation/1185000238
1444607295,rs806368,CNR1,3,1,Other,1,2,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444607295
1444607302,rs6454674,CNR1,3,2.5,Other,1,2,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444607302
1444607751,rs1799782,XRCC1,3,0,Efficacy,6,7,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444607751
1444607979,rs1042927,RRM1,3,1.25,Efficacy,3,3,gemcitabine;Platinum compounds,Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1444607979
1444608491,rs1353295,AREG,3,1.75,Efficacy,1,1,cetuximab;irinotecan;panitumumab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444608491
1444665939,rs13104811,AREG,3,2.25,Efficacy,1,1,cetuximab;irinotecan;panitumumab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444665939
1444667912,rs4880,SOD2,3,1.5,Toxicity,1,1,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1444667912
1444686969,rs11938228,TLR2,3,6.5,Efficacy,2,2,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Inflammatory Bowel Diseases;Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1444686969
1444686976,rs3804099,TLR2,3,3.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444686976
1444686983,rs2569190,CD14,3,2.25,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Colitis, Ulcerative",https://www.pharmgkb.org/clinicalAnnotation/1444686983
1444686990,rs2275913,IL17A,3,3,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Colitis, Ulcerative;Inflammatory Bowel Diseases",https://www.pharmgkb.org/clinicalAnnotation/1444686990
1444686997,rs6927172,TNFAIP3,3,3,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Colitis, Ulcerative;Inflammatory Bowel Diseases",https://www.pharmgkb.org/clinicalAnnotation/1444686997
1444687004,rs10499563,IL6,3,4,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Colitis, Ulcerative;Inflammatory Bowel Diseases",https://www.pharmgkb.org/clinicalAnnotation/1444687004
1444687025,rs5030728,TLR4,3,3.75,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444687025
1444687032,rs1554973,CNPY4,3,2.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444687032
1444701007,rs1799722,BDKRB2,3,3,Toxicity,1,1,enalapril;imidapril;lisinopril,Cough;Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444701007
1444705191,rs10848635,CACNA1C,3,0,Toxicity,1,1,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444705191
1444705198,rs10975641,GLDC,3,3.5,Efficacy,1,1,citalopram;escitalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444705198
1444705206,rs2270007,CRHR2,3,3,Efficacy,1,1,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444705206
1444706124,rs11045872,SLCO1B1,3,0,Metabolism/PK,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1444706124
1445556297,rs3211371,CYP2B6,3,4,Efficacy,2,3,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1445556297
1184999957,rs776746,CYP3A5,4,-3.25,Efficacy,5,5,tacrolimus,transplant rejection,https://www.pharmgkb.org/clinicalAnnotation/1184999957
1444672826,rs1045642,ABCB1,4,-2.25,Efficacy,4,4,pantoprazole,Helicobacter Infections,https://www.pharmgkb.org/clinicalAnnotation/1444672826
1444704833,rs1045642,ABCB1,3,2.75,Dosage,6,6,opioids,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1444704833
1444608367,rs267606617,MT-RNR1,1A,108.5,Toxicity,31,32,aminoglycoside antibacterials,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1444608367
1444706154,rs11045821,SLCO1B1,3,1.5,Metabolism/PK,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1444706154
1444668808,rs1799752,ACE,3,0.75,Efficacy,2,2,irbesartan,"Hypertension;Hypertrophy, Left Ventricular",https://www.pharmgkb.org/clinicalAnnotation/1444668808
1184749280,rs1135989,ACTG1,3,3,Toxicity,1,1,vincristine,Neurotoxicity Syndromes,https://www.pharmgkb.org/clinicalAnnotation/1184749280
1184986454,rs3099844,CYCSP5,3,1.5,Toxicity,2,2,nevirapine,Acquired Immunodeficiency Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184986454
1184986756,rs9479757,OPRM1,3,1.75,Other,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1184986756
1444666705,rs3768142,MTR,3,2.75,Toxicity,1,1,methotrexate,Agranulocytosis,https://www.pharmgkb.org/clinicalAnnotation/1444666705
1444666731,rs28364032,CRHR1,3,3.25,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444666731
1444666738,rs520210,NEDD4L,3,2.5,Efficacy,1,1,citalopram,Depression,https://www.pharmgkb.org/clinicalAnnotation/1444666738
1444666717,rs4948496,ARID5B,3,1.125,Metabolism/PK,2,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1444666717
1184749160,rs3770102,CAPG,3,3,Toxicity,1,1,vincristine,Drug Toxicity;Neurotoxicity Syndromes,https://www.pharmgkb.org/clinicalAnnotation/1184749160
1444704914,rs1045642,ABCB1,3,2,Metabolism/PK,1,1,etoposide,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1444704914
1444710680,HLA-DQB1*06:02,HLA-DQB1,3,0.5,Toxicity,4,4,Influenza vaccines,Narcolepsy,https://www.pharmgkb.org/clinicalAnnotation/1444710680
1183697617,rs45445694,TYMS,3,7.5,Toxicity,7,7,methotrexate,"Lymphoma, Non-Hodgkin;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1183697617
1184756886,HLA-DQB1*02:02,HLA-DQB1,3,0,Toxicity,1,1,acetaminophen,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1184756886
1184747857,rs9370867,MYLIP,3,2.5,Efficacy,1,1,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1184747857
1184986985,rs4648287,PTGS2,3,1.5,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184986985
1184986992,rs10157410,PLA2G4A,3,1.5,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184986992
1184987008,rs2144297,GALNT2,3,1,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184987008
1184987030,rs2144300,GALNT2,3,2,Other,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184987030
1184987041,rs3213619,ABCB1,3,1.5,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184987041
1185000225,rs776746,CYP3A5,3,4.25,Toxicity,6,6,tacrolimus,Infection,https://www.pharmgkb.org/clinicalAnnotation/1185000225
1444608377,rs1126757,IL11,3,1.5,Efficacy,1,1,escitalopram,Depression,https://www.pharmgkb.org/clinicalAnnotation/1444608377
1444665984,rs712829,EGFR,3,2.25,Efficacy,1,1,cetuximab;irinotecan;panitumumab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444665984
1444666032,UGT1A7*3,UGT1A7,3,1.5,Toxicity,1,1,irinotecan;oxaliplatin;tegafur / gimeracil / oteracil,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444666032
1444666038,UGT1A6*2a,UGT1A6,3,1.5,Toxicity,1,1,irinotecan;oxaliplatin;tegafur / gimeracil / oteracil,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444666038
1444667902,rs2241766,ADIPOQ,3,2.75,Efficacy,1,1,pioglitazone,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1444667902
1444703502,rs4291,ACE,3,2.75,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444703502
1444703509,rs3775291,TLR3,3,2.25,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444703509
1444703985,rs2734833,DRD2,3,0,Efficacy,1,1,Selective serotonin reuptake inhibitors,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444703985
1444704012,rs2279238,NR1H3,3,2.25,Toxicity,1,1,verapamil,Coronary Artery Disease;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444704012
1444704419,rs2289669,SLC47A1,3,4,Efficacy,5,5,metformin,"Diabetes Mellitus, Type 2;Polycystic Ovary Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1444704419
1445556405,rs3087374,POLG,3,4,Toxicity,1,1,valproic acid,Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1445556405
1185003565,rs396991,FCGR3A,3,4.25,Efficacy,2,3,trastuzumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1185003565
1451683665,rs523349,SRD5A2,3,2.25,Efficacy,1,1,abiraterone,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451683665
1184997034,HLA-B*35:01,HLA-B,3,5.75,Toxicity,3,3,nevirapine,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1184997034
1184986201,rs11479,TYMP,3,5.5,Toxicity,1,2,capecitabine;fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184986201
1184986298,rs9351963,KCNQ5,3,0,Toxicity,1,1,irinotecan,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184986298
1184997043,HLA-B*35:05,HLA-B,3,6.75,Toxicity,2,2,nevirapine,Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184997043
1184986567,rs1927907,TLR4,3,2.25,Other,1,1,tacrolimus,Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1184986567
1184986578,rs9535826,ATP7B,3,3,Efficacy,1,1,Platinum compounds,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184986578
1184997025,HLA-B*27:09,HLA-B,3,3,Toxicity,1,1,oxcarbazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184997025
1185000097,rs2273697,ABCC2,3,3,Toxicity,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1185000097
1444706911,rs472660,CYP3A43,3,0.25,Metabolism/PK,2,3,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444706911
1184986540,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,3,1.5,Toxicity,1,1,"sulfonamides, urea derivatives","Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1184986540
1444607768,rs6311,HTR2A,4,-2.25,Toxicity,5,6,fluvoxamine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444607768
1184997106,HLA-B*48:04,HLA-B,3,3,Toxicity,1,1,oxcarbazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184997106
1444607704,rs6759892,UGT1A6,3,7,Efficacy;Toxicity,1,4,deferiprone,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1444607704
1444607716,rs2032582,ABCB1,3,2,Metabolism/PK,2,2,ritonavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444607716
1444607723,rs1799971,OPRM1,3,8,Toxicity,1,4,hydrocodone,Constipation;dry mouth;Respiratory Insufficiency,https://www.pharmgkb.org/clinicalAnnotation/1444607723
1444712832,HLA-DRB1*07:01,HLA-DRB1,3,7.5,Toxicity,3,3,lapatinib,Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1444712832
1444607775,rs442767,DHFR,3,2.25,Toxicity,1,1,pemetrexed,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444607775
1184997213,"HLA-B*15:18, HLA-B*40:01",HLA-B,3,0.5,Toxicity,2,2,oxcarbazepine,Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184997213
1444607782,rs4149056,SLCO1B1,3,2,Toxicity,2,4,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444607782
1444607960,rs6822844,IL2,3,4.75,Efficacy,1,2,rituximab,"Lupus Erythematosus, Systemic",https://www.pharmgkb.org/clinicalAnnotation/1444607960
1444607966,rs11141915,DAPK1,3,0,Toxicity,1,1,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444607966
1444665946,rs9996584,AREG,3,4.5,Efficacy,1,2,cetuximab;irinotecan;panitumumab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444665946
1444665964,rs11942466,AREG,3,5.5,Efficacy,1,2,cetuximab;irinotecan;panitumumab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444665964
1444666756,rs6467136,PAX4,3,5.25,Efficacy,1,2,rosiglitazone,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1444666756
1444666763,rs1801133,MTHFR,3,4,Efficacy,2,2,pemetrexed,"Carcinoma, Non-Small-Cell Lung;Mesothelioma",https://www.pharmgkb.org/clinicalAnnotation/1444666763
1444666770,rs1650697,DHFR,3,2.5,Toxicity,1,1,pemetrexed,"Carcinoma, Non-Small-Cell Lung;Mesothelioma",https://www.pharmgkb.org/clinicalAnnotation/1444666770
1444666777,rs11545078,GGH,3,3,Toxicity,1,1,pemetrexed,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666777
1444666789,rs61734430,FOLR3,3,2.5,Efficacy,1,1,pemetrexed,"Carcinoma, Non-Small-Cell Lung;Mesothelioma",https://www.pharmgkb.org/clinicalAnnotation/1444666789
1444666796,rs1051298,SLC19A1,3,4,Efficacy,2,2,pemetrexed,"Carcinoma, Non-Small-Cell Lung;Mesothelioma",https://www.pharmgkb.org/clinicalAnnotation/1444666796
1444666803,rs3788189,SLC19A1,3,2,Efficacy,1,1,pemetrexed,"Carcinoma, Non-Small-Cell Lung;Mesothelioma",https://www.pharmgkb.org/clinicalAnnotation/1444666803
1444666818,rs914232,SLC19A1,3,2.5,Efficacy,1,1,pemetrexed,"Carcinoma, Non-Small-Cell Lung;Mesothelioma",https://www.pharmgkb.org/clinicalAnnotation/1444666818
1444703086,rs12708954,SLC6A2,3,3,Efficacy,1,1,atomoxetine,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1444703086
1444703230,rs2032582,ABCB1,3,0,Efficacy,1,2,fluoxetine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444703230
1444712823,HLA-DQA1*02:01,HLA-DQA1,3,6.5,Toxicity,2,2,lapatinib,Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1444712823
1184986623,rs2011425,UGT1A4,3,2.25,Metabolism/PK,5,5,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1184986623
1184988834,rs1063320,HLA-G,3,1.25,Efficacy,1,3,hmg coa reductase inhibitors,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1184988834
1445594176,rs1142345,TPMT,3,5.75,Dosage;Toxicity,6,8,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1445594176
1445594556,rs7387065,CSMD1,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445594556
1445601678,rs11189015,SLIT1,3,0,Efficacy,1,1,hydrochlorothiazide,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445601678
1449003851,"HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01",HLA-C,3,0,Efficacy,1,1,peginterferon alfa-2b;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1449003851
1449003869,rs7574865,STAT4,3,2.5,Efficacy,1,1,etanercept,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1449003869
1444703243,rs2032582,ABCB1,4,-4,Efficacy,3,5,carbamazepine;phenytoin;valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1444703243
1444708021,HLA-B*46:01,HLA-B,3,0.75,Toxicity,2,2,carbamazepine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1444708021
1444703401,rs924607,CEP72,3,5.25,Toxicity,7,8,vincristine,Peripheral Nervous System Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444703401
1444666342,rs2250242,ORM2,3,1,Metabolism/PK,1,1,docetaxel,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444666342
1444666376,rs5051,AGT,3,2.5,Efficacy,1,1,benazepril;imidapril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444666376
1444666557,rs2606345,CYP1A1,3,1.25,Metabolism/PK,2,2,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1444666557
1444666564,rs762551,CYP1A2,3,0.75,Metabolism/PK,2,2,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1444666564
1444666571,rs2470890,CYP1A2,3,1.75,Metabolism/PK,2,2,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1444666571
1444667537,rs1042151,HLA-DPB1,3,0,Toxicity,1,1,aspirin,aspirin-induced asthma;Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667537
1444667549,rs3129294,HLA-DPB2,3,0,Toxicity,1,1,aspirin,aspirin-induced asthma;Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667549
1444667566,rs3130100,ZBTB22,3,3,Toxicity,1,1,aspirin,aspirin-induced asthma;Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667566
1444702822,rs1045642,ABCB1,3,2.5,Efficacy,1,1,phenobarbital,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1444702822
1444703408,rs8187707,ABCC2,3,0.25,Toxicity,1,1,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444703408
1444703422,rs7917983,TCF7L2,3,2.5,Toxicity,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444703422
1444703529,rs2412459,EIF2AK4,3,0,Efficacy,1,1,olanzapine;quetiapine;risperidone;ziprasidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444703529
1444703537,rs2412459,EIF2AK4,3,0,Efficacy,1,1,haloperidol,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444703537
1444703544,rs7518660,IL23R,3,2.5,Toxicity,1,1,celecoxib,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444703544
1444703552,rs7438135,UGT2B7,3,3,Toxicity,1,1,mycophenolate mofetil,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444703552
1444703560,rs6506569,PTPRM,4,-1,Efficacy,2,2,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444703560
1444706709,HLA-C*01:02,HLA-C,2B,8,Toxicity,3,3,methazolamide,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1444706709
1444666130,HLA-DPB1*03:01,HLA-DPB1,2B,11,Toxicity,3,3,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444666130
1444666137,HLA-DPB1*04:01,HLA-DPB1,3,2.5,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444666137
1444666145,HLA-DRB1*11:01,HLA-DRB1,3,3,Toxicity,1,1,"Antiinflammatory agents, non-steroids",anaphylactoid reaction,https://www.pharmgkb.org/clinicalAnnotation/1444666145
1184748865,rs1476413,MTHFR,3,0,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1184748865
1184748874,rs17421511,MTHFR,3,0,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1184748874
1184748879,rs16853826,ATIC,3,2,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1184748879
1184748884,rs10197559,ATIC,3,0,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1184748884
1184748889,rs1643650,DHFR,3,0,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1184748889
1184997142,HLA-B*58:01,HLA-B,3,4.25,Toxicity,3,3,lamotrigine,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1184997142
1444608396,rs2293347,EGFR,3,3,Efficacy,1,1,fluorouracil,Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444608396
1444667499,rs3097671,HLA-DPB1,3,0,Toxicity,1,1,aspirin,aspirin-induced asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667499
1444667512,rs1042136,HLA-DPB1,3,3,Toxicity,1,1,aspirin,aspirin-induced asthma;Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667512
1444700391,rs1051730,CHRNA3,3,2.5,Toxicity,3,3,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444700391
1444608384,rs396991,FCGR3A,2B,8,Efficacy,3,3,rituximab,"Arthritis, Rheumatoid;Neuromyelitis Optica",https://www.pharmgkb.org/clinicalAnnotation/1444608384
1184997195,HLA-B*59:01,HLA-B,3,0.25,Toxicity,1,1,acetazolamide,Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184997195
1444700667,rs11568817,HTR1B,3,2.5,Toxicity,1,1,escitalopram,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444700667
1444700675,rs6311,HTR2A,3,0.75,Toxicity,6,8,escitalopram,"Anxiety Disorders;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444700675
1184756841,HLA-C*03:02,HLA-C,3,3.25,Toxicity,1,1,allopurinol,Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184756841
1184764194,rs3094188,PSORS1C3,3,0,Toxicity,1,2,allopurinol,"Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184764194
1444703032,"CYP2D6*1, CYP2D6*5, CYP2D6*10",CYP2D6,3,2,Metabolism/PK,2,2,mianserin,Depression,https://www.pharmgkb.org/clinicalAnnotation/1444703032
1184764199,rs3130501,POU5F1,3,0,Toxicity,1,1,allopurinol,"Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184764199
1184764204,rs3130931,POU5F1,3,0,Toxicity,1,2,allopurinol,"Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184764204
1184997013,HLA-B*15:19,HLA-B,3,3,Toxicity,1,1,oxcarbazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184997013
1444703063,rs4244285,CYP2C19,3,0.25,Toxicity,1,1,venlafaxine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1444703063
1444704321,rs1061622,TNFRSF1B,3,5.75,Efficacy,4,4,infliximab;Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444704321
1444704328,rs3397,TNFRSF1B,3,5.5,Efficacy,1,2,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444704328
1444704335,rs1061631,TNFRSF1B,3,0,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444704335
1444704763,rs1006737,CACNA1C,3,0,Toxicity,1,1,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444704763
1444704775,rs10121600,GRIN3A,3,1.5,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444704775
1444704869,rs1044397,CHRNA4,3,2.75,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1444704869
1444704881,rs1045642,ABCB1,3,2,Toxicity,1,1,methylprednisolone;prednisolone,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444704881
1184997120,HLA-B*56:02,HLA-B,3,3,Toxicity,3,3,phenytoin,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184997120
1184997136,HLA-B*58:01,HLA-B,4,-0.75,Toxicity,3,3,carbamazepine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184997136
1184997007,HLA-B*15:18,HLA-B,3,0,Toxicity,1,1,carbamazepine,Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184997007
1184997019,HLA-B*15:27,HLA-B,3,3.25,Toxicity,1,1,oxcarbazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184997019
1184997201,HLA-B*59:01,HLA-B,3,0,Toxicity,1,1,carbamazepine,Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184997201
1184997207,HLA-B*59:01,HLA-B,2A,8.75,Toxicity,6,6,methazolamide,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184997207
1446899836,rs9825762,SCN10A,3,3,Toxicity,1,1,carboplatin;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899836
1444607318,rs7643645,NR1I2,3,3.875,Metabolism/PK,1,3,risperidone,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444607318
1444607325,rs1061170,CFH,3,1.75,Dosage,1,1,bevacizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1444607325
1444607565,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41",CYP2D6,3,2.375,Metabolism/PK,1,3,galantamine,Dementia,https://www.pharmgkb.org/clinicalAnnotation/1444607565
1444607796,rs3785143,SLC6A2,3,3,Efficacy,1,1,atomoxetine,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1444607796
1444607803,rs1045642,ABCB1,3,3.5,Other,2,2,olanzapine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444607803
1444607827,rs2252281,SLC47A1,3,4,Efficacy,3,4,metformin,"Diabetes Mellitus, Type 2;Polycystic Ovary Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1444607827
1444607986,"CYP2B6*1, CYP2B6*6",CYP2B6,3,2.5,Efficacy;Toxicity,1,4,cyclophosphamide,"Leukemia, Lymphocytic, Chronic, B-Cell",https://www.pharmgkb.org/clinicalAnnotation/1444607986
1444608027,rs7124442,BDNF,3,1.25,Efficacy,2,2,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444608027
1444608182,rs12022243,DPYD,3,3,Toxicity,1,3,capecitabine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444608182
1444608189,rs2612091,ENOSF1,3,2.5,Toxicity,2,4,capecitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444608189
1444608201,rs2741171,ENOSF1,3,4,Toxicity,1,3,capecitabine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444608201
1444608224,rs12132152,DPYD,3,5,Toxicity,1,3,capecitabine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444608224
1444608231,rs1126442,GRIN1,3,2.25,Toxicity,1,1,methamphetamine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444608231
1444608291,rs967676,CA10,3,2,Efficacy,1,1,fluticasone propionate;montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444608291
1444667222,rs1047840,EXO1,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667222
1444667432,rs3818822,CHIA,3,3,Toxicity,1,1,aspirin,aspirin-induced asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667432
1444667585,rs7862221,TSC1,3,3,Toxicity,1,1,aspirin,aspirin-induced asthma;Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667585
1444667592,rs11819745,THRA,3,3,Toxicity,1,1,aspirin,aspirin-induced asthma;Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444667592
1444702771,rs2760118,ALDH5A1,3,3,Efficacy,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444702771
1444843493,rs3828913,MICB,3,3,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1444843493
1446899749,"CYP3A4*1, CYP3A4*22",CYP3A4,3,4.75,Metabolism/PK,4,5,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1446899749
1446899843,rs6900017,VEGFA,3,3,Toxicity,1,1,carboplatin;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899843
1446899866,rs9369421,VEGFA,3,2.5,Efficacy,1,1,carboplatin;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899866
1446899883,rs879825,VEGFA,3,3.5,Toxicity,1,1,carboplatin;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899883
1446899890,rs3594,GSR,3,3.5,Toxicity,1,1,carboplatin;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899890
1446899905,rs1801249,ATP7B,3,3,Toxicity,1,1,carboplatin;taxanes,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899905
1446903240,rs6785049,NR1I2,3,2.75,Toxicity,1,1,sunitinib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446903240
1446903310,rs17109924,LGR5,3,3.25,Efficacy,1,1,fluorouracil,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446903310
1185000522,rs1045642,ABCB1,4,-7.375,Other,11,14,atazanavir;ritonavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1185000522
1444607789,rs1176744,HTR3B,4,-0.25,Toxicity,2,3,paroxetine,Mental Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444607789
1444608040,rs7103411,BDNF,4,-0.5,Efficacy,3,3,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444608040
1446898992,rs489693,MC4R,3,4.875,Toxicity,4,5,antipsychotics,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1446898992
1451760600,rs6311,HTR2A,3,1,Toxicity,1,5,Selective serotonin reuptake inhibitors,"ability to concentrate;Depressive Disorder, Major;Diarrhea;Dizziness;Tremor",https://www.pharmgkb.org/clinicalAnnotation/1451760600
1184987378,rs4550690,MAP4K4,3,0,Toxicity,1,1,anastrozole;exemestane,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1184987378
1184987471,rs1611115,DBH,3,1.5,Other,1,1,"Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan",Substance Withdrawal Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184987471
1184996903,HLA-B*15:02,HLA-B,1A,305.75,Toxicity,4,7,oxcarbazepine,Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1184996903
1184764228,rs9469003,CYCSP5,3,0,Toxicity,1,2,allopurinol,"Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184764228
1185000534,rs2472677,NR1I2,3,7,Metabolism/PK,4,4,atazanavir,Acquired Immunodeficiency Syndrome;HIV Infections;nephrolithiasis,https://www.pharmgkb.org/clinicalAnnotation/1185000534
1184764213,rs3815087,PSORS1C1,4,-2.5,Toxicity,2,3,allopurinol,"Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184764213
1451760701,"CYP1A2*1A, CYP1A2*1F",CYP1A2,3,1.25,Metabolism/PK,5,6,clozapine,schizoaffective disorder;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451760701
1444666674,rs12819505,WNT5B,3,3,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666674
1444666681,rs10878232,WIF1,3,3,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666681
1444666688,rs11868547,AXIN2,3,3,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666688
1444666695,rs4541111,AXIN2,3,3,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666695
1444666886,rs1052555,ERCC2,3,5,Efficacy,1,2,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1444666886
1444694602,rs1045642,ABCB1,3,0.5,Efficacy,2,2,tacrolimus,"Colitis, Ulcerative",https://www.pharmgkb.org/clinicalAnnotation/1444694602
1444694616,rs1045642,ABCB1,3,1.5,Toxicity,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694616
1444703076,rs4244285,CYP2C19,3,2,Metabolism/PK,1,1,etravirine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444703076
1444704105,rs396991,FCGR3A,3,1.25,Other,1,1,antithymocyte globulin,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444704105
1444666198,HLA-DRB1*03:01,HLA-DRB1,3,1.75,Toxicity,1,1,carbamazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1444666198
1445402201,rs17143212,ABCB5,3,1.75,Toxicity,1,1,haloperidol,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1445402201
1444694609,rs1045642,ABCB1,4,-6.5,Toxicity,6,7,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694609
1444704097,rs35599367,CYP3A4,4,-0.25,Efficacy,2,2,simvastatin,Chronic Disease,https://www.pharmgkb.org/clinicalAnnotation/1444704097
1444666212,HLA-DQB1*05:01,HLA-DQB1,3,5.5,Toxicity,1,2,nevirapine,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1444666212
1185235008,rs35303484,CYP2B6,3,1.75,Metabolism/PK,4,4,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1185235008
1444608132,rs2010963,VEGFA,3,5,Efficacy,1,2,bevacizumab;pegaptanib;ranibizumab,Choroidal Neovascularization,https://www.pharmgkb.org/clinicalAnnotation/1444608132
1444608175,rs76387818,DPYD,3,5,Toxicity,1,3,capecitabine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444608175
1444666091,UGT1A1*60,UGT1A1,3,4,Efficacy,1,2,irinotecan,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444666091
1444666855,rs1045642,ABCB1,3,2.25,Toxicity,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444666855
1444667305,rs17160359,ABCB1,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667305
1444667322,rs2289310,DLG5,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667322
1444702664,rs3761847,TRAF1,3,2.25,Efficacy,2,2,adalimumab;etanercept;infliximab;Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444702664
1445401406,rs1045642,ABCB1,3,5.25,Toxicity,3,4,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1445401406
1445402226,rs1138272,GSTP1,3,0.25,Efficacy,3,3,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445402226
1446897342,rs2835859,KCNJ6,3,2.75,Dosage,1,1,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1446897342
1446897485,rs699947,VEGFA,3,3,Efficacy,2,2,bevacizumab;capecitabine;fluorouracil;irinotecan;leucovorin;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446897485
1446903556,rs56113850,CYP2A6,3,1.25,Metabolism/PK,2,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1446903556
1446903577,rs7541245,FMO5,3,2.75,Efficacy,1,1,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1446903577
1446904604,rs11623866,FNTB,3,3,Efficacy,1,1,carboplatin;lonafarnib;paclitaxel,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446904604
1446908543,rs1044396,CHRNA4,3,3,Efficacy,1,1,varenicline,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1446908543
1446908568,rs1051730,CHRNA3,3,2.75,Toxicity,1,1,Opium alkaloids and derivatives,Pain,https://www.pharmgkb.org/clinicalAnnotation/1446908568
1445401915,rs1045642,ABCB1,4,-1.5,Dosage;Metabolism/PK,6,7,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1445401915
1446904693,rs4124874,UGT1A1,3,0.25,Toxicity,1,1,deferasirox,Drug Toxicity;Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1446904693
1446903527,rs1872328,ACYP2,3,4.75,Toxicity,4,4,cisplatin,Brain Neoplasms;Deafness;Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1446903527
1444608139,HLA-C*06:02,HLA-C,3,5.25,Efficacy,1,2,ustekinumab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1444608139
1184749208,rs1045642,ABCB1,3,2.75,Efficacy,1,1,vincristine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1184749208
1184987055,rs12595985,FTO,3,1.5,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184987055
1184987062,rs9940629,FTO,3,1.5,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1184987062
1184989676,HLA-DQA1*02:01,HLA-DQA1,3,0,Toxicity,1,1,azathioprine;mercaptopurine,Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis,https://www.pharmgkb.org/clinicalAnnotation/1184989676
1446897495,rs3025039,VEGFA,3,1.25,Efficacy,3,3,bevacizumab,Breast Neoplasms;Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446897495
1446908580,rs10937158,ABCC5,3,3.25,Toxicity,1,1,fluorouracil;irinotecan;leucovorin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446908580
1446908594,rs225440,ABCG1,3,3.25,Toxicity,1,1,fluorouracil;irinotecan;leucovorin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446908594
1446908622,rs3749438,ABCC5,3,3.25,Toxicity,1,1,fluorouracil;irinotecan;leucovorin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446908622
1184756890,HLA-DQB1*05:02,HLA-DQB1,3,2.5,Toxicity,1,1,allopurinol,"Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1184756890
1184989663,HLA-DRB1*07:01,HLA-DRB1,3,0,Toxicity,1,1,azathioprine;mercaptopurine,Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis,https://www.pharmgkb.org/clinicalAnnotation/1184989663
1184756898,HLA-DRB1*13:02,HLA-DRB1,3,0,Toxicity,1,1,allopurinol,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1184756898
1184756894,HLA-DRB1*15:02,HLA-DRB1,3,0,Toxicity,1,1,allopurinol,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1184756894
1444668292,rs2683511,SP1,3,4.5,Efficacy;Metabolism/PK,1,2,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1444668292
1444668298,rs784892,AMHR2,3,3,Efficacy;Metabolism/PK,2,3,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1444668298
1444668306,rs149711321,PPARA,3,2.75,Efficacy;Metabolism/PK,1,1,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1444668306
1444673123,rs4680,COMT,3,2,Toxicity,1,1,haloperidol,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444673123
1444667292,rs3218592,REV3L,3,0,Efficacy,1,1,capecitabine;fluorouracil,Neoplasm Metastasis,https://www.pharmgkb.org/clinicalAnnotation/1444667292
1444673130,rs212091,ABCC1,3,2.25,Efficacy,1,1,lamivudine;lopinavir;ritonavir;zidovudine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444673130
1444673197,rs13207351,VEGFA,3,2.25,Efficacy,1,1,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444673197
1444673209,rs1570360,VEGFA,3,3.5,Efficacy,2,2,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444673209
1444680145,rs12248560,CYP2C19,3,0.75,Metabolism/PK,2,2,busulfan,hemopoietic stem cell transplant,https://www.pharmgkb.org/clinicalAnnotation/1444680145
1444700452,rs1059288,TAPBP,3,3,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444700452
1444700466,rs2071888,TAPBP,3,3,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444700466
1444700903,rs10306135,PTGS1,3,3.25,Toxicity,1,1,"Antiinflammatory agents, non-steroids",Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1444700903
1444700950,rs10711,CDK1,3,3.5,Toxicity,1,1,radiotherapy,pneumonitis,https://www.pharmgkb.org/clinicalAnnotation/1444700950
1444700983,rs1799983,NOS3,3,1.5,Efficacy,1,1,"Ace Inhibitors, Plain;Angiotensin II Antagonists;Beta Blocking Agents;digoxin;diuretics;spironolactone",Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1444700983
1444700991,rs1800629,TNF,3,0.75,Toxicity,2,2,ethambutol;isoniazid;pyrazinamide;rifampin,Toxic liver disease;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1444700991
1444672993,rs1128503,ABCB1,4,-11.875,Dosage;Metabolism/PK,19,22,tacrolimus,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444672993
1184749403,"SLCO1B1*1, SLCO1B1*14",SLCO1B1,3,3.5,Efficacy,1,1,fluvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1184749403
1444673032,rs2054675,CYP2B6,3,2.5,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444673032
1444673039,rs3786547,CYP2B6,3,2.5,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444673039
1444673046,rs3787429,HRH3,3,0.25,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444673046
1444673053,rs3787430,HRH3,3,3,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444673053
1444673060,rs1800470,TGFB1,3,2.75,Efficacy,1,1,rituximab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444673060
1444700775,rs12221497,NR1H3,3,2.25,Toxicity,1,1,verapamil,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1444700775
1185003571,rs1801274,FCGR2A,3,4.75,Efficacy,2,4,trastuzumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1185003571
1444699308,rs267606619,MT-RNR1,1A,102.75,Toxicity,8,9,aminoglycoside antibacterials,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1444699308
1444699743,rs267606618,MT-RNR1,1A,102,Toxicity,3,4,aminoglycoside antibacterials,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1444699743
1184996860,HLA-B*57:01,HLA-B,1A,105.75,Toxicity,1,3,flucloxacillin,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1184996860
1184749271,rs4728709,ABCB1,3,3,Toxicity,1,1,vincristine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1184749271
1444672968,"GSTT1 non-null, GSTT1 null",GSTT1,3,2,Efficacy,1,1,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444672968
1444700860,rs7699188,ABCG2,3,6,Efficacy;Toxicity,1,2,fluorouracil;irinotecan;leucovorin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1444700860
1444702764,rs1799964,TNF,3,2.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Spondylitis, Ankylosing",https://www.pharmgkb.org/clinicalAnnotation/1444702764
1444876859,rs12979860,IFNL3;IFNL4,3,2,Efficacy,1,1,deleobuvir;faldaprevir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1444876859
1445401325,rs10210302,ATG16L1,3,2.75,Efficacy,1,1,adalimumab,Crohn Disease,https://www.pharmgkb.org/clinicalAnnotation/1445401325
1445401389,rs1137101,LEPR,3,2.5,Toxicity,1,1,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1445401389
1445401399,rs1800497,ANKK1,3,2.5,Toxicity,1,1,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1445401399
1445401824,rs1113129,CYP2C8,3,2,Toxicity,1,1,paclitaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401824
1444702725,rs1061170,CFH,4,-7.5,Efficacy,10,11,bevacizumab;ranibizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1444702725
1445401817,rs1934951,CYP2C8,4,-0.5,Toxicity,2,3,paclitaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401817
1445401831,rs13181,ERCC2,4,-0.75,Toxicity,2,3,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401831
1139506787,"CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*46",CYP2A6,1B,36,Metabolism/PK,27,40,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1139506787
1445400186,rs1801086,RYR1,1A,101.25,Toxicity,11,12,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400186
1451678240,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",SLCO1B1,1A,105.5,Toxicity,8,9,rosuvastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451678240
1184755382,HLA-DRB1*03:01,HLA-DRB1,3,3,Toxicity,1,1,allopurinol,severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1184755382
1445401193,rs10161126,MVK,3,3.25,Efficacy,1,1,alendronate,Bone Diseases,https://www.pharmgkb.org/clinicalAnnotation/1445401193
1446900938,rs408626,DHFR,3,5.5,Efficacy;Toxicity,1,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1446900938
1446901291,rs1126647,CXCL8,3,1.75,Toxicity,1,1,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1446901291
1446901311,rs1800925,IL13,3,2.25,Toxicity,1,2,sunitinib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1446901311
1185000213,rs776746,CYP3A5,4,-1.5,Toxicity,4,4,tacrolimus,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1185000213
1445400222,rs193922772,RYR1,1A,102.5,Toxicity,11,12,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400222
1445400232,rs193922802,RYR1,1A,101,Toxicity,9,11,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400232
1445400247,rs193922816,RYR1,1A,103,Toxicity,9,10,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400247
1446846513,rs2229774,RARG,3,0,Toxicity,7,7,anthracyclines and related substances;daunorubicin;doxorubicin,cardiotoxicity;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446846513
1185000260,rs776746,CYP3A5,3,1.25,Toxicity,1,1,tacrolimus,Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1185000260
1185000350,rs10929303,UGT1A1,3,1.75,Toxicity,1,1,atazanavir;ritonavir,HIV Infections;nephrolithiasis,https://www.pharmgkb.org/clinicalAnnotation/1185000350
1185000362,rs1042640,UGT1A1,3,2.25,Toxicity,1,1,atazanavir;ritonavir,HIV Infections;nephrolithiasis,https://www.pharmgkb.org/clinicalAnnotation/1185000362
1185000369,rs8330,UGT1A1,3,1.75,Toxicity,1,1,atazanavir;ritonavir,HIV Infections;nephrolithiasis,https://www.pharmgkb.org/clinicalAnnotation/1185000369
1444673379,rs12505410,ABCG2,3,2,Efficacy,1,1,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444673379
1444673386,rs13120400,ABCG2,3,2,Efficacy,1,1,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444673386
1444673412,rs2725252,ABCG2,3,2,Efficacy,1,1,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1444673412
1444700808,rs12806698,RRM1,3,3,Toxicity,1,1,gemcitabine;Platinum compounds,Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1444700808
1444700867,rs1544410,VDR,3,3,Toxicity,1,1,peginterferon alfa-2a;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1444700867
1444700874,rs1611115,DBH,3,2.25,Efficacy,1,1,levodopa,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444700874
1444702778,rs2857657,CCL2,3,3,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444702778
1444702784,rs4586,CCL2,3,4.125,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444702784
1444702792,rs4795893,CCL2,3,4.125,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1444702792
1444703171,rs1800795,IL6,3,2,Efficacy,1,1,adalimumab;etanercept;infliximab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1444703171
1444703258,rs4460839,DRD2,3,0,Efficacy,1,1,Selective serotonin reuptake inhibitors,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444703258
1444703430,rs7917432,ABCC2,3,2,Toxicity,1,1,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444703430
1444703438,rs757639,OCRL,3,2,Toxicity,1,1,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444703438
1444703487,rs7551789,PTGER3,3,1.5,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444703487
1444703495,rs4292,ACE,3,2.25,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1444703495
1444704089,rs296766,AQP2,3,3.25,Toxicity,1,1,thiazolidinediones,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1444704089
1444705174,rs760761,DTNBP1,3,0,Efficacy,1,1,citalopram,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1444705174
1445401804,rs4880,SOD2,3,2,Toxicity,1,1,paclitaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401804
1445401838,rs3212986,ERCC1,3,2.75,Toxicity,1,1,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401838
1445401847,rs3212986,ERCC1,3,2,Toxicity,1,1,paclitaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401847
1445401853,rs11615,ERCC1,3,1.75,Toxicity,1,1,docetaxel,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1445401853
1445401880,rs776746,CYP3A5,3,5.5,Dosage;Metabolism/PK,4,6,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1445401880
1445401952,rs1057868,POR,3,2.5,Efficacy,1,1,atorvastatin,familial hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1445401952
1445402033,rs1128503,ABCB1,3,1.25,Efficacy,3,3,cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1445402033
1445402085,rs6295,HTR1A,3,2,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1445402085
1446898009,rs10305420,GLP1R,3,2.25,Efficacy,1,1,liraglutide,Obesity;Polycystic Ovary Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1446898009
1446898016,rs6923761,GLP1R,3,0,Efficacy,1,1,liraglutide,Obesity;Polycystic Ovary Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1446898016
1446897666,rs1933437,FLT3,3,6.5,Toxicity,4,4,sunitinib,Leukopenia;Myelosuppression;Neutropenia;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1446897666
1445400206,rs118192122,RYR1,1A,103,Toxicity,18,19,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1445400206
1451677518,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",SLCO1B1,1A,103.5,Toxicity,1,2,lovastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451677518
1444703273,rs3742106,ABCC4,3,4.5,Metabolism/PK,2,2,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444703273
1451761240,rs9349256,ABCC10,3,0.25,Toxicity,2,2,tenofovir disoproxil fumarate,HIV Infections;nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451761240
1445401303,rs10737062,CAMK1D,3,2.75,Efficacy,1,1,losartan,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445401303
1445401296,rs10752271,CAMK1D,3,2.75,Efficacy,1,1,losartan,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1445401296
1184996891,HLA-B*13:01,HLA-B,3,3.25,Toxicity,1,1,trichloroethylene,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1184996891
1184996897,HLA-B*13:02,HLA-B,3,3.25,Toxicity,1,1,oxcarbazepine,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1184996897
1451761248,rs3742106,ABCC4,3,2,Toxicity,1,1,tenofovir disoproxil fumarate,HIV Infections;nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451761248
1448100067,rs4796793,STAT3,3,2.75,Efficacy,1,1,interferons,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1448100067
1448602108,rs2942857,UGT2B10,3,3,Metabolism/PK,1,2,cotinine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448602108
1448613237,rs181781,IL3,3,2.25,Metabolism/PK,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448613237
1451678626,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",SLCO1B1,1A,101.25,Toxicity,2,3,fluvastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451678626
1451678460,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",SLCO1B1,1A,102,Toxicity,3,5,pravastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451678460
1448427005,rs1128503,ABCB1,3,3,Toxicity,2,2,gefitinib,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448427005
1448633833,"CYP2B6*1, CYP2B6*6",CYP2B6,3,2.25,Toxicity,1,1,ethambutol;isoniazid;pyrazinamide;rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448633833
1448634522,rs2032582,ABCB1,3,2.5,Toxicity,1,1,clopidogrel,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1448634522
1448258741,rs4149056,SLCO1B1,3,2.5,Toxicity,1,1,sorafenib,Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1448258741
1448423682,rs11209026,IL23R,3,3,Toxicity,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448423682
1448423689,rs3087243,CTLA4,3,2.5,Toxicity,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448423689
1448423696,rs651630,SLC12A8,3,2.5,Toxicity,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448423696
1448423703,rs10782001,FBXL19,3,2.5,Toxicity,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448423703
1448428937,rs75995567,AOX1,3,1.75,Dosage,1,1,allopurinol;febuxostat,Gout,https://www.pharmgkb.org/clinicalAnnotation/1448428937
1448428944,rs3731722,AOX1,3,2.25,Dosage,1,1,allopurinol;febuxostat,Gout,https://www.pharmgkb.org/clinicalAnnotation/1448428944
1448522754,rs11126740,CTNNA2,3,3,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448522754
1448522760,rs96844,MAP3K1,3,3.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448522760
1448525763,HLA-C*08:01,HLA-C,3,3.25,Toxicity,1,1,carbamazepine,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448525763
1448525768,HLA-C*08:01,HLA-C,3,6,Toxicity,2,2,phenytoin,"Epidermal Necrolysis, Toxic;Maculopapular Exanthema;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448525768
1448526098,rs11265618,IL6R,3,2.75,Efficacy,1,1,tocilizumab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1448526098
1448530595,rs3761548,FOXP3,3,2.5,Toxicity,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448530595
1448600720,rs7512462,SLC26A9,3,2.5,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1448600720
1448525745,HLA-A*11:01,HLA-A,3,3.25,Toxicity,2,2,carbamazepine,"Drug Hypersensitivity;Epidermal Necrolysis, Toxic;erythema exudativum multiforme;Maculopapular Exanthema;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448525745
1448525750,HLA-B*38:01,HLA-B,3,3.75,Toxicity,1,1,lamotrigine,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448525750
1448427833,rs1045642,ABCB1,3,0.5,Efficacy,2,2,granisetron,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448427833
1449565416,rs544027339,CYP2C9,3,0.25,Toxicity,1,1,phenytoin,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1449565416
1449565422,rs1029359343,CYP2C9,3,0.25,Toxicity,1,1,phenytoin,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1449565422
1448525458,rs1799732,DRD2,3,2,Toxicity,1,1,levodopa,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1448525458
1448617146,rs2032582,ABCB1,3,2.5,Toxicity,1,1,atazanavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1448617146
1448615575,rs1045642,ABCB1,4,-8.75,Efficacy,18,19,clopidogrel,platelet reactivity,https://www.pharmgkb.org/clinicalAnnotation/1448615575
1448525452,rs6280,DRD3,3,5,Toxicity,2,2,levodopa,gastrointestinal toxicity;Hallucinations;Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1448525452
1448616855,rs1048977,CDA,3,2.75,Toxicity,1,1,capecitabine,Hyperbilirubinemia;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616855
1448613011,rs7968606,ANKS1B,3,2,Efficacy,1,1,amisulpride,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448613011
1448615153,rs727479,CYP19A1,3,2,Efficacy,1,1,anastrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448615153
1448634786,rs1801252,ADRB1,3,3.5,Toxicity,1,1,Beta Blocking Agents,major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1448634786
1450374895,rs2070762,TH,3,3.5,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1450374895
1448605577,HLA-B*35:02,HLA-B,3,3.5,Toxicity,1,1,minocycline,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1448605577
1448602934,rs10741657,CYP2R1,3,3,Efficacy,1,1,peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448602934
1448612776,rs13144136,CLNK,3,0,Efficacy,1,1,Antihypertensives,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448612776
1449166396,rs1045642,ABCB1,3,4,Efficacy;Metabolism/PK,2,2,omeprazole,Gastroesophageal Reflux,https://www.pharmgkb.org/clinicalAnnotation/1449166396
1448428030,rs2306283,SLCO1B1,4,-1.25,Toxicity,3,3,irinotecan,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448428030
1448635217,"NUDT15*1, NUDT15*2, NUDT15*3",NUDT15,1A,208.125,Dosage,5,9,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448635217
1448604251,rs2032582,ABCB1,3,0,Metabolism/PK,3,3,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448604251
1448624874,rs2254638,N6AMT1,3,0,Efficacy,2,3,clopidogrel,major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1448624874
1448267381,rs72800847,STX1B,3,2.25,Dosage,1,1,warfarin,heart valve replacement,https://www.pharmgkb.org/clinicalAnnotation/1448267381
1448267389,rs3826041,CYP1A1,3,2.25,Dosage,1,1,warfarin,heart valve replacement,https://www.pharmgkb.org/clinicalAnnotation/1448267389
1448267397,rs2304429,DNMT3A,3,2.25,Dosage,1,1,warfarin,heart valve replacement,https://www.pharmgkb.org/clinicalAnnotation/1448267397
1448617231,rs1131882,TBXA2R,3,2.5,Efficacy;Toxicity,1,1,aspirin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1448617231
1448635185,rs746071566,NUDT15,3,0.25,Dosage;Toxicity,1,1,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448635185
1448635612,"GSTM1 non-null, GSTM1 null",GSTM1,3,1,Toxicity,1,2,nevirapine,"Epidermal Necrolysis, Toxic;HIV Infections;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448635612
1449190330,rs1022563,PDYN,3,1.75,Toxicity,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449190330
1449190339,rs1997794,PDYN,3,1.75,Toxicity,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449190339
1448635585,rs3745274,CYP2B6,4,-2.75,Toxicity,5,6,nevirapine,drug reaction with eosinophilia and systemic symptoms;HIV Infections;Stevens-Johnson Syndrome;Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1448635585
1448632697,rs738409,PNPLA3,3,5,Toxicity,2,2,asparaginase;cyclophosphamide;daunorubicin;prednisolone;vincristine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448632697
1447949171,HLA-B*15:13,HLA-B,3,3.75,Toxicity,1,1,phenytoin,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1447949171
1447981289,rs4292394,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981289
1447983050,rs7091672,EIF3A,3,3.25,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447983050
1447986967,rs11649514,PRKCB,3,2.5,Toxicity,1,1,atenolol,Hyperglycemia,https://www.pharmgkb.org/clinicalAnnotation/1447986967
1447952921,rs1884613,HNF4A,3,1.5,Metabolism/PK,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447952921
1447953109,rs6493497,CYP19A1,3,5,Toxicity,1,2,exemestane;letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447953109
1447953130,rs4149056,SLCO1B1,3,3.25,Toxicity,1,1,enalapril,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447953130
1447953250,rs2032582,ABCB1,3,2,Efficacy,1,1,modafinil,Narcolepsy,https://www.pharmgkb.org/clinicalAnnotation/1447953250
1447960436,rs1801253,ADRB1,3,1.5,Dosage,1,1,catecholamines,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1447960436
1447960509,rs3740065,ABCC2,3,3.25,Efficacy,2,2,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447960509
1447960745,rs130072,CCHCR1,3,3.25,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447960745
1447960775,rs2073724,TCF19,3,3.25,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447960775
1447962843,rs1128503,ABCB1,3,4,Efficacy,2,2,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1447962843
1447964136,rs2031920,CYP2E1,4,-5,Toxicity,17,17,Drugs For Treatment Of Tuberculosis,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447964136
1447963096,rs3754446,GSTM1,3,0,Metabolism/PK,1,1,busulfan,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1447963096
1447964236,rs6551665,ADGRL3,3,1,Efficacy,7,7,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1447964236
1447987005,rs2307424,NR1I3,3,2.625,Metabolism/PK,3,4,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447987005
1447987030,rs3003596,NR1I3,3,1,Metabolism/PK,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447987030
1447987045,rs3814055,NR1I2,3,1,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987045
1447987052,rs2461817,NR1I2,3,1.75,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987052
1447987059,rs7643645,NR1I2,3,1.25,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987059
1447987066,rs28365063,UGT2B7,3,1.5,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987066
1447987101,rs2740574,CYP3A4,3,1.25,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987101
1447987113,rs4803381,CYP2A6,3,1.75,Efficacy,1,1,bupropion;Drugs used in nicotine dependence,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447987113
1448102470,rs8105790,IFNL3,3,5.5,Efficacy,2,2,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448102470
1448427398,rs5370,EDN1,3,3,Efficacy,1,1,bevacizumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448427398
1448427405,rs3025039,VEGFA,3,2.5,Efficacy,1,1,bevacizumab,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448427405
1448522766,rs2546890,IL12B,3,3,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448522766
1448522772,rs6908425,CDKAL1,3,2.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448522772
1448522778,rs12191877,HLA-C,3,2,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448522778
1448522784,rs9304742,ZNF816,3,2.5,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448522784
1450373755,rs12148896,SLC28A1,3,2.75,Toxicity,1,1,gemcitabine,Neutropenia;Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450373755
1450373761,rs3825876,SLC28A1,3,2.75,Toxicity,1,1,gemcitabine,Neutropenia;Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450373761
1447987094,rs1128503,ABCB1,4,-2,Metabolism/PK,4,4,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987094
1447963234,rs1076560,DRD2,3,5.5,Toxicity,2,2,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447963234
1447986998,rs1695,GSTP1,3,0.5,Toxicity,4,4,cisplatin,Medulloblastoma;Neoplasms;Ototoxicity;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447986998
1448099568,rs2291075,SLCO1B1,3,2.5,Efficacy,1,1,cytarabine;daunorubicin;etoposide;mitoxantrone,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1448099568
1448099745,rs1799732,DRD2,3,3,Toxicity,4,5,antipsychotics,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448099745
1448102463,rs7248668,IFNL3,3,5.5,Efficacy,2,2,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448102463
1448102490,rs4803217,IFNL3,3,5,Efficacy,3,3,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,Hepatitis C;HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1448102490
1448124590,rs11568658,ABCC4,3,2,Toxicity,1,1,valganciclovir,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448124590
1448124604,rs2229109,ABCB1,3,2.5,Toxicity,1,1,valganciclovir,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448124604
1448125853,rs776746,CYP3A5,3,2,Metabolism/PK,1,1,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1448125853
1448265174,rs11125,LGALS3,3,4,Toxicity,1,1,Antibiotics,Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1448265174
1448602385,rs11124945,PLEKHH2,3,0,Toxicity,1,1,atenolol;verapamil,Diabetes Mellitus;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448602385
1449576307,rs261316,ALDH1A2,3,0,Efficacy,1,1,atenolol;hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1449576307
1449576551,rs7604115,UGT1A3,3,2,Metabolism/PK,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1449576551
1449576557,"UGT1A3*1, UGT1A3*2",UGT1A3,3,2,Metabolism/PK,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1449576557
1449576566,rs704212,ABCC9,3,2,Metabolism/PK,1,1,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1449576566
1449715913,rs1045642,ABCB1,3,2,Toxicity,1,1,fentanyl,"Pain, Postoperative;Respiratory Insufficiency",https://www.pharmgkb.org/clinicalAnnotation/1449715913
1449715919,rs2032582,ABCB1,3,0,Toxicity,1,1,fentanyl,"Pain, Postoperative;Respiratory Insufficiency",https://www.pharmgkb.org/clinicalAnnotation/1449715919
1449715928,rs1128503,ABCB1,3,0,Toxicity,1,1,fentanyl,"Pain, Postoperative;Respiratory Insufficiency",https://www.pharmgkb.org/clinicalAnnotation/1449715928
1449716035,rs7583431,ATF2,3,2.75,Efficacy,1,1,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449716035
1449747892,rs4646450,CYP3A5;ZSCAN25,3,4.75,Metabolism/PK,2,2,tacrolimus,Kidney Transplantation;liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449747892
1449747954,"CYP3A5*1, CYP3A5*3",CYP3A5,3,2,Toxicity,1,1,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449747954
1449751564,rs12248560,CYP2C19,3,2.75,Efficacy,1,1,phenazepam,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1449751564
1450815160,rs785423,TJP1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815160
1449576572,"CYP2C8*1, CYP2C8*3, CYP2C8*4",CYP2C8,3,3.5,Metabolism/PK,1,2,montelukast,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1449576572
1451825200,rs1799971,OPRM1,3,2,Toxicity,1,1,naloxone;oxycodone,Erythema,https://www.pharmgkb.org/clinicalAnnotation/1451825200
1451825220,rs4680,COMT,3,3,Toxicity,1,1,naloxone;oxycodone,Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451825220
1451825226,rs4680,COMT,3,2.5,Toxicity,1,1,naloxone;oxycodone,Erythema,https://www.pharmgkb.org/clinicalAnnotation/1451825226
1447954390,rs75039782,CFTR,3,4,Other,2,2,ataluren,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447954390
1447954397,rs77010898,CFTR,3,4.5,Other,4,4,ataluren,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447954397
1447949632,rs1540339,VDR,3,2.5,Efficacy,1,1,selective beta-2-adrenoreceptor agonists,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447949632
1447954525,rs13431554,IRS1,3,3,Efficacy,1,1,clopidogrel,"Coronary Artery Disease;Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1447954525
1447959700,rs10494227,ZNF697,3,2.5,Efficacy,1,1,interferon beta-1a;interferon beta-1b,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1447959700
1447959717,rs760316,FHIT,3,2.5,Efficacy,1,1,interferon beta-1a;interferon beta-1b,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1447959717
1447960874,rs1128503,ABCB1,3,1,Metabolism/PK,1,1,tipifarnib,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447960874
1447962768,rs705379,PON1,3,2.25,Efficacy,2,2,atorvastatin;simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1447962768
1447962855,rs1128503,ABCB1,3,2,Toxicity,1,1,simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1447962855
1447962874,rs4244285,CYP2C19,3,4.75,Metabolism/PK,2,3,nelfinavir,HIV Infections;Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447962874
1447963846,rs4341,ACE,3,2.5,Toxicity,1,1,"Thiazides, plain",Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1447963846
1447963991,rs3789243,ABCB1,3,3.5,Efficacy,2,3,antiepileptics,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447963991
1447964250,rs1947275,ADGRL3,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1447964250
1447987080,rs4148740,ABCB1,3,1,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987080
1448102306,rs4673,CYBA,3,4,Efficacy;Toxicity,2,2,doxorubicin;idarubicin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448102306
1448103875,rs2234693,ESR1,3,2.25,Toxicity,1,1,methamphetamine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448103875
1448109754,rs2305364,SLC28A1,4,-1.5,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109754
1448109591,rs316019,SLC22A2,4,-1,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109591
1447964041,rs1041983,NAT2,3,3,Toxicity,1,1,ethambutol;isoniazid;pyrazinamide;rifampin,Toxic liver disease;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447964041
1451511220,rs3758149,GGH,3,1,Metabolism/PK,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451511220
1448101278,rs684513,CHRNA5,3,1.5,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101278
1448101285,rs1695,GSTP1,3,0,Toxicity,3,3,isoniazid;rifampin,drug-induced liver injury;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448101285
1448101408,rs3806596,UGT1A3,3,5.75,Efficacy;Metabolism/PK,3,3,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1448101408
1448101436,rs13120400,ABCG2,3,4.25,Efficacy;Metabolism/PK,3,3,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1448101436
1447963042,rs1800497,ANKK1,3,4.5,Efficacy,2,2,antipsychotics;aripiprazole;risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447963042
1447979493,rs2010963,VEGFA,3,4.5,Efficacy,1,2,sorafenib,"Carcinoma, Hepatocellular",https://www.pharmgkb.org/clinicalAnnotation/1447979493
1447979507,rs2070744,NOS3,3,5.75,Efficacy,1,2,sorafenib,"Carcinoma, Hepatocellular",https://www.pharmgkb.org/clinicalAnnotation/1447979507
1447979514,rs1799983,NOS3,3,5.5,Efficacy,1,2,sorafenib,"Carcinoma, Hepatocellular",https://www.pharmgkb.org/clinicalAnnotation/1447979514
1447980904,rs1045642,ABCB1,3,2,Toxicity,1,1,"Antivirals for treatment of HIV infections, combinations;Drugs For Treatment Of Tuberculosis",HIV Infections;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447980904
1447980911,rs3745274,CYP2B6,3,2,Toxicity,1,1,"Antivirals for treatment of HIV infections, combinations;Drugs For Treatment Of Tuberculosis",HIV Infections;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447980911
1448100326,rs61361928,UGT2B7,3,0,Metabolism/PK,1,1,ticagrelor,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1448100326
1448100712,rs1128503,ABCB1,3,2.5,Toxicity,1,1,codeine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1448100712
1448101238,rs1799964,TNF,3,2.25,Toxicity,1,1,stavudine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1448101238
1448101271,rs637137,CHRNA5,3,2,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101271
1448102543,rs10877012,CYP27B1,3,0.5,Efficacy,2,2,peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448102543
1448122847,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,3,4,Dosage,1,2,warfarin,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1448122847
1447963662,rs2231142,ABCG2,4,-0.25,Toxicity,4,4,gefitinib,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447963662
1447987235,rs11947402,TSPAN5,4,-0.5,Other,1,2,citalopram;escitalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447987235
1447963570,HLA-DRB1*16:01,HLA-DRB1,3,2.5,Toxicity,1,1,flupirtine,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1447963570
1447963860,rs5443,GNB3,3,2.5,Toxicity,1,1,"Thiazides, plain",Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1447963860
1447964142,rs113993960,CFTR,3,2.25,Efficacy,1,1,cysteamine,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447964142
1447964278,rs1355368,ADGRL3,3,2.5,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1447964278
1447964324,rs4271002,NAT2,3,2.25,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447964324
1448102477,rs28416813,IFNL3,3,5,Efficacy,2,2,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic;HIV Infections",https://www.pharmgkb.org/clinicalAnnotation/1448102477
1448112196,rs2011425,UGT1A4,3,1.75,Metabolism/PK,2,2,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448112196
1183679785,rs746647,CCHCR1,3,3.25,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1183679785
1447964187,rs78655421,CFTR,1A,206,Efficacy,5,8,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447964187
1451809140,HLA-B*15:02,HLA-B,2A,11.25,Toxicity,4,5,antiepileptics,"Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1451809140
1447946219,rs2231135,ABCG2,3,2.25,Toxicity,1,1,methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1447946219
1447946226,rs1650723,DHFR,3,2.25,Toxicity,1,1,methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1447946226
1447946233,rs1053129,DHFR,3,2.25,Efficacy,1,1,methotrexate,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1447946233
1447960468,rs183484,RRM1,3,0.5,Efficacy,2,2,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447960468
1447960554,rs4344,ACE,3,2.25,Efficacy,1,1,ramipril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447960554
1447960566,rs4359,ACE,3,2.75,Efficacy,1,1,ramipril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447960566
1447960649,rs5186,AGTR1,3,1.5,Efficacy,1,1,perindopril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447960649
1447960850,rs3780126,GGH,3,1.5,Efficacy,1,1,bevacizumab;pemetrexed,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960850
1447961178,rs712830,EGFR,3,2.25,Toxicity,1,1,cetuximab;irinotecan;leucovorin;tegafur,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447961178
1447961337,rs878567,HTR1A,3,3,Toxicity,1,1,methamphetamine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447961337
1447962751,rs662,PON1,3,4.25,Efficacy,3,3,atorvastatin;simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1447962751
1447963255,rs7142143,PYGL,3,0,Efficacy,1,1,asparaginase;dexamethasone;methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1447963255
1447981158,rs6600879,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981158
1447981207,rs6600880,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981207
1447981222,rs4554144,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981222
1447981250,rs11940316,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981250
1447981259,rs7438135,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981259
1448423795,rs4818,COMT,3,3,Efficacy,1,1,quetiapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448423795
1447981089,rs11200638,HTRA1,4,-2.75,Efficacy,4,4,bevacizumab;ranibizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1447981089
1451511240,rs1544105,FPGS,3,0.25,Metabolism/PK,3,3,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451511240
1448426944,HLA-B*15:01,HLA-B,3,2.75,Efficacy,1,1,interferon beta-1a,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1448426944
1448426938,HLA-DRB1*04:01,HLA-DRB1,3,2.75,Efficacy,1,1,interferon beta-1a,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1448426938
1448109812,rs2108623,CYP4F2,4,-1,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109812
1447982582,rs2231142,ABCG2,3,5.5,Efficacy,3,3,allopurinol,Gout,https://www.pharmgkb.org/clinicalAnnotation/1447982582
1447981268,rs7662029,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981268
1447987087,rs4148739,ABCB1,3,1,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447987087
1447987264,rs875858,VAC14,3,0,Toxicity,1,1,docetaxel,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447987264
1448100187,rs2112460,CACNA1A,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100187
1448103832,rs16969968,CHRNA5,3,2.5,Other,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1448103832
1448103839,rs1051730,CHRNA3,3,2.5,Other,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1448103839
1448103846,rs5275,PTGS2,3,2.75,Efficacy,1,1,capecitabine;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448103846
1448103889,rs11788456,GRIN3A,3,1.5,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448103889
1448103910,rs2070995,KCNJ6,3,2.25,Other,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1448103910
1448103942,rs578776,CHRNA3,3,0.5,Other,1,2,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1448103942
1448103949,rs615470,CHRNA5,3,0.5,Other,1,2,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1448103949
1448103956,rs684513,CHRNA5,3,1,Other,1,2,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448103956
1448103963,rs4402960,IGF2BP2,3,1.5,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1448103963
1448103973,rs1470579,IGF2BP2,3,1.5,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1448103973
1448104005,rs2975226,SLC6A3,3,3,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448104005
1448104022,rs1205,CRP,3,2.75,Efficacy,1,1,rosuvastatin,Coronary Disease,https://www.pharmgkb.org/clinicalAnnotation/1448104022
1448104036,rs1125394,DRD2,3,3,Other,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448104036
1448112147,rs4149056,SLCO1B1,3,1.5,Toxicity,1,1,cyclophosphamide;docetaxel;doxorubicin;epirubicin;fluorouracil,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448112147
1448256864,rs50872,ERCC2,3,3.5,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448256864
1448256872,rs7170924,IL16,3,2.5,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448256872
1448256881,rs1128503,ABCB1,3,6,Toxicity,1,2,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448256881
1447963011,rs1127354,ITPA,4,-2.25,Toxicity,4,4,mercaptopurine,Myelosuppression;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1447963011
1448109578,rs17863783,UGT1A6,4,-2,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109578
1448109598,rs1149222,ABCB4,4,-1,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109598
1448109605,rs4148808,ABCB4,4,-1.5,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109605
1448109802,rs2019604,SPG7,4,-1.25,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109802
1451511344,rs1051296,SLC19A1,3,1.5,Metabolism/PK,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451511344
1447982723,rs3750920,TOLLIP,3,1.75,Efficacy,1,1,acetylcysteine,Pulmonary Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447982723
1447982732,rs7772821,TAAR6,3,2,Efficacy,1,1,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447982732
1447952936,rs6108160,PLCB1,3,3,Efficacy,1,1,Selective serotonin reuptake inhibitors,Depression,https://www.pharmgkb.org/clinicalAnnotation/1447952936
1447953072,rs183205964,TYMS,3,3,Toxicity,1,1,capecitabine;fluorouracil;tegafur,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447953072
1447953116,rs6314,HTR2A,3,1.75,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447953116
1447953123,rs7958904,HOTAIR,3,2.75,Efficacy,1,1,Platinum compounds,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447953123
1447953171,rs619586,MALAT1,3,2.25,Efficacy,1,1,Platinum compounds,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447953171
1447953178,rs2839698,H19,3,2.25,Efficacy,1,1,Platinum compounds,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447953178
1447953192,rs1800544,ADRA2A,3,2.75,Efficacy,1,1,Selective serotonin reuptake inhibitors,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1447953192
1447953263,rs2075572,OPRM1,3,0,Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447953263
1447953270,rs1799971,OPRM1,3,0,Toxicity,1,1,methadone,Opioid-Related Disorders;Sleep Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447953270
1447953277,rs2813543,ESR1,3,2.5,Toxicity,1,1,exemestane,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447953277
1447953328,rs4135385,CTNNB1,3,4,Efficacy;Toxicity,1,2,cyclophosphamide;dexamethasone;lenalidomide;thalidomide,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/1447953328
1447953340,rs4533622,CTNNB1,3,3.5,Efficacy;Toxicity,1,2,lenalidomide;thalidomide,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/1447953340
1447959508,rs4880,SOD2,3,3,Toxicity,1,1,asparaginase,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1447959508
1447959731,rs10819043,GAPVD1,3,2.5,Efficacy,1,1,interferon beta-1a;interferon beta-1b,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1447959731
1447959738,rs2291858,GAPVD1,3,2.5,Efficacy,1,1,interferon beta-1a;interferon beta-1b,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1447959738
1447960211,rs1045642,ABCB1,3,0,Efficacy,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960211
1447961194,rs8192719,CYP2B6,3,1.75,Metabolism/PK,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447961194
1447963070,rs2869950,CHRNB4,3,0,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447963070
1447964331,rs2854744,IGFBP3,3,3,Efficacy,1,1,fluorouracil,Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447964331
1447986872,rs16969968,CHRNA5,3,3,Metabolism/PK,2,2,cotinine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447986872
1447986902,rs57064725,PSMA4,3,0,Metabolism/PK,1,1,cotinine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447986902
1447986910,rs7170068,CHRNA3,3,0,Metabolism/PK,1,1,cotinine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447986910
1447986925,rs10851907,CHRNB4,3,0,Metabolism/PK,1,1,cotinine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447986925
1448103860,rs5443,GNB3,3,1.5,Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448103860
1448103928,rs3814055,NR1I2,3,3.5,Toxicity,1,1,flucloxacillin,Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1448103928
1448104043,rs6279,DRD2,3,1.75,Other,1,1,olanzapine,Bipolar Disorder;Depression,https://www.pharmgkb.org/clinicalAnnotation/1448104043
1448104050,rs6275,DRD2,3,1.75,Other,1,1,olanzapine,Bipolar Disorder;Depression,https://www.pharmgkb.org/clinicalAnnotation/1448104050
1447991854,"CYP2D6*1, CYP2D6*1xN",CYP2D6,4,-0.5,Efficacy,1,4,dolasetron;granisetron,Postoperative Nausea and Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1447991854
1447983144,rs1800012,COL1A1,3,1.5,Toxicity,1,1,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447983144
1447983163,rs2070296,NRP1,3,2.75,Efficacy,1,1,ranibizumab,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1447983163
1447946114,rs179008,TLR7,3,2.5,Efficacy,1,1,imiquimod,"Carcinoma, Basal Cell",https://www.pharmgkb.org/clinicalAnnotation/1447946114
1447946169,rs4646437,CYP3A4,3,2,Metabolism/PK,1,1,voriconazole,Mycoses,https://www.pharmgkb.org/clinicalAnnotation/1447946169
1447960484,rs2070744,NOS3,3,2,Efficacy,1,1,enalapril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447960484
1447960502,rs2242046,SLC28A1,3,1.75,Toxicity,1,1,gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960502
1447960582,rs719235,GGH,3,2.5,Toxicity,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1447960582
1447960656,rs5186,AGTR1,3,2,Efficacy,1,1,losartan,Liver Cirrhosis,https://www.pharmgkb.org/clinicalAnnotation/1447960656
1447960663,rs699,AGT,3,2,Efficacy,1,1,quinapril,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1447960663
1447960716,rs2125739,ABCC10,3,2,Metabolism/PK,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447960716
1447960731,rs1265112,CCHCR1,3,3.25,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447960731
1447963247,rs11716445,RHOA,3,3,Efficacy,1,1,pravastatin;simvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1447963247
1447981410,rs10916852,SH2D5,3,1.75,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981410
1447981430,rs7543016,CMPK1,3,1.75,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981430
1447981440,rs35687416,CMPK1,3,3.25,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981440
1447981457,rs12507552,DCTD,3,2.75,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981457
1447981465,rs274717,TENT4A,3,0,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981465
1447981474,rs274713,TENT4A,3,1.75,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981474
1447987124,rs2819742,RYR2,3,0.5,Toxicity,3,3,atorvastatin;simvastatin,Cardiovascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/1447987124
1448123001,rs1045642,ABCB1,3,1.75,Efficacy,1,1,losartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448123001
1448124426,rs2298383,ADORA2A;ADORA2A-AS1,3,2.75,Toxicity,1,1,methotrexate,Hematologic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448124426
1448265017,rs117648444,IFNL3;IFNL4,3,3.5,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448265017
1448266396,rs35599367,CYP3A4,3,2,Metabolism/PK,1,1,risperidone,Bipolar Disorder;Depression;Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448266396
1448266413,rs1523130,NR1I2,3,2,Metabolism/PK,1,1,risperidone,Bipolar Disorder;Depression;Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448266413
1448266429,rs2276707,NR1I2,3,1.5,Metabolism/PK,1,1,risperidone,Bipolar Disorder;Depression;Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448266429
1447960204,rs1042714,ADRB2,3,2.5,Toxicity,1,1,atenolol;metoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447960204
1447980691,rs3735451,CYP3A4,3,4.5,Toxicity,1,2,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1447980691
1447983940,rs762551,CYP1A2,3,1.5,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447983940
1448531661,rs17501331,ABCC1,3,1.75,Toxicity,1,1,irinotecan,Colorectal Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1448531661
1448567797,rs1057868,POR,3,1.5,Metabolism/PK,1,2,sirolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448567797
1450930440,rs508448,OPRD1,3,2.25,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450930440
1450931410,rs2074957,PIP5K1C,3,0,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450931410
1447960257,rs1061170,CFH,4,-1.25,Efficacy,3,3,photodynamic therapy,Macular Degeneration,https://www.pharmgkb.org/clinicalAnnotation/1447960257
1447963078,rs578776,CHRNA3,3,3.25,Efficacy;Toxicity,7,8,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447963078
1447963598,HLA-DQB1*05:02,HLA-DQB1,3,2.5,Toxicity,1,1,flupirtine,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1447963598
1451810680,rs2292596,AHRR,3,0,Efficacy,1,1,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451810680
1448102644,rs2299939,PTEN,3,2.5,Toxicity,1,1,carboplatin;cisplatin,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448102644
1448107270,rs2523864,HCG22,3,1.25,Toxicity,1,1,triamcinolone,Retinal Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448107270
1448107277,rs3873352,HCG22,3,2.25,Toxicity,1,1,triamcinolone,Retinal Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448107277
1448263285,rs1042718,ADRB2,3,3,Toxicity,1,1,fentanyl;propofol;remifentanil;sevoflurane,Hypotension,https://www.pharmgkb.org/clinicalAnnotation/1448263285
1447963604,rs12718541,DDC,3,2.5,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447963604
1447963644,rs265976,DRD1,3,0.25,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447963644
1447963688,rs324420,FAAH,3,2.75,Toxicity,1,1,cannabinoids,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447963688
1447963713,rs7973796,PMCH,3,1.5,Toxicity,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447963713
1447990902,rs699947,VEGFA,3,2.75,Efficacy,1,1,enalapril,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447990902
1448097768,rs232043,RRM1,3,3,Efficacy,1,1,cisplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448097768
1448097775,rs720106,RRM1,3,3,Efficacy,1,1,cisplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448097775
1448098213,rs9725457,NR1I3,3,2.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098213
1448605477,rs8450,CRTC2,3,5.75,Toxicity,1,2,cyclosporine;tacrolimus,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448605477
1447963979,rs1128503,ABCB1,4,-6.5,Efficacy,7,7,antiepileptics,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447963979
1447987204,rs7754840,CDKAL1,3,3.25,Efficacy,1,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1447987204
1447979749,rs113993960,CFTR,1A,123.375,Efficacy,11,16,ivacaftor / lumacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447979749
1447980699,rs4646440,CYP3A4,3,4.5,Toxicity,1,2,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1447980699
1447980706,rs4646437,CYP3A4,3,2.5,Toxicity,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1447980706
1447980713,rs2246709,CYP3A4,3,4.5,Toxicity,1,2,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1447980713
1447980724,rs16909440,OR52E2,3,2.5,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447980724
1447980740,rs11869731,ASIC2,3,3,Efficacy,1,1,lithium,Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447980740
1447980875,rs28371706,CYP2D6,3,1.5,Metabolism/PK,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447980875
1447980897,rs77010898,CFTR,3,0,Efficacy,1,1,curcumin;ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447980897
1448112052,rs6296,HTR1B,3,1.75,Toxicity,1,1,citalopram,"Anxiety Disorders;Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448112052
1448256890,rs12621220,IL1B,3,0,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448256890
1448256898,rs1143623,IL1B,3,0,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448256898
1448428918,rs34650714,UGT1A1;UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9,3,2.25,Dosage,1,1,allopurinol;febuxostat,Gout,https://www.pharmgkb.org/clinicalAnnotation/1448428918
1447980849,"UGT1A4*1a, UGT1A4*1b, UGT1A4*2",UGT1A4,3,1.25,Metabolism/PK,2,2,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447980849
1447963821,rs2727786,APOA1,3,2,Efficacy,1,1,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1447963821
1447963829,rs320,LPL,3,2,Efficacy,1,1,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1447963829
1447964002,rs1801282,PPARG,3,1.25,Toxicity,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447964002
1447964164,rs705379,PON1,3,1,Efficacy,1,1,atorvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1447964164
1447989803,rs2847153,TYMS,3,2.5,Efficacy,1,1,fluorouracil,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447989803
1448101213,rs2072658,CHRNB2,3,1.25,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101213
1448258734,rs2306283,SLCO1B1,3,3,Toxicity,1,1,sorafenib,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1448258734
1448259025,rs1870377,KDR,3,5,Toxicity,1,2,sorafenib,hand-foot syndrome;Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448259025
1447989739,rs78060119,DPYD,1A,98.75,Toxicity,2,3,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447989739
1447953199,rs1800544,ADRA2A,3,1.5,Efficacy,1,1,milnacipran,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447953199
1447953354,rs3087403,REV1,3,2.75,Efficacy,1,1,cisplatin,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1447953354
1447963674,rs2036657,ARRB2,3,0,Toxicity,1,1,methamphetamine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447963674
1447963798,rs1801058,GRK4,3,0.5,Efficacy,1,2,metoprolol,hypertensive nephrosclerosis,https://www.pharmgkb.org/clinicalAnnotation/1447963798
1447979561,"CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*18, CYP2A6*19, CYP2A6*46",CYP2A6,3,6.375,Metabolism/PK,8,13,tegafur,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447979561
1447989784,rs56038477,DPYD,1A,208.5,Toxicity,8,10,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447989784
1451829900,rs7662029,UGT2B7,3,2,Metabolism/PK,1,1,buprenorphine / naloxone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451829900
1451832220,rs7439366,UGT2B7,3,0,Metabolism/PK,1,1,buprenorphine / naloxone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451832220
1447960245,rs1060896,SLC28A2,3,2.5,Efficacy;Toxicity,2,3,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447960245
1447963227,rs2283265,DRD2,3,4.5,Toxicity,2,3,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447963227
1447963432,rs699,AGT,3,2.5,Efficacy,1,1,"Ace Inhibitors, Plain",Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447963432
1447964123,rs4646244,NAT2,3,4.75,Toxicity;Metabolism/PK,1,3,ethambutol;isoniazid;pyrazinamide;rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447964123
1447964264,rs6813183,ADGRL3,3,2.5,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1447964264
1448256091,rs10948059,GNMT,3,5.5,Toxicity,1,2,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448256091
1448423763,rs5993883,COMT,3,3,Efficacy,1,1,quetiapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448423763
1448423788,rs6269,COMT,3,3,Efficacy,1,1,quetiapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448423788
1448424039,rs17268282,ABCC4,3,1.375,Efficacy,1,1,furosemide,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1448424039
1448431545,rs887829,UGT1A1,3,1,Dosage,3,3,warfarin,heart valve replacement,https://www.pharmgkb.org/clinicalAnnotation/1448431545
1447953029,rs193922770,RYR1,1A,101,Toxicity,7,8,desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447953029
1447990050,rs1803274,BCHE,3,6.5,Efficacy,4,6,rivastigmine,Alzheimer Disease;Lewy Body Disease,https://www.pharmgkb.org/clinicalAnnotation/1447990050
1448097405,rs717620,ABCC2,3,2.25,Efficacy,1,1,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448097405
1448097600,rs3806596,UGT1A3,3,3.5,Toxicity,1,1,atazanavir;ritonavir,HIV Infections;Hyperbilirubinemia,https://www.pharmgkb.org/clinicalAnnotation/1448097600
1448256689,rs8192675,SLC2A2,3,0,Efficacy,1,1,metformin,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1448256689
1448266838,rs15524,CYP3A5,3,1,Metabolism/PK,1,2,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448266838
1448526040,rs10485058,OPRM1,3,1.5,Efficacy,2,2,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448526040
1447980968,rs594709,SLC22A1,3,1.25,Efficacy,1,1,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1447980968
1447983057,rs4752219,EIF3A,3,2.75,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447983057
1447983064,rs4752220,EIF3A,3,2.75,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447983064
1447983818,rs1045642,ABCB1,3,2.5,Dosage,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447983818
1448098947,rs4148386,ABCC2,3,1,Metabolism/PK,1,1,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448098947
1447960179,rs1042713,ADRB2,3,1.5,Efficacy,1,1,"Ace Inhibitors, Plain;Angiotensin II Antagonists;Beta Blocking Agents;digoxin;diuretics;spironolactone",Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1447960179
1447960225,rs1048101,ADRA1A,3,2.75,Efficacy,1,1,nifedipine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447960225
1447960403,rs451774,GPX5,3,2.75,Efficacy,1,1,carboplatin;cisplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960403
1447960599,rs5186,AGTR1,3,2,Efficacy,1,1,nitrendipine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447960599
1447960795,rs2562519,POLR3G,3,3.25,Toxicity,1,1,nevirapine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447960795
1447961322,rs778293,DAOA,3,2.75,Toxicity,1,1,methamphetamine,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447961322
1448432217,rs2228014,CXCR4,3,3,Efficacy,1,1,bevacizumab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448432217
1449191564,rs397508139,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191564
1449191574,rs77409459,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191574
1449191643,rs121908753,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191643
1449191649,rs74551128,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191649
1449191664,rs397508288,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191664
1449191682,rs397508442,CFTR,1A,200.25,Efficacy,2,4,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191682
1447963004,rs2032582,ABCB1,3,1,Metabolism/PK,1,1,cyclosporine;dicloxacillin,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447963004
1447963049,rs1805094,LEPR,3,1.25,Efficacy,1,1,atorvastatin,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1447963049
1447963442,rs2290573,ULK3,3,2.5,Efficacy,1,1,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",https://www.pharmgkb.org/clinicalAnnotation/1447963442
1449191708,rs150212784,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191708
1449191722,rs397508513,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191722
1447963458,rs2240017,TBX21,3,2.5,Efficacy,1,1,corticosteroids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447963458
1447963681,rs4790694,ARRB2,3,1.5,Toxicity,1,1,methamphetamine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447963681
1447964010,rs36118214,CYP2B6,3,1.5,Metabolism/PK,1,1,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447964010
1447964025,rs1045642,ABCB1,3,0.75,Toxicity,3,3,Drugs For Treatment Of Tuberculosis;isoniazid,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447964025
1449191734,rs121909020,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191734
1449191670,rs1800100,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191670
1449191676,rs397508435,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191676
1449191698,rs1800111,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191698
1449191752,rs186045772,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191752
1449191716,rs397508510,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191716
1449191728,rs121909019,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191728
1447990192,rs2571598,ACHE,3,1.75,Efficacy,1,1,rivastigmine,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1447990192
1447990224,rs12806698,RRM1,3,0.75,Efficacy,4,4,gemcitabine;Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447990224
1448101220,rs2229959,CHRNA4,3,0.25,Other,2,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101220
1448101260,rs3743078,CHRNA3,3,2,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101260
1448256718,rs3025040,VEGFA,3,2.25,Toxicity,1,1,sorafenib,"Carcinoma, Hepatocellular;hand-foot syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448256718
1448422839,rs1800469,TGFB1,3,2.5,Toxicity,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448422839
1448422846,rs3087465,TGFBR2,3,2.5,Toxicity,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448422846
1448109612,rs2235047,ABCB1,4,-1.25,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109612
1448264356,HLA-DRB1*04:03,HLA-DRB1,3,3.5,Toxicity,1,1,oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448264356
1447949639,rs2239179,VDR,3,3,Efficacy,1,1,selective beta-2-adrenoreceptor agonists,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447949639
1451810960,"CYP2C9*1, CYP2C9*3",CYP2C9,3,0,Toxicity,1,1,phenytoin,Stevens-Johnson Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451810960
1447963701,rs2740574,CYP3A4,3,2,Toxicity,1,1,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447963701
1447983217,rs199695765,CPA2,3,3,Toxicity,1,1,asparaginase,Pancreatitis;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1447983217
1448423436,rs12436663,PRORP,3,2.5,Efficacy,1,1,zileuton,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1448423436
1448427972,rs1439050,NTRK2,3,2.75,Toxicity,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448427972
1448428108,rs1334802,GRIK3,3,3,Toxicity,1,1,antipsychotics,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448428108
1448428117,rs363341,SLC18A2,3,3,Toxicity,1,1,antipsychotics,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448428117
1448428124,rs1124491,DRD2,3,3,Toxicity,1,1,antipsychotics,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448428124
1448428151,rs9567733,HTR2A,3,3,Toxicity,1,1,antipsychotics,Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448428151
1448428239,"CYP2C9*1, CYP2C9*2, CYP2C9*3",CYP2C9,3,1.5,Dosage;Metabolism/PK,1,2,valproic acid,Bipolar Disorder;Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448428239
1448531639,rs12720066,ABCB1,3,1.75,Toxicity,1,1,irinotecan,Colorectal Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1448531639
1448531652,rs6498588,ABCC1,3,1.75,Metabolism/PK,1,1,SN-38,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448531652
1448531802,rs3743527,ABCC1,3,1.75,Toxicity,1,1,irinotecan,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448531802
1447960443,rs1801253,ADRB1,3,1,Efficacy,1,1,"Ace Inhibitors, Plain;Angiotensin II Antagonists;Beta Blocking Agents;digoxin;diuretics;spironolactone",Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1447960443
1451666140,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46",CYP2A6,3,0,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451666140
1447959745,rs10760397,GAPVD1,3,2.5,Efficacy,1,1,interferon beta-1a;interferon beta-1b,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1447959745
1448097455,rs10934498,NR1I2,3,2.5,Metabolism/PK,1,1,irinotecan,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448097455
1448098299,rs75114882,NR1I3,3,1.5,Toxicity,1,1,docetaxel,Nasopharyngeal Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1448098299
1448102324,rs187238,IL18,3,2.5,Efficacy,1,1,interferons;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448102324
1448102337,rs1946518,IL18,3,2.5,Efficacy,1,1,interferons;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448102337
1448102407,rs6280,DRD3,3,1.75,Toxicity,1,1,methamphetamine,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1448102407
1448102422,rs1799752,ACE,3,3.5,Efficacy,1,1,fluoxetine;sertraline,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448102422
1448265266,rs3213094,IL12B,3,1.75,Efficacy,1,1,ustekinumab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448265266
1448265280,rs610604,TNFAIP3,4,-1.25,Efficacy,2,2,ustekinumab,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448265280
1448104059,rs5569,SLC6A2,4,-0.75,Efficacy,11,12,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1448104059
1448102439,rs11881222,IFNL3,2A,11.5,Efficacy,4,4,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,Hepatitis C;HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1448102439
1451834440,rs1045642,ABCB1,3,3,Toxicity,1,1,tramadol,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451834440
1448423855,rs121909011,CFTR,3,1.5,Efficacy,2,2,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1448423855
1448616179,"TPMT*1, TPMT*3A",TPMT,3,0,Toxicity,1,3,cisplatin,Ototoxicity,https://www.pharmgkb.org/clinicalAnnotation/1448616179
1448616865,rs12119882,DPYD,3,2.75,Toxicity,1,1,capecitabine,Hyperbilirubinemia;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616865
1447953291,rs3957356,GSTA1,3,2.25,Efficacy,1,1,cyclophosphamide,Lupus Nephritis,https://www.pharmgkb.org/clinicalAnnotation/1447953291
1447953304,rs6295,HTR1A,3,4.5,Efficacy,2,2,milnacipran,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447953304
1447960327,rs11710163,RAF1,3,3.5,Efficacy,1,1,carboplatin;cisplatin;docetaxel;gemcitabine;paclitaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960327
1447960335,rs11854484,SLC28A2,3,2.25,Efficacy,1,1,gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960335
1447960371,rs16886403,MAP3K1,3,3,Efficacy,1,1,carboplatin;cisplatin;docetaxel;paclitaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960371
1447960379,rs17309872,ACSS2,3,3,Efficacy,1,1,carboplatin;cisplatin;docetaxel;gemcitabine;paclitaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960379
1447984146,rs2032582,ABCB1,3,2.5,Dosage,1,1,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447984146
1447990143,rs1057910,CYP2C9,3,6,Efficacy;Metabolism/PK,2,5,irbesartan,Essential hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447990143
1447990283,rs639174,DROSHA,3,2.5,Toxicity,1,1,cyclophosphamide;cytarabine;daunorubicin;mercaptopurine;methotrexate;prednisone;vincristine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1447990283
1448097711,rs4492666,CMPK1,3,2.5,Efficacy,1,1,cisplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448097711
1448097718,rs2284449,RRM1,3,3,Efficacy,1,1,cisplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448097718
1448100861,rs2413739,PACSIN2,3,2,Toxicity,1,2,mercaptopurine;methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448100861
1448100874,rs324650,CHRM2,3,2.5,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448100874
1448100887,rs10994982,ARID5B,3,1,Metabolism/PK,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448100887
1448616900,rs4149178,SLC22A7,3,2.75,Toxicity,1,1,capecitabine,Diarrhea;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616900
1450932374,rs1801131,MTHFR,3,3.5,Toxicity,11,13,capecitabine;fluorouracil;leucovorin;oxaliplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450932374
1448423861,rs77932196,CFTR,1A,201.25,Efficacy,3,6,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1448423861
1448104189,"CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18",CYP2B6,2A,13.625,Metabolism/PK,9,12,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448104189
1451868500,rs3740563,GRK5,3,4,Efficacy,1,1,Beta Blocking Agents,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1451868500
1447961166,rs2293347,EGFR,3,4.5,Efficacy,1,2,gefitinib,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447961166
1447961329,rs881152,DUSP1,3,0.75,Efficacy,1,3,salbutamol,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447961329
1447964292,rs734644,ADGRL3,3,2.5,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1447964292
1447983071,rs1409314,EIF3A,3,3.25,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447983071
1447983078,rs10510050,EIF3A,3,3.25,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447983078
1448100229,rs1433099,LDLR,3,0,Efficacy,1,1,pravastatin,Vascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448100229
1448102633,rs2699887,PIK3CA,3,2.5,Toxicity,1,1,carboplatin;cisplatin,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448102633
1448125537,rs2071559,KDR,3,5.75,Efficacy,3,4,sorafenib,"Carcinoma, Hepatocellular;Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1448125537
1448525395,rs4819554,IL17RA,3,3,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448525395
1448615167,rs1008805,CYP19A1,3,2.5,Toxicity,1,1,anastrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448615167
1448109783,rs4148350,ABCC1,4,-1.75,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109783
1451815200,"CYP2C9*1, CYP2C9*2",CYP2C9,3,1.75,Toxicity,1,1,ketoprofen,"Dyspepsia;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451815200
1451868400,rs10787959,GRK5,3,3.5,Efficacy,1,1,Beta Blocking Agents,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1451868400
1448100630,rs6277,DRD2,4,-1.25,Efficacy,2,2,methadone,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448100630
1447963611,rs351855,FGFR4,3,1.75,Efficacy,1,1,cyclophosphamide;fluorouracil;methotrexate,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447963611
1447981346,rs61886492,FOLH1,3,1.25,Toxicity,1,1,mercaptopurine;methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1447981346
1447987211,rs7756992,CDKAL1,3,3.25,Efficacy,1,1,Dipeptidyl peptidase 4 (DPP-4) inhibitors,Diabetes Mellitus,https://www.pharmgkb.org/clinicalAnnotation/1447987211
1447987227,rs11580409,ERICH3,3,2.5,Efficacy,1,1,citalopram;escitalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447987227
1447990925,rs885036,MGAT4A,3,2.25,Efficacy,1,1,bevacizumab;capecitabine;cetuximab;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447990925
1448097805,rs3832043,UGT1A9,3,1.5,Metabolism/PK,1,1,mycophenolic acid,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448097805
1448097837,rs1803274,BCHE,3,2,Other,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448097837
1448100644,rs1804645,NCOA1,3,1,Toxicity,1,5,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448100644
1448100661,rs10509373,LRMDA,3,3.75,Efficacy,1,1,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448100661
1448100687,rs2717162,GALR1,3,5.75,Efficacy,1,2,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448100687
1448100695,rs2717162,GALR1,3,1.5,Efficacy,2,3,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448100695
1448100751,rs2269879,DOT1L,3,1,Efficacy,1,2,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448100751
1451646580,rs5326,DRD1,3,3,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451646580
1451868520,rs11198893,GRK5,3,4,Efficacy,1,1,Beta Blocking Agents,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1451868520
1451868540,rs4752292,GRK5,3,3.5,Efficacy,1,1,Beta Blocking Agents,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1451868540
1448265557,rs7958375,CUX2,3,0,Toxicity,1,1,rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448265557
1448265565,rs10946739,RIPOR2,3,0,Toxicity,1,1,rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448265565
1448265573,rs10946737,RIPOR2,3,2.25,Toxicity,2,2,Drugs For Treatment Of Tuberculosis;rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448265573
1448265581,rs320003,AGBL4,3,0,Toxicity,1,1,rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448265581
1448265598,rs319952,AGBL4,3,0,Toxicity,1,1,rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448265598
1448635176,rs766023281,NUDT15,3,0.25,Dosage;Toxicity,1,1,mercaptopurine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448635176
1448616690,HLA-C*06:02,HLA-C,3,3,Efficacy,1,1,methotrexate,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448616690
1445401427,rs11854484,SLC28A2,3,2.5,Toxicity,1,1,peginterferon alfa-2b;protease inhibitors;ribavirin,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1445401427
1447953284,rs462779,REV3L,3,2.25,Efficacy,1,1,cisplatin,Osteosarcoma,https://www.pharmgkb.org/clinicalAnnotation/1447953284
1447962613,rs340874,PROX1,3,2,Toxicity,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447962613
1447979272,rs2234693,ESR1,3,2,Efficacy,1,1,leflunomide,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1447979272
1447979279,rs6962291,TBXAS1,3,1.75,Toxicity,1,3,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1447979279
1447980677,rs1799978,DRD2,3,3.25,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1447980677
1447981282,rs7439366,UGT2B7,3,3.25,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981282
1447981372,rs4655226,CDA,3,1,Metabolism/PK,1,1,difluorodeoxyuridine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981372
1447981385,rs3750117,NT5C3A,3,1,Metabolism/PK,1,1,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981385
1447990324,rs784888,SP1,3,2.5,Efficacy;Metabolism/PK,2,3,metformin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1447990324
1448097693,rs895819,MIR27A,3,3.5,Toxicity,4,5,capecitabine;fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448097693
1450821121,rs1126742,CYP4A11,3,2.25,Efficacy,1,1,amiloride;spironolactone,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1450821121
1447987018,rs28365062,UGT2B7,4,-3.25,Metabolism/PK,6,6,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1447987018
1448109565,rs4261716,UGT1A6,4,-1.25,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109565
1447981275,rs7668258,UGT2B7,3,3.25,Efficacy,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981275
1448102294,rs3957357,GSTA1,3,1,Efficacy,2,2,cyclophosphamide;doxorubicin;prednisone;rituximab;vincristine,"Lymphoma, Large B-Cell, Diffuse",https://www.pharmgkb.org/clinicalAnnotation/1448102294
1448102368,rs671,ALDH2,3,2,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1448102368
1448259308,rs11543791,ESR1,3,1.75,Efficacy,1,1,raloxifene,Menopause;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448259308
1448531674,rs35621,ABCC1,3,1.25,Metabolism/PK,1,1,SN-38,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448531674
1448568152,rs10995,VASP,3,0,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448568152
1448109707,rs4877847,SLC28A3,4,-1.25,Toxicity,2,2,anthracyclines and related substances,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448109707
1448263578,rs628031,SLC22A1,3,1.25,Metabolism/PK,2,2,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448263578
1448102550,rs2228570,VDR,3,6,Efficacy,2,2,peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448102550
1447990940,rs696692,ERICH3,3,0,Efficacy,1,1,citalopram;escitalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447990940
1448616678,rs3761548,FOXP3,3,2.5,Efficacy,1,1,methotrexate,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448616678
1448100955,rs8192935,CES1,3,1.25,Metabolism/PK,1,1,dabigatran,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1448100955
1448101044,rs4958381,GRIA1,3,1.75,Toxicity,1,1,asparaginase,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448101044
1447961057,rs1044457,CMPK1,3,2.5,Efficacy,3,3,gemcitabine,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447961057
1447981296,rs6600893,UGT2B7,3,3.5,Efficacy;Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1447981296
1447981313,rs4148157,ABCG2,3,1.75,Metabolism/PK,1,1,topotecan,Brain Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447981313
1447982768,rs7311358,SLCO1B3,3,2.5,Toxicity,1,2,carboplatin;paclitaxel,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447982768
1448100437,rs510432,ATG5,3,2.25,Efficacy,1,1,adalimumab,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448100437
1448100444,rs1076560,DRD2,3,0,Efficacy,1,1,rasagiline,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1448100444
1448100464,rs2283265,DRD2,3,2.5,Efficacy,1,1,rasagiline,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1448100464
1448100471,rs2585428,CYP24A1,3,2,Metabolism/PK,1,1,telaprevir,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1448100471
1448100508,rs6923761,GLP1R,3,2,Efficacy,1,1,sitagliptin;vildagliptin,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1448100508
1448100514,rs2514036,ACY3,3,0,Efficacy,1,1,bisoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448100514
1448100552,rs9282564,ABCB1,3,0.75,Metabolism/PK,3,3,tacrolimus,Kidney Transplantation;lung transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448100552
1448100567,rs3740066,ABCC2,3,0.625,Metabolism/PK,3,3,mycophenolic acid,Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448100567
1448100942,rs4148738,ABCB1,3,0,Metabolism/PK,1,1,dabigatran,Atrial Fibrillation,https://www.pharmgkb.org/clinicalAnnotation/1448100942
1448101059,rs557881,SLC6A12,3,2.5,Toxicity,1,1,aspirin,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1448101059
1448101073,rs2228075,IMPDH1,3,2.25,Toxicity,1,1,mycophenolate mofetil,Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448101073
1448101086,rs622342,SLC22A1,3,3.5,Dosage;Toxicity,1,2,amantadine;Anticholinergics;Dopamine agonists;levodopa;selegiline,Parkinson Disease,https://www.pharmgkb.org/clinicalAnnotation/1448101086
1448101102,rs12042763,PTGS2,3,2.5,Efficacy,1,1,aspirin,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448101102
1448100501,rs2071197,HNF4A,4,-0.5,Efficacy;Metabolism/PK,2,3,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448100501
1448101114,rs676210,APOB,3,2.5,Efficacy,1,1,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1448101114
1448101149,rs16969968,CHRNA5,3,2.75,Toxicity,1,1,Opium alkaloids and derivatives,Pain,https://www.pharmgkb.org/clinicalAnnotation/1448101149
1448101163,rs660652,CHRNA5,3,2.25,Toxicity,1,1,nicotine;Opium alkaloids and derivatives,Pain;Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101163
1448101175,rs2072660,CHRNB2,3,1.75,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101175
1448101202,rs760370,SLC29A1,3,2,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448101202
1448101252,rs3813567,CHRNB4,3,2,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101252
1448102446,rs4803219,IFNL3,3,5.5,Efficacy,2,2,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448102446
1448104353,rs2010963,VEGFA,3,1.75,Efficacy,1,1,capecitabine;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448104353
1448266599,rs2302489,KLRD1,3,2.75,Efficacy,1,1,adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1448266599
1448266609,rs7301582,KLRC1,3,2.25,Efficacy,1,1,adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1448266609
1448100487,rs2231142,ABCG2,3,3.75,Metabolism/PK,4,5,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448100487
1448100494,rs3114020,ABCG2,3,1.25,Metabolism/PK,2,2,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448100494
1448101182,rs2072661,CHRNB2,3,3,Efficacy;Toxicity,4,5,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448101182
1448525559,rs1021737,CTH,3,3,Toxicity,1,1,busulfan;cyclophosphamide,hemopoietic stem cell transplant,https://www.pharmgkb.org/clinicalAnnotation/1448525559
1448612662,rs2741049,UGT1A10;UGT1A7;UGT1A8;UGT1A9,3,2,Efficacy,1,1,oxcarbazepine,Epilepsy;Seizures,https://www.pharmgkb.org/clinicalAnnotation/1448612662
1448612682,rs308395,FGF2,3,2,Efficacy,1,1,lenalidomide;thalidomide,Multiple Myeloma,https://www.pharmgkb.org/clinicalAnnotation/1448612682
1448613243,rs4553808,CTLA4,3,4,Metabolism/PK,1,2,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448613243
1448615614,rs10774053,CACNA1C,3,1.5,Toxicity,1,1,ritodrine,adverse events;Premature Birth,https://www.pharmgkb.org/clinicalAnnotation/1448615614
1448634752,rs2273697,ABCC2,3,3.875,Metabolism/PK,4,5,cyclosporine;mycophenolic acid,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448634752
1450374089,rs1042028,SULT1A1,3,1.75,Efficacy,1,1,acetaminophen,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450374089
1447960930,rs1799732,DRD2,3,3,Efficacy,1,1,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447960930
1447960937,rs1799732,DRD2,3,3.25,Efficacy,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447960937
1447990245,rs118204423,RYR1,3,0.25,Toxicity,1,2,succinylcholine;volatile anesthetics,Malignant Hyperthermia,https://www.pharmgkb.org/clinicalAnnotation/1447990245
1448097556,rs7586110,UGT1A7,3,3.5,Toxicity,1,1,atazanavir;ritonavir,HIV Infections;Hyperbilirubinemia,https://www.pharmgkb.org/clinicalAnnotation/1448097556
1448097574,rs17868323,UGT1A7,3,3.5,Toxicity,1,1,atazanavir;ritonavir,HIV Infections;Hyperbilirubinemia,https://www.pharmgkb.org/clinicalAnnotation/1448097574
1448097587,rs17863778,UGT1A7,3,3.5,Toxicity,1,1,atazanavir;ritonavir,HIV Infections;Hyperbilirubinemia,https://www.pharmgkb.org/clinicalAnnotation/1448097587
1448100201,rs4532,DRD1,3,2.5,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448100201
1448100313,rs28365063,UGT2B7,4,-0.25,Metabolism/PK,3,3,lamotrigine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448100313
1448100208,rs686,DRD1,3,3,Other,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1448100208
1448100215,rs17587100,INSIG2,3,0,Toxicity,2,2,antipsychotics,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448100215
1448100222,rs2071303,HFE,3,2.75,Efficacy,1,1,adalimumab,Crohn Disease,https://www.pharmgkb.org/clinicalAnnotation/1448100222
1448100242,rs2738466,LDLR,3,0,Efficacy,1,1,pravastatin,Vascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448100242
1448100249,rs6092,SERPINE1,3,2.75,Toxicity,1,1,dexamethasone,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448100249
1448100257,rs1800795,IL6,3,2.25,Toxicity,1,1,peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448100257
1448100265,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,0,Toxicity,1,1,peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448100265
1448100306,rs3765534,ABCC4,3,2.5,Toxicity,2,2,azathioprine;mercaptopurine,Inflammatory Bowel Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448100306
1448100334,rs56324128,CYP3A4,3,0,Metabolism/PK,1,1,ticagrelor,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1448100334
1448100340,rs62471956,CYP3A43,3,0,Metabolism/PK,1,1,ticagrelor,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1448100340
1448100347,rs4149056,SLCO1B1,3,0,Metabolism/PK,1,1,ticagrelor,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1448100347
1448100354,rs113681054,SLCO1B1,3,0,Metabolism/PK,1,1,ticagrelor,Acute coronary syndrome,https://www.pharmgkb.org/clinicalAnnotation/1448100354
1451773100,rs10494366,NOS1AP,3,1.5,Toxicity,1,1,digoxin,Shortened QT interval,https://www.pharmgkb.org/clinicalAnnotation/1451773100
1448123834,rs2535629,ITIH3,3,1.5,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448123834
1449146785,rs2228000,XPC,3,1.5,Toxicity,1,2,Platinum compounds,"Carcinoma, Non-Small-Cell Lung;gastrointestinal toxicity;Hematologic Diseases;Leukopenia",https://www.pharmgkb.org/clinicalAnnotation/1449146785
1449146832,rs9394992,SLC29A1,3,3.25,Efficacy,1,1,tipiracil hydrochloride;trifluridine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449146832
1449146840,rs760370,SLC29A1,3,3.25,Efficacy,1,1,tipiracil hydrochloride;trifluridine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449146840
1449147022,rs12979860,IFNL3;IFNL4,3,2.5,Efficacy,1,1,sofosbuvir;velpatasvir;voxilaprevir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1449147022
1449147609,rs2740574,CYP3A4,3,1,Efficacy,1,2,buprenorphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1449147609
1448264343,HLA-B*15:01,HLA-B,3,3,Toxicity,1,1,oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448264343
1447990578,rs2306283,SLCO1B1,3,1.5,Metabolism/PK,2,2,mycophenolic acid,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1447990578
1448099065,rs10898815,NUMA1,3,2.25,Efficacy,1,1,calcium channel blockers,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448099065
1448099080,rs588076,PICALM,3,2.25,Efficacy,1,1,calcium channel blockers,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448099080
1448099093,rs117532069,DOK5,3,0,Toxicity,1,1,cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine,Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448099093
1448099100,rs11868035,SREBF1,3,1,Toxicity,1,1,hmg coa reductase inhibitors,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448099100
1448259317,rs1042597,UGT1A8,3,1.75,Efficacy,1,1,raloxifene,Menopause;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448259317
1448264186,rs10846744,SCARB1,3,2.5,Efficacy,1,1,peginterferon alfa-2a;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448264186
1448519686,"CYP3A4*1, CYP3A4*22",CYP3A4,3,2,Metabolism/PK,1,1,exemestane,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448519686
1448615137,rs1045642,ABCB1,3,2,Toxicity,1,1,anastrozole,Arthralgia;Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448615137
1448615147,rs2032582,ABCB1,3,1.5,Metabolism/PK,1,1,anastrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448615147
1448124242,rs2046934,P2RY12,3,1.75,Efficacy,2,2,clopidogrel,major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1448124242
1448124216,rs1330344,PTGS1,3,2.25,Efficacy,1,1,clopidogrel,major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1448124216
1183532576,rs429358,APOE,3,2.5,Efficacy,1,1,simvastatin,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1183532576
1447982797,rs4149117,SLCO1B3,3,5,Toxicity,2,2,carboplatin;paclitaxel,Lung Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447982797
1447982832,rs1695,GSTP1,3,2.75,Efficacy,1,1,dimethyl fumarate,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1447982832
1448103935,rs10494366,NOS1AP,3,1.75,Efficacy,1,1,repaglinide,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1448103935
1448265605,rs393994,AGBL4,3,0,Toxicity,1,1,rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1448265605
1448636111,rs11506105,EGFR,3,3,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448636111
1450933001,rs7041,GC,3,2,Efficacy,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1450933001
1450933052,rs610604,TNFAIP3,3,2,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,"Arthritis, Psoriatic;Psoriasis",https://www.pharmgkb.org/clinicalAnnotation/1450933052
1450933104,rs2159140,MAP2K4,3,1.75,Toxicity,1,1,ethanol,Alcoholism;Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1450933104
1450933110,rs2271339,ADGRL3,3,2,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450933110
1450934055,rs2231137,ABCG2,3,3.75,Dosage,1,1,imatinib,Drug Toxicity;Gastrointestinal Stromal Tumors,https://www.pharmgkb.org/clinicalAnnotation/1450934055
1450934203,rs121908547,SCN4A,3,0,Efficacy,1,1,mexiletine,Myotonic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450934203
1450934656,rs869312138,GLA;HNRNPH2,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934656
1451702428,HLA-B*07:02,HLA-B,3,2.75,Toxicity,1,1,sulfamethoxazole / trimethoprim,Respiratory Insufficiency,https://www.pharmgkb.org/clinicalAnnotation/1451702428
1043880143,rs708272,CETP,3,2.5,Efficacy,1,1,hmg coa reductase inhibitors,Coronary Artery Disease,https://www.pharmgkb.org/clinicalAnnotation/1043880143
1448264329,HLA-B*40:02,HLA-B,3,4,Toxicity,1,1,oxcarbazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448264329
1447960269,rs1065634,NRAS,3,2.75,Efficacy,1,1,carboplatin;cisplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1447960269
1447960309,rs1143634,IL1B,3,1.5,Efficacy,1,1,infliximab,Crohn Disease,https://www.pharmgkb.org/clinicalAnnotation/1447960309
1447964180,rs6493497,CYP19A1,3,0,Efficacy,1,1,anastrozole;exemestane;letrozole,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447964180
1447990932,rs442767,DHFR,3,1.75,Toxicity,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1447990932
1448100089,rs713729,PICK1,3,4,Other,1,2,methamphetamine,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1448100089
1448100110,rs231775,CTLA4,3,2.25,Toxicity,1,1,cyclosporine,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448100110
1448100117,rs49411,FHIT,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100117
1448100132,rs672170,RGS17,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100132
1448100139,rs16873129,RAPGEF5,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100139
1448100146,rs2299267,PON2,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100146
1448100158,rs4737771,CRH,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100158
1448100165,rs10997242,CTNNA3,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100165
1448100173,rs2532560,PARP11,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100173
1448100180,rs9315310,NBEA,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100180
1448100521,rs3814995,NPHS1,3,0,Efficacy,1,1,losartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1448100521
1448258925,rs717620,ABCC2,3,1.75,Toxicity,1,1,sorafenib,Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1448258925
1451702465,HLA-C*07:02,HLA-C,3,2.75,Toxicity,1,1,sulfamethoxazole / trimethoprim,Respiratory Insufficiency,https://www.pharmgkb.org/clinicalAnnotation/1451702465
1447960948,rs1019385,GRIN2B,3,5,Dosage,1,2,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1447960948
1447961028,rs1799929,NAT2,3,7.25,Toxicity,8,9,Drugs For Treatment Of Tuberculosis,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1447961028
1447961074,rs992160,CDC5L,3,2.5,Efficacy,1,1,gemcitabine,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447961074
1447961344,rs846664,TAS2R16,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1447961344
1448099908,rs5985,F13A1,3,2.75,Efficacy,1,1,photodynamic therapy,Choroidal Neovascularization,https://www.pharmgkb.org/clinicalAnnotation/1448099908
1448532313,rs12979860,IFNL3;IFNL4,3,3.5,Efficacy,1,1,ledipasvir;sofosbuvir,"Hepatitis C, Chronic;Recurrence",https://www.pharmgkb.org/clinicalAnnotation/1448532313
1449156809,rs1611131,DBH,3,3,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449156809
1449156815,rs2070762,TH,3,1,Toxicity,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449156815
1447948727,"CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10",CYP2D6,3,2.5,Toxicity,5,5,gefitinib,"Adenocarcinoma;Carcinoma, Non-Small-Cell Lung;Drug Toxicity;Exanthema;Toxic liver disease",https://www.pharmgkb.org/clinicalAnnotation/1447948727
1447990855,rs6500843,RBFOX1,3,1.75,Efficacy,1,1,antineoplastic agents,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447990855
1448098232,rs2502815,NR1I3,3,2.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098232
1448098287,rs2501873,NR1I3,3,2,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098287
1448098293,rs10538494,NR1I3,3,2.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098293
1448098304,rs3732359,NR1I2,3,2,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098304
1448098315,rs3732360,NR1I2,3,2,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098315
1448098320,rs3814058,NR1I2,3,2.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098320
1448098325,rs11185647,RXRA,3,2,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1448098325
1448098354,rs1536475,RXRA,3,1.5,Toxicity,1,1,docetaxel,Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098354
1448099112,rs79085477,BMP7,3,0,Toxicity,1,1,cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine,Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448099112
1448099135,rs141059755,LINC00251,3,0,Toxicity,1,1,cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine,Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1448099135
1448099156,rs2273618,HNF4A,3,2,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448099156
1448099162,rs3746574,HNF4A,3,1.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448099162
1448099178,rs6130615,HNF4A,3,1.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448099178
1448099320,rs2234753,RXRA,3,1.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448099320
1448276473,rs4149056,SLCO1B1,3,2.25,Efficacy,1,1,rosiglitazone,"Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1448276473
1448099149,rs2032582,ABCB1,3,1,Efficacy,2,3,tramadol,"Fractures, Bone;Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1448099149
1447954378,rs113993959,CFTR,3,4.5,Other,4,4,ataluren,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1447954378
1183491175,rs776746,CYP3A5,3,2.5,Efficacy,1,1,rosuvastatin,Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1183491175
1444843613,rs12980275,IFNL3,3,6.5,Efficacy,7,7,peginterferon alfa-2a;peginterferon alfa-2b;ribavirin,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1444843613
1448099168,rs6413517,RXRA,3,1.5,Toxicity,1,1,docetaxel,Anemia;Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448099168
1448099784,rs12613732,GALNT14,3,2,Efficacy,1,1,cisplatin;fluorouracil;mitoxantrone,"Carcinoma, Hepatocellular",https://www.pharmgkb.org/clinicalAnnotation/1448099784
1448099828,rs1801157,CXCL12,3,2.25,Efficacy,1,1,alemtuzumab;chlorambucil;cyclophosphamide;fludarabine;prednisone;rituximab;vincristine,"Leukemia, Lymphocytic, Chronic, B-Cell",https://www.pharmgkb.org/clinicalAnnotation/1448099828
1451703980,"HLA-C*06:02, HLA-C*07:27, HLA-C*08:01",HLA-C,2B,10.5,Toxicity,2,4,sulfamethoxazole / trimethoprim,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1451703980
1448568208,rs2227983,EGFR,3,1.5,Efficacy,2,2,cetuximab,Head and Neck Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448568208
1448632491,rs35112940,CD33,3,2,Efficacy,1,1,gemtuzumab ozogamicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1448632491
1447949088,rs3077,HLA-DPA1,3,2.5,Efficacy,1,1,peginterferon alfa-2b,"Hepatitis B, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1447949088
1448098975,rs2228171,LRP2,3,2.25,Toxicity,1,1,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098975
1448099022,rs3957357,GSTA1,3,1.75,Metabolism/PK,1,1,busulfan,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448099022
1448103867,rs4305746,TAAR6,3,1.75,Efficacy,1,1,aripiprazole,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1448103867
1451704000,"HLA-B*13:01, HLA-B*15:02, HLA-B*38:02",HLA-B,2A,11.5,Toxicity,2,4,sulfamethoxazole / trimethoprim,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1451704000
1448126020,rs1870377,KDR,3,5,Efficacy,1,2,sorafenib,"Carcinoma, Hepatocellular",https://www.pharmgkb.org/clinicalAnnotation/1448126020
1448522748,rs2916205,PGLYRP4,3,2,Efficacy,1,1,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1448522748
1448532363,rs8099917,IFNL3;IFNL4,3,2.5,Efficacy,1,1,ledipasvir;sofosbuvir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1448532363
1449156051,HLA-B*67:01,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156051
1449156167,HLA-B*35:10,HLA-B,3,0,Toxicity,1,1,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156167
1449156175,HLA-C*04:01,HLA-C,2B,17,Toxicity,8,9,nevirapine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Exanthema;Hypersensitivity;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449156175
1448112486,rs11052877,CD69,3,2.75,Efficacy,1,1,tocilizumab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1448112486
1448112493,rs4910008,GALNT18,3,1.75,Efficacy,1,1,tocilizumab,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1448112493
1451704080,"NAT2*4, NAT2*5A, NAT2*5B, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*14A, NAT2*14B",NAT2,3,2.25,Toxicity,6,6,sulfamethoxazole / trimethoprim,adverse events;Hypersensitivity;severe cutaneous adverse reactions,https://www.pharmgkb.org/clinicalAnnotation/1451704080
1451704120,rs1799931,NAT2,3,0.5,Toxicity,2,2,sulfamethoxazole / trimethoprim,adverse events;Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1451704120
1447991729,rs57098334,SLC6A4,3,2.75,Efficacy,1,2,paroxetine,Depression,https://www.pharmgkb.org/clinicalAnnotation/1447991729
1450932250,rs4986893,CYP2C19,3,1,Toxicity,1,1,ethambutol;isoniazid;pyrazinamide;rifampin,Maculopapular Exanthema;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1450932250
1448603625,rs1800896,IL10,4,-0.75,Metabolism/PK,2,2,tacrolimus,Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448603625
982043234,rs1937840,AKR1C3,3,3,Efficacy,1,1,docetaxel;doxorubicin,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982043234
982042110,rs2010851,WNT5B,3,2,Other,1,1,fluorouracil,Colonic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982042110
1043873018,rs12800734,GRIK4,3,2.25,Efficacy,1,1,antidepressants,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1043873018
1183631792,rs11144870,RFK,3,0,Efficacy,1,1,citalopram;escitalopram,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1183631792
1183693485,rs1049353,CNR1,3,1,Toxicity,3,3,aripiprazole;clozapine;haloperidol;olanzapine;quetiapine;risperidone,Autism Spectrum Disorder;Psychotic Disorders;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1183693485
1185000451,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",CYP3A5,3,2.5,Metabolism/PK,2,2,atazanavir;ritonavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1185000451
1446898324,rs2279343,CYP2B6,3,0.25,Efficacy,1,2,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1446898324
1446899639,rs11155012,ECT2L,3,1.75,Efficacy,1,1,anthracyclines and related substances,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1446899639
1448112600,rs7937567,CSNK2A3;GALNT18,3,2.25,Efficacy,1,1,cisplatin,Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448112600
1448112607,rs10964552,MLLT3,3,2.25,Efficacy,1,1,cisplatin,Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448112607
1448112614,rs244898,RARS,3,2.25,Efficacy,1,1,cisplatin,Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448112614
1448567993,rs1800896,IL10,3,1.25,Metabolism/PK,1,1,sirolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448567993
1449576983,rs3828743,DSE;TSPYL1,3,5,Efficacy,1,2,abiraterone;prednisolone,Prostatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449576983
1451704127,rs1799930,NAT2,3,0,Toxicity,2,2,sulfamethoxazole / trimethoprim,adverse events;Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1451704127
1448616381,rs4788863,SLC16A5,3,1.75,Toxicity,2,2,cisplatin,Neoplasms;Ototoxicity;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616381
1449140069,rs6785049,NR1I2,3,3,Toxicity;Metabolism/PK,1,2,sirolimus;temsirolimus,gastrointestinal toxicity;Myelosuppression;Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449140069
1449140085,rs2032582,ABCB1,3,1,Metabolism/PK,1,1,sirolimus;temsirolimus,hematopoietic stem cell transplantation;Kidney Transplantation;Urinary Bladder Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449140085
1450823713,rs2514218,DRD2,3,1.5,Toxicity,1,1,aripiprazole,Psychomotor Agitation,https://www.pharmgkb.org/clinicalAnnotation/1450823713
1446897383,rs4646,CYP19A1,3,5.75,Efficacy,2,2,tamoxifen,Breast Neoplasms;Menopause,https://www.pharmgkb.org/clinicalAnnotation/1446897383
1450931979,rs2242480,CYP3A4,3,2.5,Efficacy,1,1,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450931979
982030836,rs10929302,UGT1A1,2A,11.75,Toxicity,7,8,irinotecan,Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/982030836
982030854,rs9606186,COMT,3,2.25,Efficacy,2,3,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/982030854
1183491446,rs20455,KIF6,3,4,Efficacy,3,3,atorvastatin,Coronary Disease;Hypercholesterolemia;Myocardial Infarction,https://www.pharmgkb.org/clinicalAnnotation/1183491446
1185012209,HLA-A*24:02,HLA-A,3,5.875,Toxicity,5,5,carbamazepine,"drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1185012209
1447990271,rs274622,GRM3,3,2.5,Other,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1447990271
1448255939,rs1800629,TNF,3,2.25,Toxicity,1,1,sorafenib,"Carcinoma, Hepatocellular;hand-foot syndrome",https://www.pharmgkb.org/clinicalAnnotation/1448255939
1447990913,rs885036,MGAT4A,3,2.25,Efficacy,1,1,bevacizumab;capecitabine;oxaliplatin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447990913
1444706201,rs4149032,SLCO1B1,3,0,Metabolism/PK,1,1,rifampin,Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1444706201
1444842113,HLA-C*14:03,HLA-C,3,3.25,Toxicity,1,1,ticlopidine,Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1444842113
1444842126,"UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*37",UGT1A1,3,2.75,Toxicity,2,2,pazopanib,"Carcinoma, Renal Cell",https://www.pharmgkb.org/clinicalAnnotation/1444842126
1447943591,rs1045642,ABCB1,3,1.75,Efficacy,1,1,agomelatine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1447943591
1447949305,rs1045642,ABCB1,3,0.5,Toxicity,1,2,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1447949305
1447952819,rs1059150,ATP5F1E,3,2.5,Efficacy,1,1,adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1447952819
1447952825,rs1072388,GRIN2B,3,0,Efficacy,1,1,clozapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1447952825
1447952831,rs1264457,HLA-E,3,2,Efficacy,1,1,adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1447952831
1447964542,rs1128503,ABCB1,3,2.25,Toxicity,1,1,capecitabine,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447964542
1448098344,rs62576288,RXRA,3,1.5,Toxicity,1,1,docetaxel,Nasopharyngeal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448098344
1448099574,rs2291075,SLCO1B1,3,2.5,Efficacy,1,1,cytarabine;daunorubicin;etoposide;mitoxantrone,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1448099574
1448100125,rs766127,MTRF1L,3,0,Efficacy,1,1,antidepressants,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1448100125
1448100235,rs1799852,TF,3,0,Efficacy,1,1,adalimumab,Crohn Disease,https://www.pharmgkb.org/clinicalAnnotation/1448100235
1448100826,rs7349683,EPHA5,3,2,Toxicity,4,4,paclitaxel,Breast Neoplasms;Ovarian Neoplasms;Peripheral Nervous System Diseases,https://www.pharmgkb.org/clinicalAnnotation/1448100826
1448104015,rs2606345,CYP1A1,3,5,Efficacy,2,2,carbamazepine;phenobarbital;phenytoin;valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448104015
1448259106,rs4291,ACE,3,2,Efficacy,1,1,captopril,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1448259106
1448276321,rs79206939,FTO,3,3.75,Toxicity,1,1,azathioprine;mercaptopurine,Irritable Bowel Syndrome;Leukopenia,https://www.pharmgkb.org/clinicalAnnotation/1448276321
1448615319,rs1045642,ABCB1,3,1,Toxicity,1,1,clopidogrel,Coronary Disease;Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1448615319
1448616890,rs2270860,SLC22A7,3,2.75,Toxicity,1,1,capecitabine,Drug Toxicity;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616890
1444706245,rs4363657,SLCO1B1,4,-2,Toxicity,2,2,simvastatin,Muscular Diseases,https://www.pharmgkb.org/clinicalAnnotation/1444706245
1444672986,rs3135506,APOA5,3,8,Efficacy,3,4,fenofibrate,Hypertriglyceridemia,https://www.pharmgkb.org/clinicalAnnotation/1444672986
1447961082,rs112445441,KRAS,3,3.125,Efficacy,8,8,cetuximab,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1447961082
1447681932,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41",CYP2D6,1A,116.4375,Metabolism/PK,12,21,metoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447681932
1448265356,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,4,-0.875,Toxicity,2,3,valproic acid,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/1448265356
1448634065,rs4646316,COMT,3,0.25,Toxicity,1,1,cisplatin,Neoplasms;nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1448634065
1448634071,rs9332377,COMT,3,0.25,Toxicity,1,1,cisplatin,Neoplasms;nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1448634071
1448634742,rs717620,ABCC2,3,3,Metabolism/PK,1,2,cyclosporine;mycophenolic acid,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1448634742
982031723,rs6431558,UGT1A8,3,1,Other,1,1,ABT-751,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/982031723
1183606758,rs2238032,CACNA1C,3,6.75,Efficacy,2,4,calcium channel blockers,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183606758
1448616882,rs4678145,UMPS,3,3.25,Toxicity,1,1,capecitabine,Asthenia;Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448616882
1448616922,rs699517,TYMS,3,5.5,Toxicity,1,2,capecitabine,Asthenia;Nausea;Neoplasms;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1448616922
1444694588,rs1045642,ABCB1,4,-11.125,Dosage;Metabolism/PK,47,52,tacrolimus,Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1444694588
1448640301,rs3918290,DPYD,4,-3.5,Efficacy,3,4,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448640301
655385129,rs3846662,HMGCR,3,0,Other,1,1,simvastatin,Cardiovascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/655385129
655385409,rs1801252,ADRB1,3,0,Efficacy,4,4,metoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/655385409
1043872988,rs861539,KLC1;XRCC3,3,2.5,Efficacy,1,1,fluorouracil;irinotecan;leucovorin,Colorectal Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1043872988
1183605989,rs2239128,CACNA1C,3,2.5,Efficacy,1,3,calcium channel blockers,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1183605989
1183700517,rs11080344,NOS2,3,0.75,Toxicity,2,2,isoniazid;rifampin,Toxic liver disease;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1183700517
1444704963,rs3761422,ADORA2A,3,0,Toxicity,1,1,caffeine,Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/1444704963
1448125499,rs2257212,SLC15A2,3,2.5,Efficacy,1,1,sorafenib,"Carcinoma, Hepatocellular",https://www.pharmgkb.org/clinicalAnnotation/1448125499
1449157000,rs1129844,CCL11,3,2.75,Toxicity,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449157000
1449157284,rs678849,OPRD1,3,0.25,Efficacy,1,2,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449157284
1449164443,rs12979860,IFNL3;IFNL4,3,2.75,Efficacy,1,1,peginterferon alfa-2a;peginterferon alfa-2b,Myeloproliferative Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449164443
1449167245,rs2886059,ALDH1L1,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167245
1449191952,rs113993960,CFTR,3,0,Toxicity,1,1,ivacaftor / lumacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191952
1449192683,rs75527207,CFTR,3,1.5,Efficacy,1,1,ivacaftor;tezacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449192683
1449269278,rs2108622,CYP4F2,4,-3,Other,5,6,warfarin,over-anticoagulation,https://www.pharmgkb.org/clinicalAnnotation/1449269278
1449271075,rs112783657,CBR3,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271075
981201946,rs1801158,DPYD,1A,87.75,Toxicity,13,14,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981201946
1450810975,rs894160,PLIN1,3,3,Toxicity,1,1,rosiglitazone,"Diabetes Mellitus, Type 2;Weight gain",https://www.pharmgkb.org/clinicalAnnotation/1450810975
981201962,rs1801159,DPYD,1A,86.75,Toxicity,13,16,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/981201962
827843617,rs3918290,DPYD,1A,255.75,Toxicity,52,62,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/827843617
1450944540,rs1128503,ABCB1,3,0.25,Toxicity,1,1,cyclosporine,hematopoietic stem cell transplantation;Neurotoxicity Syndromes,https://www.pharmgkb.org/clinicalAnnotation/1450944540
1450945347,rs1047303,HSD3B1,3,3.25,Efficacy,1,1,glucocorticoids,Asthma,https://www.pharmgkb.org/clinicalAnnotation/1450945347
1451526333,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",SLCO1B1,1A,222.75,Toxicity,14,19,simvastatin,statin-related myopathy,https://www.pharmgkb.org/clinicalAnnotation/1451526333
637880087,rs316019,SLC22A2,3,1,Toxicity,3,3,cisplatin,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/637880087
1450812229,rs2236857,OPRD1,3,0.5,Toxicity,3,3,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812229
1450813775,rs1799732,DRD2,3,2.25,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450813775
1450815148,rs2164660,PDE4D,3,0,Efficacy,1,1,quetiapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815148
1450820507,rs3845446,CACNA1E,3,0.5,Dosage,2,2,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450820507
613978931,rs3812718,SCN1A,2B,15.25,Dosage,6,7,carbamazepine,Epilepsy,https://www.pharmgkb.org/clinicalAnnotation/613978931
1183630664,rs55886062,DPYD,1A,206.25,Toxicity,13,15,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1183630664
1043859155,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",CYP2D6,1A,203.8125,Metabolism/PK,13,19,clomipramine,"Depressive Disorder, Major;Mental Disorders",https://www.pharmgkb.org/clinicalAnnotation/1043859155
1447814391,rs201279313,SLC25A31,3,0,Efficacy,1,1,atenolol;hydrochlorothiazide;metoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1447814391
1448266008,rs77010898,CFTR,3,1,Efficacy,1,2,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1448266008
1448266986,rs316019,SLC22A2,3,5,Toxicity,1,2,Platinum compounds,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1448266986
1448531101,rs8192950,CES1,3,2.25,Efficacy,1,1,clopidogrel,"Constriction, Pathologic;Ischemic Attack, Transient;Stroke",https://www.pharmgkb.org/clinicalAnnotation/1448531101
1450963020,rs1799793,ERCC2,3,2,Toxicity,1,1,Platinum compounds,"Carcinoma, Non-Small-Cell Lung;pneumonitis",https://www.pharmgkb.org/clinicalAnnotation/1450963020
1450963060,rs1799793,ERCC2,3,2.5,Toxicity,1,1,Platinum compounds,"adverse events;Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1450963060
655384666,rs429358,APOE,3,2.25,Toxicity,1,1,"Antivirals for treatment of HIV infections, combinations;ritonavir",HIV Infections;Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/655384666
655387652,rs1799978,DRD2,4,-1,Efficacy,4,4,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/655387652
1447673005,rs9923231,VKORC1,1B,26,Toxicity,17,17,warfarin,over-anticoagulation,https://www.pharmgkb.org/clinicalAnnotation/1447673005
655386075,rs1045642,ABCB1,3,2,Efficacy,4,5,cytarabine,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/655386075
1183684172,rs2032582,ABCB1,3,5.25,Efficacy,4,5,cytarabine;daunorubicin;dexrazoxane;idarubicin,"Leukemia, Myeloid, Acute",https://www.pharmgkb.org/clinicalAnnotation/1183684172
1447959515,rs1042713,ADRB2,3,1.75,Efficacy,1,1,propranolol,Liver Cirrhosis,https://www.pharmgkb.org/clinicalAnnotation/1447959515
1447672658,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11",CYP2C9,1A,139.75,Toxicity,29,34,warfarin,over-anticoagulation,https://www.pharmgkb.org/clinicalAnnotation/1447672658
1447672988,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11",CYP2C9,1A,342.375,Toxicity,33,50,warfarin,Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1447672988
1449005135,"CYP3A5*1, CYP3A5*3",CYP3A5,4,-1.75,Toxicity,1,2,cyclosporine;tacrolimus,Kidney Transplantation;transplant rejection,https://www.pharmgkb.org/clinicalAnnotation/1449005135
1449165704,"CYP3A5*1, CYP3A5*3",CYP3A5,3,4,Metabolism/PK,11,12,cyclosporine,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1449165704
1449309910,"CYP3A5*1, CYP3A5*3",CYP3A5,3,1.5,Metabolism/PK,1,1,tacrolimus,Nephrotic Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1449309910
1449716378,"CYP3A5*1, CYP3A5*3",CYP3A5,3,2,Toxicity,2,2,fentanyl,Neoplasms;Pain,https://www.pharmgkb.org/clinicalAnnotation/1449716378
1450371828,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",CYP3A5,3,0.75,Efficacy;Metabolism/PK,1,6,maraviroc,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1450371828
1449713943,"CYP3A5*1, CYP3A5*3, CYP3A5*6",CYP3A5,3,7.875,Metabolism/PK,5,6,fentanyl,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449713943
1448423466,"CYP3A5*1, CYP3A5*3",CYP3A5,3,2.25,Toxicity,1,1,carboplatin;paclitaxel,Leukopenia;Neutropenia;Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1448423466
1451100007,rs324498,PTPRD,3,0,Efficacy,1,1,Antihypertensives,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451100007
1451103240,rs4149117,SLCO1B3,3,2.5,Efficacy,1,1,mycophenolic acid,lung transplantation;overall survival,https://www.pharmgkb.org/clinicalAnnotation/1451103240
1451103560,rs6473797,OPRK1,3,2.75,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451103560
1449188311,rs1799971,OPRM1,4,-19.75,Toxicity,25,26,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1449188311
1450811261,rs1229984,ADH1B,3,7.25,Toxicity,3,3,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450811261
1451110071,rs61826952,RABGAP1L,3,2.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451110071
1451110320,rs2838956,SLC19A1,3,0,Toxicity,1,1,methotrexate,"adverse events;Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451110320
1444704359,rs4149056,SLCO1B1,3,7.5,Metabolism/PK,7,7,lopinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1444704359
1451116100,rs4149056,SLCO1B1,3,1,Metabolism/PK,1,1,amprenavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1451116100
1184989990,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,7,Efficacy,8,12,fluvoxamine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1184989990
1450812488,rs1799971,OPRM1,3,0.125,Toxicity,4,8,opioids,adverse events;Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1450812488
1451117640,rs12521868,C5orf56,3,3,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451117640
1451117646,rs1275988,KCNK3,3,3,Efficacy,1,1,candesartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451117646
1451118241,rs1378942,CSK,3,3,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118241
1451118277,rs12579720,PDE3A,3,3,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118277
1451118320,rs6722745,SULT1C3,3,3,Efficacy,1,1,candesartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118320
1451118326,rs4387287,STN1,3,3,Efficacy,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118326
1451118332,rs8068318,TBX2,3,3,Efficacy,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118332
1451118338,rs932764,PLCE1,3,3,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118338
1451118340,rs10995311,ADO,3,3,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118340
1451119080,rs147451859,PPCDC,3,0,Toxicity,1,1,docetaxel;FEC100;gemcitabine;trastuzumab;zoledronate,Amenorrhea,https://www.pharmgkb.org/clinicalAnnotation/1451119080
981238341,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11",CYP2C9,1A,675.75,Dosage,130,215,warfarin,Cardiovascular Diseases,https://www.pharmgkb.org/clinicalAnnotation/981238341
1451120960,rs2133896,ANKS1B,3,2.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451120960
1451120980,rs2133896,ANKS1B,3,2.5,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451120980
1451123020,rs910080,PDYN,3,0.75,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451123020
1451125512,rs9262132,ATAT1,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125512
1451125520,rs9262143,PPP1R18,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125520
1451125532,rs3130985,CDSN;PSORS1C1,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125532
1451125538,rs1049709,HLA-C,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125538
1451125544,rs3094086,MUCL3,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125544
981203689,rs717620,ABCC2,3,0.75,Toxicity,5,5,tenofovir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/981203689
1451125564,rs3130907,HCP5,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125564
1451125570,rs11229,PRRC2A,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125570
1451125580,rs1800629,TNF,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125580
1451125600,rs10885,PRRC2A,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125600
1451125620,rs3115672,MSH5,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125620
1451125640,rs10491684,DOCK8,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125640
1451125646,rs1058932,CYP2C8,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125646
1451125660,rs11572078,CYP2C8,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125660
1451125666,rs6119,SERPINA5,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125666
1451125672,rs6504649,XYLT2,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125672
1451125680,rs6113,SERPINA5,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125680
1451125687,rs6118,SERPINA5,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125687
1451125693,rs73450548,ETS2,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125693
1451544841,rs1801253,ADRB1,4,-3.25,Efficacy,4,4,Beta Blocking Agents,"Cardiomyopathy, Dilated;Heart Failure",https://www.pharmgkb.org/clinicalAnnotation/1451544841
1451544860,rs61767072,ADRA2C,3,3,Efficacy,2,3,Beta Blocking Agents,"Cardiomyopathy, Dilated;Death",https://www.pharmgkb.org/clinicalAnnotation/1451544860
1451544880,rs1042713,ADRB2,4,-3,Efficacy,4,5,Beta Blocking Agents,"Cardiomyopathy, Dilated;Heart Failure",https://www.pharmgkb.org/clinicalAnnotation/1451544880
1451544980,rs10799590,CNIH3,3,2.5,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451544980
1451547422,rs1544105,FPGS,3,2.25,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451547422
1451548374,rs4149009,SLCO1A2,3,0.5,Metabolism/PK,2,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451548374
1451905680,HLA-DRB1*04:02,HLA-DRB1,3,1.25,Toxicity,1,1,clozapine,Agranulocytosis,https://www.pharmgkb.org/clinicalAnnotation/1451905680
1451143820,"NAT2*5, NAT2*6, NAT2*7, NAT2*14",NAT2,3,1,Toxicity,5,5,hydralazine,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451143820
1451952760,rs4035887,EPAS1,3,1.5,Toxicity,1,2,sorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451952760
1451954480,rs4864950,KDR,3,0.75,Toxicity,1,2,regorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451954480
1451980660,rs1801394,FASTKD3;MTRR,3,2,Efficacy,1,1,sevoflurane,sedation,https://www.pharmgkb.org/clinicalAnnotation/1451980660
1451952780,rs4864950,KDR,3,3.5,Toxicity,1,1,sorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451952780
1451952700,rs444904,PIK3R5,3,1.5,Toxicity,1,2,sorafenib,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451952700
1451954540,rs1868089,EPAS1,3,3,Toxicity,1,1,sorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451954540
1451954560,rs7557402,EPAS1,2B,3,Toxicity,1,1,sorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451954560
1451158880,rs36120609,GSTM3,3,4.25,Toxicity,2,4,cisplatin;cyclophosphamide,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451158880
1451159780,rs371194629,HLA-G,3,2.5,Efficacy,2,2,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451159780
1451162986,"UGT1A1*1, UGT1A1*28",UGT1A1,3,1.75,Efficacy,1,1,raloxifene,bone density,https://www.pharmgkb.org/clinicalAnnotation/1451162986
1451163060,"UGT1A1*1, UGT1A1*28",UGT1A1,3,1.5,Metabolism/PK,2,3,raloxifene,Osteoporosis,https://www.pharmgkb.org/clinicalAnnotation/1451163060
1451165201,"UGT1A1*1, UGT1A1*28",UGT1A1,3,3,Toxicity,1,1,tranilast,Hyperbilirubinemia,https://www.pharmgkb.org/clinicalAnnotation/1451165201
1451165381,"UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28",UGT1A1,3,5.25,Toxicity,2,2,nilotinib,Hyperbilirubinemia,https://www.pharmgkb.org/clinicalAnnotation/1451165381
1451204520,"UGT1A1*1, UGT1A1*28",UGT1A1,3,2.75,Toxicity,2,2,sorafenib,"Carcinoma, Hepatocellular;Hyperbilirubinemia",https://www.pharmgkb.org/clinicalAnnotation/1451204520
1451954568,rs11125039,PRKCE,3,2.5,Toxicity,1,1,sorafenib,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451954568
1451954620,rs11651488,MAP2K6,3,3,Toxicity,1,1,sorafenib,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1451954620
1451954626,rs17682789,CDH13,3,3,Toxicity,1,1,sorafenib,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1451954626
1451954640,rs9927200,WWOX,3,3,Toxicity,1,1,sorafenib,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1451954640
1451212480,rs9282564,ABCB1,3,2.5,Toxicity,1,1,opioids,Death;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451212480
1451212500,rs4680,COMT,3,3,Toxicity,1,1,opioids,Death;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451212500
1451163884,"UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*36, UGT1A1*37",UGT1A1,1A,135.25,Toxicity,17,23,atazanavir;atazanavir / ritonavir,HIV Infections;Hyperbilirubinemia,https://www.pharmgkb.org/clinicalAnnotation/1451163884
1451954600,rs1346563,ADAMTS18,3,3,Toxicity,1,1,sorafenib,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451954600
1451151340,rs1042522,TP53,3,2.75,Toxicity,5,6,antineoplastic agents,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451151340
1451151380,rs1042522,TP53,3,5,Efficacy,4,4,Platinum compounds,overall survival,https://www.pharmgkb.org/clinicalAnnotation/1451151380
1451215020,"UGT1A1*1, UGT1A1*6, UGT1A1*28",UGT1A1,1B,27.375,Toxicity,24,29,FOLFIRI;irinotecan,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1451215020
1451549101,rs11280056,ENOSF1;TYMS,3,3.25,Toxicity,3,3,methotrexate,gastrointestinal toxicity;mucositis;Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451549101
1451954607,rs2330951,EGFR,3,2.5,Toxicity,1,1,sorafenib,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451954607
1450929222,rs1045642,ABCB1,3,5.75,Dosage,4,4,fentanyl,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450929222
1451114600,rs45445694,TYMS,3,1.75,Toxicity,14,14,fluorouracil,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451114600
1451114960,rs45445694,TYMS,3,3.25,Efficacy,13,13,fluorouracil;FOLFIRI;FOLFOX,overall survival;progression-free survival,https://www.pharmgkb.org/clinicalAnnotation/1451114960
1451243628,rs9923231,VKORC1,3,7.25,Toxicity,7,7,acenocoumarol,Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1451243628
1184133833,"CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28",CYP2B6,1A,361.5,Metabolism/PK,44,69,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1184133833
1451237326,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C",TPMT,1A,109.125,Dosage,9,11,azathioprine,dose reduction,https://www.pharmgkb.org/clinicalAnnotation/1451237326
1451242500,"CYP2B6*1, CYP2B6*6, CYP2B6*26",CYP2B6,1A,200.5,Dosage,4,6,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1451242500
1451243676,rs9923231,VKORC1,2A,8.25,Toxicity,3,4,phenprocoumon,Hemorrhage;over-anticoagulation;time above therapeutic range,https://www.pharmgkb.org/clinicalAnnotation/1451243676
1451245360,rs1051266,SLC19A1,2A,14.125,Efficacy,9,10,methotrexate,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451245360
1451250540,rs121434569,EGFR,2B,8.75,Efficacy,16,16,gefitinib,"Carcinoma, Non-Small-Cell Lung;Drug Resistance",https://www.pharmgkb.org/clinicalAnnotation/1451250540
1451251080,"CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",CYP3A4,2A,9.75,Dosage,8,8,tacrolimus,Kidney Transplantation;Organ Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451251080
1451237200,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9",TPMT,1A,221.25,Dosage,20,27,mercaptopurine,dose reduction,https://www.pharmgkb.org/clinicalAnnotation/1451237200
1451237240,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6",TPMT,1A,222.25,Toxicity,37,44,azathioprine,Leukopenia;Myelosuppression,https://www.pharmgkb.org/clinicalAnnotation/1451237240
1450929125,rs1051730,CHRNA3,3,2.5,Dosage,2,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450929125
1450929131,rs1051730,CHRNA3,3,2,Other,1,1,nicotine,Pregnancy,https://www.pharmgkb.org/clinicalAnnotation/1450929131
1451954660,rs917881,EGFR,3,1.5,Toxicity,1,2,sorafenib,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1451954660
1451954683,rs12948059,MAP2K6,3,2.5,Toxicity,1,1,sorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451954683
1449733531,rs8124728,SAMHD1,3,2.75,Toxicity,1,1,stavudine,HIV Infections;Peripheral Nervous System Diseases,https://www.pharmgkb.org/clinicalAnnotation/1449733531
1450812260,rs2236861,OPRD1,3,1,Toxicity,2,2,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812260
1451952740,rs12366035,VEGFB,3,1.5,Toxicity,1,2,sorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451952740
1451954720,rs9973653,EPAS1,3,3,Toxicity,1,1,sorafenib,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1451954720
1449003966,rs4720833,MAFK,3,0.75,Toxicity,2,2,isoniazid,drug-induced liver injury;Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1449003966
1449167106,rs17685420,PEBP4,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167106
1449167120,rs3210967,ZDHHC7,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167120
1449167147,rs10413455,ZNF134,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167147
1449167178,rs2071421,ARSA,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167178
1449167200,rs12302749,SPSB2,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167200
1449167211,rs10420097,ZNF211,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167211
1449167228,rs3810818,CORO7,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167228
1449167256,rs9901675,FXR2,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167256
1449167267,rs4805162,ZNF565,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167267
1449167278,rs4562,ELP5,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167278
1449168649,rs61908411,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168649
1449715840,rs540825,OPRM1,3,2,Toxicity,1,1,fentanyl,Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1449715840
1450810399,rs648893,OPRM1,3,0,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810399
1450930833,rs7178270,CHRNB4,3,3,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450930833
1449167469,rs11552708,SENP3,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167469
1449167480,rs1061735,ESYT2,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167480
1449167495,rs11553441,RRP7A,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167495
1449167512,rs362272,HTT,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167512
1449167529,rs757978,FARP2,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167529
1449167546,rs17279558,GGH,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167546
1449167584,rs2013169,PURA,3,0,Efficacy,1,1,methylphenidate,Attention Deficit Disorder with Hyperactivity,https://www.pharmgkb.org/clinicalAnnotation/1449167584
1449168093,rs9310657,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168093
1449168330,rs9310658,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168330
1449168337,rs7616119,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168337
1449168343,rs7653345,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168343
1449168350,rs9819548,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168350
1449168357,rs13093500,ZNF385D,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168357
1449168454,rs4639250,TTC37,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168454
1449168461,rs9369266,TREML4,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168461
1450812253,rs1534891,CSNK1E,3,0,Toxicity,2,2,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812253
1449171009,rs2740574,CYP3A4,3,2.25,Dosage,2,2,buprenorphine,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449171009
1449168468,rs13204353,TREML4,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168468
1449168475,rs10123866,INVS,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168475
1449168482,rs7472,TEX10,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168482
1449168489,rs10124893,TEX10,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168489
1449168496,rs7035619,TEX10,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168496
1449168503,rs6479008,TEX10,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168503
1449168510,rs10989064,TEX10,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168510
1449168517,rs3124955,FCN2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168517
1449168524,rs3128624,FCN2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168524
1449168531,rs61908402,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168531
1449168538,rs61908403,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168538
1449168545,rs61908404,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168545
1449168552,rs61908405,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168552
1449168559,rs17724452,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168559
1449168565,rs17724464,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168565
1449168572,rs17786394,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168572
1449168579,rs17786400,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168579
1449168586,rs61908406,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168586
1449168593,rs17786412,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168593
1449168600,rs61908407,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168600
1449168607,rs61908408,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168607
1449168614,rs61908409,ANO2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168614
1449168691,rs12595802,ATP10A,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168691
1449168698,rs3889402,MIEF2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168698
1449168705,rs12603700,MIEF2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168705
1449168712,rs56355515,MIEF2,3,0,Efficacy,1,1,duloxetine,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1449168712
1450808778,rs1800497,DRD2,3,2,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450808778
1450814192,rs671531,OPRM1,3,1.75,Efficacy,1,1,highly active antiretroviral therapy (haart),HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1450814192
1450814424,rs1801131,MTHFR,3,2.75,Efficacy,2,2,"l-methylfolate;Vitamin B-complex, Incl. Combinations","Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814424
1450814430,rs1801133,MTHFR,3,2.75,Efficacy,2,2,"l-methylfolate;Vitamin B-complex, Incl. Combinations","Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450814430
1450814563,rs11503014,GABRA2,3,2,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450814563
1450815114,rs6688363,ATP1A2,3,0,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815114
1450815136,rs17382202,PDE4D,3,0,Efficacy,1,1,quetiapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815136
1450928823,rs2036527,CHRNA5,3,2.25,Efficacy,1,1,varenicline,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450928823
1450929810,rs1045642,ABCB1,3,2,Dosage,2,2,oxycodone,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450929810
1450934868,rs1718125,P2RX7,3,0.25,Dosage,2,2,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450934868
1449296086,"CYP3A4*1, CYP3A4*18",CYP3A4,4,-2.25,Dosage,3,4,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449296086
1449566334,HLA-A*24:02,HLA-A,3,2.25,Toxicity,1,1,phenytoin,"Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome",https://www.pharmgkb.org/clinicalAnnotation/1449566334
1449715590,rs7439366,UGT2B7,3,1,Efficacy,2,2,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1449715590
1449748202,rs20455,KIF6,3,1.5,Efficacy,1,2,rosuvastatin,Hypercholesterolemia,https://www.pharmgkb.org/clinicalAnnotation/1449748202
1450376319,rs78239784,CFHR4,3,3,Toxicity,1,1,phenytoin,Maculopapular Exanthema,https://www.pharmgkb.org/clinicalAnnotation/1450376319
1450809657,rs5443,GNB3,3,3.5,Efficacy,1,1,sibutramine,Obesity,https://www.pharmgkb.org/clinicalAnnotation/1450809657
1450810375,rs495491,OPRM1,3,1.25,Toxicity,2,2,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450810375
1450812204,rs694066,GAL,3,0,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812204
1450812241,rs3778151,OPRM1,3,1.5,Toxicity,3,3,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812241
1450812247,rs6473797,OPRK1,3,0,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812247
1450813875,rs8109525,CYP2B6,3,2.75,Efficacy,1,1,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813875
1450933023,rs1544410,VDR,3,2,Efficacy,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1450933023
1450806640,rs1799972,OPRM1,4,-1.5,Toxicity,2,2,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450806640
1450806626,rs1799971,OPRM1,4,-5.5,Toxicity,11,12,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450806626
1450935200,rs2740574,CYP3A4,3,0,Metabolism/PK,2,2,cyclosporine,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1450935200
1450811641,rs1128503,ABCB1,4,-2.25,Dosage,4,4,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450811641
1450935050,HLA-A*32:01,HLA-A,3,3,Toxicity,2,2,vancomycin,drug reaction with eosinophilia and systemic symptoms,https://www.pharmgkb.org/clinicalAnnotation/1450935050
1449190104,rs1045642,ABCB1,3,1.75,Toxicity,1,1,antineoplastic agents,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1449190104
1449190397,rs62638690,OPRM1,3,3,Toxicity,1,1,cocaine;heroin,Cocaine-Related Disorders;Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1449190397
1449190422,rs1076560,DRD2,3,3.5,Other,3,3,opioids,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449190422
1449271003,rs117341846,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271003
1449271039,rs55633228,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271039
1450808106,rs9479757,OPRM1,3,2,Dosage,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450808106
1450813540,rs72552266,CYP2A13,3,2.5,Toxicity,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813540
1450934191,rs886043595,SCN4A,3,0,Efficacy,1,1,mexiletine,Myotonic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450934191
1449275238,rs1799971,OPRM1,4,-4,Toxicity,12,12,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1449275238
1450813547,"CYP2A6*1, CYP2A6*1x2, CYP2A6*2",CYP2A6,3,3,Toxicity,1,2,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450813547
1450811035,rs104894021,KCNH2,3,0,Efficacy,1,2,disopyramide,short qt syndrome 1,https://www.pharmgkb.org/clinicalAnnotation/1450811035
1450811044,rs104894021,KCNH2,3,0,Efficacy,1,2,quinidine,short qt syndrome 1,https://www.pharmgkb.org/clinicalAnnotation/1450811044
1450811267,rs2031920,CYP2E1,3,0,Toxicity,3,4,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450811267
1450811379,"CYP2B6*1, CYP2B6*6",CYP2B6,3,1.25,Efficacy,2,2,bupropion,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450811379
1450815104,rs813676,TJP1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815104
1450815154,rs711355,TJP1,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815154
1450815172,rs2636719,PPA2,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815172
1450826899,rs1799971,OPRM1,3,2.75,Dosage,1,1,alfentanil,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450826899
1450826949,rs1799971,OPRM1,3,1.75,Efficacy,6,6,fentanyl,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450826949
1450929037,rs795484,TAOK3,3,2.5,Dosage,1,1,opioids,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450929037
1450929137,rs1051730,CHRNA3,3,3,Other,1,1,Drugs used in nicotine dependence;nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450929137
1450933011,rs1983023,UGT1A3,3,2.5,Efficacy,1,1,deferasirox,beta-Thalassemia,https://www.pharmgkb.org/clinicalAnnotation/1450933011
1450936577,rs28362731,AQP1,3,2.5,Toxicity,1,1,cisplatin,Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1450936577
1450936592,rs1049305,AQP1,3,2,Toxicity,1,1,cisplatin,Anemia;Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1450936592
1450826957,rs1799971,OPRM1,3,1,Efficacy,5,5,morphine,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450826957
1450929798,rs1045642,ABCB1,4,-3.5,Dosage,6,6,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450929798
1450929792,rs1045642,ABCB1,3,3,Dosage,2,2,methadone,Pain,https://www.pharmgkb.org/clinicalAnnotation/1450929792
1450826969,rs1799971,OPRM1,3,0.5,Dosage,3,3,oxycodone,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450826969
1451415691,HLA-DQA1*01:03,HLA-DQA1,3,2.75,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis;Graves Disease,https://www.pharmgkb.org/clinicalAnnotation/1451415691
1449270985,rs41412545,INSR,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270985
1449270991,rs118129530,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270991
1449270997,rs56022120,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449270997
1449271009,rs117951771,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271009
1449271015,rs148235907,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271015
1449271021,rs138602176,PIK3R2,3,0,Toxicity,1,1,cyclophosphamide;epirubicin;fluorouracil,Breast Neoplasms;Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1449271021
1449271288,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2.5,Efficacy,1,1,buprenorphine;methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449271288
1450375065,rs238406,ERCC2,3,3,Toxicity,1,1,bleomycin;cisplatin;etoposide,Leukopenia;Testicular Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1450375065
1450807362,rs2075572,OPRM1,3,2.25,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450807362
1450822690,rs678849,OPRD1,3,3.5,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450822690
1450822710,"SLCO1B1*1, SLCO1B1*15",SLCO1B1,3,3.5,Toxicity,1,1,rifampin,drug-induced liver injury,https://www.pharmgkb.org/clinicalAnnotation/1450822710
1450823123,rs562859,OPRM1,3,3.5,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450823123
1450932256,rs9332096,CYP2C9,3,3.5,Toxicity,2,2,ethambutol;isoniazid;pyrazinamide;rifampin,Maculopapular Exanthema;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1450932256
1449310414,"CYP2D6*1, CYP2D6*2xN",CYP2D6,3,0,Toxicity,1,1,hydrocodone,Drug Toxicity,https://www.pharmgkb.org/clinicalAnnotation/1449310414
1450810363,rs3778156,OPRM1,3,3.25,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450810363
1450811346,rs1799971,OPRM1,3,1.5,Efficacy,1,1,nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450811346
1450812210,rs510769,OPRM1,3,3.5,Toxicity,2,2,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812210
1450812223,rs3766951,OPRD1,3,3,Toxicity,2,2,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1450812223
1450824225,rs429358,APOE,3,3,Efficacy,1,1,hmg coa reductase inhibitors,Alzheimer Disease,https://www.pharmgkb.org/clinicalAnnotation/1450824225
1450826931,rs1799971,OPRM1,3,3.625,Dosage,9,9,fentanyl,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450826931
1450826975,rs1799971,OPRM1,3,1.25,Dosage,4,4,sufentanil,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450826975
1449752836,"HLA-DRB1*15:01, HLA-DRB1*16:02",HLA-DRB1,3,0,Toxicity,1,2,dapsone,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1449752836
1449266588,rs1045642,ABCB1,3,5.625,Metabolism/PK,7,8,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449266588
1449266582,rs7439366,UGT2B7,3,1.5,Metabolism/PK,1,1,(R)-methadone;methadone;S-EDDP,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449266582
1449752831,HLA-A*24:02,HLA-A,3,0,Toxicity,1,1,dapsone,Drug Hypersensitivity,https://www.pharmgkb.org/clinicalAnnotation/1449752831
1450815098,rs10170310,SPOPL,3,0,Efficacy,1,1,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815098
1450931960,rs5441,GNB3;P3H3,3,2.75,Efficacy,1,1,sertraline,"Depressive Disorder, Major",https://www.pharmgkb.org/clinicalAnnotation/1450931960
1450934500,rs869312136,GLA;HNRNPH2,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934500
1450934662,rs398123217,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934662
1450936557,rs1049305,AQP1,3,2.5,Toxicity,1,1,cisplatin,Mesothelioma;Thrombocytopenia,https://www.pharmgkb.org/clinicalAnnotation/1450936557
1450936586,rs1049305,AQP1,3,2,Toxicity,1,1,cisplatin,Alopecia;Mesothelioma,https://www.pharmgkb.org/clinicalAnnotation/1450936586
1452003988,rs6686529,KCNK2,3,2.5,Efficacy,1,1,sevoflurane,sedation,https://www.pharmgkb.org/clinicalAnnotation/1452003988
1449003875,rs2233945,PSORS1C1,3,2.5,Efficacy,1,1,etanercept,"Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1449003875
1449003918,rs199564443,FOXF2,3,0,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis,https://www.pharmgkb.org/clinicalAnnotation/1449003918
1449003926,rs1071816,HLA-B,3,0,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis,https://www.pharmgkb.org/clinicalAnnotation/1449003926
1449191764,rs34911792,CFTR,3,0,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191764
1449191874,rs397508453,CFTR,3,2,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191874
1449192420,rs74551128,CFTR,3,0.25,Efficacy,1,1,ivacaftor / lumacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449192420
1449192431,rs397508602,CFTR,3,0.25,Efficacy,1,1,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449192431
1449192570,rs121909047,CFTR,3,0,Efficacy,2,2,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449192570
1450809956,rs2075572,OPRM1,3,2.25,Toxicity,1,1,methamphetamine,methamphetamine dependence,https://www.pharmgkb.org/clinicalAnnotation/1450809956
1450811519,"CYP2B6*1, CYP2B6*6",CYP2B6,3,2.125,Metabolism/PK,2,2,cotinine;nicotine,Tobacco Use Disorder,https://www.pharmgkb.org/clinicalAnnotation/1450811519
1450815130,rs2980976,TNFRSF11A,3,0,Efficacy,1,1,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1450815130
1450826981,rs1799971,OPRM1,3,2.25,Efficacy,1,1,acetaminophen;tramadol,neuropathic pain,https://www.pharmgkb.org/clinicalAnnotation/1450826981
1451985380,rs2242480,CYP3A4,2A,11.125,Dosage,6,6,fentanyl,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451985380
1451989360,rs2242480,CYP3A4,2A,24.5,Metabolism/PK,11,14,tacrolimus,Kidney Transplantation;liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451989360
1449717812,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*10",CYP2D6,3,2.875,Dosage,3,4,carvedilol,Heart Failure,https://www.pharmgkb.org/clinicalAnnotation/1449717812
1451985160,rs2242480,CYP3A4,3,2,Toxicity,1,1,sufentanil,Respiratory Insufficiency,https://www.pharmgkb.org/clinicalAnnotation/1451985160
1451985292,rs2242480,CYP3A4,3,6.5,Efficacy,1,3,atorvastatin,Hyperlipidemias,https://www.pharmgkb.org/clinicalAnnotation/1451985292
1451985280,rs2242480,CYP3A4,3,0.5,Toxicity,1,2,tacrolimus,liver transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451985280
1449191758,rs75541969,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191758
1449191770,rs11971167,CFTR,1A,200,Efficacy,1,3,ivacaftor,Cystic Fibrosis,https://www.pharmgkb.org/clinicalAnnotation/1449191770
1449003946,HLA-B*08:01,HLA-B,3,0,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis,https://www.pharmgkb.org/clinicalAnnotation/1449003946
1449003951,HLA-B*27:05,HLA-B,3,0,Toxicity,1,1,Antithyroid Preparations,Agranulocytosis,https://www.pharmgkb.org/clinicalAnnotation/1449003951
1449266594,rs9282564,ABCB1,3,1.5,Metabolism/PK,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1449266594
1450808823,rs1799971,OPRM1,3,3.75,Toxicity,4,5,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1450808823
1450934668,rs397515874,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934668
1450934711,rs727504348,GLA,3,0,Efficacy,1,1,migalastat,Fabry Disease,https://www.pharmgkb.org/clinicalAnnotation/1450934711
1450935171,rs1799971,OPRM1,3,2.75,Toxicity,1,1,tianeptine,"Depressive Disorder, Major;suicidal ideation",https://www.pharmgkb.org/clinicalAnnotation/1450935171
1451103260,rs4149117,SLCO1B3,3,2,Efficacy,1,1,mycophenolic acid,chronic lung allograft dysfunction;lung transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451103260
1451103280,rs7311358,SLCO1B3,3,3,Efficacy,1,1,mycophenolic acid,lung transplantation;overall survival,https://www.pharmgkb.org/clinicalAnnotation/1451103280
1451103320,rs4149117,SLCO1B3,3,2.5,Efficacy,1,1,mycophenolic acid,lung transplantation;transplant rejection,https://www.pharmgkb.org/clinicalAnnotation/1451103320
1451103340,rs7311358,SLCO1B3,3,2.5,Efficacy,1,1,mycophenolic acid,lung transplantation;transplant rejection,https://www.pharmgkb.org/clinicalAnnotation/1451103340
1451103360,rs7311358,SLCO1B3,3,0,Efficacy,1,1,mycophenolic acid,chronic lung allograft dysfunction;lung transplantation,https://www.pharmgkb.org/clinicalAnnotation/1451103360
1451105061,rs222749,TRPV1,3,2.5,Efficacy,1,1,botulinum toxin type a,Migraine NOS,https://www.pharmgkb.org/clinicalAnnotation/1451105061
1451105080,rs3781719,CALCA,3,2,Efficacy,1,1,botulinum toxin type a,Migraine NOS,https://www.pharmgkb.org/clinicalAnnotation/1451105080
1451105228,rs12364283,DRD2,3,3.5,Toxicity,1,1,heroin,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451105228
1451985181,rs2242480,CYP3A4,3,3.5,Dosage,5,5,sufentanil,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451985181
1450826987,rs1799971,OPRM1,3,7,Dosage,8,9,opioids,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1450826987
1451106200,rs45545233,SLC4A1,3,0,Efficacy,1,1,atenolol;metoprolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451106200
1451106460,rs2251214,SYT1,3,3.5,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451106460
1451106705,rs28363170,SLC6A3,3,2.5,Efficacy,1,1,disulfiram,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451106705
1451107342,rs1042713,ADRB2,3,1.75,Efficacy,1,1,atenolol;metoprolol,Tachycardia,https://www.pharmgkb.org/clinicalAnnotation/1451107342
1451107360,rs1042714,ADRB2,3,1.75,Efficacy,1,1,atenolol;metoprolol,Tachycardia,https://www.pharmgkb.org/clinicalAnnotation/1451107360
1451114072,rs679899,APOB,3,3,Toxicity,1,1,warfarin,heart valve replacement;Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1451114072
1451114080,rs1367117,APOB,3,3,Toxicity,1,1,warfarin,heart valve replacement;Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1451114080
1451116049,rs776746,CYP3A;CYP3A5;ZSCAN25,3,1.25,Metabolism/PK,1,1,lopinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1451116049
1451116107,"CYP3A4*1, CYP3A4*22",CYP3A4,3,1.5,Metabolism/PK,2,2,lopinavir,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1451116107
1451117580,rs757081,NUCB2,3,3,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451117580
1451117590,rs9306160,RRP1B,3,3,Efficacy,1,1,atenolol,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451117590
1451117620,rs3184504,SH2B3,3,3,Efficacy,1,1,candesartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451117620
1451118364,rs10224002,PRKAG2,3,3,Efficacy,1,1,hydrochlorothiazide,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118364
1451118370,rs740406,DOT1L;PLEKHJ1,3,3,Efficacy,1,1,candesartan,Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451118370
1451118940,rs114077267,MCOLN1,3,1.5,Toxicity,1,1,opioids,Overdose,https://www.pharmgkb.org/clinicalAnnotation/1451118940
1451118946,rs115208233,MCOLN1,3,1.25,Toxicity,1,1,opioids,Overdose,https://www.pharmgkb.org/clinicalAnnotation/1451118946
1451118960,rs116181528,MCOLN1,3,1.25,Toxicity,1,1,opioids,Overdose,https://www.pharmgkb.org/clinicalAnnotation/1451118960
1451120280,rs1801133,MTHFR,3,0.25,Toxicity,1,1,phenobarbital;phenytoin,Epilepsy;Psychotic Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451120280
1451120561,rs28404156,BST1,3,1.5,Efficacy,1,1,"Beta blocking agents, selective",Hypertension,https://www.pharmgkb.org/clinicalAnnotation/1451120561
1451120760,rs1525085,DGKB,3,0,Toxicity,1,1,antipsychotics,Weight gain,https://www.pharmgkb.org/clinicalAnnotation/1451120760
1451120986,rs2133896,ANKS1B,3,2.5,Toxicity,1,1,methamphetamine,methamphetamine dependence,https://www.pharmgkb.org/clinicalAnnotation/1451120986
1451124240,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",SLC6A4,3,2,Toxicity,2,2,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451124240
1451124260,rs2066713,SLC6A4,3,3.25,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451124260
1451124280,rs25531,SLC6A4,3,2.75,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451124280
1451124300,rs4251417,SLC6A4,3,3.25,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451124300
1450807831,rs1799971,OPRM1,4,-1.5,Toxicity,5,5,cannabinoids;cocaine;ethanol;nicotine;opioids,Substance-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1450807831
1451124486,rs7439366,UGT2B7,3,2,Efficacy,1,1,morphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451124486
1451124852,rs9679162,GALNT14,3,1.75,Efficacy,1,1,cisplatin;fluorouracil,Liver Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451124852
1451124880,rs9679162,GALNT14,3,1.5,Efficacy,1,1,sorafenib,Hepatitis C;Liver Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451124880
1451125500,rs2233980,C6orf15,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125500
1451125506,rs5877,SERPINC1,3,2.5,Toxicity,1,1,carboplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung;Thrombocytopenia",https://www.pharmgkb.org/clinicalAnnotation/1451125506
1451126020,rs11854484,SLC28A2,3,2.75,Toxicity,1,1,tenofovir disoproxil fumarate,HIV Infections;nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451126020
1451126040,rs2248359,CYP24A1,3,2.25,Toxicity,1,1,tenofovir disoproxil fumarate,HIV Infections;nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451126040
1451126064,rs4646536,CYP27B1,3,3.25,Toxicity,1,1,tenofovir disoproxil fumarate,HIV Infections;nephrotoxicity,https://www.pharmgkb.org/clinicalAnnotation/1451126064
1451126200,rs2229109,ABCB1,3,1.75,Efficacy,1,1,temozolomide,Glioma,https://www.pharmgkb.org/clinicalAnnotation/1451126200
1451126312,rs616147,MOBP,3,2,Efficacy,1,1,creatine,Amyotrophic Lateral Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1451126312
1451127140,rs901865,HRH1,3,3,Toxicity,1,1,desloratadine,sedation;Urticaria,https://www.pharmgkb.org/clinicalAnnotation/1451127140
1452004551,rs1127354,ITPA,3,2.5,Efficacy,1,1,azathioprine,liver transplantation;transplant rejection,https://www.pharmgkb.org/clinicalAnnotation/1452004551
1451737580,rs3749187,ZDHHC3,3,3.5,Efficacy,1,1,aspirin;clopidogrel,Acute coronary syndrome;major adverse cardiac events (mace),https://www.pharmgkb.org/clinicalAnnotation/1451737580
1451129800,rs1034936,CACNA1C,3,2.5,Toxicity,1,1,ethanol,Alcoholism;Bipolar Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451129800
1451129880,rs6295,HTR1A,3,0.75,Efficacy,1,2,lurasidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451129880
1451130528,rs3740065,ABCC2,3,2.5,Toxicity,1,1,Drugs For Treatment Of Tuberculosis,Toxic liver disease;Tuberculosis,https://www.pharmgkb.org/clinicalAnnotation/1451130528
1451952720,rs917881,EGFR,3,1.5,Toxicity,1,2,sorafenib,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1451952720
1451130640,rs4774388,RORA,3,2.25,Efficacy,1,1,interferon beta-1a,Multiple Sclerosis,https://www.pharmgkb.org/clinicalAnnotation/1451130640
1451131729,rs11227247,RELA,3,2.5,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Toxic liver disease",https://www.pharmgkb.org/clinicalAnnotation/1451131729
1451131735,rs2272733,IKBKB,3,2.5,Efficacy,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Exanthema",https://www.pharmgkb.org/clinicalAnnotation/1451131735
1451131750,rs2151222,IKBKE,3,2.5,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Diarrhea",https://www.pharmgkb.org/clinicalAnnotation/1451131750
1451131761,rs12142086,IKBKE,3,2.5,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Exanthema",https://www.pharmgkb.org/clinicalAnnotation/1451131761
1451131767,rs2233406,NFKBIA,3,2,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Diarrhea",https://www.pharmgkb.org/clinicalAnnotation/1451131767
1451131781,rs2233407,NFKBIA,3,2,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Toxic liver disease",https://www.pharmgkb.org/clinicalAnnotation/1451131781
1451131787,rs9694958,IKBKB,3,2,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Exanthema",https://www.pharmgkb.org/clinicalAnnotation/1451131787
1451131820,rs3748022,IKBKE,3,2,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Exanthema",https://www.pharmgkb.org/clinicalAnnotation/1451131820
1451131840,rs2233409,NFKBIA,3,2.5,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Diarrhea",https://www.pharmgkb.org/clinicalAnnotation/1451131840
1451131846,rs2053071,NFKBIB;SIRT2,3,2,Toxicity,1,1,gefitinib,Toxic liver disease,https://www.pharmgkb.org/clinicalAnnotation/1451131846
1451131852,rs2695121,NR1H2,3,2,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Diarrhea",https://www.pharmgkb.org/clinicalAnnotation/1451131852
1451131858,rs577001,TAB2,3,2,Toxicity,1,1,gefitinib,Diarrhea,https://www.pharmgkb.org/clinicalAnnotation/1451131858
1451131860,rs8904,NFKBIA,3,2,Toxicity,1,1,gefitinib,"Carcinoma, Non-Small-Cell Lung;Exanthema",https://www.pharmgkb.org/clinicalAnnotation/1451131860
1451134300,rs4633,COMT,3,2,Toxicity,1,1,opioids,Dizziness,https://www.pharmgkb.org/clinicalAnnotation/1451134300
1451134540,rs4633,COMT,3,2,Toxicity,1,1,opioids,"Sexual Dysfunctions, Psychological",https://www.pharmgkb.org/clinicalAnnotation/1451134540
1451135380,rs2032582,ABCB1,3,0.75,Dosage,2,2,sufentanil,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451135380
1451133765,rs1045642,ABCB1,3,2.5,Efficacy,1,1,morphine;nortriptyline,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451133765
1451815160,"CYP2C9*1, CYP2C9*3",CYP2C9,3,2.75,Efficacy,1,1,ketoprofen,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451815160
1451135574,rs2366929,ADGRV1,3,0,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451135574
1451137805,rs10457090,OPRM1,3,3.25,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451137805
1451137828,rs589046,OPRM1,3,3.25,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451137828
1451138160,rs3749034,GAD1,3,3,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451138160
1451138166,rs3762556,GAD1,3,3,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451138166
1451138182,rs769404,GAD1,3,0.5,Dosage,1,2,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451138182
1451138860,rs3802279,OPRK1,3,2.5,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451138860
1451138880,rs3802281,OPRK1,3,2.5,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451138880
1451138886,rs963549,OPRK1,3,2.5,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451138886
1451139960,rs36024412,CRYBG2,3,0,Toxicity,1,1,opioids,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451139960
1451141140,rs168107,CLCC1,3,0,Toxicity,1,1,opioids,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451141140
1451141146,rs41269255,POM121L2,3,0,Toxicity,1,1,opioids,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451141146
1451141152,rs9393888,ZNF165,3,0,Toxicity,1,1,opioids,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451141152
1451141160,rs11882256,MUC16,3,0,Toxicity,1,1,opioids,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451141160
1451141166,rs12305038,PDE3A,3,0,Toxicity,1,2,opioids,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451141166
1451141180,rs10405238,ZNF568,3,0,Toxicity,1,1,opioids,Nausea;Vomiting,https://www.pharmgkb.org/clinicalAnnotation/1451141180
1451550960,rs3804100,TLR2,3,2.5,Dosage,1,1,morphine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451550960
1451138140,rs3762555,GAD1,3,3,Dosage,1,1,methadone,Heroin Dependence,https://www.pharmgkb.org/clinicalAnnotation/1451138140
1451145100,rs588765,CHRNA5,3,0,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451145100
1451145106,rs16969968,CHRNA3;CHRNA5,3,0,Toxicity,1,1,cocaine,Cocaine-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451145106
1451146140,rs10770141,TH,3,3,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451146140
1451146160,rs10770140,TH,3,3,Toxicity,1,1,opioids,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451146160
1451146222,rs1800035,ADRA2A,3,2.75,Efficacy,1,1,dexmedetomidine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451146222
1451146241,rs201376588,ADRA2A,3,2.75,Efficacy,1,1,dexmedetomidine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451146241
1451146260,rs775887911,ADRA2A,3,2.75,Efficacy,1,1,dexmedetomidine,"Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451146260
1451148025,rs933271,COMT;TXNRD2,3,2.5,Efficacy,1,1,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451148025
1451148520,rs4680,COMT,3,2.5,Toxicity,1,1,opioids,Hyperalgesia,https://www.pharmgkb.org/clinicalAnnotation/1451148520
1451144780,"CYP3A4*1, CYP3A4*22",CYP3A4,3,1.25,Efficacy,1,2,alprazolam,Alcoholism;Anxiety Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451144780
1451149000,rs1042173,SLC6A4,3,2.5,Dosage,1,1,morphine,Pain,https://www.pharmgkb.org/clinicalAnnotation/1451149000
1451149980,rs6421482,PDE4B,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451149980
1451149992,rs1260326,GCKR,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451149992
1451150040,rs13382553,THSD7B,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451150040
1451150060,rs62250713,CADM2,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451150060
1451150086,rs13125415,ADH1C,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451150086
1451150092,rs13135092,SLC39A8,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451150092
1451151460,rs2533200,DPP6,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451151460
1451151484,rs576859,MED19;TMX2,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451151484
1451151496,rs12296477,SLC4A8,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451151496
1451151522,rs72768626,TNRC6A,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451151522
1451151540,rs9937709,FTO,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451151540
1451151560,rs492602,FUT2,3,1.5,Toxicity,1,1,ethanol,Alcoholism,https://www.pharmgkb.org/clinicalAnnotation/1451151560
1451151857,rs6313,HTR2A,3,0.25,Efficacy,2,2,risperidone,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451151857
1451151920,rs6313,HTR2A,3,2,Efficacy,2,3,olanzapine,Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451151920
1451152801,"CYP2D6*1, CYP2D6*3, CYP2D6*4",CYP2D6,3,2.5,Toxicity,1,1,hydrocodone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451152801
1451152821,"CYP2D6*1, CYP2D6*3, CYP2D6*4",CYP2D6,3,2.5,Toxicity,1,1,codeine,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451152821
1451153940,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",CYP2D6,3,1.375,Dosage,3,3,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451153940
1451155125,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN",CYP2D6,1A,200.75,Toxicity,3,5,tramadol,cardiotoxicity;Respiratory Insufficiency,https://www.pharmgkb.org/clinicalAnnotation/1451155125
1451152827,"CYP2D6*1, CYP2D6*3, CYP2D6*4",CYP2D6,3,2.5,Toxicity,1,1,oxycodone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451152827
1451153963,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",CYP2D6,3,1.125,Efficacy,5,6,methadone,Heroin Dependence;Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451153963
1451154980,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",CYP2D6,1A,233.25,Efficacy,13,22,tramadol,"Pain;Pain, Postoperative",https://www.pharmgkb.org/clinicalAnnotation/1451154980
1451905420,"CYP2C19*1, CYP2C19*2, CYP2C19*3",CYP2C19,3,2.5,Efficacy,1,1,"sulfonamides, urea derivatives","Diabetes Mellitus, Type 2",https://www.pharmgkb.org/clinicalAnnotation/1451905420
1451217440,rs12979860,IFNL3;IFNL4,3,1,Efficacy,3,3,peginterferon alfa-2a,"Hepatitis B, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1451217440
1451217520,rs12979860,IFNL3;IFNL4,3,2.5,Efficacy,1,1,sofosbuvir,"Hepatitis C, Chronic",https://www.pharmgkb.org/clinicalAnnotation/1451217520
1451217560,rs12979860,IFNL3;IFNL4,3,2,Efficacy,1,1,interferons,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1451217560
1451223500,rs1799971,OPRM1,3,1,Toxicity,2,2,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451223500
1451223520,rs1799971,OPRM1,3,1.25,Toxicity,1,1,morphine,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451223520
1451223540,rs2279343,CYP2B6,3,1.5,Toxicity,1,1,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451223540
1451223580,rs351776,PNOC,3,0,Toxicity,1,1,buprenorphine,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451223580
1451223586,rs351776,PNOC,3,0,Toxicity,1,1,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451223586
1451223592,rs3745274,CYP2A7P1;CYP2B6,3,1.5,Toxicity,1,1,methadone,Neonatal Abstinence Syndrome,https://www.pharmgkb.org/clinicalAnnotation/1451223592
1451161878,"CYP2B6*1, CYP2B6*6",CYP2B6,4,-1.25,Dosage,2,2,methadone,Opioid-Related Disorders,https://www.pharmgkb.org/clinicalAnnotation/1451161878
1451217540,rs12979860,IFNL3;IFNL4,3,1,Efficacy,1,2,interferons,Hepatitis C,https://www.pharmgkb.org/clinicalAnnotation/1451217540
1451184626,HLA-A*31:01,HLA-A,3,0.25,Toxicity,1,1,oxcarbazepine,drug reaction with eosinophilia and systemic symptoms,https://www.pharmgkb.org/clinicalAnnotation/1451184626
1451253260,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81",CYP2D6,1A,202.5,Toxicity,14,17,venlafaxine,"agitation;Alcohol-Related Disorders;cardiotoxicity;Depression;Depressive Disorder;Depressive Disorder, Major;Drug Toxicity;dysphoria;Edema;Nausea;Obsessive-Compulsive Disorder;Tachycardia;Vomiting",https://www.pharmgkb.org/clinicalAnnotation/1451253260
1451265448,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",CYP2D6,1A,205.375,Toxicity,3,5,imipramine,Depressive Disorder,https://www.pharmgkb.org/clinicalAnnotation/1451265448
1451266120,rs67376798,DPYD,1A,104,Toxicity,3,4,tegafur,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451266120
1451266065,rs3918290,DPYD,1A,104,Toxicity,3,4,tegafur,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451266065
1451266020,rs55886062,DPYD,1A,102.25,Toxicity,2,3,tegafur,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451266020
1451257700,rs1801394,MTRR,3,4.75,Efficacy,3,3,methotrexate,"Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid",https://www.pharmgkb.org/clinicalAnnotation/1451257700
1451263060,rs78132896,EPHA7,3,1.625,Toxicity,1,1,warfarin,Hemorrhage,https://www.pharmgkb.org/clinicalAnnotation/1451263060
1183680656,rs1057868,POR,4,-0.5,Toxicity,3,3,tacrolimus,Kidney Transplantation,https://www.pharmgkb.org/clinicalAnnotation/1183680656
1451256440,rs3813929,HTR2C,3,2.75,Toxicity,11,11,olanzapine,Mental Disorders;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451256440
1451256448,rs3813929,HTR2C,3,4,Toxicity,8,8,risperidone,Mental Disorders;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451256448
1451256466,rs3813929,HTR2C,3,3,Toxicity,5,5,clozapine,Mental Disorders;Schizophrenia,https://www.pharmgkb.org/clinicalAnnotation/1451256466
1451274840,rs1059513,STAT6,3,2.25,Efficacy,1,1,esomeprazole,eosinophilic esophagitis,https://www.pharmgkb.org/clinicalAnnotation/1451274840
1451282140,rs4646,CYP19A1,3,5,Efficacy,2,2,tamoxifen,Breast Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451282140
1451204660,"UGT1A1*1, UGT1A1*28",UGT1A1,1A,224,Toxicity,33,40,FOLFIRI;irinotecan,Neutropenia,https://www.pharmgkb.org/clinicalAnnotation/1451204660
1451243980,"CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38",CYP2B6,1A,211.5,Toxicity,12,14,efavirenz,HIV Infections,https://www.pharmgkb.org/clinicalAnnotation/1451243980
1451551426,rs11615,ERCC1,3,1.75,Efficacy,1,1,cisplatin;gemcitabine,"Carcinoma, Non-Small-Cell Lung",https://www.pharmgkb.org/clinicalAnnotation/1451551426
1451551460,rs11615,ERCC1,3,0,Efficacy,1,1,cisplatin,Pancreatic Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451551460
1450813831,rs746071566,NUDT15,3,4,Toxicity,1,1,azathioprine;mercaptopurine;thioguanine,Inflammatory Bowel Diseases;Myelosuppression,https://www.pharmgkb.org/clinicalAnnotation/1450813831
1451289660,rs59086055,DPYD,1A,100,Toxicity,1,2,fluorouracil,Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451289660
1451551520,rs3212986,ERCC1,4,-1.25,Efficacy,3,3,cisplatin,Esophageal Neoplasms;Ovarian Neoplasms;Stomach Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451551520
1451551528,rs2336219,ERCC1,3,0,Efficacy,1,1,cisplatin,Ovarian Neoplasms,https://www.pharmgkb.org/clinicalAnnotation/1451551528
1451551846,rs11545077,GGH,3,2.5,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451551846
1451551817,rs3758149,GGH,3,2.5,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451551817
1451551883,rs11545076,GGH,3,2.5,Efficacy,1,1,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451551883
1451553326,rs45445694,C18orf56;TYMS,4,-1,Metabolism/PK,2,2,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451553326
1451553595,rs1045642,ABCB1,4,-1.25,Efficacy,2,3,methotrexate,Precursor Cell Lymphoblastic Leukemia-Lymphoma,https://www.pharmgkb.org/clinicalAnnotation/1451553595
1451553580,rs1045642,ABCB1,3,0,Metabolism/PK,5,5,methotrexate,"Burkitt Lymphoma;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma",https://www.pharmgkb.org/clinicalAnnotation/1451553580
1452018880,rs12885713,CALM1,3,2.5,Efficacy,1,1,cyclosporine,Psoriasis,https://www.pharmgkb.org/clinicalAnnotation/1452018880
1451566760,rs1800497,ANKK1;DRD2,3,1.5,Efficacy,1,1,bupropion;naltrexone,Obesity,https://www.pharmgkb.org/clinicalAnnotation/1451566760
